
<html lang="en"     class="pb-page"  data-request-id="b8fc240c-cc95-45d4-a913-e158c2636b87"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01287;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration" /></meta><meta name="dc.Creator" content="Inés  González-Gil" /></meta><meta name="dc.Creator" content="Debora  Zian" /></meta><meta name="dc.Creator" content="Henar  Vázquez-Villa" /></meta><meta name="dc.Creator" content="Gloria  Hernández-Torres" /></meta><meta name="dc.Creator" content="R. Fernando  Martínez" /></meta><meta name="dc.Creator" content="Nora  Khiar-Fernández" /></meta><meta name="dc.Creator" content="Richard  Rivera" /></meta><meta name="dc.Creator" content="Yasuyuki  Kihara" /></meta><meta name="dc.Creator" content="Isabel  Devesa" /></meta><meta name="dc.Creator" content="Sakthikumar  Mathivanan" /></meta><meta name="dc.Creator" content="Cristina Rosell  del Valle" /></meta><meta name="dc.Creator" content="Emma  Zambrana-Infantes" /></meta><meta name="dc.Creator" content="María  Puigdomenech" /></meta><meta name="dc.Creator" content="Giovanni  Cincilla" /></meta><meta name="dc.Creator" content="Melchor  Sanchez-Martinez" /></meta><meta name="dc.Creator" content="Fernando  Rodríguez de Fonseca" /></meta><meta name="dc.Creator" content="Antonio V.  Ferrer-Montiel" /></meta><meta name="dc.Creator" content="Jerold  Chun" /></meta><meta name="dc.Creator" content="Rubén  López-Vales" /></meta><meta name="dc.Creator" content="María L.  López-Rodríguez" /></meta><meta name="dc.Creator" content="Silvia  Ortega-Gutiérrez" /></meta><meta name="dc.Description" content="Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need ..." /></meta><meta name="Description" content="Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 2, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01287" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01287" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01287" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01287" /></link>
        
    
    

<title>A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01287" /></meta><meta property="og:title" content="A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0023.jpeg" /></meta><meta property="og:description" content="Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs. Activation of the type 1 lysophosphatidic acid (LPA1) receptor is a crucial factor in the initiation of NP. Hence, it is conceivable that a functional antagonism strategy could lead to NP mitigation. Here we describe a new series of LPA1 agonists among which derivative (S)-17 (UCM-05194) stands out as the most potent and selective LPA1 receptor agonist described so far (Emax = 118%, EC50 = 0.24 μM, KD = 19.6 nM; inactive at autotaxin and LPA2–6 receptors). This compound induces characteristic LPA1-mediated cellular effects and prompts the internalization of the receptor leading to its functional inactivation in primary sensory neurons and to an efficacious attenuation of the pain perception in an in vivo model of NP." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01287"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01287">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01287&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01287&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01287&amp;href=/doi/10.1021/acs.jmedchem.9b01287" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2372-2390</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01136" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01339" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA<sub>1</sub>), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Inés González-Gil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Inés González-Gil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=In%C3%A9s++Gonz%C3%A1lez-Gil">Inés González-Gil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Debora Zian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debora Zian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debora++Zian">Debora Zian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Henar Vázquez-Villa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Henar Vázquez-Villa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Henar++V%C3%A1zquez-Villa">Henar Vázquez-Villa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7911-3160" title="Orcid link">http://orcid.org/0000-0001-7911-3160</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gloria Hernández-Torres</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gloria Hernández-Torres</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gloria++Hern%C3%A1ndez-Torres">Gloria Hernández-Torres</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">R. Fernando Martínez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">R. Fernando Martínez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=R.+Fernando++Mart%C3%ADnez">R. Fernando Martínez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nora Khiar-Fernández</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nora Khiar-Fernández</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nora++Khiar-Fern%C3%A1ndez">Nora Khiar-Fernández</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Rivera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Rivera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Rivera">Richard Rivera</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuyuki Kihara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuyuki Kihara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuyuki++Kihara">Yasuyuki Kihara</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isabel Devesa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabel Devesa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IDiBE, Universidad Miguel Hernández de Elche, E-03202 Alicante, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabel++Devesa">Isabel Devesa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sakthikumar Mathivanan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sakthikumar Mathivanan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IDiBE, Universidad Miguel Hernández de Elche, E-03202 Alicante, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sakthikumar++Mathivanan">Sakthikumar Mathivanan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cristina Rosell del Valle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Rosell del Valle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Investigación Biomédica de Málaga, UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, E-29010 Málaga, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina+Rosell++del+Valle">Cristina Rosell del Valle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emma Zambrana-Infantes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emma Zambrana-Infantes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Investigación Biomédica de Málaga, UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, E-29010 Málaga, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emma++Zambrana-Infantes">Emma Zambrana-Infantes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María Puigdomenech</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María Puigdomenech</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Bellaterra, E-08193 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa++Puigdomenech">María Puigdomenech</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giovanni Cincilla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giovanni Cincilla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molomics, Barcelona Science Park, Baldiri i Reixac 4-8, E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Cincilla">Giovanni Cincilla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melchor Sanchez-Martinez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melchor Sanchez-Martinez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molomics, Barcelona Science Park, Baldiri i Reixac 4-8, E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melchor++Sanchez-Martinez">Melchor Sanchez-Martinez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fernando Rodríguez de Fonseca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fernando Rodríguez de Fonseca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Investigación Biomédica de Málaga, UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, E-29010 Málaga, Spain</div><div class="loa-info-affiliations-info">Departamento de Psicobiología, Facultad de Psicología, Universidad Complutense de Madrid, Pozuelo de Alarcón, E-28223 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Rodr%C3%ADguez+de+Fonseca">Fernando Rodríguez de Fonseca</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio V. Ferrer-Montiel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio V. Ferrer-Montiel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IDiBE, Universidad Miguel Hernández de Elche, E-03202 Alicante, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+V.++Ferrer-Montiel">Antonio V. Ferrer-Montiel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jerold Chun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jerold Chun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jerold++Chun">Jerold Chun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rubén López-Vales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rubén López-Vales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Bellaterra, E-08193 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rub%C3%A9n++L%C3%B3pez-Vales">Rubén López-Vales</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7615-9550" title="Orcid link">http://orcid.org/0000-0001-7615-9550</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María L. López-Rodríguez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María L. López-Rodríguez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#bdd0d1c8c7d1cffdc8ded093d8ce"><span class="__cf_email__" data-cfemail="ee83829b94829cae9b8d83c08b9d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+L.++L%C3%B3pez-Rodr%C3%ADguez">María L. López-Rodríguez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8607-1085" title="Orcid link">http://orcid.org/0000-0001-8607-1085</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Silvia Ortega-Gutiérrez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Ortega-Gutiérrez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f88b91978a8c9d9f99b88d9b95d69d8b"><span class="__cf_email__" data-cfemail="77041e1805031210163702141a591204">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Ortega-Guti%C3%A9rrez">Silvia Ortega-Gutiérrez</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01287&amp;href=/doi/10.1021%2Facs.jmedchem.9b01287" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2372–2390</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 2, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 August 2019</li><li><span class="item_label"><b>Published</b> online</span>2 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01287" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01287</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2372%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIn%25C3%25A9s%2BGonz%25C3%25A1lez-Gil%252C%2BDebora%2BZian%252C%2BHenar%2BV%25C3%25A1zquez-Villa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01287%26title%3DA%2BNovel%2BAgonist%2Bof%2Bthe%2BType%2B1%2BLysophosphatidic%2BAcid%2BReceptor%2B%2528LPA1%2529%252C%2BUCM-05194%252C%2BShows%2BEfficacy%2Bin%2BNeuropathic%2BPain%2BAmelioration%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2390%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01287"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1487</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01287" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Inés&quot;,&quot;last_name&quot;:&quot;González-Gil&quot;},{&quot;first_name&quot;:&quot;Debora&quot;,&quot;last_name&quot;:&quot;Zian&quot;},{&quot;first_name&quot;:&quot;Henar&quot;,&quot;last_name&quot;:&quot;Vázquez-Villa&quot;},{&quot;first_name&quot;:&quot;Gloria&quot;,&quot;last_name&quot;:&quot;Hernández-Torres&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Fernando Martínez&quot;},{&quot;first_name&quot;:&quot;Nora&quot;,&quot;last_name&quot;:&quot;Khiar-Fernández&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Rivera&quot;},{&quot;first_name&quot;:&quot;Yasuyuki&quot;,&quot;last_name&quot;:&quot;Kihara&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;Devesa&quot;},{&quot;first_name&quot;:&quot;Sakthikumar&quot;,&quot;last_name&quot;:&quot;Mathivanan&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Rosell del Valle&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;Zambrana-Infantes&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Puigdomenech&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Cincilla&quot;},{&quot;first_name&quot;:&quot;Melchor&quot;,&quot;last_name&quot;:&quot;Sanchez-Martinez&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Rodríguez de Fonseca&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;V. Ferrer-Montiel&quot;},{&quot;first_name&quot;:&quot;Jerold&quot;,&quot;last_name&quot;:&quot;Chun&quot;},{&quot;first_name&quot;:&quot;Rubén&quot;,&quot;last_name&quot;:&quot;López-Vales&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;L. López-Rodríguez&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Ortega-Gutiérrez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2372-2390&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01287&quot;},&quot;abstract&quot;:&quot;Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs. Activation of the type 1 lysophosphatidic acid (LPA1) receptor is a crucial factor in the initiation of NP. Hence, it is conceivable that a functional antagonism strategy could lead to NP mitigation. Here we describe a new series of LPA1 agonists among which derivative (S)-17 (UCM-05194) stands out as the most potent and selective LPA1 receptor agonist described so far (Emax = 118%, EC50 = 0.24 μM, KD = 19.6 nM; inactive at autotaxin and LPA2–6 receptors). This compound induces characteristic LPA1-mediated cellular effects and prompts the internalization of the receptor leading to its functional inactivation in primary sensory neurons and to an efficacious attenuation of the pain perception in an in vivo model of NP.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01287&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01287" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01287&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01287" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01287&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01287" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01287&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01287&amp;href=/doi/10.1021/acs.jmedchem.9b01287" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01287" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01287" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01287%26sid%3Dliteratum%253Aachs%26pmid%3D31790581%26genre%3Darticle%26aulast%3DGonz%25C3%25A1lez-Gil%26date%3D2020%26atitle%3DA%2BNovel%2BAgonist%2Bof%2Bthe%2BType%2B1%2BLysophosphatidic%2BAcid%2BReceptor%2B%2528LPA1%2529%252C%2BUCM-05194%252C%2BShows%2BEfficacy%2Bin%2BNeuropathic%2BPain%2BAmelioration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2372%26epage%3D2390%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs. Activation of the type 1 lysophosphatidic acid (LPA<sub>1</sub>) receptor is a crucial factor in the initiation of NP. Hence, it is conceivable that a functional antagonism strategy could lead to NP mitigation. Here we describe a new series of LPA<sub>1</sub> agonists among which derivative (<i>S</i>)-<b>17</b> (UCM-05194) stands out as the most potent and selective LPA<sub>1</sub> receptor agonist described so far (<i>E</i><sub>max</sub> = 118%, EC<sub>50</sub> = 0.24 μM, <i>K</i><sub>D</sub> = 19.6 nM; inactive at autotaxin and LPA<sub>2–6</sub> receptors). This compound induces characteristic LPA<sub>1</sub>-mediated cellular effects and prompts the internalization of the receptor leading to its functional inactivation in primary sensory neurons and to an efficacious attenuation of the pain perception in an <i>in vivo</i> model of NP.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lysophosphatidic acid (LPA, 1-acyl-<i>sn</i>-glycerol-3-phosphate) is a lipid mediator required for maintaining the homeostasis of numerous physiological processes but also participates in the development of various pathological conditions. Although LPA can denote a variety of lysophospholipids with saturated (16:0, 18:0) and unsaturated (16:1, 18:1, 18:2, 20:4) acyl chains, in the context of LPA as a signaling molecule and thus along this work, LPA refers to 1-oleoyl-<i>sn</i>-glycerol-3-phosphate. LPA acts through six different receptors (LPA<sub>1–6</sub>) that belong to the G protein-coupled receptor (GPCR) superfamily.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> These six receptors can be further divided into two groups, the endothelial differentiation gene (EDG) family (LPA<sub>1–3</sub>) and the phylogenetically distant non-EDG family (LPA<sub>4–6</sub>).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Genetic deletion studies, overexpression models, and other chemical tools have provided insight into some of the many biological effects, mechanisms, and medical application of LPA signaling.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> Because LPA signaling has been implicated in cancer,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> fibrosis,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> and pain,<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> LPA receptors are regarded as promising drug targets.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Among all these effects, LPA has recently attracted attention because of its emerging role as an important factor in neuropathic pain (NP).<a onclick="showRef(event, 'ref13 ref14 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref17 ref18">(13,14,17,18)</a> NP is a type of chronic pain caused by a lesion or disease of the somatosensory system, including peripheral fibers and central neurons. It affects around 10% of the general population and its incidence is likely to increase. Patients with NP do not usually respond to standard pain treatments such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), or weak opioids. In general, available pharmacological treatments for NP are only moderately efficacious with effectiveness in less than 50% of patients, and they are also associated with adverse effects.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Mechanistically, NP arises because peripheral sensory and central neurons show a gain of excitation or a loss of inhibition prompting a permanent state of hyperexcitability. In this scenario, the brain receives abnormal sensory messages that translate into continuous burning pain and abnormal sensory sensations such as allodynia (pain as a result of non-noxious stimuli) and hyperalgesia (increased response to a normally painful stimuli). Several signaling pathways have been described that contribute to NP neuropathy, including pathways activated through inflammatory molecules, growth factors, and lipid metabolites. Signaling through these pathways causes changes in the function and expression of voltage-gated sodium, calcium, and potassium channels and also leads to abnormal function of second-order nociceptive and inhibitory neurons. As this situation becomes chronic, it leads to a permanent maladaptive plasticity that none of the pharmacological therapies currently available can reverse.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> NP seriously compromises the quality of life of affected people and clearly represents a currently unmet clinical need. Consequently, there is a pressing demand for the development of efficacious new drugs that can be used either alone or in combination with existing therapies to provide a long-term alleviation of chronic pain through novel mechanisms of action. Among the different factors involved in NP, LPA has been characterized as crucial for NP initiation.<a onclick="showRef(event, 'ref13 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref18">(13,18)</a> NP is attenuated in <i>Lpar1</i>-deficient mice, indicating that LPA signaling through the LPA<sub>1</sub> is responsible for pain transmission.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Direct antagonists of LPA<sub>1</sub> such as the compound Ki-16425, have shown efficacy in inhibiting NP but only for limited periods of time.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This fact suggests not only that initial LPA signaling through LPA<sub>1</sub> is important for NP initiation but that LPA signaling may exacerbate chronic pain through subsequent signaling mechanisms including LPA<sub>1</sub>-dependent regulation of pain-related molecules, feed forward pain facilitation caused by the LPA<sub>3</sub>-stimulated production of LPA following the initial LPA<sub>1</sub> activation,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and concomitant LPA mediated activation of the transient receptor potential vanilloid 1 (TRPV1) ion channel, which also dramatically contributes to the NP onset.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> Therefore, we hypothesized that a longer period of LPA<sub>1</sub> desensitization will be a more efficacious strategy for ameliorating NP. This strategy has been already successfully used in the development of fingolimod (FTY720 or Gilenya), the first oral disease-modifying drug for treating multiple sclerosis, and a nonselective agonist of sphingosine 1-phosphate (S1P) that behaves as a functional S1P<sub>1</sub> and S1P<sub>3–5</sub> antagonist or receptor modulator, inducing receptor internalization and degradation after binding and activation.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a></div><div class="NLM_p last">In this work, we describe the development of a potent new LPA<sub>1</sub> selective agonist that behaves as a functional receptor antagonist and shows efficacy in an <i>in vivo</i> mouse model of NP.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Very few agonists of the LPA<sub>1</sub> have been reported to date.<a onclick="showRef(event, 'ref6 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref6 ref28 ref29">(6,28,29)</a> The first LPA-based agonist was <i>N</i>-acylethanolamide phosphoric acid (2-[(9<i>Z</i>)-octadec-9-enoylamino]ethyl dihydrogen phosphate or NAEPA, <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which was characterized as a dual LPA<sub>1/2</sub> agonist.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Several changes in its structure have led to ligands with improved activity and, in some cases, such as derivative <b>2</b>, selectivity for LPA<sub>1</sub> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), with EC<sub>50</sub> values of 221 nM and 1089 nM at LPA<sub>1</sub> and LPA<sub>2</sub>, respectively.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In an attempt to identify new structures devoid of the fatty acid moiety, Astellas Pharma reported a series of indoloquinolizines with agonist activity at the LPA<sub>1</sub>. Among them, compound <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) exhibited the best EC<sub>50</sub> value (3.6 μM),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> although selectivity was not discussed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative LPA<sub>1</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Considering this paucity of LPA<sub>1</sub> selective agonists and the lack of an LPA<sub>1</sub>/agonist complex crystal structure,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we attempted to identify novel LPA<sub>1</sub> agonists using the structure of the endogenous ligand as a starting point (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Initially, modifications were made in two parts of the LPA molecule, the acid group and the hydrophobic moiety, keeping the LPA stereochemistry constant. With respect to the acid group, several structure–activity relationship studies suggested that changes in the LPA polar headgroup would be poorly tolerated.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In particular, it has been shown that the presence of free acid groups that retain their negative charge under physiological conditions is an important requirement for activity. Hence, we decided to replace the phosphate with carboxylic and boronic acids or with a tetrazole moiety (compounds <b>4</b>–<b>11</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), all of which have been described as suitable isosteres.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> With respect to the hydrophobic moiety, modifications in the length of the fatty acid chain were studied (compounds <b>12</b>–<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In addition, based on our previous results showing that fatty acid chains can be replaced by phenyl and biphenyl moieties,<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> we incorporated a variety of phenyl and biphenyl-containing subunits (compounds <b>17</b>–<b>26</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of new LPA<sub>1</sub> agonists <b>4</b>–<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Changes in the Polar Head of LPA</h3><div class="NLM_p">Compounds <b>4</b>–<b>11</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) were obtained by coupling of oleoyl chloride with the corresponding alcohol or glycerol derivatives <b>27</b>–<b>33</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Information</a> for details) in the presence of 2,4,6-collidine at low temperature. For all the diols employed, this reaction was completely regioselective, and only the acylation at <i>sn</i>-1 position of the glycerol moiety was observed. Carboxylic acid derivatives <b>34</b>–<b>39</b> were then deprotected with TFA to yield the final products <b>4</b>–<b>9</b>. In the case of the malonic acid derivatives <b>35</b> and <b>36</b>, this reaction led to the formation of lactones <b>5</b> and <b>6</b> as a mixture of diastereoisomers instead of free dicarboxylic acids. Thus, in order to avoid cyclization, the hydroxy group was masked with a methyl group (compound <b>7</b>) or removed (derivatives <b>8</b> and <b>9</b>). Boronic acid <b>10</b> was obtained by transformation of the pinacolyl boronate ester <b>40</b> into the corresponding trifluoroborate salt, followed by hydrolysis with trimethylsilyl chloride to yield the desired boronic acid. Finally, treatment of nitrile <b>41</b> with sodium azide led to tetrazole <b>11</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4</b>–<b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Glycerol or alcohol derivatives (<b>27</b>–<b>33</b>), 2,4,6-collidine, DCM, −78 °C to rt, 24 h, 36–99%; (b) TFA, DCM, rt, 16–18 h, 52–99%; (c) trimethylsilyldiazomethane, HBF<sub>4</sub>, DCM, 0 °C, 90 min, 38%; (d) (i) KHF<sub>2</sub>, CH<sub>3</sub>OH/H<sub>2</sub>O, rt, 30 min, 99%; (ii) TMSCl, CH<sub>3</sub>CN/H<sub>2</sub>O, rt, 1 h, 60%; (e) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, MW, 160 °C, 45 min, 18%.</p></p></figure><div class="NLM_p last">The ability of compounds <b>4</b>–<b>11</b> to activate the LPA<sub>1</sub> was assessed by measuring the extent of calcium mobilization in LPA<sub>1</sub> stably transfected RH7777 cells, as the binding of an LPA<sub>1</sub> agonist causes an increase in intracellular calcium levels, which can be quantified using a fluorescence-based assay. Among these compounds, only derivatives <b>6</b> and <b>7</b> were able to activate the receptor [<i>E</i><sub>max</sub> (<b>6</b>) = 33%, EC<sub>50</sub> (<b>6</b>) = 1.7 μM; <i>E</i><sub>max</sub> (<b>7</b>) = 74%, EC<sub>50</sub> (<b>7</b>) = 6 μM], whereas the rest of the compounds did not induce calcium mobilization at the highest concentration of compound tested (10 μM). Although these results indicate that other polar moieties can mimic the LPA phosphate group, these derivatives are less potent inducers of calcium mobilization than LPA.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Changes in the Hydrophobic Moiety of LPA: Modification of Fatty Acid Chain Length</h3><div class="NLM_p">The hydrophobic moiety plays an important role in LPA receptor activity. To study the influence of this part of the molecule on receptor activity, comprehensive changes were made to the overall length of the fatty acid chain (compounds <b>12</b>–<b>16</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) and aromatic rings were incorporated (compounds <b>17</b>–<b>26</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Modification of the fatty acid chain length required the preparation of the noncommercial carboxylic acids <b>42</b>–<b>44</b> by stereoselective <i>cis</i>-hydrogenation of the corresponding alkynyl derivatives (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Information</a> for details) and glycerol <b>45</b>, obtained following a synthetic procedure previously developed in our group.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Regioselective esterification between the corresponding fatty acid and the protected phosphorylated diol <b>45</b> yielded derivatives <b>46</b>–<b>50</b>, which were deprotected to provide the final compounds <b>12</b>–<b>16</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>12</b>–<b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCC, DMAP, DCM, −20 °C to rt, 16 h, 12–49%; (b) TFA, DCM, rt, 4–5 h, 90–99%.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>17</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCC, DMAP, DCM, −20 °C to rt, 16 h, 10–58%; (b) (i) TMSBr, DCM, rt, 4 h; (ii) MeOH/H<sub>2</sub>O, rt, 1 h, 90%; (c) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 74–99%.</p></p></figure><div class="NLM_p">The results obtained for LPA<sub>1</sub> agonist activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) highlight the tremendous influence exerted by the hydrophobic chain length. In this regard, compounds <b>12</b>–<b>16</b> show that variations of just one methylene unit can turn a compound inactive (for example, derivative <b>15</b> shows an activity comparable to LPA, whereas <b>16</b> is inactive) or increase its activity almost 2-fold, as shown by compounds <b>15</b> (<i>E</i><sub>max</sub> = 88%; EC<sub>50</sub> = 3.6 μM) and <b>14</b> (<i>E</i><sub>max</sub> = 202%; EC<sub>50</sub> = 2.1 μM). These data suggest that the optimal chain is that of palmitoleic acid, present in compound <b>13</b> (<i>E</i><sub>max</sub> = 205%; EC<sub>50</sub> = 0.45 μM), the most potent derivative within the series and more active than the endogenous ligand LPA (<i>E</i><sub>max</sub> = 100%; EC<sub>50</sub> = 0.83 μM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Agonist Activities of Compounds <b>12</b>–<b>16</b> at LPA<sub>1</sub> Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0018.gif" alt="" id="GRAPHIC-d7e1135-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="±">127 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">2.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="±">205 ± 9</td><td class="colsep0 rowsep0" align="char" char=".">0.45 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char="±">202 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">2.1 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 2</td><td class="colsep0 rowsep0" align="char" char=".">3.6 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char="±">NE<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LPA</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char="±">100</td><td class="colsep0 rowsep0" align="char" char=".">0.83 ± 0.02</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>E</i><sub>max</sub> = maximal efficacy of the drug/maximal efficacy of LPA, expressed as the percentage.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">For <i>E</i><sub>max</sub> > 30%, EC<sub>50</sub> values are expressed as mean ± SEM from a minimum of two independent experiments performed in triplicate.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">No effect was observed at the highest concentration of compound tested (10 μM).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Changes in the Hydrophobic Moiety of LPA: Derivatives Containing Aromatic Rings</h3><div class="NLM_p">Previous data from our group showed that unsaturated fatty acid chains can be replaced by phenyl groups.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Our results observed with derivatives <b>12</b>–<b>16</b>, together with studies using other lipid-binding GPCRs,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> show the importance of aliphatic chain length on activity. To determine if the distance between the aromatic rings and the phosphorylated glycerol moiety (<i>n</i>) influences activity, compounds <b>17</b>–<b>26</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) were prepared. Their synthesis required the preparation of carboxylic acids <b>51</b>–<b>56</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Information</a> for details) and the conveniently protected phosphorylated glycerol. Initially, looking for synthetic simplicity and high yields, the ethyl group was selected for phosphate protection (intermediate <b>57</b>). However, using standard conditions to remove the ethyl groups from intermediate <b>59</b> with TMSBr yielded bromine derivative <b>17</b> instead of the expected product. The structure of <b>17</b> was determined by nuclear magnetic resonance (NMR) and high pressure liquid chromatography coupled to mass spectrometry (HPLC-MS). The benzyl group was therefore selected as the phosphate protecting group for intermediates <b>60</b>–<b>68</b>, which, after hydrogenation, led to the target compounds <b>18</b>–<b>26</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><div class="NLM_p">All the synthesized compounds, including the initially unexpected derivative <b>17</b>, were tested for LPA<sub>1</sub> activity. The data obtained (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) confirms that the fatty acid chain can be replaced by phenyl and biphenyl moieties and that the distance between the ester group and the aromatic subunit influences agonist activity, as small changes in the number of methylene units dramatically affects <i>E</i><sub>max</sub> and EC<sub>50</sub> values. For example, compound <b>19</b>, with <i>n</i> = 7, is inactive, whereas derivative <b>20</b>, with <i>n</i> = 8, is almost as active as LPA, and derivative <b>25</b> shows the highest activity when compared to either compound <b>24</b> or <b>26</b>. In all cases, the optimal chain was the one with <i>n</i> = 9. Finally, the excellent activity of compound <b>17</b> at the LPA<sub>1</sub> receptor is remarkable.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Agonist Activities of Compounds <b>17</b>–<b>26</b> at LPA<sub>1</sub> Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0019.gif" alt="" id="GRAPHIC-d7e1426-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0020.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>E</i><sub>max</sub> = maximal efficacy of the drug/maximal efficacy of LPA, expressed as the percentage.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">For <i>E</i><sub>max</sub> > 30%, EC<sub>50</sub> values are expressed as mean ± SEM from a minimum of two independent experiments performed in triplicate.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">No effect was observed at the highest concentration of compound tested (10 μM).</p></div></div><div></div></div><div class="NLM_p">In summary, from the modifications carried out in the hydrophobic moiety of LPA, three compounds, derivatives <b>13</b>, <b>17</b>, and <b>21</b>, with <i>E</i><sub>max</sub> values of 205%, 118%, and 112%, respectively, and EC<sub>50</sub> values of 0.45, 0.24, and 0.5 μM respectively, have activities greater than that of the endogenous ligand LPA (<i>E</i><sub>max</sub> = 100%; EC<sub>50</sub> = 0.83 μM) and stand out within the series.</div><div class="NLM_p">The possibility of optimizing the structure by combination of the best phosphate free polar heads identified so far (the fluorine containing moieties of compounds <b>6</b> and <b>7</b>) with the optimal hydrophobic subunits (the aliphatic chains of palmitoleic acid, in compound <b>13</b>, and of 10-phenyldecanoic acid, in derivatives <b>17</b> and <b>21</b>) was assessed with the synthesis of compounds <b>69</b>–<b>72</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Information</a> for details). In the case of derivative <b>71</b>, its chromatographic purification allowed the separation of the two diastereoisomers. The absolute configuration of the chiral carbon bonded to the fluorine atom was determined on the basis of NOE experiments and <sup>1</sup>H and <sup>19</sup>F NMR spectra. Compound <b>72</b> was obtained as 1:1 mixture of diastereoisomers. Among these derivatives, only compound <b>69</b> showed some agonist activity (<i>E</i><sub>max</sub> and EC<sub>50</sub> values of 43% ± 6% and 1.4% ± 0.6 μM, respectively), whereas the rest of the compounds were inactive at the highest concentration tested (10 μM).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>69</b>–<b>72</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From the obtained results, derivative <b>17</b>, which contains a chiral center, was identified as the compound with the greatest activity (<i>E</i><sub>max</sub> and EC<sub>50</sub> values of 118% of 0.24 ± 0.09 μM, respectively). In order to establish its absolute configuration, the two enantiomers of <b>17</b> were synthesized from the corresponding (<i>S</i>)- or (<i>R</i>)-oxiran-2-ylmethanol (glycidol), which was phosphorylated using the conditions previously employed. The oxirane ring was opened, and the resulting intermediates (<i>S</i>)- and (<i>R</i>)-<b>74</b> were coupled with 10-phenyldecanoic acid (<b>53</b>). Final removal of the benzyl groups yielded the target compounds (<i>S</i>)- and (<i>R</i>)-<b>17</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Comparison of the specific optical rotation values revealed that compound <b>17</b>, obtained in the phosphate deprotection reaction (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) was the <i>S</i> enantiomer. Therefore, after confirming that (<i>S</i>)-<b>17</b> was indeed the active enantiomer (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), we carried out some structural exploration around this compound (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Modifications included changing the length of its methylenic chain (derivatives <b>76</b> and <b>77</b>) and replacing it with palmitoleic and oleic acid chains (compounds <b>78</b> and <b>79</b>). However, none of these compounds had agonist activities that were significantly better than that obtained with (<i>S</i>)-<b>17</b>, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of (<i>S</i>)- and (<i>R</i>)-<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <sup><i>i</i></sup>Pr<sub>2</sub>NP(OBn)<sub>2</sub>, 1<i>H</i>-tetrazole, DCM, rt, 2 h; (ii) <i>m</i>CPBA, DCM, −30 °C, 90 min, 86–95%; (b) TBABr, TFA, CHCl<sub>3</sub>, rt, 10 min, 89–99%; (c) <b>53</b>, DCC, DMAP, DCM, rt, 18 h, 68–73%; (d) H<sub>2</sub>, 10% Pd/C EtOH, rt, 97–99%.</p></p></figure><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Analogues of Compound (<i>S</i>)-<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>52</b>, 11-phenylundecanoic acid, or palmitoleic acid, DCC, DMAP, DCM, rt, 5 h, 55–96%; (b) oleoyl chloride, pyridine, DCM, rt, 18 h, 15%; (c) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 72–80%; (d) TFA, DCM, rt, 5 h, 81–93%.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Agonist Activities of Analogs of (<i>S</i>)-<b>17</b> at LPA<sub>1</sub> Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0021.gif" alt="" id="GRAPHIC-d7e1737-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last"><i>E</i><sub>max</sub> = maximal efficacy of the drug/maximal efficacy of LPA, expressed as the percentage.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">For <i>E</i><sub>max</sub>> 30%, EC<sub>50</sub> values are expressed as mean ± SEM from a minimum of two independent experiments performed in triplicate.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">No effect was observed at the highest concentration of compound tested (10 μM).</p></div></div><div></div></div><div class="NLM_p">In addition, we analyzed the effect of the replacement of the ester for an amide group. Hence, the synthesis of the corresponding amides (<b>85</b>–<b>87</b>) of three representative LPA<sub>1</sub> agonists identified so far [(<i>S</i>)-<b>17</b>, and phosphate free compounds <b>7</b> and <b>69</b>] was addressed as depicted in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>, and their activity at LPA<sub>1</sub> receptor was determined (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). However, whereas amides <b>85</b> and <b>86</b> could be readily obtained by coupling of intermediate amine <b>88</b> with palmitoleic acid or oleyl chloride, respectively, access to amide <b>87</b> was more difficult than initially expected. In this case, removal of the Boc group of intermediate <b>91</b> followed by condensation of the free amine with the <i>N</i>-hydroxysuccinimidyl ester of 10-phenyldecanoic acid led to aziridine <b>92</b> due to an intramolecular cyclization instead of formation of the desired amide <b>87</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Further attempts to open the aziridine ring with bromide allowed the isolation of intermediate <b>93</b>, which after hydrogenation to remove the remaining benzyl group yielded a complex mixture of unidentified products. This result suggests that target amide <b>87</b> has a low intrinsic stability. Therefore, only compounds <b>85</b> and <b>86</b> were assessed for LPA<sub>1</sub> activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The obtained results reflect the key influence of the oxygen atom, as the two studied amides displayed a dramatic loss of activity in terms of both <i>E</i><sub>max</sub> and EC<sub>50</sub> values when compared with their ester analogues.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Amides <b>85</b>–<b>87</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) palmitoleic acid, EDC, HOBt, DMF, rt, 18 h, 37%; (b) oleoyl chloride, Et<sub>3</sub>N, DCM, rt, 18 h, 46%; (c) TFA, DCM, rt, 18 h, 69–99%; (d) TFA, DCM, rt, 16 h, 99%; (e) <i>N</i>-hydroxysuccinimidyl ester of <b>53</b>, Et<sub>3</sub>N, DCM, rt, 12 h, 48%; (f) MgBr<sub>2</sub>·OEt<sub>2</sub>, Et<sub>2</sub>O, rt, 4 h, 99%; (g) H<sub>2</sub>, 10% Pd/C, EtOH, rt.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Agonist Activities of Amides <b>85</b> and <b>86</b> at LPA<sub>1</sub> Receptor in Comparison with Their Ester Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0022.gif" alt="" id="GRAPHIC-d7e1919-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last"><i>E</i><sub>max</sub> = maximal efficacy of the drug/maximal efficacy of LPA, expressed as the percentage.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">For <i>E</i><sub>max</sub> > 30%, EC<sub>50</sub> values are expressed as mean ± SEM from a minimum of two independent experiments, performed in triplicate.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">No effect was observed at the highest concentration of compound tested (10 μM).</p></div></div><div></div></div><div class="NLM_p">In summary, the results obtained up to this moment identify compound (<i>S</i>)-<b>17</b>, with an excellent EC<sub>50</sub> value of 0.24 μM, as the most potent within the series, being able to activate LPA<sub>1</sub> with a slightly higher intensity (118%) than the endogenous ligand LPA. In addition, we confirmed the binding of (<i>S</i>)-<b>17</b> to the LPA<sub>1</sub> receptor using backscattering interferometry (BSI),<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> a technique that detects changes in refractive index (RI) due to variations in molecular structure, dipole moment, polarizability, conformation, and solvation that occur upon binding of a ligand to a protein. Thus, BSI can be used to measure binding affinities by detecting changes in the RI of mixtures of protein and ligand after incubation to reach equilibrium. In this case, increasing concentrations of (<i>S</i>)-<b>17</b> were incubated with a constant quantity of LPA<sub>1</sub>-expresssing membrane homogenates and the difference between the signals of protein–ligand complex and free protein solution was plotted versus ligand concentration to obtain a saturation binding curve from which the dissociation constant (<i>K</i><sub>D</sub>) was obtained (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S1</a>), resulting in a <i>K</i><sub>D</sub> value of 19.9 nM for compound (<i>S</i>)-<b>17</b> and of 5.6 nM for LPA, used as reference. We also carried out molecular docking studies to propose a plausible binding mode between the ligand and the receptor. The results showed that (<i>S</i>)-<b>17</b> can interact with LPA<sub>1</sub> in a similar manner to LPA and other known LPA<sub>1</sub> agonists.<a onclick="showRef(event, 'ref33 ref45'); return false;" href="javascript:void(0);" class="ref ref33 ref45">(33,45)</a> The phosphate moiety of (<i>S</i>)-<b>17</b> establishes three hydrogen bonds with Arg124, Thr113, and Trp121, and the carbonyl moiety of the ligand forms an additional hydrogen bond with Gln125. In addition, (<i>S</i>)-<b>17</b> establishes hydrophobic interactions with Tyr102, Ile128, Leu132, Tyr202, Trp210, Leu297, and Ala300 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Two images (0°–180° views) of the binding mode between (<i>S</i>)-<b>17</b> and the LPA<sub>1</sub>receptor (active conformation) as predicted by docking calculations. Blue lines represent hydrogen bonds and gray dashed lines hydrophobic interactions. Residues marked in green are reported in the literature<a onclick="showRef(event, 'ref33 ref45'); return false;" href="javascript:void(0);" class="ref ref33 ref45">(33,45)</a> to bind to other agonists. The LPA<sub>1</sub> active state model was retrieved from the GPCRdb<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> (structure file provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Due to the high sequence similarity among LPA<sub>1–3</sub>, a selectivity profile was determined for all compounds with LPA<sub>1</sub> agonist activity (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Table 1</a>). In addition, for compound (<i>S</i>)-<b>17</b>, we studied its selectivity against LPA<sub>4–6</sub> receptors and also against the enzyme autotaxin (ATX), involved in the biosynthesis of LPA, and its antagonist capacity at the LPA<sub>1</sub> receptor. Remarkably, this compound showed 10-fold selectivity versus LPA<sub>5</sub> receptor and more than 50-fold selectivity versus any of the other analyzed targets, making this compound the most potent and selective LPA<sub>1</sub> agonist described so far. In addition, we assessed the reversibility of the binding and the stability of the compound. To determine whether derivative (<i>S</i>)-<b>17</b> activates LPA<sub>1</sub> in a reversible manner, we carried out a wash out experiment. The obtained results indicate that, after incubation and removal of the compound, the receptor recovers its ability for activation, thus ruling out a covalent binding between LPA<sub>1</sub> and the compound (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S2</a>). Additionally, the compound remains stable (>85%) up to 8 h at 37 °C both in PBS and in culture media (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S3</a>), making (<i>S</i>)-<b>17</b> an excellent candidate for assessing LPA<sub>1</sub>-mediated cellular effects <i>in vitro</i> and for modulation of NP <i>in vivo</i>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cellular Effects of (<i>S</i>)-<b>17</b>: Induction of Neurite Retraction, Cellular Migration, and Internalization of the LPA<sub>1</sub> Receptor</h3><div class="NLM_p">We have shown that (<i>S</i>)-<b>17</b> has the ability to bind to LPA<sub>1</sub> and activate calcium mobilization. Several <i>in vitro</i> assays were performed to determine if (<i>S</i>)-<b>17</b> has the ability to recapitulate LPA induce cellular changes. In agreement with its ability to function as a receptor agonist, (<i>S</i>)-<b>17</b> induced neurite retraction, as indicated by a rounded cellular morphology, in a manner similar to that of LPA (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In addition, (<i>S</i>)-<b>17</b> induced cell migration of LPA<sub>1</sub> overexpressing B103 cells in a transwell chamber assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Finally, the ability of (<i>S</i>)-<b>17</b> to induce LPA<sub>1</sub> internalization was assessed in B103 neuroblastoma cells overexpressing an enhanced green fluorescent–LPA<sub>1</sub> fusion receptor [EGFP–LPA<sub>1</sub>]. The results obtained clearly show that in the absence of stimulus, the receptor is localized to plasma membrane (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), whereas in the presence of an agonist (LPA or (<i>S</i>)-<b>17</b>) the receptor is internalized, as indicated by the presence of the green fluorescence inside the cell (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B,C). Consistent with its ability to act as an agonist <i>in vitro</i>, (<i>S</i>)-<b>17</b> was able to mimic other LPA mediated cellular effects including neurite retraction, cellular migration, and LPA<sub>1</sub> internalization. Receptor desensitization, through internalization, is of special importance because it is a mechanism of protection against LPA mediated NP that occurs through LPA<sub>1</sub> signaling.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound (<i>S</i>)-<b>17</b> induces neurite retraction. B103 neuroblastoma cells overexpressing EGFP–LPA<sub>1</sub> receptor were treated with (A, D) vehicle (0.1% fatty acid free bovine serum albumin), (B) LPA, or (C, E) (<i>S</i>)-<b>17</b>. Cells were then fixed and stained with phalloidin and DAPI and analyzed under fluorescence microscopy for visualization of LPA (green), cell morphology (red), and nuclei (blue). The number of cells with retracted neurites was counted and expressed as the percentage of the total number of cells (F). The data shown correspond to the mean ± SEM of the number of cells counted in two independent experiments and three different slides per experiment. *<i>p</i> < 0.05; **<i>p</i> < 0.01 vs BSA (Student’s <i>t</i> test). Samples were imaged under the same conditions using a Zeiss fluorescence microscope (A–C, bars 100 μm) or Zeiss fluorescence confocal microscope (D, E, bars 10 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound (<i>S</i>)-<b>17</b> induces cellular migration. B103 neuroblastoma cells overexpressing LPA<sub>1</sub> receptor were seeded (2.5 × 10<sup>5</sup> cells) into the upper chamber of the transwell, and vehicle (0.1% fatty acid free bovine serum albumin), LPA (1 μM), or (<i>S</i>)-<b>17</b> (1 μM) was added in the lower chamber. After allowing the cells to migrate for 5 h, migratory cells were stained with 0.1% crystal violet solution and counted. Images shown are representative of the migratory cells in the presence of (A) vehicle, (B) LPA (1 μM), or (C) (<i>S</i>)-<b>17</b> (1 μM). (D) Data in the bar graph correspond to the mean ± SEM of the number of cells counted in two independent experiments and three different transwell chambers per experiment. *<i>p</i> < 0.05; **<i>p</i> < 0.01 vs BSA (Student’s <i>t</i> test). Samples were imaged under the same conditions by using a Zeiss microscope (bar 50 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound (<i>S</i>)-<b>17</b> induces internalization of the LPA<sub>1</sub> receptor. B103 neuroblastoma cells overexpressing EGFP–LPA<sub>1</sub> were treated with (A) vehicle (0.1% fatty acid free bovine serum albumin), (B) LPA (1 μM), or (C) (<i>S</i>)-<b>17</b> (1 μM). The cells were then fixed, stained with phalloidin and DAPI, and analyzed under fluorescence microscopy for visualization of LPA<sub>1</sub> (green), cell morphology (red), and nuclei (blue). Green fluorescence in the cytosol in panels B and C shows internalization of the LPA<sub>1</sub>, which, in the absence of agonist, appears almost exclusively in the cell membrane. Images shown are representative of two independent experiments and at least three different fields per experiment. All samples were imaged under the same conditions using a Zeiss fluorescence confocal microscope (bar 10 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Functional Desensitization Induced by (<i>S</i>)-<b>17</b></h3><div class="NLM_p">The observed internalization of the LPA<sub>1</sub> after treatment with the agonist (<i>S</i>)-<b>17</b> strongly suggests its associated functional desensitization. We sought to confirm this aspect in dorsal root ganglia (DRG) primary culture, since sensory neurons express LPA<sub>1</sub> receptor and, thus, represent a more relevant model than cell lines. As expected, Ca<sup>2+</sup> microfluorometric measurements show that 10 μM LPA induces Ca<sup>2+</sup> influx in DRG neurons (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), as detected by an increase in the Fluo-4 fluorescence.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> After the first application of LPA, neurons desensitize and the Ca<sup>2+</sup> response is notably reduced in a second LPA application (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). LPA produced intracellular Ca<sup>2+</sup> changes in TRPV1-expressing nociceptors, as capsaicin also triggered a Ca<sup>2+</sup> influx in all LPA responsive neurons, although not all capsaicin responding neurons were activated by LPA. Importantly, stimulation of LPA/capsaicin responding neurons with 40 mM KCl indicate that changes in cytosolic Ca<sup>2+</sup> concentrations were recorded in viable, healthy nociceptors. A similar behavior was observed for (<i>S</i>)-<b>17</b>, which under the same experimental paradigm (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B), activated the LPA<sub>1</sub> receptor TRPV1-sensitive DRG nociceptors. Akin to LPA, repeated instillation of compound (<i>S</i>)-<b>17</b> induced a reduction of the Ca<sup>2+</sup> responses, consistent with the desensitization of the LPA<sub>1</sub> receptor (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S4</a> for representative calcium microfluorography recordings).</div><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Repeated application of (<i>S</i>)-<b>17</b> reduces the activation of DRG neurons. Measurement of calcium-influx peak intensity elicited on cultured neonatal sensory neurons upon two repetitive applications of 10 μM LPA (A) or (<i>S</i>)-<b>17</b> (B) and one of 500 nM capsaicin (Caps). A10 s pulse of 40 mM KCl was applied to distinguish neuronal viability. Data represent fluorescence expressed as mean ± SEM. First pulse was compared to the second by <i>t</i> test paired values, ***<i>p</i> < 0.001. All neurons that responded to LPA or (<i>S</i>)-<b>17</b> were also activated by capsaicin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further substantiate the neuronal activity of compound (<i>S</i>)-<b>17</b>, we also investigated its effect on nociceptor excitability using multielectrode array (MEA) technology<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S5</a> for the experimental protocol). For this purpose, rat nociceptors were cultured in MEA chips and stimulated with LPA or (<i>S</i>)-<b>17</b> and capsaicin and KCl. As seen in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, a first pulse of LPA or (<i>S</i>)-<b>17</b> provoked the firing of action potentials that were attenuated upon a second instillation of the compounds. Akin to the calcium microfluorography, LPA sensitive neurons also responded to capsaicin. Analysis of the mean spike frequency clearly demonstrates that the nociceptor desensitization was produced by the repeated instillation of LPA or (<i>S</i>)-<b>17</b>. It should be noted that LPA modified nociceptor excitability/desensitization by a direct action on the LPA<sub>1</sub> receptor and not by sensitizing TRPV1 channels, as LPA induced nociceptor excitability was insensitive to capsazepine (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figures S6 and S7</a>).</div><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Repeated application of (<i>S</i>)-<b>17</b> decreases neuronal firing activity of DRG neurons. Graphs show the 10 μM LPA (A) or (<i>S</i>)-<b>17</b> (B) on mediated neuronal firing activity on neonatal rat DRG neurons. LPA and (<i>S</i>)-<b>17</b> were applied in two consecutive pulses. Neurons were exposed to 500 nM capsaicin (Caps) at the end of the recording to measure TRPV1 sensitivity of the neuronal networks exposed to LPA or (<i>S</i>)-<b>17</b>. Data represent mean spike frequency (Hz) and are expressed as mean ± SEM. Number of cultures ≥2. Comparison between pulses was performed by <i>t</i> test paired values. *<i>p</i> < 0.05; ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further confirmation of the <i>in vivo</i> desensitization of DRG neurons induced by (<i>S</i>)-<b>17</b> was obtained assessing the effect of repeated administration of the compound on the writhing response induced by administration of 0.6% acetic acid. Animals were injected with a daily dose for 5 days with vehicle (3% BSA) or (<i>S</i>)-<b>17</b> (10 mg/kg) and the acetic acid-induced writhing response was analyzed on the fifth day 60 min after first injection. The results obtained show that the total number of writhes was markedly decreased in the (<i>S</i>)-<b>17</b>-treated mice compared to the vehicle-treated group (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A), this reduction being especially remarkable in the first 10 min (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). These results are consistent the LPA<sub>1</sub> desensitization produced by the repeated administration of (<i>S</i>)-<b>17</b>, since acute single administration of (<i>S</i>)-<b>17</b> increased the number of writhes in the first minutes after the administration (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S8</a>).</div><figure id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Acetic acid-induced writhing responses were decreased by repeated (<i>S</i>)-<b>17</b> administration. Mice received a daily dose of vehicle (3% BSA) or (<i>S</i>)-<b>17</b> (10 mg/kg) for 5 days. On the last day, mice were injected with 0.6% acetic acid solution (AA) 60 min after the administration of (<i>S</i>)-<b>17</b>. Data show mean ± SEM of writhes observed by experimenters blind to experimental conditions. *<i>p</i> < 0.05 compared with (<i>S</i>)-<b>17</b>-treated group (Student’s <i>t</i> test); **<i>p</i> < 0.0001 compared with AA group (one-way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound (<i>S</i>)-<b>17</b> Reduces NP <i>in Vivo</i></h3><div class="NLM_p">After confirming that (<i>S</i>)-<b>17</b> effectively induces receptor desensitization <i>in vitro</i> and <i>in vivo</i>, we tested its efficacy in the NP <i>in vivo</i> model produced by spared nerve injury (SNI). This is induced by transecting two of three branches of the sciatic nerve, the tibial and common peroneal nerves. SNI mimics some of the major features observed in clinical NP, and it is characterized by the development of long-lasting mechanical hypersensitivity in the mouse hind paw. This can be quantified with an electronic Von Frey algesimeter by measuring mechanical nociceptive threshold after applying a mechanical stimulus in the plantar surface of the hind paw.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> After SNI, mice were treated daily with vehicle or with 10 mg/kg (<i>S</i>)-<b>17</b> (intraperitoneally, ip) and 3, 10, and 21 days postsurgery, the mechanical nociceptive threshold was assessed. As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, the mechanical nociceptive threshold reached by the treated mice was significantly superior compared to vehicle-treated mice, indicating that (<i>S</i>)-<b>17</b> protected against NP. To discard unspecific unwanted effects, we confirmed that at the selected dose (<i>S</i>)-<b>17</b> did not induce any alteration in the exploratory or locomotor activity (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">Supporting Figure S9</a>). These results strongly support the fact that agonist stimulation of the LPA<sub>1</sub> receptor leads to its desensitization and to attenuation of NP.</div><figure id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound (<i>S</i>)-<b>17</b> significantly attenuates mechanical hypersensitivity after SNI in mice, an animal model of NP. Effect of ip injection of (<i>S</i>)-<b>17</b> (10 mg/kg) or vehicle on nociceptive behavior over time in mice with SNI. Data are expressed as mean ± SEM, <i>n</i> = 10/group. ****<i>p</i> < 0.0001, **<i>p</i> < 0.01 compared with vehicle-treated group (two-way repeated measures ANOVA with Bonferroni’s post hoc test for multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this work, we report the most potent and selective LPA<sub>1</sub> agonist identified to date, compound (<i>S</i>)-<b>17</b>, with <i>E</i><sub>max</sub> and EC<sub>50</sub> values of 118% and 0.24 μM, respectively, and a <i>K</i><sub>D</sub> value of 19.9 nM at the LPA<sub>1</sub> receptor and selectivity against the LPA<sub>2</sub> and LPA<sub>3</sub> receptors. In agreement with this <i>in vitro</i> profile, (<i>S</i>)-<b>17</b> induces characteristic LPA<sub>1</sub>-mediated cellular effects such as neuronal cell rounding and cellular migration. Importantly, this agonist also induces LPA<sub>1</sub> internalization that leads to functional receptor desensitization. <i>In vivo</i>, (<i>S</i>)-<b>17</b> shows remarkable efficacy in reducing NP pain perception. Considering that NP affects up to 10% of the Western adult population and that about half of the patients do not respond to common analgesics, it is clear that new therapies are eagerly awaited for this unmet need. Our results strongly support the hypothesis that agonist stimulation of LPA<sub>1</sub> can lead to functional receptor antagonism and to the amelioration of NP. These results provide a new alternative for the development of novel more efficacious antinociceptive molecules with new mechanisms of action that are devoid of undesired side effects.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis</h3><div class="NLM_p">Unless otherwise stated, the starting materials, reagents, and solvents were purchased as high-grade commercial products from Sigma-Aldrich, ABCR, Acros, Biotage, Fluka, Lancaster, Scharlab, or Panreac. Dichloromethane (DCM), diethyl ether, and tetrahydrofuran (THF) were dried using a Pure Solv Micro 100 Liter solvent purification system. Triethylamine and pyridine were dried over CaH<sub>2</sub> and distilled prior to its use. Alcohol-free chloroform was obtained by washing with water, drying over MgSO<sub>4</sub>, filtering, and distilling over P<sub>2</sub>O<sub>5</sub>. Ethylenediamine was dried over 4 Å molecular sieves, distilled, and used immediately. All nonaqueous reactions were performed under an argon atmosphere in oven-dried glassware. Reactions under MW irradiation were performed in a Biotage Initiatior 2.5 reactor, and hydrogenation reactions were carried out in a ThalesNano H-Cube HC 2-SS continuous-flow hydrogenation reactor using CatCart catalyst cartridges. Analytical thin-layer chromatography (TLC) was run on Merck silica gel plates (Kieselgel 60 F-254), with detection by UV light (λ = 254 nm), ninhydrin solution, or 10% phosphomolybdic acid solution in ethanol. Flash chromatography was performed on glass column using silica gel type 60 (particle size 230–400 mesh, Merck) or on a Varian 971-FP flash purification system using silica gel cartridges (Varian, particle size 50 μm). All compounds were obtained as oils, except for those whose melting points (mp) are indicated, which were solids. Mp (uncorrected) was determined on a Stuart Scientific electrothermal apparatus. Optical rotation [α] was measured on an Anton Paar MCP 100 modular circular polarimeter using a sodium lamp (λ = 589 nm) with a 1 dm path length; concentrations are given as g/100 mL. Infrared (IR) spectra were measured on a Bruker Tensor 27 instrument equipped with a Specac ATR accessory of 5200–650 cm<sup>–1</sup> transmission range; frequencies (ν) are expressed in cm<sup>–1</sup>. <sup>1</sup>H, <sup>13</sup>C, and <sup>31</sup>P NMR spectra were recorded on a Bruker Avance III 700 MHz (<sup>1</sup>H, 700 MHz; <sup>13</sup>C, 175 MHz), Bruker Avance 500 MHz (<sup>1</sup>H, 500 MHz; <sup>13</sup>C, 125 MHz; <sup>31</sup>P, 202 MHz), or Bruker DPX 300 MHz (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75 MHz; <sup>31</sup>P, 121 MHz) instrument at room temperature (rt) at the Universidad Complutense de Madrid’s NMR core facility. Proton-coupled <sup>19</sup>F-NMR spectra were recorded on a Bruker DPX 300 MHz. Chemical shifts (δ) are expressed in parts per million relative to the residual solvent peak <sup>1</sup>H and <sup>13</sup>C nucleus (acetone<i>-d</i><sub>6</sub>, δ<sub>H</sub> = 2.05, δ<sub>C</sub> = 29.84; CDCl<sub>3</sub>, δ<sub>H</sub> = 7.26, δ<sub>C</sub> = 77.16; DMSO-<i>d</i><sub>6</sub>: δ<sub>H</sub> = 2.50, δ<sub>C</sub> = 39.52; methanol-<i>d</i><sub>4</sub>: δ<sub>H</sub> = 3.31, δ<sub>C</sub> = 49.00), to internal phosphoric acid for <sup>31</sup>P nucleus, and to internal (trifluoromethyl)benzene for <sup>19</sup>F nucleus; coupling constants (<i>J</i>) are in hertz (Hz). The following abbreviations are used to describe peak patterns when appropriate: s (singlet), d (doublet), t (triplet), q (quartet), qt (quintuplet), m (multiplet), app (apparent), and br (broad). 2D NMR experiments (H,H-COSY, HMQC, and HMBC) of representative compounds were carried out to assign protons and carbons of the new structures. High resolution mass spectrometry (HRMS) was carried out on a FTMS Bruker APEX Q IV spectrometer in electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) mode at Universidad Complutense de Madrid’s mass spectrometry core facility. For all final compounds, purity was determined by HPLC-MS, and satisfactory chromatograms confirmed a purity of at least 95% for all tested compounds. HPLC-MS analysis was performed using an Agilent 1200LC-MSD VL instrument. LC separation was achieved with a Zorbax Eclipse XDB-C18 column (5 μm, 4.6 mm × 150 mm) or Zorbax SB-C3 (5 μm, 2.1 mm × 50 mm) together with a guard column (5 μm, 4.6 mm × 12.5 mm). The gradient mobile phases consisted of A (95:5 water/methanol) and B (5:95 water/methanol) with 0.1% ammonium hydroxide and 0.1% formic acid as the solvent modifiers. MS analysis was performed with an ESI source. The capillary voltage was set to 3.0 kV, and the fragmentor voltage was set at 25 eV. The drying gas temperature was 350 °C, the drying gas flow was 10 L/min, and the nebulizer pressure was 20 psi.</div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure 1: Deprotection of <i>tert</i>-Butyl Esters and Alkyl Di-<i>tert</i>-butyl Phosphates</h4><div class="NLM_p last">TFA (25 or 75 equiv) was added to a solution of the corresponding <i>tert</i>-butyl derivative (1 equiv) in anhydrous DCM (20 mL/mmol), and the reaction was stirred at rt until disappearance of the starting material. The mixture was then treated with brine, and the aqueous phase was extracted with DCM. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The solvent was evaporated under reduced pressure to afford the corresponding final compounds <b>4</b>–<b>9</b>, <b>12</b>–<b>16</b>, <b>69</b>–<b>72</b>, <b>78</b>, <b>79</b>, <b>85</b>, and <b>86</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure 2: Deprotection of Dibenzyl Phosphates</h4><div class="NLM_p last">The corresponding dibenzyl phosphate was dissolved in absolute ethanol (0.2 mL/mg), and the solution was pumped through H-Cube HC 2-SS reactor using a 10% Pd/C CatCart cartridge, under full-H<sub>2</sub> mode at a flow rate of 1 mL/min at rt. Solvent was then removed under reduced pressure to afford the corresponding final compounds (<i>S</i>)- and (<i>R</i>)-<b>17</b>, <b>18</b>–<b>26</b>, <b>76</b>, and <b>77</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> [(2<i>S</i>)-2-Hydroxy-3-{[(9<i>Z</i>)-octadec-9-enoyl]oxy}propoxy]acetic Acid, <b>4</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>4</b> was obtained from <i>tert</i>-butyl ester <b>34</b> (48 mg, 84 μmol) and TFA (0.16 mL, 2.10 mmol) in 52% yield. Chromatography: EtOAc/ethanol, 20:1 to 1:5. <i>R</i><sub><i>f</i></sub>: 0.11 (EtOAc/ethanol, 8:2). IR (ATR): 3301 (O–H), 1737 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 0.88 (t, <i>J</i> = 6.6, 3H, CH<sub>3</sub>); 1.26–1.29 (m, 20H, 10CH<sub>2</sub>); 1.52–1.65 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.93–2.05 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.30 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 3.32–3.60 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>O); 3.76–3.92 (br s, 2H, C<u class="uu">H</u><sub>2</sub>CO<sub>2</sub>H); 3.95–4.19 (m, 3H, CO<sub>2</sub>CH<sub>2</sub>, CH); 5.26–5.35 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz): δ 14.3 (CH<sub>3</sub>); 22.9, 25.0 (2CH<sub>2</sub>); 27.3, 27.4 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.2, 29.3, 29.4, 29.47, 29.48, 29.7, 29.8, 29.9, 32.1 (9CH<sub>2</sub>); 34.2 (<u class="uu">C</u>H<sub>2</sub>CO); 64.8 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 65.8 (CH); 70.5 (<u class="uu">C</u>H<sub>2</sub>CO<sub>2</sub>H); 72.1 (CH<u class="uu">C</u>H<sub>2</sub>O); 130.0, 130.2 (2CH<sub>alkene</sub>); 173.4, 173.8 (2CO). [α]<sub>D</sub><sup>20</sup>: −1.6 (<i>c</i> = 1.00, CHCl<sub>3</sub>). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>23</sub>H<sub>41</sub>O<sub>6</sub> ([M – H]<sup>−</sup>) 413.2909, found 413.2890. HPLC-MS retention time (min): 14.37.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (5<i>S</i>)-5-{[(9<i>Z</i>)-Octadec-9-enoyloxy]methyl}-2-oxotetrahydrofuran-3-carboxylic Acid, <b>5</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>5</b> was obtained from di-<i>tert</i>-butyl ester <b>35</b> (169 mg, 0.30 mmol) and TFA (0.58 mL, 7.53 mmol) in 88% yield. Chromatography: EtOAc/ethanol, 20:1 to 1:5. <i>R</i><sub><i>f</i></sub>: 0.13 (EtOAc/ethanol, 8:2). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): mixture of diastereoisomers A/B (1:1): δ 0.88 (t, <i>J</i> = 7.2, 3H, CH<sub>3</sub>); 1.27–1.30 (m, 20H, 10CH<sub>2</sub>); 1.61–1.64 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.97–2.03 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.35 (dt, <i>J</i> = 7.7, 1.8, 2H, C<u class="uu">H</u><sub>2</sub>CO); 2.37–2.41 (m, 1H, 1/2C<u class="uu">H</u><sub>2</sub>CHCO<sub>2</sub>H<sub>A</sub>); 2.47–2.54 (m, 1H, 1/2C<u class="uu">H</u><sub>2</sub>CHCO<sub>2</sub>H<sub>B</sub>); 2.62–2.68 (m, 1H, 1/2C<u class="uu">H</u><sub>2</sub>CHCO<sub>2</sub>H<sub>B</sub>); 2.78–2.84 (m, 1H, 1/2C<u class="uu">H</u><sub>2</sub>CHCO<sub>2</sub>H<sub>A</sub>); 3.71–3.76 (m, 1H, C<u class="uu">H</u>CO<sub>2</sub>H); 4.19 (dd, <i>J</i> = 12.6, 4.6, 1H, 1/2CO<sub>2</sub>CH<sub>2A</sub>); 4.23 (dd, <i>J</i> = 12.5, 5.8, 1H, 1/2CO<sub>2</sub>CH<sub>2B</sub>); 4.35–4.40 (m, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.74–4.79 (m, 1H, CO<sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>A</sub>); 4.89–4.94 (m, 1H, CO<sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>B</sub>); 5.30–5.38 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz): mixture of diastereoisomers A/B (1:1): δ 14.3 (CH<sub>3</sub>); 22.8 (CH<sub>2</sub>); 24.9 and 24.94 (CH<sub>2</sub>); 27.3, 27.37 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 27.9, 29.2, 29.22, 29.3, 29.5, 29.7, 29.8, 29.9, 31.1 (9CH<sub>2</sub>); 32.1 (<u class="uu">C</u>H<sub>2</sub>CHCO<sub>2</sub>H); 34.0 and 34.1 (<u class="uu">C</u>H<sub>2</sub>CO); 46.0 and 46.2 (<u class="uu">C</u>HCO<sub>2</sub>H); 64.4 and 64.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 76.7 and 76.8 (CO<sub>2</sub>CH<sub>2</sub><u class="uu">C</u>H); 129.85 and 129.8 (CH<sub>alkene</sub>); 130.17 and 130.19 (CH<sub>alkene</sub>); 171.9, 172.1 (CO<sub>2</sub>H, CO<sub>lactone</sub>); 173.4 and 173.6 (CO). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>23</sub>H<sub>39</sub>O<sub>4</sub> ([M −CO<sub>2</sub>H]<sup>−</sup>) 379.2854, found 379.2861. HPLC-MS retention time (min): 14.37.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (5<i>S</i>)-3-Fluoro-5-{[(9<i>Z</i>)-octadec-9-enoyloxy]methyl}-2-oxotetrahydrofuran-3-carboxylic Acid, <b>6</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>6</b> was obtained from di-<i>tert</i>-butyl ester <b>36</b> (80 mg, 0.14 mmol) and TFA (0.27 mL, 3.50 mmol) without further purification in quantitative yield. IR (ATR): 3466 (O–H), 1795 (C═O), 1742 (C═O), 1163 (C–F). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): mixture of diastereoisomers A/B (1:1): δ 0.88 (t, <i>J</i> = 6.8, 3H, CH<sub>3</sub>); 1.21–1.37 (m, 20H, 10CH<sub>2</sub>); 1.59–1.66 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.99–2.02 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.37 (t, <i>J</i> = 7.5, CH<sub>2</sub>CO); 2.46–2.55 (m, 1H, 1/2CH<sub>2</sub>CF<sub>A</sub>); 2.76 (app dd, <i>J</i> = 26.1, 7.2, 2H, CH<sub>2</sub>CF<sub>B</sub>); 2.97–3.03 (m, 1H, 1/2CH<sub>2</sub>CF<sub>A</sub>); 4.24 (dd, <i>J</i> = 12.6, 4.8, 1H, 1/2CO<sub>2</sub>CH<sub>2A</sub>); 4.29 (dd, <i>J</i> = 12.5, 6.0, 1H, 1/2CO<sub>2</sub>CH<sub>2B</sub>); 4.42–4.46 (m, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.90–4.99 (m, 1H, CH); 5.31–5.38 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz): mixture of diastereoisomers A/B (1:1): δ 14.2 (CH<sub>3</sub>); 22.8, 24.9 (2CH<sub>2</sub>); 27.3, 27.4 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.2, 29.22, 29.3, 29.5, 29.7, 29.81, 29.84, 29.9, 32.0 (9CH<sub>2</sub>); 34.0 and 34.08 (<u class="uu">C</u>H<sub>2</sub>CO); 34.9 (d, <i>J</i> = 22.4) and 35.0 (d, <i>J</i> = 21.7, <u class="uu">C</u>H<sub>2</sub>CF); 63.6 and 63.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 75.7 (d, <i>J</i> = 2.9) and 76.5 (CH); 91.7 (d, <i>J</i> = 197.8) and 92.1 (d, <i>J</i> = 200.9, CF); 129.9 (CH<sub>alkene</sub>); 130.16 and 130.18 (CH<sub>alkene</sub>); 167.5 (d, <i>J</i> = 23.3, CO); 167.8 (d, <i>J</i> = 24.7, CO); 173.8 and 173.84 (CO). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>24</sub>H<sub>38</sub>FO<sub>6</sub> ([M – H]<sup>−</sup>) 441.2658, found 441.2667. HPLC-MS retention time (min): 21.16.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Fluoro[(2<i>S</i>)-2-methoxy-3-{[(9<i>Z</i>)-octadec-9-enoyl]oxy}propyl]propanedioic Acid, <b>7</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>7</b> was obtained from di-<i>tert</i>-butyl ester <b>37</b> (10 mg, 17 μmol) and TFA (98 μL, 1.28 mmol) without further purification in 95% yield. IR (ATR): 3525 (O–H), 1742 (C═O), 1160 (C–F). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 700 MHz): δ 0.90 (t, <i>J</i> = 7.1, 3H, CH<sub>3</sub>); 1.29–1.33 (m, 20H, 10CH<sub>2</sub>); 1.61–1.63 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.02–2.05 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>), 2.24–2.30 (m, 1H, 1/2CH<sub>2</sub>CF); 2.35 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.45–2.52 (m, 1H, 1/2CH<sub>2</sub>CF); 3.33 (s, 3H, OCH<sub>3</sub>); 3.63–3.65 (m, 1H, CH); 4.04 (dd, <i>J</i> = 11.7, 4.9, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.25 (dd, <i>J</i> = 11.7, 3.9, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 5.32–5.37 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 175 MHz): δ 14.5 (CH<sub>3</sub>); 23.8, 26.0 (2CH<sub>2</sub>); 28.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.2 (2CH<sub>2</sub>); 30.3, 30.4, 30.5, 30.6, 30.8, 30.9, 33.1 (7CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 38.4 (d, <i>J</i> = 20.1, <u class="uu">C</u>H<sub>2</sub>CF); 58.1 (OCH<sub>3</sub>); 65.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 76.0 (CH); 94.4 (d, <i>J</i> = 192.5, CF); 130.8, 130.9 (2CH<sub>alkene</sub>); 170.9 (br s, 2CO<sub>2</sub>H); 175.2 (CO). [α]<sub>D</sub><sup>20</sup>: +29.5 (<i>c</i> = 0.20, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>25</sub>H<sub>42</sub>FO<sub>7</sub>([M – H]<sup>−</sup>) 473.2915, found 473.2922. HPLC-MS retention time (min): 14.51.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (3-{[(9<i>Z</i>)-Octadec-9-enoyl]oxy}propyl)propanedioic Acid, <b>8</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>8</b> was obtained from di-<i>tert</i>-butyl ester <b>38</b> (96 mg, 0.18 mmol) and TFA (0.34 mL, 4.45 mmol) without further purification in 90% yield. IR (ATR): 3100 (O–H), 1735 (C═O). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 0.87 (t, <i>J</i> = 6.7, 3H, CH<sub>3</sub>); 1.26–1.30 (m, 20H, 10CH<sub>2</sub>); 1.56–1.65 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CH(CO<sub>2</sub>H)<sub>2</sub>); 1.70–1.80 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.93–2.07 (m, 6H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>, C<u class="uu">H</u><sub>2</sub>CH(CO<sub>2</sub>H)<sub>2</sub>); 2.30 (t, <i>J</i> = 7.6, 2H, CH<sub>2</sub>CO); 3.48 (t, <i>J</i> = 7.4, 1H, CH); 4.11 (t, <i>J</i> = 6.1, 2H, CO<sub>2</sub>CH<sub>2</sub>); 5.28–5.39 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75 MHz): δ 14.1 (CH<sub>3</sub>); 22.7; 24.9; 25.3; 26.3 (4CH<sub>2</sub>); 27.2; 27.24 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 27.9; 29.1; 29.2 (3CH<sub>2</sub>); 29.3 (2CH<sub>2</sub>); 29.6; 29.7; 29.8; 31.9 (4CH<sub>2</sub>); 34.3 (<u class="uu">C</u>H<sub>2</sub>CO); 51.0 (CH); 63.5 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 129.8; 130.0 (2CH<sub>alkene</sub>); 174.1 (2CO<sub>2</sub>H); 174.3 (CO). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>24</sub>H<sub>41</sub>O<sub>6</sub> ([M – H]<sup>−</sup>) 425.2909, found 425.2898. HPLC-MS retention time (min): 15.18.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Fluoro(3-{[(9<i>Z</i>)-octadec-9-enoyl]oxy}propyl)propanedioic Acid, <b>9</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>9</b> was obtained from di-<i>tert</i>-butyl ester <b>39</b> (61 mg, 0.11 mmol) and TFA (0.21 mL, 2.75 mmol) without further purification in 90% yield. IR (ATR): 1738 (C═O), 1166 (C–F). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 0.88 (t, <i>J</i> = 6.6, 3H, CH<sub>3</sub>); 1.18–1.39 (m, 20H, 10CH<sub>2</sub>); 1.54–1.67 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.70–1.85 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CF);1.93–2.04 (m,4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.20–2.45 (m, 2H, CH<sub>2</sub>CF); 2.41 (t, <i>J</i> = 7.6, 2H, CH<sub>2</sub>CO); 4.02–4.18 (m, 2H, CO<sub>2</sub>CH<sub>2</sub>);5.27–5.41 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75 MHz): δ 14.1 (CH<sub>3</sub>); 22.7; 24.9 (2CH<sub>2</sub>); 24.93 (d, <i>J</i> = 2.8, <u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>CF); 27.2; 27.23 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.1; 29.2 (2CH<sub>2</sub>); 29.3 (2CH<sub>2</sub>); 29.5; 29.7; 29.74; 29.8 (4CH<sub>2</sub>); 31.1 (d, <i>J</i> = 21.6, <u class="uu">C</u>H<sub>2</sub>CF); 31.9 (CH<sub>2</sub>); 34.3 (<u class="uu">C</u>H<sub>2</sub>CO); 63.29 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 129.7; 130.0 (2CH<sub>alkene</sub>); 174.7 (CO); 2CO<sub>2</sub>H and CF not observed. HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>24</sub>H<sub>40</sub>FO<sub>6</sub> ([M – H]<sup>−</sup>) 443.2814, found 443.2824. HPLC-MS retention time (min): 16.75.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> {4-[(2<i>S</i>)-2-Hydroxy-3-{[(9<i>Z</i>)-octadec-9-enoyl]oxy}propoxy]phenyl}boronic Acid, <b>10</b></h4><div class="NLM_p">To a solution of boronate ester <b>40</b> (50 mg, 0.09 mmol, 1 equiv) in methanol (2 mL), a 4.5 M solution of potassium hydrogen fluoride in water was added (111 μL, 0.50 mmol, 5.6 equiv), and the reaction was stirred at rt for 30 min. Then, solvent was evaporated under reduced pressure, and the crude was dissolved in hot acetone and filtered. The filtrate was concentrated under reduced pressure to afford potassium trifluorido{4-[(2<i>S</i>)-2-hydroxy-3-{[(9<i>Z</i>)-octadec-9-enoyl]oxy}propoxy]phenyl}borate in quantitative yield. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 0.90 (t, <i>J</i> = 6.6, 3H, CH<sub>3</sub>); 1.30–1.37 (m, 20H, 10CH<sub>2</sub>); 1.60–1.64 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.02–2.04 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.36 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 3.94–4.02 (m, 2H, C<u class="uu">H</u><sub>2</sub>OAr); 4.09–4.28 (m, 3H, CH, CO<sub>2</sub>CH<sub>2</sub>); 5.29–5.40 (m, 2H, 2CH<sub>alkene</sub>); 6.79 (d, <i>J</i> = 8.0, 2H, 2CH<sub>Ar</sub>); 7.42 (d, <i>J</i> = 8.3, 2H, 2CH<sub>Ar</sub>). [α]<sub>D</sub><sup>20</sup>: +2.4 (<i>c</i> = 0.9, methanol). MS (ESI, <i>m</i>/<i>z</i>): 521.3 [M–OH]<sup>−</sup>.</div><div class="NLM_p last">To a solution of the borate salt (30 mg, 54 μmol, 1 equiv) in acetonitrile (0.5 mL), water (3 μL, 0.16 mmol, 3 equiv) and trimethylsilyl chloride (20 μL, 0.16 mmol, 3 equiv) were added, and the mixture was stirred for 1 h at rt. Then, a saturated aqueous solution of NaHCO<sub>3</sub> was added, and the reaction mixture was extracted with DCM. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Flash chromatography of the residue (hexane/EtOAc, 10:1 to 1:1, followed by EtOAc/ethanol, 10:1 to 5:1) afforded compound <b>10</b> in 60% yield. <i>R</i><sub><i>f</i></sub>: 0.30 (hexane/EtOAc, 1:1). IR (ATR): 1740 (C═O), 1368 (B–O), 1242 (B–C). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 0.87 (t, <i>J</i> = 6.5, 3H, CH<sub>3</sub>); 1.26–1.30 (m, 20H, 10CH<sub>2</sub>); 1.63–1.67 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.99–2.01 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.38 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 4.03–4.12 (m, 2H, C<u class="uu">H</u><sub>2</sub>OAr); 4.24–4.37 (m, 3H, CH, CO<sub>2</sub>CH<sub>2</sub>); 5.27–5.40 (m, 2H, 2CH<sub>alkene</sub>); 7.02 (d, <i>J</i> = 8.5, 2H, 2CH<sub>Ar</sub>); 8.16 (d, <i>J</i> = 8.4, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz): δ 14.3 (CH<sub>3</sub>); 22.8, 25.1 (2CH<sub>2</sub>); 27.3, 27.4 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.2 (2CH<sub>2</sub>); 29.3 (CH<sub>2</sub>); 29.5 (2CH<sub>2</sub>); 29.7, 29.8, 29.9, 32.1 (4CH<sub>2</sub>); 34.3 (<u class="uu">C</u>H<sub>2</sub>CO); 65.4 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.6 (<u class="uu">C</u>H<sub>2</sub>OAr); 68.8 (CH); 114.2 (2CH<sub>Ar</sub>); 129.9, 130.2 (2CH<sub>alkene</sub>); 137.6 (2CH<sub>Ar</sub>); 141.1 (C<sub>Ar</sub>); 174.2 (CO); CB not observed. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>27</sub>H<sub>46</sub>BO<sub>6</sub> ([M + H]<sup>+</sup>) 477.3387, found 477.3395. HPLC-MS retention time (min): 22.85.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (2<i>S</i>)-2-Hydroxy-3-(1<i>H</i>-tetrazol-5-yl)propyl (9<i>Z</i>)-Octadec-9-enoate, <b>11</b></h4><div class="NLM_p last">To a solution of intermediate <b>41</b> (64 mg, 0.18 mmol, 1 equiv) in dry DMF (0.3 mL), sodium azide (13 mg, 0.19 mmol, 1.1 equiv) and NH<sub>4</sub>Cl (12 mg, 0.23 mmol, 1.3 equiv) were added. The mixture was heated at 160 °C under MW irradiation for 45 min. Then, the solvent was removed under reduced pressure, and the crude was purified by flash chromatography (hexane to hexane/EtOAc, 6:4) to afford compound <b>11</b> in 18% yield. IR (ATR): 3390 (O–H, N–H), 1738 (C═O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 500 MHz): δ 0.90 (t, <i>J</i> = 6.9, 3H, CH<sub>3</sub>); 1.29–1.33 (m, 20H, 10CH<sub>2</sub>); 1.58–1.64 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.01–2.05 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.34 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 3.07 (dd, <i>J</i> = 14.9, 8.2, 1H, 1/2CH<sub>2</sub>CN); 3.18 (dd, <i>J</i> = 14.9, 4.6, 1H, 1/2CH<sub>2</sub>CN); 4.06–4.12 (m, 2H, CO<sub>2</sub>CH<sub>2</sub>); 4.17–4.22 (m, 1H, CH); 5.31–5.37 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 14.4 (CH<sub>3</sub>); 23.7, 25.9 (2CH<sub>2</sub>); 28.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.3 (<u class="uu">C</u>H<sub>2</sub>CN); 30.18, 30.19, 30.3, 30.33, 30.4, 30.6, 30.8, 30.84, 33.1 (9CH<sub>2</sub>); 34.8 (<u class="uu">C</u>H<sub>2</sub>CO); 68.2 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.3 (CH); 130.8, 130.9 (2CH<sub>alkene</sub>); 155.5 (CN); 175.2 (CO). [α]<sub>D</sub><sup>20</sup>: +31.7 (<i>c</i> = 0.09, methanol). HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>22</sub>H<sub>40</sub>N<sub>4</sub>NaO<sub>3</sub> ([M + Na]<sup>+</sup>) 431.2998, found 431.2978. HPLC-MS retention time (min): 19.45.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl (9<i>Z</i>)-Tetradec-9-enoate, <b>12</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>12</b> was obtained from di-<i>tert</i>-butyl phosphate <b>46</b> (7 mg, 14 μmol) and TFA (27 μL, 0.35 mmol) without further purification in 99% yield. IR (ATR): 3375 (O–H), 1737 (C═O), 1182 (P═O), 1058 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 500 MHz): δ 0.91 (t, <i>J</i> = 7.0, 3H, CH<sub>3</sub>); 1.29–1.30 (m, 12H, 6CH<sub>2</sub>);1.60–1.63 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.02–2.04 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.36 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 3.96–3.98 (m, 3H, CH, CH<sub>2</sub>OP); 4.07–4.17 (m, 2H, CO<sub>2</sub>CH<sub>2</sub>); 5.29–5.40 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 14.3 (CH<sub>3</sub>); 23.4, 26.0 (2CH<sub>2</sub>); 27.9, 28.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.1, 30.2, 30.3, 30.8, 33.1 (5CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 66.2 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 67.6 (d, <i>J</i> = 5.2, CH<sub>2</sub>OP); 69.8 (d, <i>J</i> = 6.9, CH); 130.8, 130.83 (2CH<sub>alkene</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.23. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>17</sub>H<sub>32</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 379.2891, found 379.2848. HPLC-MS retention time (min): 9.81.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl (9<i>Z</i>)-Hexadec-9-enoate, <b>13</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>13</b> was obtained from di-<i>tert</i>-butyl phosphate <b>47</b> (24 mg, 46 μmol) and TFA (88 μL, 1.15 mmol) without further purification in 90% yield. IR (ATR): 3392 (O–H), 1737 (C═O), 1176 (P═O), 1057 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 0.90 (t, <i>J</i> = 6.7, 3H, CH<sub>3</sub>); 1.29–1.33 (m, 16H, 8CH<sub>2</sub>); 1.60–1.64 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.00–2.04 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.36 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 3.92–4.04 (m, 3H, CH, CH<sub>2</sub>OP); 4.15 (ABX system, <i>J</i> = 11.4, 5.5, 4.2, 2H, CO<sub>2</sub>CH<sub>2</sub>); 5.29–5.40 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 14.5 (CH<sub>3</sub>); 23.7, 26.0 (2CH<sub>2</sub>); 28.1, 28.2 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.1 (CH<sub>2</sub>); 30.2 (2CH<sub>2</sub>); 30.3, 30.8, 30.84, 32.9 (4CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 66.2 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 67.6 (d, <i>J</i> = 5.3, CH<sub>2</sub>OP); 69.8 (d, <i>J</i> = 8.0, CH); 130.8, 130.9 (2CH<sub>alkene</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.79. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>19</sub>H<sub>37</sub>NaO<sub>7</sub>P ([M + Na]<sup>+</sup>) 431.2175, found 431.2169. HPLC-MS retention time (min): 10.06.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl (9<i>Z</i>)-Heptadec-9-enoate, <b>14</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>14</b> was obtained from di-<i>tert</i>-butyl phosphate <b>48</b> (6 mg, 12 μmol) and TFA (22 μL, 0.30 mmol) without further purification in 99% yield. IR (ATR): 3347 (O–H), 1737 (C═O), 1652 (C═C), 1186 (P═O), 1082 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 700 MHz): δ 0.90 (t, <i>J</i> = 6.7, 3H, CH<sub>3</sub>); 1.29–1.33 (m, 18H, 9CH<sub>2</sub>); 1.60–1.64 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.01–2.04 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>), 2.36 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 3.89–3.91 (m, 2H, CH<sub>2</sub>OP); 3.95–3.98 (m, 1H, CH); 4.11 (dd, <i>J</i> = 11.4, 6.2, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.18 (dd, <i>J</i> = 11.4, 4.3, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 5.29–5.40 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 175 MHz): δ 14.5 (CH<sub>3</sub>); 23.7, 26.0 (2CH<sub>2</sub>); 28.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.2, 30.22, 30.3, 30.34, 30.8, 30.82, 30.9, 33.1 (8CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 66.4 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 67.2 (d, <i>J</i> = 5.2, CH<sub>2</sub>OP); 70.1 (d, <i>J</i> = 7.9, CH); 130.8, 130.9 (2CH<sub>alkene</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 4.34. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>20</sub>H<sub>39</sub>NaO<sub>7</sub>P ([M + Na]<sup>+</sup>) 445.2331, found 445.2311. HPLC-MS retention time (min): 10.42.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl (9<i>Z</i>)-Nonadec-9-enoate, <b>15</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>15</b> was obtained from di-<i>tert</i>-butyl phosphate <b>49</b> (24 mg, 43 μmol) and TFA (82 μL, 1.08 mmol) without further purification in 99% yield. IR (ATR): 3360 (O–H), 1738 (C═O), 1181 (P═O), 1060 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 0.90 (t, <i>J</i> = 6.6, 3H, CH<sub>3</sub>); 1.29–1.33 (m, 22H, 11CH<sub>2</sub>); 1.59–1.64 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.02–2.04 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.35 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 3.91–4.05 (m, 3H, CH, CH<sub>2</sub>OP); 4.15 (ABX system, <i>J</i> = 11.4, 5.6, 4.3, 2H, CO<sub>2</sub>CH<sub>2</sub>); 5.29–5.40 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 14.4 (CH<sub>3</sub>); 23.7, 26.0 (2CH<sub>2</sub>); 28.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.2 (2CH<sub>2</sub>); 30.3 (2CH<sub>2</sub>); 30.5, 30.6, 30.7 (3CH<sub>2</sub>); 30.8 (2CH<sub>2</sub>); 33.1 (CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 66.3 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 67.5 (d, <i>J</i> = 4.8, CH<sub>2</sub>OP); 69.9 (d, <i>J</i> = 7.7, CH); 130.8, 130.9 (2CH<sub>alkene</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.88. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>22</sub>H<sub>43</sub>NaO<sub>7</sub>P ([M + Na]<sup>+</sup>) 473.2644, found 473.2642. HPLC-MS retention time (min): 11.30.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl (9<i>Z</i>)-Icos-9-enoate, <b>16</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>16</b> was obtained from di-<i>tert</i>-butyl phosphate <b>50</b> (9 mg, 16 μmol) and TFA (30 μL, 0.40 mmol) without further purification in 92% yield. IR (ATR): 3350 (O–H), 1738 (C═O), 1179 (P═O), 1059 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 700 MHz): δ 0.90 (t, <i>J</i> = 7.0, 3H, CH<sub>3</sub>); 1.29–1.33 (m, 24H, 12CH<sub>2</sub>); 1.60–1.63 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.02–2.05 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.35 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 3.94 (app t, <i>J</i> = 5.7, 2H, CH<sub>2</sub>OP); 3.97–4.00 (m, 1H, CH); 4.11 (dd, <i>J</i> = 11.4, 6.0, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.18 (dd, <i>J</i> = 11.4, 4.3, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 5.32–5.37 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 175 MHz): δ 14.5 (CH<sub>3</sub>); 23.8, 26.0 (2CH<sub>2</sub>); 28.1, 28.14 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.2, 30.3, 30.5, 30.6 (4CH<sub>2</sub>); 30.7 (2CH<sub>2</sub>); 30.77 (2CH<sub>2</sub>); 30.8 (2CH<sub>2</sub>); 33.1 (CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 66.1 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 67.6 (d, <i>J</i> = 5.3, CH<sub>2</sub>OP); 69.7 (d, <i>J</i> = 7.6, CH); 130.8, 130.9 (2CH<sub>alkene</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.16. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>23</sub>H<sub>45</sub>NaO<sub>7</sub>P ([M + Na]<sup>+</sup>) 487.2801, found 487.2798. HPLC-MS retention time (min): 12.35.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2<i>S</i>)-1-Bromo-3-(phosphonooxy)propan-2-yl 10-Phenyldecanoate, (<i>S</i>)-<b>17</b></h4><div class="NLM_p last">Following general procedure 2, compound (<i>S</i>)-<b>17</b> was obtained from dibenzyl phosphate (<i>S</i>)-<b>75</b> (50 mg, 0.08 mmol) in 99% yield. IR (ATR): 3360 (O–H), 1738 (C═O), 1199 (P═O), 1025 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 500 MHz): δ 1.32 (m, 10H, 5CH<sub>2</sub>); 1.60–1.65 (m, 4H, 2CH<sub>2</sub>); 2.37 (t, <i>J</i> = 7.3, 2H, CH<sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.6, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.58 (dd, <i>J</i> = 10.9, 5.9, 1H, 1/2CH<sub>2</sub>Br); 3.66 (dd, <i>J</i> = 10.9, 4.9, 1H, 1/2CH<sub>2</sub>Br); 4.12–4.18 (m, 2H, CH<sub>2</sub>OP); 5.14–5.19 (m, 1H, CH); 7.11–7.17 (m, 3H, 3CH<sub>Ar</sub>); 7.23 (t, <i>J</i> = 7.5, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 26.0, 30.1, 30.3, 30.31 (4CH<sub>2</sub>); 30.5 (2CH<sub>2</sub>); 30.8 (CH<sub>2</sub>Br); 32.7 (CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 66.3 (d, <i>J</i> = 5.0, CH<sub>2</sub>OP); 72.5 (d, <i>J</i> = 8.3, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 144.0 (C<sub>Ar</sub>); 174.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.10. [α]<sub>D</sub><sup>20</sup>: +4.8 (<i>c</i> = 0.50, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>19</sub>H<sub>29</sub><sup>79</sup>BrO<sub>6</sub>P ([M(<sup>79</sup>Br) – H]<sup>−</sup>: 463.0891, found 463.0896; calculated for C<sub>19</sub>H<sub>29</sub><sup>81</sup>BrO<sub>6</sub>P ([M(<sup>81</sup>Br) – H]<sup>−</sup>) 465.0870, found 465.0876. HPLC-MS retention time (min): 26.05.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (2<i>R</i>)-1-Bromo-3-(phosphonooxy)propan-2-yl 10-Phenyldecanoate, (<i>R</i>)-<b>17</b></h4><div class="NLM_p last">Following general procedure 2, compound (<i>R</i>)-<b>17</b> was obtained from dibenzyl phosphate (<i>R</i>)-<b>75</b> (69 mg, 0.11 mmol) in 97% yield. The spectroscopic data are in agreement with those reported for its enantiomer (<i>S</i>)-<b>17</b>. [α]<sub>D</sub><sup>20</sup>: −4.6 (<i>c</i> = 0.50, methanol).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 7-Phenylheptanoate, <b>18</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>18</b> was obtained from dibenzyl phosphate <b>60</b> (30 mg, 56 μmol) in 85% yield. IR (ATR): 1737 (C═O), 1258 (P═O), 1025 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.33–1.36 (m, 4H, 2CH<sub>2</sub>); 1.56–1.67 (m, 4H, 2CH<sub>2</sub>); 2.35 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.60 (t, <i>J</i> = 7.5, 2H, PhCH<sub>2</sub>); 3.95–4.01 (m, 3H, CH, CH<sub>2</sub>OP); 4.10 (dd, <i>J</i> = 11.3, 5.4, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.17 (dd, <i>J</i> = 11.3, 4.3, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 7.10–7.17 (m, 3H, 3CH<sub>Ar</sub>); 7.21–7.26 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 25.9; 29.9; 30.0; 32.6 (4CH<sub>2</sub>); 34.8 (CH<sub>2</sub>CO); 36.8 (PhCH<sub>2</sub>); 65.9 (CO<sub>2</sub>CH<sub>2</sub>); 68.1 (d, <i>J</i> = 5.7, CH<sub>2</sub>OP); 69.3 (d, <i>J</i> = 8.3, CH); 126.6 (CH<sub>Ar</sub>); 129.3 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 143.9 (C<sub>Ar</sub>); 175.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.09. [α]<sub>D</sub><sup>20</sup>: +5.3 (<i>c</i> = 0.47, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>16</sub>H<sub>24</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 359.1265, found 359.1273. HPLC-MS retention time (min): 21.72.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 8-Phenyloctanoate, <b>19</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>19</b> was obtained from dibenzyl phosphate <b>61</b> (63 mg, 0.11 mmol) in 80% yield. IR (ATR): 1737 (C═O), 1027 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.33 (app s, 6H, 3CH<sub>2</sub>); 1.58–1.60 (m, 4H, 2CH<sub>2</sub>);2.27–2.37 (m, 2H, CH<sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.5, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.59–3.61 (m, 3H, CH, CH<sub>2</sub>OP); 3.99–4.41 (m, 2H, CO<sub>2</sub>CH<sub>2</sub>); 7.10–7.16 (m, 3H, 3CH<sub>Ar</sub>); 7.21–7.26 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 25.9, 30.07, 30.1, 30.2, 32.6 (5CH<sub>2</sub>); 34.8 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 65.8 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.1 (d, <i>J</i> = 5.0, CH<sub>2</sub>OP); 69.3 (br s, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 143.9 (C<sub>Ar</sub>); 175.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.04. [α]<sub>D</sub><sup>20</sup>: +2.8 (<i>c</i> = 1.58, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>17</sub>H<sub>26</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 373.1422, found 373.1432. HPLC-MS retention time (min): 8.07.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 9-Phenylnonanoate, <b>20</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>20</b> was obtained from dibenzyl phosphate <b>62</b> (90 mg, 0.16 mmol) in 99% yield. IR (ATR): 3355 (O–H), 1737 (C═O), 1259 (P═O), 1029 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.32 (app s, 8H, 4CH<sub>2</sub>); 1.60 (br s, 4H, 2CH<sub>2</sub>);2.34 (t, <i>J</i> = 7.4, 2H, C<u class="uu">H</u><sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.8, 2H, Ph<u class="uu">C</u>H<sub>2</sub>); 3.67–3.79 (m, 1H, CH); 3.98–4.00 (m, 2H, CH<sub>2</sub>OP); 4.07–4.21 (m, 2H, CO<sub>2</sub>CH<sub>2</sub>); 7.09–7.17 (m, 3H, 3CH<sub>Ar</sub>); 7.21–7.26 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 25.9, 30.1, 30.2, 30.3, 30.4, 32.7 (6CH<sub>2</sub>); 34.8 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 65.8 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.1 (d, <i>J</i> = 6.0, CH<sub>2</sub>OP); 69.3 (d, <i>J</i> = 8.3, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 143.9 (C<sub>Ar</sub>); 175.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.05. [α]<sub>D</sub><sup>20</sup>: +2.5 (<i>c</i> = 1.13, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>18</sub>H<sub>28</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 387.1578, found 387.1591. HPLC-MS retention time (min): 8.34.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 10-Phenyldecanoate, <b>21</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>21</b> was obtained from dibenzyl phosphate <b>63</b> (20 mg, 34 μmol) in 80% yield. IR (ATR): 1739 (C═O), 1051 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 500 MHz): δ 1.29–1.32 (m, 10H, 5CH<sub>2</sub>); 1.61 (m, 4H, 2CH<sub>2</sub>); 2.35 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.6, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.96–4.01 (m, 3H, CH, CH<sub>2</sub>OP); 4.11 (dd, <i>J</i> = 11.3, 5.3, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.17 (dd, <i>J</i> = 11.3, 4.1, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 7.11–7.16 (m, 3H, 3CH<sub>Ar</sub>); 7.23 (t, <i>J</i> = 7.5, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 26.0, 30.2, 30.3, 30.34 (4CH<sub>2</sub>); 30.5 (2CH<sub>2</sub>); 32.7 (CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 65.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.1 (d, <i>J</i> = 5.7, CH<sub>2</sub>OP); 69.4 (d, <i>J</i> = 8.1, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 144.0 (C<sub>Ar</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 202 MHz): δ 3.14. [α]<sub>D</sub><sup>20</sup>: +2.3 (<i>c</i> = 0.40, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>19</sub>H<sub>30</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 401.1735, found 401.1734. HPLC-MS retention time (min): 24.37.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 11-Phenylundecanoate, <b>22</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>22</b> was obtained from dibenzyl phosphate <b>64</b> (5 mg, 8 μmol) in 82% yield. IR (ATR): 3387 (O–H), 1739 (C═O), 1262 (P═O), 1014 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.26–1.32 (m, 12H, 6CH<sub>2</sub>); 1.53–1.68 (m, 4H, 2CH<sub>2</sub>); 2.35 (t, <i>J</i> = 7.5, 2H, CH<sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.7, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.69–3.74 (m, 1H, CH); 3.98–4.02 (m, 2H, CH<sub>2</sub>OP); 4.08–4.16 (m, 2H, CO<sub>2</sub>CH<sub>2</sub>); 7.10–7.16 (m, 3H, 3CH<sub>Ar</sub>); 7.21–7.26 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 25.8, 30.2, 30.3, 30.4, 30.55, 30.56, 30.7, 32.8 (8CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 65.8 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.1 (d, <i>J</i> = 5.6, CH<sub>2</sub>OP); 69.3 (d, <i>J</i> = 8.9, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 144.0 (C<sub>Ar</sub>); 175.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.07. [α]<sub>D</sub><sup>20</sup>: +0.2 (<i>c</i> = 0.32, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>20</sub>H<sub>32</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 415.1891, found 415.1906. HPLC-MS retention time (min): 27.56.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 15-Phenylpentadecanoate, <b>23</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>23</b> was obtained from dibenzyl phosphate <b>65</b> (20 mg, 31 μmol) in 90% yield. IR (ATR): 1738 (C═O), 1259 (P═O), 1083 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.28–1.32 (m, 20H, 10CH<sub>2</sub>); 1.57–1.64 (m, 4H, 2CH<sub>2</sub>); 2.35 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.5, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.97–4.35 (m, 5H, CO<sub>2</sub>CH<sub>2</sub>, CH, CH<sub>2</sub>OP); 7.08–7.16 (m, 3H, 3CH<sub>Ar</sub>); 7.21–7.26 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 26.0, 30.2, 30.3, 30.4, 30.59, 30.6, 30.7 (7CH<sub>2</sub>); 30.73 (2CH<sub>2</sub>); 30.75 (2CH<sub>2</sub>); 32.8 (CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 64.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 67.1 (d, <i>J</i> = 5.3, CH<sub>2</sub>OP); 68.3 (d, <i>J</i> = 8.3, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 144.0 (C<sub>Ar</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.11. [α]<sub>D</sub><sup>20</sup>: +4.2 (<i>c</i> = 0.40, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>24</sub>H<sub>40</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 471.2517, found 471.2520. HPLC-MS retention time (min): 33.42.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 7-([1,1′-Biphenyl]-4-yl)heptanoate, <b>24</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>24</b> was obtained from dibenzyl phosphate <b>66</b> (27 mg, 43 μmol) in 74% yield. IR (ATR): 1720 (C═O), 1058 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.36–1.40 (m, 4H, 2CH<sub>2</sub>); 1.60–1.70 (m, 4H, 2CH<sub>2</sub>); 2.36 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.64 (t, <i>J</i> = 7.5, 2H, ArC<u class="uu">H</u><sub>2</sub>); 3.97–4.01 (m, 3H, CH, CH<sub>2</sub>OP); 4.11 (dd, <i>J</i> = 11.3, 5.3, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.17 (dd, <i>J</i> = 11.3, 4.1, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 7.24 (d, <i>J</i> = 8.1, 2H, 2CH<sub>Ar</sub>); 7.30 (t, <i>J</i> = 7.5, 1H, CH<sub>Ar</sub>); 7.40 (t, <i>J</i> = 7.6, 2H, 2CH<sub>Ar</sub>); 7.51 (d, <i>J</i> = 8.2, 2H, 2CH<sub>Ar</sub>); 7.58 (d, <i>J</i> = 7.7, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 25.9; 29.9; 30.0; 32.5 (4CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.4 (Ar<u class="uu">C</u>H<sub>2</sub>); 65.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.1 (d, <i>J</i> = 5.4, CH<sub>2</sub>OP); 69.3 (d, <i>J</i> = 8.3, CH); 127.8 (2CH<sub>Ar</sub>); 127.84 (2CH<sub>Ar</sub>); 128.0 (CH<sub>Ar</sub>); 129.8 (2CH<sub>Ar</sub>); 129.9 (2CH<sub>Ar</sub>); 139.9; 142.4; 143.1 (3C<sub>Ar</sub>); 175.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.11. [α]<sub>D</sub><sup>20</sup>: +7.6 (<i>c</i> = 0.67, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>22</sub>H<sub>28</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 435.1578, found 435.1562. HPLC-MS retention time (min): 26.61.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 10-([1,1′-Biphenyl]-4-yl)decanoate, <b>25</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>25</b> was obtained from dibenzyl phosphate <b>67</b> (20 mg, 30 μmol) in 85% yield. IR (ATR): 3314 (C═O), 1654 (C═O), 1015 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 500 MHz,): δ 1.28–1.35 (m, 10H, 5CH<sub>2</sub>); 1.58–1.66 (m, 4H, 2CH<sub>2</sub>); 2.35 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.64 (t, <i>J</i> = 7.5, 2H, ArC<u class="uu">H</u><sub>2</sub>); 3.96–4.00 (m, 3H, CH, CH<sub>2</sub>OP); 4.11 (dd, <i>J</i> = 11.4, 5.4, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.17 (dd, <i>J</i> = 11.4, 4.2, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 7.24 (d, <i>J</i> = 8.1, 2H, 2CH<sub>Ar</sub>); 7.29 (t, <i>J</i> = 7.4, 1H, CH<sub>Ar</sub>); 7.40 (t, <i>J</i> = 7.7, 2H, 2CH<sub>Ar</sub>); 7.51 (d, <i>J</i> = 8.2, 2H, 2CH<sub>Ar</sub>); 7.58 (dd, <i>J</i> = 8.3, 1.1, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 26.0; 30.2; 30.3; 30.4; 30.5; 30.52; 32.7 (7CH<sub>2</sub>); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.5 (Ar<u class="uu">C</u>H<sub>2</sub>); 65.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 68.1 (d, <i>J</i> = 5.6, CH<sub>2</sub>OP); 69.3 (d, <i>J</i> = 8.2, CH); 127.8 (2CH<sub>Ar</sub>); 127.83 (2CH<sub>Ar</sub>); 128.0 (CH<sub>Ar</sub>); 129.8 (2CH<sub>Ar</sub>); 129.9 (2CH<sub>Ar</sub>); 139.9; 142.5; 143.2 (3C<sub>Ar</sub>); 175.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 3.11. HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>25</sub>H<sub>34</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 477.2048, found 477.2029. HPLC-MS retention time (min): 10.49.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (2<i>R</i>)-2-Hydroxy-3-(phosphonooxy)propyl 13-([1,1′-Biphenyl]-4-yl)tridecanoate, <b>26</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>26</b> was obtained from dibenzyl phosphate <b>68</b> (37 mg, 53 μmol) as a white solid in 91% yield. Mp: 95–97 °C. IR (ATR): 1730 (C═O), 1258 (P═O), 1027 (P–O). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): δ 1.23–1.29 (m, 16H, 8CH<sub>2</sub>); 1.49–1.52 (m, 2H, CH<sub>2</sub>); 1.57–1.60 (m, 2H, CH<sub>2</sub>); 2.28 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.60 (t, <i>J</i> = 7.6, 2H, ArC<u class="uu">H</u><sub>2</sub>); 3.35 (br s, 1H, OH); 3.73–3.76 (m, 2H, CH<sub>2</sub>OP); 3.79–3.85 (m, 1H, CH); 3.94 (dd, <i>J</i> = 11.2, 6.0, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 4.02 (dd, <i>J</i> = 11.2, 4.3, 1H, 1/2CO<sub>2</sub>CH<sub>2</sub>); 7.27 (d, <i>J</i> = 8.1, 2H, 2CH<sub>Ar</sub>); 7.33 (t, <i>J</i> = 7.3, 1H, CH<sub>Ar</sub>); 7.44 (t, <i>J</i> = 7.7, 2H, 2CH<sub>Ar</sub>); 7.56 (d, <i>J</i> = 8.1, 2H, 2CH<sub>Ar</sub>); 7.63 (d, <i>J</i> = 7.3, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 126 MHz): δ 26.4; 28.5; 28.6; 28.7; 28.8; 28.9 (6CH<sub>2</sub>); 28.98 (2CH<sub>2</sub>); 29.0; 30.9 (2CH<sub>2</sub>); 33.4 (<u class="uu">C</u>H<sub>2</sub>CO); 34.7 (Ar<u class="uu">C</u>H<sub>2</sub>); 64.9 (CO<sub>2</sub><u class="uu">C</u>H<sub>2</sub>); 66.1 (d, <i>J</i> = 5.3, CH<sub>2</sub>OP); 67.3 (d, <i>J</i> = 7.8, CH); 126.4 (2CH<sub>Ar</sub>); 126.5 (2CH<sub>Ar</sub>); 127.1 (CH<sub>Ar</sub>); 128.85 (2CH<sub>Ar</sub>); 128.87 (2CH<sub>Ar</sub>); 137.5; 140.1; 141.6 (3C<sub>Ar</sub>); 172.9 (CO). <sup>31</sup>P NMR (DMSO-<i>d</i><sub>6</sub>, 121 MHz): δ 2.16. [α]<sub>D</sub><sup>20</sup>: limited solubility. HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>28</sub>H<sub>40</sub>O<sub>7</sub>P ([M – H]<sup>−</sup>) 519.2517, found 519.2508. HPLC-MS retention time (min): 12.15.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (2<i>S</i>)-1-Bromo-3-(phosphonooxy)propan-2-yl 9-Phenylnonanoate, <b>76</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>76</b> was obtained from dibenzyl phosphate <b>81</b> (249 mg, 0.39 mmol) in 80% yield. <i>R</i><sub><i>f</i></sub>: 0.51 (DCM/EtOAc, 10:1). IR (ATR): 3320 (O–H), 1021 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.33 (app s, 8H, 4CH<sub>2</sub>); 1.59–1.66 (m, 4H, 2CH<sub>2</sub>); 2.38 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 2.60 (t, <i>J</i> = 7.7, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.63 (ABX system, <i>J</i> = 11.0, 6.0, 4.9, 2H, CH<sub>2</sub>Br); 4.14 (app t, <i>J</i> = 5.9, 2H, CH<sub>2</sub>OP); 5.17 (qt, <i>J</i> = 5.2, 1H, CH); 7.10–7.17 (m, 3H, 3CH<sub>Ar</sub>); 7.22–7.27 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 24.9, 29.1, 29.2, 29.3, 29.4, 29.7 (6CH<sub>2</sub>); 31.7 (CH<sub>2</sub>Br); 33.9 (<u class="uu">C</u>H<sub>2</sub>CO); 35.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 65.3 (d, <i>J</i> = 5.1, CH<sub>2</sub>OP); 71.5 (d, <i>J</i> = 8.3, CH); 125.6 (CH<sub>Ar</sub>); 128.2 (2CH<sub>Ar</sub>); 128.4 (2CH<sub>Ar</sub>); 143.0 (C<sub>Ar</sub>); 173.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 2.76. [α]<sub>D</sub><sup>20</sup>: +0.95 (<i>c</i> = 0.57, methanol). HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>18</sub>H<sub>28</sub><sup>79</sup>BrNaO<sub>6</sub>P ([M(<sup>79</sup>Br)+Na]<sup>+</sup>) 473.0705, found 473.0681; calculated for C<sub>18</sub>H<sub>28</sub><sup>81</sup>BrNaO<sub>6</sub>P ([M(<sup>81</sup>Br) + Na]<sup>+</sup>) 475.0684, found 475.0666. HPLC-MS retention time (min): 9.42.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (2<i>S</i>)-1-Bromo-3-(phosphonooxy)propan-2-yl 11-Phenylundecanoate, <b>77</b></h4><div class="NLM_p last">Following general procedure 2, compound <b>77</b> was obtained from dibenzyl phosphate <b>82</b> (48 mg, 73 μmol) in 72% yield. <i>R</i><sub><i>f</i></sub>: 0.46 (DCM/EtOAc, 10:1). IR (ATR): 3336 (O–H), 1689 (C═O), 1251 (P═O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 300 MHz): δ 1.26–1.36 (m, 12H, 6CH<sub>2</sub>); 1.56–1.68 (m, 4H, 2CH<sub>2</sub>); 2.37 (t, <i>J</i> = 7.3, 2H, CH<sub>2</sub>CO); 2.59 (t, <i>J</i> = 7.6, 2H, PhC<u class="uu">H</u><sub>2</sub>); 3.62 (ABX system, <i>J</i> = 10.9, 6.0, 4.8, 2H, CH<sub>2</sub>Br); 4.13 (app t, <i>J</i> = 5.0, 2H, CH<sub>2</sub>OP); 5.16 (qt, <i>J</i> = 5.1, 1H, CH); 7.10–7.16 (m, 3H, 3CH<sub>Ar</sub>); 7.21–7.26 (m, 2H, 2CH<sub>Ar</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 75 MHz): δ 26.0, 30.1, 30.3, 30.4, 30.5, 30.55, 30.62, 30.8 (8CH<sub>2</sub>); 32.8 (CH<sub>2</sub>Br); 34.9 (<u class="uu">C</u>H<sub>2</sub>CO); 36.9 (Ph<u class="uu">C</u>H<sub>2</sub>); 66.3 (d, <i>J</i> = 4.9, CH<sub>2</sub>OP); 72.5 (d, <i>J</i> = 8.8, CH); 126.6 (CH<sub>Ar</sub>); 129.2 (2CH<sub>Ar</sub>); 129.4 (2CH<sub>Ar</sub>); 144.0 (C<sub>Ar</sub>); 174.3 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 121 MHz): δ 2.82. [α]<sub>D</sub><sup>20</sup>: −7.8 (<i>c</i> = 0.81, methanol). HRMS (MALDI, <i>m</i>/<i>z</i>): calculated for C<sub>20</sub>H<sub>32</sub>Na<sup>79</sup>BrO<sub>6</sub>P ([M(<sup>79</sup>Br) + Na]<sup>+</sup>) 501.1018, found 501.1002; calculated for C<sub>20</sub>H<sub>32</sub>Na<sup>81</sup>BrO<sub>6</sub>P ([M(<sup>81</sup>Br) + Na]<sup>+</sup>) 503.0997, found 503.1019. HPLC-MS retention time (min): 10.06.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2<i>S</i>)-1-Bromo-3-(phosphonooxy)propan-2-yl (9<i>Z</i>)-Hexadec-9-enoate, <b>78</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>78</b> was obtained from <i>tert</i>-butyl ester <b>83</b> (4 mg, 6.9 μmol) and TFA (40 μL, 0.51 mmol) in 93% yield. IR (ATR): 1741 (C═O), 1457 (C═C), 1015 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 500 MHz): δ 0.93 (t, <i>J</i> = 6.8, 3H, CH<sub>3</sub>); 1.29–1.42 (m, 16H, 8CH<sub>2</sub>);1.56–1.70 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.03–2.06 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.40 (t, <i>J</i> = 7.4, 2H, CH<sub>2</sub>CO); 3.62 (dd, <i>J</i> = 10.9, 6.1, 1H, 1/2CH<sub>2</sub>Br); 3.70 (dd, <i>J</i> = 10.7, 4.5, 1H, 1/2CH<sub>2</sub>Br); 4.05–4.17 (m, 2H, CH<sub>2</sub>OP); 5.13–5.24 (m, 1H, CH); 5.31–5.44 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 125 MHz): δ 13.4 (CH<sub>3</sub>); 22.7 (CH<sub>2</sub>); 25.0, 25.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 27.1, 27.13, 27.14, 29.0, 29.2, 29.77, 29.78, 29.8, 31.9 (9CH<sub>2</sub>); 33.9 (<u class="uu">C</u>H<sub>2</sub>CO); 60.5 (d, <i>J</i> = 7.2, CH<sub>2</sub>OP); 64.9 (d, <i>J</i> = 5.3, CH); 129.8, 129.9 (2CH<sub>alkene</sub>); 173.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 202 MHz): δ 2.88. [α]<sub>D</sub><sup>20</sup>: +5.9 (<i>c</i> = 0.09, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>19</sub>H<sub>35</sub><sup>79</sup>BrO<sub>6</sub>P ([M(<sup>79</sup>Br) – H]<sup>−</sup>) 469.1360, found 469.1361; calculated for C<sub>19</sub>H<sub>35</sub><sup>81</sup>BrO<sub>6</sub>P ([M(<sup>81</sup>Br) – H]<sup>−</sup>) 471.1340, found 471.1342. HPLC-MS retention time (min): 23.25.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (2<i>S</i>)-1-Bromo-3-(phosphonooxy)propan-2-yl (9<i>Z</i>)-Octadec-9-enoate, <b>79</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>79</b> was obtained from di-<i>tert</i>-butyl phosphate <b>84</b> (5 mg, 8.17 μmol) and TFA (15 μL, 204 μmol) without further purification in 81% yield. IR (ATR): 1739 (C═O), 1666 (C═C), 1071 (P–O). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 700 MHz): δ 0.90 (t, <i>J</i> = 7.0, 3H, CH<sub>3</sub>); 1.28–1.35 (m, 20H, 10CH<sub>2</sub>); 1.62–1.65 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 2.02–2.05 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.37 (td, <i>J</i> = 7.4, 3.2, 2H, CH<sub>2</sub>CO); 3.60 (dd, <i>J</i> = 11.0, 6.1, 1H, 1/2CH<sub>2</sub>Br); 3.68 (dd, <i>J</i> = 11.0, 4.6, 1H, 1/2CH<sub>2</sub>Br); 4.07–4.12 (m, 2H, CH<sub>2</sub>OP); 5.14–5.18 (m, 1H, CH); 5.32–5.37 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>, 175 MHz): δ 14.5 (CH<sub>3</sub>); 23.8, 26.0 (2CH<sub>2</sub>); 28.1 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 30.1, 30.2, 30.3, 30.4, 30.5, 30.6, 30.8, 30.9, 31.1, 33.1 (10CH<sub>2</sub>); 35.0 (<u class="uu">C</u>H<sub>2</sub>CO); 66.0 (d, <i>J</i> = 3.1, CH<sub>2</sub>OP); 72.8 (d, <i>J</i> = 5.5, CH); 130.8, 130.9 (2CH<sub>alkene</sub>); 174.4 (CO). <sup>31</sup>P NMR (methanol-<i>d</i><sub>4</sub>, 202 MHz): δ 3.36. [α]<sub>D</sub><sup>20</sup>: +3.3 (<i>c</i> = 0.33, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>21</sub>H<sub>39</sub><sup>79</sup>BrO<sub>6</sub>P ([M(<sup>79</sup>Br) – H]<sup>−</sup>) 497.1673, found 497.1664; calculated for C<sub>21</sub>H<sub>39</sub><sup>81</sup>BrO<sub>6</sub>P ([M(<sup>81</sup>Br) – H]<sup>−</sup>) 499.1653, found 499.1642. HPLC-MS retention time (min): 25.58.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Fluoro[(2<i>S</i>)-3-{[(9<i>Z</i>)-hexadec-9-enoyl]amino}-2-methoxypropyl]propanedioic Acid, <b>85</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>85</b> was obtained from <i>tert</i>-butyl ester <b>89</b> (10 mg, 18 μmol) and TFA (104 μL, 1.34 mmol) in 99% yield. <i>R</i><sub><i>f</i></sub>: 0.17 (hexane/EtOAc, 6:4). IR (ATR): 3273 (N–H), 1646 (C═O, broad). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 700 MHz): δ 0.88 (t, <i>J</i> = 7.0, 3H, CH<sub>3</sub>); 1.25–1.34 (m, 16H, 8CH<sub>2</sub>); 1.54–1.67 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO); 1.95–2.04 (m, 4H, 2C<u class="uu">H</u><sub>2</sub>CH<sub>alkene</sub>); 2.19–2.56 (m, 4H, CH<sub>2</sub>CO, CH<sub>2</sub>CF); 3.24–3.70 (m, 6H, NHC<u class="uu">H</u><sub>2</sub>, CH, OCH<sub>3</sub>); 5.30–5.36 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 175 MHz): δ 14.3 (CH<sub>3</sub>); 22.8, 26.0 (2CH<sub>2</sub>); 27.4 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.1, 29.4, 29.5 (3CH<sub>2</sub>); 29.88 (2CH<sub>2</sub>); 29.93, 31.9, 36.6 (3CH<sub>2</sub>); 36.7 (br s, <u class="uu">C</u>H<sub>2</sub>CF); 42.2 (br s, NHCH<sub>2</sub>); 57.6 (OCH<sub>3</sub>); 74.5 (CH); 129.8, 130.1 (2CH<sub>alkene</sub>); 169.3 (br s, 2CO<sub>2</sub>H); 175.6 (CONH); CF not observed. [α]<sub>D</sub><sup>20</sup>: −0.5 (<i>c</i> = 0.14, methanol). HRMS (ESI, <i>m</i>/<i>z</i>): calculated for C<sub>23</sub>H<sub>39</sub>FNO<sub>6</sub> ([M – H]<sup>−</sup>) 444.2767, found 444.2784. HPLC-MS retention time (min): 29.71.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Fluoro[(2<i>S</i>)-2-methoxy-3-{[(9<i>Z</i>)-octadec-9-enoyl]amino}propyl]propanedioic Acid, <b>86</b></h4><div class="NLM_p last">Following general procedure 1, compound <b>86</b> was obtained from <i>tert</i>-butyl ester <b>90</b> (18 mg, 31 μmol) and TFA (178 μL, 2.30 mmol) in 69% yield. <i>R</i><sub><i>f</i></sub>: 0.19 (hexane/EtOAc, 6:4). IR (ATR): ν 1734 (C═O), 1648 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 700 MHz): δ 0.88 (t, <i>J</i> = 6.3, 3H, CH<sub>3</sub>); 1.25–1.26 (m, 20H, 10CH<sub>2</sub>); 1.53–1.67 (m, 2H, <u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>CO); 1.94–2.04 (m, 4H, 2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 2.13–2.58 (m, 4H, CH<sub>2</sub>CO; CH<sub>2</sub>CF); 3.11–3.66 (m, 6H, NHC<u class="uu">H</u><sub>2</sub>, CH, OCH<sub>3</sub>); 5.27–5.40 (m, 2H, 2CH<sub>alkene</sub>). <sup>13</sup>C NMR (CDCl<sub>3,</sub> 175 MHz): 14.3 (CH<sub>3</sub>); 22.8; 25.9 (2CH<sub>2</sub>); 27.4 (2<u class="uu">C</u>H<sub>2</sub>CH<sub>alkene</sub>); 29.48; 29.5; 29.7; 29.71; 29.86; 29.9; 29.94; 32.1; 33.9; 36.5 (10CH<sub>2</sub>); 36.6 (br s, <u class="uu">C</u>H<sub>2</sub>CF); 41.2 (br s, NHCH<sub>2</sub>); 57.5 (OCH<sub>3</sub>); 75.3 (CH); 129.8; 130.1 (2CH<sub>alkene</sub>); 169.4 (br s, 2CO<sub>2</sub>H); 174.9 (CONH); CF not observed. [α]<sub>D</sub><sup>20</sup>: −2.07 (<i>c</i> = 0.28, methanol). HRMS (ESI, <i>m</i>/<i>z</i>):calculated for C<sub>25</sub>H<sub>43</sub>FNO<sub>6</sub> ([M – H]<sup>−</sup>) 472.3080, found 472.3095. HPLC-MS retention time (min): 21.44.</div></div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Cell Lines and Culture</h3><div class="NLM_p last">RH7777 hepatoma cells stably expressing the LPA<sub>1</sub> receptor and their corresponding nontransfected controls were kindly provided by Prof. Gabor Tigyi (University of Tennessee Health Science Center, Memphis, Tennessee). Retrovirus expression vector (LZRS-EGFP) and Phoenix retrovirus producer cell lines were provided by Prof. Garry P. Nolan (Stanford University, Stanford, California). Collagen, poly(<span class="smallcaps smallerCapital">d</span>-lysine), poly(<span class="smallcaps smallerCapital">l</span>-lysine), and LPA were purchased from Aldrich. Capsaicin was purchased from Sigma. Ionomycin was purchased from Cayman. All other reagents were from Gibco. All cells were grown in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% nonessential amino acids, 1% sodium pyruvate, 100 U/mL penicillin, and 100 μg/mL streptomycin in a 5% CO<sub>2</sub> humidified atmosphere at 37 °C. For passage, cells were rinsed with phosphate buffered saline (PBS) and incubated with 0.125% trypsin, 0.02% EDTA solution for 2 min at 37 °C. Detached cells were resuspended in growth medium, counted if necessary, and split onto fresh dishes.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Generation of LPA<sub>1–3</sub> Overexpressing Cell Lines</h3><div class="NLM_p last">Cell lines stably expressing LPA<sub>1–3</sub> receptors were generated by retroviral infection of B103 cells. Lipofectamine 2000 transfection reagent (Invitrogen) was used to transfect the Phoenix ecotropic packaging cell line with retroviral constructs expressing FLAG-tagged human LPA<sub>1–3</sub> cDNAs and EGFP. An internal ribosomal entry site (IRES) allowed dual expression of both the LPA<sub>1–3</sub> receptors and EGFP. Retroviral supernatant was harvested 48 h post-transfection, filtered through a 0.45 μm filter, and added to B103 cells in the presence of Polybrene (Sigma). Cells were centrifuged for 90 min at 28 °C, after which the retroviral supernatant was replaced by DMEM. B103 cells expressing high levels of LPA<sub>1–3</sub> and high levels of EGFP were isolated by FACS using a Vantage DiVa I instrument. Control B103 cells transfected with empty vector were also obtained and used as control throughout the experiments.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Evaluation of Receptor Activation by Ca<sup>2+</sup> Mobilization Assay</h3><div class="NLM_p last">Changes in intracellular calcium levels were measured using the fluorescent calcium sensitive dye Fluo-4 NW (Invitrogen). RH7777 cells or B103 cells were plated on poly(<span class="smallcaps smallerCapital">d</span>-lysine) or collagen-coated, respectively, black-wall clear-bottom 96-well plates (Corning) at a density of 50000 cells/well and cultured overnight. The culture medium was then replaced with Fluo-4 NW dye loading solution containing 2.5 μM probenecid and incubated for 30 min at 37 °C followed by an additional 30 min at rt. Fluorescence changes were registered in a FluoStar Optima instrument (BMG Labtech) at 525 nm using an excitation wavelength of 494 nm. Each well was monitored for 240 s. Twenty microliters of the test compound from a 6× stock solution in assay buffer was added 120 s after starting the measurement. Ca<sup>2+</sup> transient increase was quantified by calculating the difference between maximum and baseline values for each well. As positive controls, 10 μM LPA and 10 μM ionomycin were included in every experiment. At this concentration, LPA induced a response about 30–33% of the one shown by ionomycin, which is in agreement with previously described results.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The data presented are from two to four independent experiments carried out in triplicate or quadruplicate. Dose–response curves were generated and EC<sub>50</sub> values calculated by nonlinear regression analysis using PRISM software version 5 (GraphPad Software Inc., San Diego, CA, USA). For assessing covalent binding, after the initial stimulation with compound (<i>S</i>)-<b>17</b>, media was removed, cells were washed with buffer, and after 30 min, fresh compound was added and Ca<sup>2+</sup> mobilization was measured as described above.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Activity at LPA<sub>4–6</sub> Receptors</h3><div class="NLM_p last">B103 naive cells were transiently transfected with pCXN2.1 vectors harboring hLPA<sub>4</sub>, hLPA<sub>5</sub>, and hLPA<sub>6</sub>, plated onto 384 well plates, and cultured overnight. The media was replaced with FreeStype 293 Expression Medium 4 h before the assay. Cells were loaded with Fluo-4 dye in the presence of 5 mM probenecid for 1 h. Ca<sup>2+</sup> signaling was monitored with a Hamamatsu FDSS7000 instrument.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> In Silico Experiments</h3><div class="NLM_p last">Docking calculations were performed using Autodock4<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (ga_num_evals = 40000000, ga_run = 100, and all the other parameters set to their default values). The LPA<sub>1</sub> active state model was retrieved from the GPCRdb<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> (2019, March 11th release, downloaded 2019, October 2; structure file provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb" class="ext-link">Supporting Information</a>) and prepared for docking using pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pqr">2pqr</a><a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> with propka<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> protonation option at a pH of 7.4 and the peoepb force field.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> (<i>S</i>)-<b>17</b> was modeled using RDKIT, and its protonation state was adjusted at pH 7.4 by ChemAxon cxcalc module. Binding mode pictures were created using PyMOL v1.8 and PLIP v1.4.4.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Stability Studies</h3><div class="NLM_p last">These studies were carried out as previously described with minor modifications.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> For chemical stability, to a vial containing 998 μL of PBS, pH 7.4, 2 μL of a 25 mM solution of test compound in DMSO was added, and the mixture was kept at rt. Remaining compound at each time point was quantified by HPLC-MS (SIM mode) using the peak area integration normalized with an internal standard. To determine the stability in cellular culture medium, 12 μL of a 50 mM solution of test compound in DMSO was added to 1188 μL of cellular culture medium prewarmed at 37 °C. Samples were incubated at 37 °C, and 200 μL aliquots were taken at the corresponding time points. Each aliquot was quenched in 200 μL of cold ACN, vortexed, incubated for 10 min in ice and centrifuged at 39000<i>g</i> for 10 min. Supernatants were then analyzed by HPLC-MS using SIM mode, and quantification was estimated by using the peak area integration normalized with an internal standard.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Receptor Internalization and Neurite Retraction Assay</h3><div class="NLM_p last">B103 neuroblastoma cells overexpressing EGFP–LPA<sub>1</sub> receptor were plated on poly(<span class="smallcaps smallerCapital">l</span>-lysine)-coated glass coverslips in 24-well plates (5 × 10<sup>4</sup> cells per well) and serum-starved overnight. For the experiment, media was replaced with 1 mL of fresh serum-free DMEM supplemented with 0.1% FAF BSA, 1 μM LPA, or (<i>S</i>)-<b>17</b>. After 15 min, cells were fixed with 4% paraformaldehyde and permeabilized with 0.025% Triton X-100/PBS for 15 min. Immunocytochemistry experiments were carried out following experimental procedures previously described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Briefly, F-actin was detected with rhodamine–phalloidin (Sigma) in PBS and nuclei with DAPI (Sigma). For neurite retraction, samples were visualized on a fluorescence microscopy (Carl Zeiss). For receptor internalization, cells were analyzed using confocal fluorescence microscopy (Carl Zeiss).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Migration Assay</h3><div class="NLM_p last">Cell migration was measured in Transwell chambers (PET membrane with 8 μm pore size, Becton Dickinson). Bottom membrane of transwells was precoated overnight at 4 °C with 10 μg/mL of collagen solution in PBS. B103 neuroblastoma cells overexpressing LPA<sub>1</sub> receptor were serum-starved overnight, and then harvested with 0.125% trypsin containing 0.02% EDTA, washed once, counted, and resuspended in serum-free DMEM. The cells were seeded into the upper chamber (2.5 × 10<sup>5</sup> cells per transwell), and 0.1% FAF BSA, 1 μM LPA, or (<i>S</i>)-<b>17</b> was placed in the lower chamber. Cells were allowed to migrate for 5 h at 37 °C. Nonmigratory cells were removed from the top filter surface with a cotton swab. Migratory cells attached to the underside of the transwells were washed with PBS, stained with 0.1% crystal violet solution, and counted under a microscope.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Primary Culture of Sensory Neurons</h3><div class="NLM_p last">DRG were harvested from neonatal Wistar rats (3–5 days old). Ganglia were digested with 0.25% (w/v) collagenase (type IA) in DMEM-glutamax (Invitrogen) with 1% penicillin–streptomycin (5000 U/mL, Invitrogen) for 1 h (37 °C, 5% CO<sub>2</sub>). After digestion, rat DRG was mechanically dissociated using a glass Pasteur pipet. Single cell suspension was passed through a 100 μm cell strainer and washed with DMEM glutamax plus 10% fetal bovine serum (FBS; Invitrogen) and 1% penicillin–streptomycin. Cells were seeded in 30 μL of medium containing cells on MEA chambers previously coated with poly(<span class="smallcaps smallerCapital">l</span>-lysine) (8.33 μg/mL) and laminin (5 μg/mL). After 2 h, medium was replaced with DMEM glutamax, 10% FBS, and 1% penicillin–streptomycin, supplemented with mouse 2.5s NGF 50 ng/mL (Promega), and 1.25 μg/mL cytosine arabinoside when required (37 °C, 5% CO<sub>2</sub>). All experiments were made 48 h after cell seeding.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Microelectrode Array (MEA)</h3><div class="NLM_p last">Extracellular recordings were made using multiple electrode planar arrays of 60-electrode thin MEA chips, with 30 μm diameter electrodes and 200 μm interelectrode spacing with an integrated reference electrode (Multichannel Systems GmbH). The electrical activity of primary sensory neuron was recorded by the MEA1060 System (Multi Channel Systems GmbH, <a href="http://www.multichannelsystems.com" class="extLink">http://www.multichannelsystems.com</a>) and MC_Rack software version 4.3.0 at a sampling rate of 25 kHz. Fifteen second application of 10 μM of LPA and its derivatives was perfused to identify evoked neuronal spikes on cultured rat DRG neurons, using continuous perfusion system (2 mL/min flux). Capsaicin (500 nM) was applied at the end of the protocol to measure TRPV1 sensitivity of the neurons that were exposed to LPA or (<i>S</i>)-<b>17</b>. Data were analyzed using MC_RACK spike sorter and Neuroexplorer Software (Nex Technologies). An evoked spike was defined when the amplitude of the neuronal electrical activity overcame a threshold set at −20 μV. The recorded signals were then processed to extract mean spike frequency.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Calcium Microfluorography</h3><div class="NLM_p last">DRG on coverslips loaded with 5 μM fluo-4-acetoxymethyl ester (Fluo-4AM) plus 0.02% pluronic acid (Molecular Probes, Invitrogen) in HBSS extracellular solution (in mM, 140 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, 5 <span class="smallcaps smallerCapital">d</span>-glucose, and 10 HEPES, pH 7.4) for 1 h (37 °C, 5% CO<sub>2</sub>) mounted in a RC-25 chamber (Harvard Apparatus) were continuously perfused with test solutions at rt. Fluorescence from individual neurons was monitored through a 10× air objective (Aixiovert 200 inverted microscope, Carl Zeiss) with an ORCA-ER CCD camera (Hamamatsu Photonics). Preprogrammed protocols were applied via computer-controlled pinch valves (Bioscience Tools, 5 mL/min flux). Fluo-4AM was excited at 500 nm, and emitted fluorescence was filtered at 535 nm (Lambda- 10–2-filter wheel, Sutter Instruments). Images were processed with AquaCosmos package software (Hamamatsu Photonics). LPA and (<i>S</i>)-<b>17</b> were perfused at 10 μM for 10 s. TRPV1 channel activity was evoked with 10 s application of capsaicin at 1 μM. Ten second pulse of 40 mM KCl was applied to distinguish neuronal viability. Ionomycin was used at 5 μM. Intracellular Ca<sup>2+</sup> increase was calculated as fluorescence difference between baseline and the peak reached. An evoked response was defined when intensity overcame 20% of baseline. For MEA and calcium microfluorography experiments, LPA and (<i>S</i>)-<b>17</b> were dissolved in DMSO at a stock concentration of 10 mM and then diluted in the standard external solution to use at a final concentration of 10 μM. Capsaicin was dissolved in DMSO at a stock concentration of 10 mM and used at 500 nM final concentration.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Writhing Assay and Locomotor and Exploratory Activity</h3><div class="NLM_p last">Writhing (abdominal contraction) was generated by an ip injection of 10 mL/kg of 0.6% acetic acid solution. Mice were randomly allocated to receive the corresponding treatment (9 animals per treatment). Exploratory and locomotor activity was assessed in the open field test (OFT). The apparatus was four open field arenas made of gray Plexiglas with the following dimensions: 40 × 40 × 30 cm<sup>3</sup> (Panlab, Barcelona, Spain). Light intensity in the test room was 70 lx. Mice were habituated for 30 min before starting the test. Compound (<i>S</i>)-<b>17</b> (1, 3, and 10 mg/kg) and vehicle (BSA 3%) at a total volume of 10 mL/kg were injected ip 30 min before placing the animal in the open field. Throughout the session, treatments were counterbalanced between arenas. Immobility and time spent in the center area of the test were digitally recorded (Sony DCR-SX65E) during 30 min session. Behavior was analyzed using Ethovision XT 9.0 (Noldus Information Technology, Wageningen, The Nederlands). The OFT was cleaned between mice with ethanol (30%). Compound (<i>S</i>)-<b>17</b> was dissolved in 3% fatty acid free BSA (Sigma-Aldrich) at dose 10 mg/kg and administered at volume of 10 mL/kg. Adult C57BL/6 male mice (35–40 g) were housed under controlled environment conditions (temperature 22.5 ± 0.5 °C, humidity 64% ± 1%, 12/12-h light/dark cycle, and free access to food and water). All experiments were carried out in compliance with the European Commission on Animal Care (EU Directive 2010/63/EU). Experimental protocols were approved by The Local Ethical Committee for Animal Research of the University of Malaga. Results are expressed as the mean ± SEM. Data were analyzed by <i>t</i>-Student or one-way analysis of variance (ANOVA) followed, when appropriated, by the Newman–Keuls Multiple Comparisons test. A value of <i>p</i> < 0.05 was considered as statistical significant. All statistical analyses were performed using the Graphpad Prism version 5.04 software (GraphPad Software, San Diego, CA, USA).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Spared Nerve Injury and Treatment</h3><div class="NLM_p">All surgical procedures were approved by the Universitat Autònoma de Barcelona Animal Care Committee (CEEAH 4273) and followed the guidelines of the European Commission on Animal Care (EU Directive 2010/63/EU). Adult female C57Bl/6J mice (10–12 weeks old) were anesthetized with a mixture of ketamine (90 mg/kg) and xylazine (10 mg/kg). An incision was made on the lateral surface of the thigh to expose the three branches of the left sciatic nerve: the sural, common peroneal, and tibial nerves. Both tibial and common peroneal nerves were ligated with a 10.0 silk suture and transected approximately at 2 mm distal to the ligation. The sural nerve was left intact. Then, the muscles and skin were sutured, and the wound was disinfected. Mice were left to recover on a warm pad and returned to their home cages.</div><div class="NLM_p last">Mice were randomly assigned to each treatment group. (<i>S</i>)-<b>17</b> was diluted in 0.5% DMSO and administered daily at a dose of 10 mg/kg, starting 1 h after the injury. Control mice received equivalent volume of the vehicle.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Mechanical Nociceptive Threshold</h3><div class="NLM_p last">Sensibility to mechanical stimuli was measured with an electronic Von Frey algesimeter (Bioseb) before surgery and at different times after injury. Mice were placed on a wire net platform in Plexiglas chambers for approximately 15 min before the experiment for habituation. The Von Frey probe was pressed against the midplantar surface of the hind paw. Nociceptive response for mechanical sensitivity was expressed as the force (in grams) at which mice withdrew the hind paw in response to the mechanical stimulus. The mechanical nociceptive threshold was taken as the mean of three measurements per test with a 5 min interval between each measurement.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01287" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01287?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01287</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Representative plots of BSI signal vs ligand concentration for the determination of affinity constant, reversibility and stability studies, representative calcium microfluorography recordings on neonatal rat cultures, experimental protocol for microelectrode array (MEA) and representative MEA recordings, effect of acute administration of (<i>S</i>)-<b>17</b> in the acetic acid-induced writhing responses, effect of (<i>S</i>)-<b>17</b> in the exploratory or locomotor activity of mice, activity at LPA<sub>2</sub> and LPA<sub>3</sub> receptors for all compounds with agonist activity at the LPA<sub>1</sub> receptor, detailed synthetic procedures, and characterization data of all intermediates (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Structure of the LPA<sub>1</sub> receptor (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_001.csv">jm9b01287_si_001.csv (2.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf">jm9b01287_si_002.pdf (1.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb">jm9b01287_si_003.pdb (184.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01287" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María L. López-Rodríguez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8607-1085" title="Orcid link">http://orcid.org/0000-0001-8607-1085</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#acc1c0d9d6c0deecd9cfc182c9df"><span class="__cf_email__" data-cfemail="1a77766f6076685a6f7977347f69">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Ortega-Gutiérrez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8af9e3e5f8feefedebcaffe9e7a4eff9"><span class="__cf_email__" data-cfemail="4a392325383e2f2d2b0a3f2927642f39">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Inés González-Gil</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debora Zian</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henar Vázquez-Villa</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7911-3160" title="Orcid link">http://orcid.org/0000-0001-7911-3160</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gloria Hernández-Torres</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Fernando Martínez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nora Khiar-Fernández</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Rivera</span> - <span class="hlFld-Affiliation affiliation">Sanford
Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuyuki Kihara</span> - <span class="hlFld-Affiliation affiliation">Sanford
Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel Devesa</span> - <span class="hlFld-Affiliation affiliation">IDiBE, Universidad
Miguel Hernández de Elche, E-03202 Alicante, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sakthikumar Mathivanan</span> - <span class="hlFld-Affiliation affiliation">IDiBE, Universidad
Miguel Hernández de Elche, E-03202 Alicante, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Rosell del Valle</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Investigación Biomédica de Málaga, UGC Salud
Mental, Universidad de Málaga, Hospital
Universitario Regional de Málaga, E-29010 Málaga, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma Zambrana-Infantes</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Investigación Biomédica de Málaga, UGC Salud
Mental, Universidad de Málaga, Hospital
Universitario Regional de Málaga, E-29010 Málaga, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Puigdomenech</span> - <span class="hlFld-Affiliation affiliation">Departament
de Biologia Cel·lular, Fisiologia i Immunologia, Institut de
Neurociències, Centro de Investigación Biomédica
en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Bellaterra, E-08193 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Cincilla</span> - <span class="hlFld-Affiliation affiliation">Molomics, Barcelona Science Park, Baldiri
i Reixac 4-8, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melchor Sanchez-Martinez</span> - <span class="hlFld-Affiliation affiliation">Molomics, Barcelona Science Park, Baldiri
i Reixac 4-8, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Rodríguez de Fonseca</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Investigación Biomédica de Málaga, UGC Salud
Mental, Universidad de Málaga, Hospital
Universitario Regional de Málaga, E-29010 Málaga, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Psicobiología, Facultad de Psicología, Universidad Complutense de Madrid, Pozuelo de Alarcón, E-28223 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio V. Ferrer-Montiel</span> - <span class="hlFld-Affiliation affiliation">IDiBE, Universidad
Miguel Hernández de Elche, E-03202 Alicante, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerold Chun</span> - <span class="hlFld-Affiliation affiliation">Sanford
Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rubén López-Vales</span> - <span class="hlFld-Affiliation affiliation">Departament
de Biologia Cel·lular, Fisiologia i Immunologia, Institut de
Neurociències, Centro de Investigación Biomédica
en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Bellaterra, E-08193 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7615-9550" title="Orcid link">http://orcid.org/0000-0001-7615-9550</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>I.G.-G. and D.Z. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work has been awarded with the Almirall Prize for Young Researchers from the Sociedad Española de Química Terapéutica (SEQT) to I.G.-G. This work has been supported by the Spanish Ministerio de Economía y Competitividad (MINECO, Grants SAF2016-78792-R to M.L.L.-R. and S.O.-G., SAF2015-66275-C2-1 and RTI2018-097189-B-C21 to A.V.F.-M., and SAF2016-79774-R to R.L.-V.), Wings for Life International Foundation, and Red de Terapia Celular (TERCEL) to R.L.-V., Instituto de Salud Carlos III MINECO and Regional Development Funds-European Union (ERdf-EU) (Grant PI16/01698 to F.R.F.), and National Institutes of Health (NS084398 to J.C.). The authors thank MINECO for predoctoral F.P.U. grants to I.G.-G. and D.Z. RH7777 hepatoma cells stably expressing the LPA<sub>1</sub> receptor and their corresponding nontransfected controls were kindly provided by Prof. Gabor Tigyi (University of Tennessee Health Science Center, Memphis, Tennessee). Retrovirus expression vector (LZRS-EGFP) and Phoenix retrovirus producer cell lines were provided by Prof. Garry P. Nolan (Stanford University, Stanford, California).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BSI</td><td class="NLM_def"><p class="first last">backscattering interferometry</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6′-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglia</p></td></tr><tr><td class="NLM_term">EDG</td><td class="NLM_def"><p class="first last">endothelial differentiation gene</p></td></tr><tr><td class="NLM_term">EGFP</td><td class="NLM_def"><p class="first last">enhanced green fluorescent protein</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal receptor activation</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">FAF BSA</td><td class="NLM_def"><p class="first last">fatty acid free bovine serum albumin</p></td></tr><tr><td class="NLM_term">Fluo-4AM</td><td class="NLM_def"><p class="first last">fluo-4-acetoxymethyl ester</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">MEA</td><td class="NLM_def"><p class="first last">multielectrode array</p></td></tr><tr><td class="NLM_term">NE</td><td class="NLM_def"><p class="first last">no effect</p></td></tr><tr><td class="NLM_term">NP</td><td class="NLM_def"><p class="first last">neuropathic pain</p></td></tr><tr><td class="NLM_term">OFT</td><td class="NLM_def"><p class="first last">open field test</p></td></tr><tr><td class="NLM_term">RI</td><td class="NLM_def"><p class="first last">refractive index</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SNI</td><td class="NLM_def"><p class="first last">spared nerve injury</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr><tr><td class="NLM_term">TRPV1</td><td class="NLM_def"><p class="first last">transient receptor potential vanilloid 1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 61 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">LPA receptors: subtypes and biological actions</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.010909.105753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1146%2Fannurev.pharmtox.010909.105753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=20055701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=157-186&author=J.+W.+Choiauthor=D.+R.+Herrauthor=K.+Noguchiauthor=Y.+C.+Yungauthor=C.+W.+Leeauthor=T.+Mutohauthor=M.+E.+Linauthor=S.+T.+Teoauthor=K.+E.+Parkauthor=A.+N.+Mosleyauthor=J.+Chun&title=LPA+receptors%3A+subtypes+and+biological+actions&doi=10.1146%2Fannurev.pharmtox.010909.105753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptors: subtypes and biological actions</span></div><div class="casAuthors">Choi, Ji Woong; Herr, Deron R.; Noguchi, Kyoko; Yung, Yun C.; Lee, Chang-Wook; Mutoh, Tetsuji; Lin, Mu-En; Teo, Siew T.; Park, Kristine E.; Mosley, Alycia N.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-186</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling mol. by binding to and activating at least 5 known G protein-coupled receptors (GPCRs): LPA1-LPA5.  They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice.  The biol. roles of LPA are diverse and include developmental, physiol., and pathophysiol. effects.  This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors.  Studies using cloned receptors and genetic knockout mice were instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ systems such as the nervous system.  This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru4MuMgWgZ7LVg90H21EOLACvtfcHk0liCB_ThLP76cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D&md5=995861e6d3dcc7193eba9b4948b4811d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.010909.105753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.010909.105753%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DPark%26aufirst%3DK.%2BE.%26aulast%3DMosley%26aufirst%3DA.%2BN.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptors%253A%2520subtypes%2520and%2520biological%2520actions%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D157%26epage%3D186%26doi%3D10.1146%2Fannurev.pharmtox.010909.105753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maceyka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophospholipid receptor nomenclature review: IUPHAR Review 8</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">3575</span>– <span class="NLM_lpage">3594</span>, <span class="refDoi"> DOI: 10.1111/bph.12678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fbph.12678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=24602016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKltr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3575-3594&author=Y.+Kiharaauthor=M.+Maceykaauthor=S.+Spiegelauthor=J.+Chun&title=Lysophospholipid+receptor+nomenclature+review%3A+IUPHAR+Review+8&doi=10.1111%2Fbph.12678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptor nomenclature review: IUPHAR Review 8</span></div><div class="casAuthors">Kihara, Yasuyuki; Maceyka, Michael; Spiegel, Sarah; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3575-3594</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Lysophospholipids encompass a diverse range of small, membrane-derived phospholipids that act as extracellular signals.  The signalling properties are mediated by 7-transmembrane GPCRs, constituent members of which have continued to be identified after their initial discovery in the mid-1990s.  Here we briefly review this class of receptors, with a particular emphasis on their protein and gene nomenclatures that reflect their cognate ligands.  There are six lysophospholipid receptors that interact with lysophosphatidic acid (LPA): protein names LPA1 - LPA6 and italicized gene names LPAR1-LPAR6 (human) and Lpar1-Lpar6 (non-human).  There are five sphingosine 1-phosphate (S1P) receptors: protein names S1P1-S1P5 and italicized gene names S1PR1-S1PR5 (human) and S1pr1-S1pr5 (non-human).  Recent addns. to the lysophospholipid receptor family have resulted in the proposed names for a lysophosphatidyl inositol (LPI) receptor - protein name LPI1 and gene name LPIR1 (human) and Lpir1 (non-human) - and three lysophosphatidyl serine receptors - protein names LyPS1, LyPS2, LyPS3 and gene names LYPSR1-LYPSR3 (human) and Lypsr1-Lypsr3 (non-human) along with a variant form that does not appear to exist in humans that is provisionally named LyPS2L.  This nomenclature incorporates previous recommendations from the International Union of Basic and Clin. Pharmacol., the Human Genome Organization, the Gene Nomenclature Committee, and the Mouse Genome Informatix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhfJ41i-PyrVg90H21EOLACvtfcHk0liCB_ThLP76cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKltr3E&md5=e3d6ec17060a9981ff3711c28c18b7e3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fbph.12678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12678%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520receptor%2520nomenclature%2520review%253A%2520IUPHAR%2520Review%25208%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3575%26epage%3D3594%26doi%3D10.1111%2Fbph.12678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaho, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hla, T.</span></span> <span> </span><span class="NLM_article-title">Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">6299</span>– <span class="NLM_lpage">6320</span>, <span class="refDoi"> DOI: 10.1021/cr200273u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200273u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WksLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6299-6320&author=V.+A.+Blahoauthor=T.+Hla&title=Regulation+of+mammalian+physiology%2C+development%2C+and+disease+by+the+sphingosine+1-phosphate+and+lysophosphatidic+acid+receptors&doi=10.1021%2Fcr200273u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Mammalian Physiology, Development, and Disease by the Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors</span></div><div class="casAuthors">Blaho, Victoria A.; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6299-6320</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on the current state and understanding of all bona fide memebers of the sphingosine 1-phosphate and lysophosphatidic acid receptor families, wtih emphasis on their contribution to the regulation of specific cell types in various systems, such as lymphatic and cardiovascular system, immune system, stem cells, nervous system, and reproductive system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZd8pE9-qccbVg90H21EOLACvtfcHk0liCB_ThLP76cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WksLzJ&md5=ba7a9d8bf106c3a443589249ffef2ca4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr200273u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200273u%26sid%3Dliteratum%253Aachs%26aulast%3DBlaho%26aufirst%3DV.%2BA.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520mammalian%2520physiology%252C%2520development%252C%2520and%2520disease%2520by%2520the%2520sphingosine%25201-phosphate%2520and%2520lysophosphatidic%2520acid%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6299%26epage%3D6320%26doi%3D10.1021%2Fcr200273u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Insights into the pharmacological relevance of lysophospholipid receptors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01622.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fj.1476-5381.2011.01622.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=21838759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=829-844&author=T.+Mutohauthor=R.+Riveraauthor=J.+Chun&title=Insights+into+the+pharmacological+relevance+of+lysophospholipid+receptors&doi=10.1111%2Fj.1476-5381.2011.01622.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the pharmacological relevance of lysophospholipid receptors</span></div><div class="casAuthors">Mutoh, Tetsuji; Rivera, Richard; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">829-844</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery of lysophospholipid (LP) 7-transmembrane, G protein-coupled receptors (GPCRs) that began in the 1990s, together with research into the functional roles of the major LPs known as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), have opened new research avenues into their biol. processes and mechanisms.  Major examples of LP signaling effects include embryogenesis, nervous system development, vascular development, uterine implantation, immune cell trafficking, and inflammatory reactions.  LP signaling also influences the pathophysiol. of many diseases including cancer, autoimmune and inflammatory diseases, which indicate that LP receptors may be attractive targets for pharmacol. therapies.  A key example of such a therapeutic agent is the S1P receptor modulator FTY720, which upon phosphorylation and continued drug exposure, acts as an S1P receptor functional antagonist.  This compd. (also known as fingolimod or Gilenya) has recently been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.  Continued basic and translational research on LP signaling should provide novel insights into both basic biol. mechanisms, as well as novel therapeutic approaches to combat a range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qOGwbmBPirVg90H21EOLACvtfcHk0liYk--6j1LKWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D&md5=cf240e202ccfa00c40366f7309e36b78</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01622.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01622.x%26sid%3Dliteratum%253Aachs%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520the%2520pharmacological%2520relevance%2520of%2520lysophospholipid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D829%26epage%3D844%26doi%3D10.1111%2Fj.1476-5381.2011.01622.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddard, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirendil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid signaling in the nervous system</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.neuron.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25695267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1SitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2015&pages=669-682&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=H.+Mirendilauthor=J.+Chun&title=Lysophosphatidic+acid+signaling+in+the+nervous+system&doi=10.1016%2Fj.neuron.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic Acid Signaling in the Nervous System</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Mirendil, Hope; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">669-682</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The brain is composed of many lipids with varied forms that serve not only as structural components but also as essential signaling mols.  Lysophosphatidic acid (LPA) is an important bioactive lipid species that is part of the lysophospholipid (LP) family.  LPA is primarily derived from membrane phospholipids and signals through six cognate G protein-coupled receptors (GPCRs), LPA1-6.  These receptors are expressed on most cell types within central and peripheral nervous tissues and have been functionally linked to many neural processes and pathways.  This Review covers a current understanding of LPA signaling in the nervous system, with particular focus on the relevance of LPA to both physiol. and diseased states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0xVVbnrMJR7Vg90H21EOLACvtfcHk0liYk--6j1LKWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1SitbY%253D&md5=df1b32a1816062199c2561b0638212c4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DMirendil%26aufirst%3DH.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520signaling%2520in%2520the%2520nervous%2520system%26jtitle%3DNeuron%26date%3D2015%26volume%3D85%26spage%3D669%26epage%3D682%26doi%3D10.1016%2Fj.neuron.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llona-Minguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghassemian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helleday, T.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2015.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.plipres.2015.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25704399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtlCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=51-75&author=S.+Llona-Minguezauthor=A.+Ghassemianauthor=T.+Helleday&title=Lysophosphatidic+acid+receptor+%28LPAR%29+modulators%3A+The+current+pharmacological+toolbox&doi=10.1016%2Fj.plipres.2015.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox</span></div><div class="casAuthors">Llona-Minguez, Sabin; Ghassemian, Artin; Helleday, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-75</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lysophosphatidic acids (LPA) are key lipid-signalling mols. that regulate a remarkably diverse set of cellular events, such as motility, chemotaxis, cell cycle progression, viability, and wound healing.  The physiol. and pathophysiol. consequences of LPA signalling are evident and misregulation of LPA signalling can lead to pathologies like cancer, atherosclerosis, ischemia, and fibrosis.  LPA exerts its biol. actions mainly through several types of G protein-coupled receptors, some of which display opposing or redundant effects.  For this reason, selective LPA receptor small-mol. ligands can shine light on LPA biol. and present an exciting opportunity for drug discovery endeavors.  This review provides insights into the detailed chem. nature and pharmacol. profile of the small-mols. thus far developed as LPA receptor modulators, as well as information on the prepn. of key pharmaceuticals.  This summary will facilitate future research efforts and nurture collaboration between chemists and biologists working in this emerging field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiRAFaoJ2JmbVg90H21EOLACvtfcHk0liYk--6j1LKWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtlCrtr4%253D&md5=9427a8a1e7a51be2f5f65e0c53cf0400</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2015.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2015.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DLlona-Minguez%26aufirst%3DS.%26aulast%3DGhassemian%26aufirst%3DA.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DLysophosphatidic%2520acid%2520receptor%2520%2528LPAR%2529%2520modulators%253A%2520The%2520current%2520pharmacological%2520toolbox%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2015%26volume%3D58%26spage%3D51%26epage%3D75%26doi%3D10.1016%2Fj.plipres.2015.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddard, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1194/jlr.R046458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1194%2Fjlr.R046458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=24643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1192-1214&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=J.+Chun&title=LPA+receptor+signaling%3A+pharmacology%2C+physiology%2C+and+pathophysiology&doi=10.1194%2Fjlr.R046458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1214</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biol. actions and demonstrates medicinal relevance.  LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors.  These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs.  LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies.  These studies have revealed physiol. and pathophysiol. influences on virtually every organ system and developmental stage of an organism.  These include the nervous, cardiovascular, reproductive, and pulmonary systems.  Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity.  These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7Ll3PB1oubVg90H21EOLACvtfcHk0lgbNMGCQjKz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK&md5=77271408ffda2fab00e7e0a0f32540d9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046458%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptor%2520signaling%253A%2520pharmacology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1192%26epage%3D1214%26doi%3D10.1194%2Fjlr.R046458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tigyi, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balazs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span> <span> </span><span class="NLM_article-title">Regulation of tumor cell - microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2018.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.jbior.2018.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30243984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGmu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=183-193&author=G.+J.+Tigyiauthor=J.+Yueauthor=D.+D.+Normanauthor=E.+Szaboauthor=A.+Baloghauthor=L.+Balazsauthor=G.+Zhaoauthor=S.+C.+Lee&title=Regulation+of+tumor+cell+-+microenvironment+interaction+by+the+autotaxin-lysophosphatidic+acid+receptor+axis&doi=10.1016%2Fj.jbior.2018.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis</span></div><div class="casAuthors">Tigyi, Gabor J.; Yue, Junming; Norman, Derek D.; Szabo, Erzsebet; Balogh, Andrea; Balazs, Louisa; Zhao, Guannan; Lee, Sue Chin</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">183-193</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The lipid mediator lysophosphatidic acid (LPA) in biol. fluids is primarily produced by cleavage of lysophospholipids by the lysophospholipase D enzyme Autotaxin (ATX).  LPA has been identified and abundantly detected in the culture medium of various cancer cell types, tumor effusates, and ascites fluid of cancer patients.  Our current understanding of the physiol. role of LPA established its role in fundamental biol. responses that include cell proliferation, metab., neuronal differentiation, angiogenesis, cell migration, hematopoiesis, inflammation, immunity, wound healing, regulation of cell excitability, and the promotion of cell survival by protecting against apoptotic death.  These essential biol. responses elicited by LPA are seemingly hijacked by cancer cells in many ways; transcriptional upregulation of ATX leading to increased LPA levels, enhanced expression of multiple LPA GPCR subtypes, and the downregulation of its metabolic breakdown.  Recent studies have shown that overexpression of ATX and LPA GPCR can lead to malignant transformation, enhanced proliferation of cancer stem cells, increased invasion and metastasis, reprogramming of the tumor microenvironment and the metastatic niche, and development of resistance to chemo-, immuno-, and radiation-therapy of cancer.  The fundamental role of LPA in cancer progression and the therapeutic inhibition of the ATX-LPA axis, although highly appealing, remains unexploited as drug development to these targets has not reached into the clinic yet.  The purpose of this brief review is to highlight some unique signaling mechanisms engaged by the ATX-LPA axis and emphasize the therapeutic potential that lies in blocking the mol. targets of the LPA system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7gL_yPvwNRbVg90H21EOLACvtfcHk0lgbNMGCQjKz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGmu7vM&md5=be1c9117ed3c0be419eda98ca74a68d7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2018.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2018.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DTigyi%26aufirst%3DG.%2BJ.%26aulast%3DYue%26aufirst%3DJ.%26aulast%3DNorman%26aufirst%3DD.%2BD.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DBalogh%26aufirst%3DA.%26aulast%3DBalazs%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%2BC.%26atitle%3DRegulation%2520of%2520tumor%2520cell%2520-%2520microenvironment%2520interaction%2520by%2520the%2520autotaxin-lysophosphatidic%2520acid%2520receptor%2520axis%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2019%26volume%3D71%26spage%3D183%26epage%3D193%26doi%3D10.1016%2Fj.jbior.2018.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hisano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hla, T.</span></span> <span> </span><span class="NLM_article-title">Bioactive lysolipids in cancer and angiogenesis</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.pharmthera.2018.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30048709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyitLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2019&pages=91-98&author=Y.+Hisanoauthor=T.+Hla&title=Bioactive+lysolipids+in+cancer+and+angiogenesis&doi=10.1016%2Fj.pharmthera.2018.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive lysolipids in cancer and angiogenesis</span></div><div class="casAuthors">Hisano, Yu; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  While normal angiogenesis is crit. for development and tissue growth, pathol. angiogenesis is important for the growth and spread of cancers by supplying nutrients and oxygen as well as providing a conduit for distant metastasis.  The interaction among extracellular matrix mols., tumor cells, endothelial cells, fibroblasts, and immune cells is crit. in pathol. angiogenesis, in which various angiogenic growth factors, chemokines, and lipid mediators produced from these cells as well as hypoxic microenvironment promote angiogenesis by regulating expression and/or activity of various related genes.  Sphingosine 1-phosphate and lysophosphatidic acid, bioactive lipid mediators which act via specific G protein-coupled receptors, play crit. roles in angiogenesis.  In addn., other lipid mediators including prostaglandin E2, lipoxin, and resolvins are produced in a stimulus-dependent manner and have pro- or anti-angiogenic effects, presumably through their specific GPCRs.  Dysregulated lipid mediator signaling pathways are obsd. in the contxt of some tumors.  This review will focus on LPA and S1P, two bioactive lipid mediators in their regulation of angiogenesis and cell migration that are crit. for tumor growth and spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwSxGLzui3O7Vg90H21EOLACvtfcHk0lgbNMGCQjKz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyitLrK&md5=562462bf612c7cf15b175aae811cb34c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DHisano%26aufirst%3DY.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DBioactive%2520lysolipids%2520in%2520cancer%2520and%2520angiogenesis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D193%26spage%3D91%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2018.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J. P.</span></span> <span> </span><span class="NLM_article-title">Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCjsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=527-553&author=Y.+M.+Liuauthor=K.+Nepaliauthor=J.+P.+Liou&title=Idiopathic+pulmonary+fibrosis%3A+current+status%2C+recent+progress%2C+and+emerging+targets&doi=10.1021%2Facs.jmedchem.6b00935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets</span></div><div class="casAuthors">Liu, Yi-Min; Nepali, Kunal; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">527-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Idiopathic pulmonary fibrosis (IPF), a chronic and progressive fibrosing interstitial pneumonia is a fatal lung disease with a median survival time of 3-5 years.  Problems in accurate diagnosis, poor prognosis, limited clin. therapy and high mortality rate together demonstrate that the development of efficient therapeutic strategies for IPF is an important future endeavor.  Deeper understanding of pathogenesis and identification of biomarkers and pathways involved might lead in the future to the emergence of some agents as novel therapeutics for IPF.  This review article presents the pathogenesis, therapeutic interventions, treatment approaches, and strategies employed for the design of antifibrotic agents for the treatment of IPF along with the patent literature from the last 10 years.  With a dozen antifibrotic agents with exciting preclin. potential in the armory, it seems certain that some of them will advance to clin. stage investigations.  The results of clin. trials for some of the new agents are also awaited, to assess their benefits in terms of efficacy and survival benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizofQCxRDlrVg90H21EOLACvtfcHk0lg9cg7FJXLbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCjsLjK&md5=9c6f4f3ebde53b7d2afa625b8de4cf4d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DNepali%26aufirst%3DK.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26atitle%3DIdiopathic%2520pulmonary%2520fibrosis%253A%2520current%2520status%252C%2520recent%2520progress%252C%2520and%2520emerging%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D527%26epage%3D553%26doi%3D10.1021%2Facs.jmedchem.6b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tager, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCamera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polosukhin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi-Shah, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1038/nm1685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+A.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak&doi=10.1038%2Fnm1685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0lg9cg7FJXLbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D45%26epage%3D54%26doi%3D10.1038%2Fnm1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juarez-Contreras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Lazaro, S. L.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid and ion channels as molecular mediators of pain</span>. <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">462</span>, <span class="refDoi"> DOI: 10.3389/fnmol.2018.00462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.3389%2Ffnmol.2018.00462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30618613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlymt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=462&author=R.+Juarez-Contrerasauthor=T.+Rosenbaumauthor=S.+L.+Morales-Lazaro&title=Lysophosphatidic+acid+and+ion+channels+as+molecular+mediators+of+pain&doi=10.3389%2Ffnmol.2018.00462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid and ion channels as molecular mediators of pain</span></div><div class="casAuthors">Juarez-Contreras, Rebeca; Rosenbaum, Tamara; Morales-Lazaro, Sara L.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">462</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Lysophosphatidic acid or LPA is a phospholipid which has been extensively linked to the generation and maintenance of pain.  Several ion channels have also been shown to participate in this pathol. process but the link between LPA and these proteins in pain has just recently gained interest.  In this respect, the field has advanced by detg. the mol. mechanisms by which LPA promotes changes in the function of some ion channels.  While some of the actions of LPA include modulation of signaling pathways assocd. to its specific receptors, other include a direct interaction with a region in the structure of ion channels to affect their gating properties.  Here, we focus on the known effects of LPA on some transient receptor potential, sodium, potassium, and calcium channels.  As the field moves forward, mechanisms are unveiled with the hope of understanding the underlying causes of pain in order to target these and control this pathophysiol. state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ1JsRESw-XrVg90H21EOLACvtfcHk0lg9cg7FJXLbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlymt7zK&md5=399af2cf9eeb5c2320d60691d1cf41a4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2018.00462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2018.00462%26sid%3Dliteratum%253Aachs%26aulast%3DJuarez-Contreras%26aufirst%3DR.%26aulast%3DRosenbaum%26aufirst%3DT.%26aulast%3DMorales-Lazaro%26aufirst%3DS.%2BL.%26atitle%3DLysophosphatidic%2520acid%2520and%2520ion%2520channels%2520as%2520molecular%2520mediators%2520of%2520pain%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2018%26volume%3D11%26spage%3D462%26doi%3D10.3389%2Ffnmol.2018.00462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashid, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contos, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1038/nm1060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnm1060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=15195086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=712-718&author=M.+Inoueauthor=M.+H.+Rashidauthor=R.+Fujitaauthor=J.+J.+Contosauthor=J.+Chunauthor=H.+Ueda&title=Initiation+of+neuropathic+pain+requires+lysophosphatidic+acid+receptor+signaling&doi=10.1038%2Fnm1060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span></div><div class="casAuthors">Inoue, Makoto; Rashid, Md Harunor; Fujita, Ryousuke; Contos, James J. A.; Chun, Jerold; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">712-718</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid with activity in the nervous system mediated by G-protein-coupled receptors.  Here, we examd. the role of LPA signaling in the development of neuropathic pain by pharmacol. and genetic approaches, including the use of mice lacking the LPA1 receptor.  Wild-type animals with nerve injury develop behavioral allodynia and hyperalgesia paralleled by demyelination in the dorsal root and increased expression of both the protein kinase C γ-isoform within the spinal cord dorsal horn and the α2δ1 calcium channel subunit in dorsal root ganglia.  Intrathecal injection of LPA induced behavioral, morphol. and biochem. changes similar to those obsd. after nerve ligation.  In contrast, mice lacking a single LPA receptor (LPA1, also known as EDG2) that activates the Rho-Rho kinase pathway do not develop signs of neuropathic pain after peripheral nerve injury.  Inhibitors of Rho and Rho kinase also prevented these signs of neuropathic pain.  These results imply that receptor-mediated LPA signaling is crucial in the initiation of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTzbCOHf9jX7Vg90H21EOLACvtfcHk0lhqcF8w1Tifmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D&md5=15f4760e4fd3b46c97c289be7b430058</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnm1060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1060%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DRashid%26aufirst%3DM.%2BH.%26aulast%3DFujita%26aufirst%3DR.%26aulast%3DContos%26aufirst%3DJ.%2BJ.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DInitiation%2520of%2520neuropathic%2520pain%2520requires%2520lysophosphatidic%2520acid%2520receptor%2520signaling%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D712%26epage%3D718%26doi%3D10.1038%2Fnm1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">17608</span>– <span class="NLM_lpage">17617</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.330183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1074%2Fjbc.M111.330183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=22461625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFSntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=17608-17617&author=M.+E.+Linauthor=R.+R.+Riveraauthor=J.+Chun&title=Targeted+deletion+of+LPA5+identifies+novel+roles+for+lysophosphatidic+acid+signaling+in+development+of+neuropathic+pain&doi=10.1074%2Fjbc.M111.330183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Deletion of LPA5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain</span></div><div class="casAuthors">Lin, Mu-En; Rivera, Richard R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">17608-17617</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid that serves as an extracellular signaling mol. acting through cognate G protein-coupled receptors designated LPA1-6 that mediate a wide range of both normal and pathol. effects.  Previously, LPA1, a Gαi-coupled receptor (which also couples to other Gα proteins) to reduce cAMP, was shown to be essential for the initiation of neuropathic pain in the partial sciatic nerve ligation (PSNL) mouse model.  Subsequent gene expression studies identified LPA5, a Gα12/13- and Gq-coupled receptor that increases cAMP, in a subset of dorsal root ganglion neurons and also within neurons of the spinal cord dorsal horn in a pattern complementing, yet distinct from LPA1, suggesting its possible involvement in neuropathic pain.  We therefore generated an Lpar5 null mutant by targeted deletion followed by PSNL challenge.  Homozygous null mutants did not show obvious base-line phenotypic defects.  However, following PSNL, LPA5-deficient mice were protected from developing neuropathic pain.  They also showed reduced phosphorylated cAMP response element-binding protein expression within neurons of the dorsal horn despite continued up-regulation of the characteristic pain-related markers Caα2δ1 and glial fibrillary acidic protein, results that were distinct from those previously obsd. for LPA1 deletion.  These data expand the influences of LPA signaling in neuropathic pain through a second LPA receptor subtype, LPA5, involving a mechanistically distinct downstream signaling pathway compared with LPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TrpAIPAZTrVg90H21EOLACvtfcHk0lhqcF8w1Tifmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFSntLc%253D&md5=cf64de15dc5a69abaa96499de85d8c75</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.330183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.330183%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DRivera%26aufirst%3DR.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DTargeted%2520deletion%2520of%2520LPA5%2520identifies%2520novel%2520roles%2520for%2520lysophosphatidic%2520acid%2520signaling%2520in%2520development%2520of%2520neuropathic%2520pain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D17608%26epage%3D17617%26doi%3D10.1074%2Fjbc.M111.330183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoddard, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span>. <i>Biomol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.4062/biomolther.2014.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.4062%2Fbiomolther.2014.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1-11&author=N.+C.+Stoddardauthor=J.+Chun&title=Promising+pharmacological+directions+in+the+world+of+lysophosphatidic+acid+signaling&doi=10.4062%2Fbiomolther.2014.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span></div><div class="casAuthors">Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BTIHA3</span>;
        ISSN:<span class="NLM_cas:issn">1976-9148</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6.  These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body.  The diversity and specificity of LPA signaling, esp. in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development.  Several LPAR-specific analogs and small mols. have been synthesized and are efficacious in attenuating pathol. in disease models.  To date, at least three compds. have passed phase I and phase II clin. trials for idiopathic pulmonary fibrosis and systemic sclerosis.  This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEf1nGhuRyPrVg90H21EOLACvtfcHk0lhqcF8w1Tifmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D&md5=53d877ee381f9363918850f0b499bb11</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4062%2Fbiomolther.2014.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4062%252Fbiomolther.2014.109%26sid%3Dliteratum%253Aachs%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DPromising%2520pharmacological%2520directions%2520in%2520the%2520world%2520of%2520lysophosphatidic%2520acid%2520signaling%26jtitle%3DBiomol.%2520Ther.%26date%3D2015%26volume%3D23%26spage%3D1%26epage%3D11%26doi%3D10.4062%2Fbiomolther.2014.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophospholipid receptors in drug discovery</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2014.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.yexcr.2014.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25499971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVygt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2015&pages=171-177&author=Y.+Kiharaauthor=H.+Mizunoauthor=J.+Chun&title=Lysophospholipid+receptors+in+drug+discovery&doi=10.1016%2Fj.yexcr.2014.11.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptors in drug discovery</span></div><div class="casAuthors">Kihara, Yasuyuki; Mizuno, Hirotaka; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-177</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysophospholipids (LPs), including lysophosphatidic acid (LPA), sphingosine 1-phospate (S1P), lysophosphatidylinositol (LPI), and lysophosphatidylserine (LysoPS), are bioactive lipids that transduce signals through their specific cell-surface G protein-coupled receptors, LPA1-6, S1P1-5, LPI1, and LysoPS1-3, resp.  These LPs and their receptors have been implicated in both physiol. and pathophysiol. processes such as autoimmune diseases, neurodegenerative diseases, fibrosis, pain, cancer, inflammation, metabolic syndrome, bone formation, fertility, organismal development, and other effects on most organ systems.  Advances in the LP receptor field have enabled the development of novel small mols. targeting LP receptors for several diseases.  Most notably, fingolimod (FTY720, Gilenya, Novartis), an S1P receptor modulator, became the first FDA-approved medicine as an orally bioavailable drug for treating relapsing forms of multiple sclerosis.  This success is currently being followed by multiple, mechanistically related compds. targeting S1P receptor subtypes, which are in various stages of clin. development.  In addn., an LPA1 antagonist, BMS-986020 (Bristol-Myers Squibb), is in Phase 2 clin. development for treating idiopathic pulmonary fibrosis, as a distinct compd., SAR100842 (Sanofi) for the treatment of systemic sclerosis and related fibrotic diseases.  This review summarizes the current state of drug discovery in the LP receptor field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtxRltguGZnLVg90H21EOLACvtfcHk0lj1ku8i-Xvtrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVygt7%252FI&md5=fc286c4c8862b052b2b263dd07f02755</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2014.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2014.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520receptors%2520in%2520drug%2520discovery%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2015%26volume%3D333%26spage%3D171%26epage%3D177%26doi%3D10.1016%2Fj.yexcr.2014.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, G. K.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.neuropharm.2016.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=27059127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=608-617&author=M.+Velascoauthor=C.+O%E2%80%99Sullivanauthor=G.+K.+Sheridan&title=Lysophosphatidic+acid+receptors+%28LPARs%29%3A+Potential+targets+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.neuropharm.2016.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain</span></div><div class="casAuthors">Velasco, Maria; O'Sullivan, Catherine; Sheridan, Graham K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">608-617</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neuropathic pain can arise from lesions to peripheral or central nerve fibers leading to spontaneous action potential generation and a lowering of the nociceptive threshold.  Clin., neuropathic pain can manifest in many chronic disease states such as cancer, diabetes or multiple sclerosis (MS).  The bioactive lipid, lysophosphatidic acid (LPA), via activation of its receptors (LPARs), is thought to play a central role in both triggering and maintaining neuropathic pain.  In particular, following an acute nerve injury, the excitatory neurotransmitters glutamate and substance P are released from primary afferent neurons leading to upregulated synthesis of lysophosphatidylcholine (LPC), the precursor for LPA prodn.  LPC is converted to LPA by autotaxin (ATX), which can then activate macrophages/microglia and modulate neuronal functioning.  A ubiquitous feature of animal models of neuropathic pain is demyelination of damaged nerves.  It is thought that LPA contributes to demyelination through several different mechanisms.  Firstly, high levels of LPA are produced following macrophage/microglial activation that triggers a self-sustaining feed-forward loop of de novo LPA synthesis.  Secondly, macrophage/microglial activation contributes to inflammation-mediated demyelination of axons, thus initiating neuropathic pain.  Therefore, targeting LPA prodn. and/or the family of LPA-activated G protein-coupled receptors (GPCRs) may prove to be fruitful clin. approaches to treating demyelination and the accompanying neuropathic pain.  This review discusses our current understanding of the role of LPA/LPAR signalling in the initiation of neuropathic pain and suggests potential targeted strategies for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBnp_IOtLNnbVg90H21EOLACvtfcHk0lj1ku8i-Xvtrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOnsbw%253D&md5=306e8b37719a3bc2b2af82666d3e7b7e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DVelasco%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%26aulast%3DSheridan%26aufirst%3DG.%2BK.%26atitle%3DLysophosphatidic%2520acid%2520receptors%2520%2528LPARs%2529%253A%2520Potential%2520targets%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D608%26epage%3D617%26doi%3D10.1016%2Fj.neuropharm.2016.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">S55</span>– <span class="NLM_lpage">S65</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000000813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1097%2Fj.pain.0000000000000813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28151833" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2017&pages=S55-S65&author=H.+Ueda&title=Lysophosphatidic+acid+signaling+is+the+definitive+mechanism+underlying+neuropathic+pain&doi=10.1097%2Fj.pain.0000000000000813"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000000813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000000813%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLysophosphatidic%2520acid%2520signaling%2520is%2520the%2520definitive%2520mechanism%2520underlying%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2017%26volume%3D158%26spage%3DS55%26epage%3DS65%26doi%3D10.1097%2Fj.pain.0000000000000813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colloca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhassira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarnitsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccleston, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S. N.</span></span> <span> </span><span class="NLM_article-title">Neuropathic pain</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17002</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2017.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnrdp.2017.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28205574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17002&author=L.+Collocaauthor=T.+Ludmanauthor=D.+Bouhassiraauthor=R.+Baronauthor=A.+H.+Dickensonauthor=D.+Yarnitskyauthor=R.+Freemanauthor=A.+Truiniauthor=N.+Attalauthor=N.+B.+Finnerupauthor=C.+Ecclestonauthor=E.+Kalsoauthor=D.+L.+Bennettauthor=R.+H.+Dworkinauthor=S.+N.+Raja&title=Neuropathic+pain&doi=10.1038%2Fnrdp.2017.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain</span></div><div class="casAuthors">Colloca Luana; Ludman Taylor; Bouhassira Didier; Baron Ralf; Dickenson Anthony H; Yarnitsky David; Freeman Roy; Truini Andrea; Attal Nadine; Finnerup Nanna B; Eccleston Christopher; Eccleston Christopher; Kalso Eija; Bennett David L; Dworkin Robert H; Raja Srinivasa N</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7-10% of the general population.  Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the ageing global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.  Indeed, imbalances between excitatory and inhibitory somatosensory signalling, alterations in ion channels and variability in the way that pain messages are modulated in the central nervous system all have been implicated in neuropathic pain.  The burden of chronic neuropathic pain seems to be related to the complexity of neuropathic symptoms, poor outcomes and difficult treatment decisions.  Importantly, quality of life is impaired in patients with neuropathic pain owing to increased drug prescriptions and visits to health care providers, as well as the morbidity from the pain itself and the inciting disease.  Despite challenges, progress in the understanding of the pathophysiology of neuropathic pain is spurring the development of new diagnostic procedures and personalized interventions, which emphasize the need for a multidisciplinary approach to the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtG6bfcFGVpLJzI8owOhpDfW6udTcc2eZQ42tFTAEl6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D&md5=003498925636e0a417267ad96d446782</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.2%26sid%3Dliteratum%253Aachs%26aulast%3DColloca%26aufirst%3DL.%26aulast%3DLudman%26aufirst%3DT.%26aulast%3DBouhassira%26aufirst%3DD.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DYarnitsky%26aufirst%3DD.%26aulast%3DFreeman%26aufirst%3DR.%26aulast%3DTruini%26aufirst%3DA.%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DEccleston%26aufirst%3DC.%26aulast%3DKalso%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26atitle%3DNeuropathic%2520pain%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2017%26volume%3D3%26spage%3D17002%26doi%3D10.1038%2Fnrdp.2017.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.05987.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fj.1471-4159.2009.05987.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=19222705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=603-610&author=L.+Maauthor=M.+Matsumotoauthor=W.+Xieauthor=M.+Inoueauthor=H.+Ueda&title=Evidence+for+lysophosphatidic+acid+1+receptor+signaling+in+the+early+phase+of+neuropathic+pain+mechanisms+in+experiments+using+Ki-16425%2C+a+lysophosphatidic+acid+1+receptor+antagonist&doi=10.1111%2Fj.1471-4159.2009.05987.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist</span></div><div class="casAuthors">Ma, Lin; Matsumoto, Misaki; Xie, Weijiao; Inoue, Makoto; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">603-610</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Lysophosphatidic acid is a bioactive lipid mediator with neuronal activities.  We previously reported a crucial role for lysophosphatidic acid 1 receptor-mediated signaling in neuropathic pain mechanisms.  Intrathecal administration of lysophosphatidic acid (1 nmol) induced abnormal pain behaviors, such as thermal hyperalgesia, mech. allodynia, A-fiber hypersensitization, and C-fiber hyposensitization, all of which were also obsd. in partial sciatic nerve injury-induced neuropathic pain.  Ki-16425 (30 mg/kg, i.p.), a lysophosphatidic acid 1 receptor antagonist, completely blocked lysophosphatidic acid-induced neuropathic pain-like behaviors, when administered 30 min but not 90 min before lysophosphatidic acid injection, suggesting that Ki-16425 is a short-lived inhibitor.  The blockade of nerve injury-induced neuropathic pain by Ki-16425 was max. as late as 3 h after the injury but not after this crit. period.  The administration of Ki-16425 at 3 h but not at 6 h after injury also blocked neurochem. changes, including up-regulation of voltage-gated calcium channel α2δ-1 subunit expression in dorsal root ganglion and redn. of substance P expression in the spinal dorsal horn.  All of these results using Ki-16425 suggest that lysophosphatidic acid 1 receptor-mediated signaling which underlies the development of neuropathic pain works at an early stage of the crit. period after nerve injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJPsXQUIYYjLVg90H21EOLACvtfcHk0lhZnV2nSOo4DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKnsrw%253D&md5=70bba2d18056fe13b05fac0e01bdf6da</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.05987.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.05987.x%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DEvidence%2520for%2520lysophosphatidic%2520acid%25201%2520receptor%2520signaling%2520in%2520the%2520early%2520phase%2520of%2520neuropathic%2520pain%2520mechanisms%2520in%2520experiments%2520using%2520Ki-16425%252C%2520a%2520lysophosphatidic%2520acid%25201%2520receptor%2520antagonist%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D109%26spage%3D603%26epage%3D610%26doi%3D10.1111%2Fj.1471-4159.2009.05987.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1186%2F1744-8069-5-64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=19912636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BD1MjotFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=64&author=L.+Maauthor=H.+Uchidaauthor=J.+Nagaiauthor=M.+Inoueauthor=J.+Chunauthor=J.+Aokiauthor=H.+Ueda&title=Lysophosphatidic+acid-3+receptor-mediated+feed-forward+production+of+lysophosphatidic+acid%3A+an+initiator+of+nerve+injury-induced+neuropathic+pain&doi=10.1186%2F1744-8069-5-64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain</span></div><div class="casAuthors">Ma Lin; Uchida Hitoshi; Nagai Jun; Inoue Makoto; Chun Jerold; Aoki Junken; Ueda Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We previously reported that intrathecal injection of lysophosphatidylcholine (LPC) induced neuropathic pain through activation of the lysophosphatidic acid (LPA)-1 receptor, possibly via conversion to LPA by autotaxin (ATX).  RESULTS:  We examined in vivo LPA-induced LPA production using a biological titration assay with B103 cells expressing LPA1 receptors.  Intrathecal administration of LPC caused time-related production of LPA in the spinal dorsal horn and dorsal roots, but not in the dorsal root ganglion, spinal nerve or sciatic nerve.  LPC-induced LPA production was markedly diminished in ATX heterozygotes, and was abolished in mice that were deficient in LPA3, but not LPA1 or LPA2 receptors.  Similar time-related and LPA3 receptor-mediated production of LPA was observed following intrathecal administration of LPA.  In an in vitro study using spinal cord slices, LPA-induced LPA production was also mediated by ATX and the LPA3 receptor.  Intrathecal administration of LPA, in contrast, induced neuropathic pain, which was abolished in mice deficient in LPA1 or LPA3 receptors.  CONCLUSION:  These findings suggest that feed-forward LPA production is involved in LPA-induced neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOdtdCr68yBhJ5E29YNGvQfW6udTcc2eZYvL3qO8fwPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjotFWqtQ%253D%253D&md5=71f28dbea8f1f2732e8d88143cad5d4a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-64%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DUchida%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DJ.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLysophosphatidic%2520acid-3%2520receptor-mediated%2520feed-forward%2520production%2520of%2520lysophosphatidic%2520acid%253A%2520an%2520initiator%2520of%2520nerve%2520injury-induced%2520neuropathic%2520pain%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D64%26doi%3D10.1186%2F1744-8069-5-64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morabito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustizieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattioli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragozzino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oddi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verderio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, S.</span></span> <span> </span><span class="NLM_article-title">TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15292</span>, <span class="refDoi"> DOI: 10.1038/ncomms15292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fncomms15292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28489079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BC1crlslKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15292&author=M.+C.+Marroneauthor=A.+Morabitoauthor=M.+Giustizieriauthor=V.+Chiurchiuauthor=A.+Leutiauthor=M.+Mattioliauthor=S.+Marinelliauthor=L.+Rigantiauthor=M.+Lombardiauthor=E.+Muranaauthor=A.+Totaroauthor=D.+Piomelliauthor=D.+Ragozzinoauthor=S.+Oddiauthor=M.+Maccarroneauthor=C.+Verderioauthor=S.+Marinelli&title=TRPV1+channels+are+critical+brain+inflammation+detectors+and+neuropathic+pain+biomarkers+in+mice&doi=10.1038%2Fncomms15292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice</span></div><div class="casAuthors">Marrone Maria Cristina; Morabito Annunziato; Giustizieri Michela; Mattioli Marzia; Marinelli Sara; Marinelli Silvia; Marrone Maria Cristina; Giustizieri Michela; Chiurchiu Valerio; Leuti Alessandro; Mattioli Marzia; Totaro Antonio; Oddi Sergio; Maccarrone Mauro; Marinelli Silvia; Morabito Annunziato; Chiurchiu Valerio; Maccarrone Mauro; Marinelli Sara; Verderio Claudia; Riganti Loredana; Verderio Claudia; Lombardi Marta; Murana Emanuele; Ragozzino Davide; Piomelli Daniele; Ragozzino Davide; Oddi Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15292</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The capsaicin receptor TRPV1 has been widely characterized in the sensory system as a key component of pain and inflammation.  A large amount of evidence shows that TRPV1 is also functional in the brain although its role is still debated.  Here we report that TRPV1 is highly expressed in microglial cells rather than neurons of the anterior cingulate cortex and other brain areas.  We found that stimulation of microglial TRPV1 controls cortical microglia activation per se and indirectly enhances glutamatergic transmission in neurons by promoting extracellular microglial microvesicles shedding.  Conversely, in the cortex of mice suffering from neuropathic pain, TRPV1 is also present in neurons affecting their intrinsic electrical properties and synaptic strength.  Altogether, these findings identify brain TRPV1 as potential detector of harmful stimuli and a key player of microglia to neuron communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_P31OZw-1AVMGsG_HTXYFfW6udTcc2eYdAtvUqztkGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crlslKksg%253D%253D&md5=1d6a32f0a63bc278058e311b32a535b3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms15292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15292%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DM.%2BC.%26aulast%3DMorabito%26aufirst%3DA.%26aulast%3DGiustizieri%26aufirst%3DM.%26aulast%3DChiurchiu%26aufirst%3DV.%26aulast%3DLeuti%26aufirst%3DA.%26aulast%3DMattioli%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DS.%26aulast%3DRiganti%26aufirst%3DL.%26aulast%3DLombardi%26aufirst%3DM.%26aulast%3DMurana%26aufirst%3DE.%26aulast%3DTotaro%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DRagozzino%26aufirst%3DD.%26aulast%3DOddi%26aufirst%3DS.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DVerderio%26aufirst%3DC.%26aulast%3DMarinelli%26aufirst%3DS.%26atitle%3DTRPV1%2520channels%2520are%2520critical%2520brain%2520inflammation%2520detectors%2520and%2520neuropathic%2520pain%2520biomarkers%2520in%2520mice%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15292%26doi%3D10.1038%2Fncomms15292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Lazaro, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorente, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierra-Ramirez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Romero, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Renteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Flores, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islas, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13092</span>, <span class="refDoi"> DOI: 10.1038/ncomms13092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fncomms13092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=27721373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GnsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13092&author=S.+L.+Morales-Lazaroauthor=I.+Llorenteauthor=F.+Sierra-Ramirezauthor=A.+E.+Lopez-Romeroauthor=M.+Ortiz-Renteriaauthor=B.+Serrano-Floresauthor=S.+A.+Simonauthor=L.+D.+Islasauthor=T.+Rosenbaum&title=Inhibition+of+TRPV1+channels+by+a+naturally+occurring+omega-9+fatty+acid+reduces+pain+and+itch&doi=10.1038%2Fncomms13092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch</span></div><div class="casAuthors">Morales-Lazaro, Sara L.; Llorente, Itzel; Sierra-Ramirez, Felix; Lopez-Romero, Ana E.; Ortiz-Renteria, Miguel; Serrano-Flores, Barbara; Simon, Sidney A.; Islas, Leon D.; Rosenbaum, Tamara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13092</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transient receptor potential vanilloid 1 (TRPV1) ion channel is mainly found in primary nociceptive afferents whose activity has been linked to pathophysiol. conditions including pain, itch and inflammation.  Consequently, it is important to identify naturally occurring antagonists of this channel.  Here we show that a naturally occurring monounsatd. fatty acid, oleic acid, inhibits TRPV1 activity, and also pain and itch responses in mice by interacting with the vanilloid (capsaicin)-binding pocket and promoting the stabilization of a closed state conformation.  Moreover, we report an itch-inducing mol., cyclic phosphatidic acid, that activates TRPV1 and whose pruritic activity, as well as that of histamine, occurs through the activation of this ion channel.  These findings provide insights into the mol. basis of oleic acid inhibition of TRPV1 and also into a way of reducing the pathophysiol. effects resulting from its activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowG-C7OwYVAbVg90H21EOLACvtfcHk0lhtY0EvoaORfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GnsbfJ&md5=a9b538704686bd547de931f5b306c4c4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fncomms13092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13092%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Lazaro%26aufirst%3DS.%2BL.%26aulast%3DLlorente%26aufirst%3DI.%26aulast%3DSierra-Ramirez%26aufirst%3DF.%26aulast%3DLopez-Romero%26aufirst%3DA.%2BE.%26aulast%3DOrtiz-Renteria%26aufirst%3DM.%26aulast%3DSerrano-Flores%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DS.%2BA.%26aulast%3DIslas%26aufirst%3DL.%2BD.%26aulast%3DRosenbaum%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520TRPV1%2520channels%2520by%2520a%2520naturally%2520occurring%2520omega-9%2520fatty%2520acid%2520reduces%2520pain%2520and%2520itch%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13092%26doi%3D10.1038%2Fncomms13092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Posadas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picazo-Juarez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorente, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jara-Oseguera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Lazaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante-Alcalde, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islas, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, T.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/nchembio.712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnchembio.712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gt7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=78-85&author=A.+Nieto-Posadasauthor=G.+Picazo-Juarezauthor=I.+Llorenteauthor=A.+Jara-Osegueraauthor=S.+Morales-Lazaroauthor=D.+Escalante-Alcaldeauthor=L.+D.+Islasauthor=T.+Rosenbaum&title=Lysophosphatidic+acid+directly+activates+TRPV1+through+a+C-terminal+binding+site&doi=10.1038%2Fnchembio.712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site</span></div><div class="casAuthors">Nieto-Posadas, Andres; Picazo-Juarez, Giovanni; Llorente, Itzel; Jara-Oseguera, Andres; Morales-Lazaro, Sara; Escalante-Alcalde, Diana; Islas, Leon D.; Rosenbaum, Tamara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-85</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Since 1992, there has been growing evidence that the bioactive phospholipid lysophosphatidic acid (LPA), whose amts. are increased upon tissue injury, activates primary nociceptors resulting in neuropathic pain.  The TRPV1 ion channel is expressed in primary afferent nociceptors and is activated by phys. and chem. stimuli.  Here we show that in control mice LPA produces acute pain-like behaviors, which are substantially reduced in Trpv1-null animals.  Our data also demonstrate that LPA activates TRPV1 through a unique mechanism that is independent of G protein-coupled receptors, contrary to what has been widely shown for other ion channels, by directly interacting with the C terminus of the channel.  We conclude that TRPV1 is a direct mol. target of the pain-producing mol. LPA and that this constitutes, to our knowledge, the first example of LPA binding directly to an ion channel to acutely regulate its function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-yrDUVv1cOrVg90H21EOLACvtfcHk0lhtY0EvoaORfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gt7zL&md5=50afa5380912eaa311bbd41da9696c37</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.712%26sid%3Dliteratum%253Aachs%26aulast%3DNieto-Posadas%26aufirst%3DA.%26aulast%3DPicazo-Juarez%26aufirst%3DG.%26aulast%3DLlorente%26aufirst%3DI.%26aulast%3DJara-Oseguera%26aufirst%3DA.%26aulast%3DMorales-Lazaro%26aufirst%3DS.%26aulast%3DEscalante-Alcalde%26aufirst%3DD.%26aulast%3DIslas%26aufirst%3DL.%2BD.%26aulast%3DRosenbaum%26aufirst%3DT.%26atitle%3DLysophosphatidic%2520acid%2520directly%2520activates%2520TRPV1%2520through%2520a%2520C-terminal%2520binding%2520site%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D78%26epage%3D85%26doi%3D10.1038%2Fnchembio.712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumruker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heining, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmouder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtin, P.</span></span> <span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1038/nrd3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis&doi=10.1038%2Fnrd3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0ljXxnJl5EwuLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897%26doi%3D10.1038%2Fnrd3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huwiler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zangemeister-Wittke, U.</span></span> <span> </span><span class="NLM_article-title">The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.pharmthera.2017.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=29127024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2018&pages=34-49&author=A.+Huwilerauthor=U.+Zangemeister-Wittke&title=The+sphingosine+1-phosphate+receptor+modulator+fingolimod+as+a+therapeutic+agent%3A+Recent+findings+and+new+perspectives&doi=10.1016%2Fj.pharmthera.2017.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives</span></div><div class="casAuthors">Huwiler, Andrea; Zangemeister-Wittke, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-49</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The immunomodulatory drug fingolimod (FTY720, GilenyaR) was approved for oral treatment of relapsing-remitting multiple sclerosis, due to its impressive efficacy and good tolerability.  Pharmacol., it acts as an unselective agonist of sphingosine 1-phosphate receptors (S1PR) and as a selective functional antagonist of the S1P1 subtype by induction of receptor downregulation.  Since S1P1 is crucial for the regulation of lymphocyte trafficking, its downregulation causes redistribution of the immune cells to secondary lymphoid tissues, resulting in the depletion from the circulation and hence immunosuppression.  Numerous preclin. studies have since been performed with the aim to increase the spectrum of potential indications for fingolimod with emphasis on other autoimmune disorders and diseases assocd. with inflammation and uncontrolled cell proliferation, including cancer.  As an alternative to fingolimod, novel S1PR modulators with a more selective receptor activation profile and improved pharmacokinetic performance and tolerability have also been developed.  Preclin. and clin. studies are ongoing to investigate their therapeutic potential.  This review discusses the most relevant preclin. and clin. findings from S1PR-targeting and from less-well defined off-target effects reported in the literature, and reveals perspectives for using fingolimod and functionally-related derivs. and new formulations in the management of an increasing no. of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxIFabr0iscrVg90H21EOLACvtfcHk0ljXxnJl5EwuLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLrK&md5=dfe07cfa6544d89f24f3a90f2fe99088</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DThe%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520fingolimod%2520as%2520a%2520therapeutic%2520agent%253A%2520Recent%2520findings%2520and%2520new%2520perspectives%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D185%26spage%3D34%26epage%3D49%26doi%3D10.1016%2Fj.pharmthera.2017.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonnalagadda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaho, V. A.</span></span> <span> </span><span class="NLM_article-title">Fingolimod: Lessons learned and new opportunities for treating multiple sclerosis and other disorders</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010818-021358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1146%2Fannurev-pharmtox-010818-021358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30625282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms12rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=149-170&author=J.+Chunauthor=Y.+Kiharaauthor=D.+Jonnalagaddaauthor=V.+A.+Blaho&title=Fingolimod%3A+Lessons+learned+and+new+opportunities+for+treating+multiple+sclerosis+and+other+disorders&doi=10.1146%2Fannurev-pharmtox-010818-021358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders</span></div><div class="casAuthors">Chun, Jerold; Kihara, Yasuyuki; Jonnalagadda, Deepa; Blaho, Victoria A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">149-170</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration-approved oral therapy for relapsing forms of multiple sclerosis (MS).  Research on modified fungal metabolites converged with basic science studies that had identified lysophospholipid (LP) sphingosine 1-phosphate (S1P) receptors, providing mechanistic insights on fingolimod while validating LP receptors as drug targets.  Mechanism of action (MOA) studies identified receptor-mediated processes involving the immune system and the central nervous system (CNS).  These dual actions represent a more general theme for S1P and likely other LP receptor modulators.  Fingolimod's direct CNS activities likely contribute to its efficacy in MS, with particular relevance to treating progressive disease stages and forms that involve neurodegeneration.  The evolving understanding of fingolimod's MOA has provided strategies for developing next-generation compds. with superior attributes, suggesting new ways to target S1P as well as other LP receptor modulators for novel therapeutics in the CNS and other organ systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXXtaxAvhsIrVg90H21EOLACvtfcHk0ljXxnJl5EwuLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms12rsQ%253D%253D&md5=e59dccb5360c3fd980ee55d4fd647461</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010818-021358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010818-021358%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DJonnalagadda%26aufirst%3DD.%26aulast%3DBlaho%26aufirst%3DV.%2BA.%26atitle%3DFingolimod%253A%2520Lessons%2520learned%2520and%2520new%2520opportunities%2520for%2520treating%2520multiple%2520sclerosis%2520and%2520other%2520disorders%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2019%26volume%3D59%26spage%3D149%26epage%3D170%26doi%3D10.1146%2Fannurev-pharmtox-010818-021358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gil, I. Z.D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zian, D.</span></span> <span> </span><span class="NLM_article-title">The status of the lysophosphatidic acid receptor type 1 (LPA1R)</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1039/C4MD00333K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1039%2FC4MD00333K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFynsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=13-23&author=I.+Z.D.+Gonzalez-Gilauthor=H.+V%C3%A1zquez-Villaauthor=S.+Ortega-Guti%C3%A9rrezauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguezauthor=D.+Zian&title=The+status+of+the+lysophosphatidic+acid+receptor+type+1+%28LPA1R%29&doi=10.1039%2FC4MD00333K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The status of the lysophosphatidic acid receptor type 1 (LPA1R)</span></div><div class="casAuthors">Gonzalez-Gil, Ines; Zian, Debora; Vazquez-Villa, Henar; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-23</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Lysophospholipids are lipid mols. that are receiving growing attention because, in addn. to their structural function in the cell membrane, they are now regarded as important regulators for diverse biol. functions through activation of specific receptors.  These receptors have been characterized during the last two decades as G protein-coupled receptors (GPCRs) and, among them, two families stand out: lysophosphatidic acid (LPA1-6) and sphingosine 1-phoshate (S1P1-5) receptors.  Despite their interest, the high structural similarity between them has restrained the development of selective and high affinity ligands and therefore the elucidation of the role of these receptors in the central nervous system (CNS).  This review provides an overview about the different LPA receptors with a special focus on the LPA1 subtype from a medicinal chem. perspective.  It summarizes the most recent developments in the search for selective and specific agonists and antagonists of the LPA1 receptor and highlights their current status in the drug development pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqspIAyjerkAbVg90H21EOLACvtfcHk0ljXxnJl5EwuLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFynsb7I&md5=82923b68a6e2717c063f95602963a8e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC4MD00333K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00333K%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Gil%26aufirst%3DI.%2BZ.D.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26aulast%3DZian%26aufirst%3DD.%26atitle%3DThe%2520status%2520of%2520the%2520lysophosphatidic%2520acid%2520receptor%2520type%25201%2520%2528LPA1R%2529%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D13%26epage%3D23%26doi%3D10.1039%2FC4MD00333K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prestwich, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serban, M.</span></span> <span> </span><span class="NLM_article-title">Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1781</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">594</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2008.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.bbalip.2008.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=18454946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=588-594&author=G.+D.+Prestwichauthor=J.+Gajewiakauthor=H.+Zhangauthor=X.+Xuauthor=G.+Yangauthor=M.+Serban&title=Phosphatase-resistant+analogues+of+lysophosphatidic+acid%3A+agonists+promote+healing%2C+antagonists+and+autotaxin+inhibitors+treat+cancer&doi=10.1016%2Fj.bbalip.2008.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatase-resistant analogues of lysophosphatidic acid: Agonists promote healing, antagonists and autotaxin inhibitors treat cancer</span></div><div class="casAuthors">Prestwich, Glenn D.; Gajewiak, Joanna; Zhang, Honglu; Xu, Xiaoyu; Yang, Guanghui; Serban, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">588-594</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Isoform-selective agonists and antagonists of the lysophosphatidic acid (LPA) G protein-coupled receptors (GPCRs) have important potential applications in cell biol. and therapy.  LPA GPCRs regulate cancer cell proliferation, invasion, angiogenesis, and also biochem. resistance to chemotherapy- and radiotherapy-induced apoptosis.  LPA and its analogs also are feedback inhibitors of the enzyme lysophospholipase D (lysoPLD, a.k.a., autotaxin, ATX), a central regulator of invasion and metastasis.  For cancer therapy, the optimal therapeutic profile would be a metabolically-stabilized, pan-LPA receptor antagonist that also inhibited lysoPLD.  For protection of gastrointestinal mucosa and lymphocytes, LPA agonists would be desirable to minimize or reverse radiation or chem.-induced injury.  Analogs of lysophosphatidic acid (LPA) that are chem. modified to be less susceptible to phospholipases and phosphatases show activity as long-lived receptor-specific agonists and antagonists for LPA receptors, as well as inhibitors for the lysoPLD activity of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbAx_0KTH-bVg90H21EOLACvtfcHk0liVvhqD49NfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbnM&md5=bb1b32df29c8abe58284d7c455a4612a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DSerban%26aufirst%3DM.%26atitle%3DPhosphatase-resistant%2520analogues%2520of%2520lysophosphatidic%2520acid%253A%2520agonists%2520promote%2520healing%252C%2520antagonists%2520and%2520autotaxin%2520inhibitors%2520treat%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D588%26epage%3D594%26doi%3D10.1016%2Fj.bbalip.2008.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreihofer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heasley, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhin, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span> <span> </span><span class="NLM_article-title">Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1124/mol.60.6.1173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1124%2Fmol.60.6.1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=11723223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1173-1180&author=C.+E.+Heiseauthor=W.+L.+Santosauthor=A.+M.+Schreihoferauthor=B.+H.+Heasleyauthor=Y.+V.+Mukhinauthor=T.+L.+Macdonaldauthor=K.+R.+Lynch&title=Activity+of+2-substituted+lysophosphatidic+acid+%28LPA%29+analogs+at+LPA+receptors%3A+discovery+of+a+LPA1%2FLPA3+receptor+antagonist&doi=10.1124%2Fmol.60.6.1173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist</span></div><div class="casAuthors">Heise, Christopher E.; Santos, Webster L.; Schreihofer, Ann M.; Heasley, Brian H.; Mukhin, Yurii V.; Macdonald, Timothy L.; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1173-1180</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The physiol. implications of lysophosphatidic acid occupancy of individual receptors are largely unknown because selective agonists/antagonists are unavailable currently.  The mol. cloning of three high-affinity lysophosphatidic acid receptors, LPA1, LPA2, and LPA3, provides a platform for developing receptor type-selective ligands.  Starting with an N-acyl ethanolamide phosphate LPA analog, we made a series of substitutions at the second carbon to generate compds. with varying spatial, stereochem., and electronic characteristics.  Anal. of this series at each recombinant LPA receptor using a guanosine 5'-O-(3-[35S]thio)triphosphate (GTP[γ35S]) binding assay revealed sharp differences in activity.  Our results suggest that these receptors have one spatially restrictive binding pocket that interacts with the 2-substituted moieties and prefers small hydrophobic groups and hydrogen bonding functionalities.  The agonist activity predicted by the GTP[γ35S] binding assay was reflected in the activity of a subset of compds. in increasing arterial pressure in anesthetized rats.  One compd. with a bulky hydrophobic group (VPC12249) was a dual LPA1/LPA3 competitive antagonist.  Several compds. that had smaller side chains were LPA1-selective agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHdbLqk7fOkbVg90H21EOLACvtfcHk0liVvhqD49NfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVOitro%253D&md5=c3acc6cc4520590f581d3c215e3740e6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.6.1173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.6.1173%26sid%3Dliteratum%253Aachs%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26aulast%3DSchreihofer%26aufirst%3DA.%2BM.%26aulast%3DHeasley%26aufirst%3DB.%2BH.%26aulast%3DMukhin%26aufirst%3DY.%2BV.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DActivity%2520of%25202-substituted%2520lysophosphatidic%2520acid%2520%2528LPA%2529%2520analogs%2520at%2520LPA%2520receptors%253A%2520discovery%2520of%2520a%2520LPA1%252FLPA3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1173%26epage%3D1180%26doi%3D10.1124%2Fmol.60.6.1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heasley, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3473</span>– <span class="NLM_lpage">3476</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.bmcl.2004.04.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=15177455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3473-3476&author=W.+L.+Santosauthor=B.+H.+Heasleyauthor=R.+Jaroszauthor=K.+M.+Carterauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Synthesis+and+biological+evaluation+of+phosphonic+and+thiophosphoric+acid+derivatives+of+lysophosphatidic+acid&doi=10.1016%2Fj.bmcl.2004.04.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid</span></div><div class="casAuthors">Santos, Webster L.; Heasley, Brian H.; Jarosz, Renata; Carter, Karen M.; Lynch, Kevin R.; Macdonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3473-3476</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Using an N-oleoyl ethanolamide scaffold, a series of phosphate polar head group analogs of LPA comprised of various α-substituted phosphonates and thiophosphates was prepd.  In a broken cell GTP[γ35S] binding assay, agonist activity was evaluated at the three LPA receptors of the endothelial differentiation gene (Edg) family.  This study has resulted in the discovery of a non-hydrolyzable LPA1-selective agonist.  Addnl., thiophosphate I bears an isosteric phosphate mimetic that confers agonism at the LPA1 receptor but not LPA2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7CKG5c-ljsLVg90H21EOLACvtfcHk0liVvhqD49NfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gnu7o%253D&md5=8c303b1a4b5989b06171a688c0ef661d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.061%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DW.%2BL.%26aulast%3DHeasley%26aufirst%3DB.%2BH.%26aulast%3DJarosz%26aufirst%3DR.%26aulast%3DCarter%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520phosphonic%2520and%2520thiophosphoric%2520acid%2520derivatives%2520of%2520lysophosphatidic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3473%26epage%3D3476%26doi%3D10.1016%2Fj.bmcl.2004.04.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, E.</span>; <span class="NLM_string-name">Kondo, Y.</span>; <span class="NLM_string-name">Shishikura, J.</span>; <span class="NLM_string-name">Takahashi, M.</span>; <span class="NLM_string-name">Sakamoto, K.</span>; <span class="NLM_string-name">Soga, T.</span>; <span class="NLM_string-name">Orita, M.</span></span> <span> </span><span class="NLM_article-title">Benzyl-12b-methyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine derivatives as LPA receptor agonists</span>. Japanese Patent <span class="NLM_patent">JP 2008297278 A</span> <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E.+Kawanami&author=Y.+Kondo&author=J.+Shishikura&author=M.+Takahashi&author=K.+Sakamoto&author=T.+Soga&author=M.+Orita&title=Benzyl-12b-methyl-1%2C2%2C3%2C4%2C6%2C7%2C12%2C12b-octahydroindolo%5B2%2C3-a%5Dquinolizine+derivatives+as+LPA+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawanami%26aufirst%3DE.%26atitle%3DBenzyl-12b-methyl-1%252C2%252C3%252C4%252C6%252C7%252C12%252C12b-octahydroindolo%255B2%252C3-a%255Dquinolizine%2520derivatives%2520as%2520LPA%2520receptor%2520agonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terakado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshaviak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmar-Rovira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of antagonist bound human lysophosphatidic acid receptor 1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1633</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.cell.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=26091040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Squ73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1633-1643&author=J.+E.+Chrencikauthor=C.+B.+Rothauthor=M.+Terakadoauthor=H.+Kurataauthor=R.+Omiauthor=Y.+Kiharaauthor=D.+Warshaviakauthor=S.+Nakadeauthor=G.+Asmar-Roviraauthor=M.+Mileniauthor=H.+Mizunoauthor=M.+T.+Griffithauthor=C.+Rodgersauthor=G.+W.+Hanauthor=J.+Velasquezauthor=J.+Chunauthor=R.+C.+Stevensauthor=M.+A.+Hanson&title=Crystal+structure+of+antagonist+bound+human+lysophosphatidic+acid+receptor+1&doi=10.1016%2Fj.cell.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of antagonist bound human lysophosphatidic acid receptor 1</span></div><div class="casAuthors">Chrencik, Jill E.; Roth, Christopher B.; Terakado, Masahiko; Kurata, Haruto; Omi, Rie; Kihara, Yasuyuki; Warshaviak, Dora; Nakade, Shinji; Asmar-Rovira, Guillermo; Mileni, Mauro; Mizuno, Hirotaka; Griffith, Mark T.; Rodgers, Caroline; Han, Gye Won; Velasquez, Jeffrey; Chun, Jerold; Stevens, Raymond C.; Hanson, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1633-1643</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lipid biol. continues to emerge as an area of significant therapeutic interest, particularly as the result of an enhanced understanding of the wealth of signaling mols. with diverse physiol. properties.  This growth in knowledge is epitomized by lysophosphatidic acid (LPA), which functions through interactions with at least 6 cognate G protein-coupled receptors.  Here, the authors present 3 crystal structures of LPA1 in complex with antagonist tool compds. selected and designed through structural and stability analyses.  Structural anal. combined with mol. dynamics identified a basis for ligand access to the LPA1 binding pocket from the extracellular space contrasting with the proposed access for the sphingosine 1-phosphate receptor.  Characteristics of the LPA1 binding pocket raised the possibility of promiscuous ligand recognition of phosphorylated endocannabinoids.  Cell-based assays confirmed this hypothesis, linking the distinct receptor systems through metabolically related ligands with potential functional and therapeutic implications for treatment of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrool6xhfptULVg90H21EOLACvtfcHk0lhGvrRPK2lyvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Squ73O&md5=ac5af6b8dd80b5311e95a8eb133957b5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DTerakado%26aufirst%3DM.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DOmi%26aufirst%3DR.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DWarshaviak%26aufirst%3DD.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DAsmar-Rovira%26aufirst%3DG.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DRodgers%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DVelasquez%26aufirst%3DJ.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520antagonist%2520bound%2520human%2520lysophosphatidic%2520acid%2520receptor%25201%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1633%26epage%3D1643%26doi%3D10.1016%2Fj.cell.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parrill, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tigyi, G.</span></span> <span> </span><span class="NLM_article-title">Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1831</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2012.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.bbalip.2012.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=2-12&author=A.+L.+Parrillauthor=G.+Tigyi&title=Integrating+the+puzzle+pieces%3A+the+current+atomistic+picture+of+phospholipid-G+protein+coupled+receptor+interactions&doi=10.1016%2Fj.bbalip.2012.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Integrating the puzzle pieces: The current atomistic picture of phospholipid-G protein coupled receptor interactions</span></div><div class="casAuthors">Parrill, Abby L.; Tigyi, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1831</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  A compelling question of how phospholipids interact with their target receptors has been of interest since the first receptor-mediated effects were reported.  The recent report of a crystal structure for the S1P1 receptor in complex with an antagonist phospholipid provides interesting perspective on the insights that had previously been gained through structure-activity studies of the phospholipids, as well as modeling and mutagenesis studies of the receptors.  This review integrates these varied lines of investigation in the context of their various contributions to our current understanding of phospholipid-receptor interactions.  This article is part of a Special Issue entitled Advances in Lysophospholipid Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra2WiZKB7wybVg90H21EOLACvtfcHk0lhGvrRPK2lyvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWmsr%252FE&md5=dc7142f1c65a2a4c4a7d9df3ad5d75d6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2012.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2012.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DIntegrating%2520the%2520puzzle%2520pieces%253A%2520the%2520current%2520atomistic%2520picture%2520of%2520phospholipid-G%2520protein%2520coupled%2520receptor%2520interactions%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2013%26volume%3D1831%26spage%3D2%26epage%3D12%26doi%3D10.1016%2Fj.bbalip.2012.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span> <span> </span><span class="NLM_article-title">Carboxylic acid (bio)isosteres in drug design</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fcmdc.201200585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=23361977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=385-395&author=C.+Ballatoreauthor=D.+M.+Hurynauthor=A.+B.+Smith&title=Carboxylic+acid+%28bio%29isosteres+in+drug+design&doi=10.1002%2Fcmdc.201200585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylic Acid (Bio)Isosteres in Drug Design</span></div><div class="casAuthors">Ballatore, Carlo; Huryn, Donna M.; Smith, Amos B.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-395</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The carboxylic acid functional group can be an important constituent of a pharmacophore, however, the presence of this moiety can also be responsible for significant drawbacks, including metabolic instability, toxicity, as well as limited passive diffusion across biol. membranes.  To avoid some of these shortcomings while retaining the desired attributes of the carboxylic acid moiety, medicinal chemists often investigate the use of carboxylic acid (bio)isosteres.  The same type of strategy can also be effective for a variety other purposes, for example, to increase the selectivity of a biol. active compd. or to create new intellectual property.  Several carboxylic acid isosteres have been reported, however, the outcome of any isosteric replacement cannot be readily predicted as this strategy is generally found to be dependent upon the particular context (i.e., the characteristic properties of the drug and the drug-target).  As a result, screening of a panel of isosteres is typically required.  In this context, the discovery and development of novel carboxylic acid surrogates that could complement the existing palette of isosteres remains an important area of research.  The goal of this Minireview is to provide an overview of the most commonly employed carboxylic acid (bio)isosteres and to present representative examples demonstrating the use and utility of each isostere in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEcl3NtfHu7Vg90H21EOLACvtfcHk0ljciRSiLwXl9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D&md5=cff8233af1c386439789a0e4ebcb4331</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200585%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DCarboxylic%2520acid%2520%2528bio%2529isosteres%2520in%2520drug%2520design%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D385%26epage%3D395%26doi%3D10.1002%2Fcmdc.201200585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lassalas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasfargeas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayendran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Structure property relationships of carboxylic acid isosteres</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3183</span>– <span class="NLM_lpage">3203</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3183-3203&author=P.+Lassalasauthor=B.+Gayauthor=C.+Lasfargeasauthor=M.+J.+Jamesauthor=V.+Tranauthor=K.+G.+Vijayendranauthor=K.+R.+Brundenauthor=M.+C.+Kozlowskiauthor=C.+J.+Thomasauthor=A.+B.+Smithauthor=D.+M.+Hurynauthor=C.+Ballatore&title=Structure+property+relationships+of+carboxylic+acid+isosteres&doi=10.1021%2Facs.jmedchem.5b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Property Relationships of Carboxylic Acid Isosteres</span></div><div class="casAuthors">Lassalas, Pierrik; Gay, Bryant; Lasfargeas, Caroline; James, Michael J.; Tran, Van; Vijayendran, Krishna G.; Brunden, Kurt R.; Kozlowski, Marisa C.; Thomas, Craig J.; Smith, Amos B.; Huryn, Donna M.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3183-3203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of a carboxylic acid with a surrogate structure, or (bio)-isostere, is a classical strategy in medicinal chem.  The general underlying principle is that by maintaining the features of the carboxylic acid crit. for biol. activity, but appropriately modifying the physicochem. properties, improved analogs may result.  In this context, a systematic assessment of the physicochem. properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design.  Herein we report the structure-property relationships (SPR) of 35 phenylpropionic acid derivs., in which the carboxylic acid moiety is replaced with a series of known isosteres.  The data set generated provides an assessment of the relative impact on the physicochem. properties that these replacements may have compared to the carboxylic acid analog.  As such, this study presents a framework for how to rationally apply isosteric replacements of the carboxylic acid functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIF98i2ITNrLVg90H21EOLACvtfcHk0ljciRSiLwXl9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D&md5=34490fc72fdb321d8c9751bef1bf79c5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01963%26sid%3Dliteratum%253Aachs%26aulast%3DLassalas%26aufirst%3DP.%26aulast%3DGay%26aufirst%3DB.%26aulast%3DLasfargeas%26aufirst%3DC.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DTran%26aufirst%3DV.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DKozlowski%26aufirst%3DM.%2BC.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DStructure%2520property%2520relationships%2520of%2520carboxylic%2520acid%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3183%26epage%3D3203%26doi%3D10.1021%2Facs.jmedchem.5b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljciRSiLwXl9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisneros, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorklund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gil, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrano, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1021/jm201327p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201327p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=824-836&author=J.+A.+Cisnerosauthor=E.+Bjorklundauthor=I.+Gonzalez-Gilauthor=Y.+Huauthor=A.+Canalesauthor=F.+J.+Medranoauthor=A.+Romeroauthor=S.+Ortega-Gutierrezauthor=C.+J.+Fowlerauthor=M.+L.+Lopez-Rodriguez&title=Structure-activity+relationship+of+a+new+series+of+reversible+dual+monoacylglycerol+lipase%2Ffatty+acid+amide+hydrolase+inhibitors&doi=10.1021%2Fjm201327p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of a New Series of Reversible Dual Monoacylglycerol Lipase/Fatty Acid Amide Hydrolase Inhibitors</span></div><div class="casAuthors">Cisneros, Jose A.; Bjorklund, Emmelie; Gonzalez-Gil, Ines; Hu, Yanling; Canales, Angeles; Medrano, Francisco J.; Romero, Antonio; Ortega-Gutierrez, Silvia; Fowler, Christopher J.; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">824-836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), play independent and nonredundant roles in the body.  This makes the development of both selective and dual inhibitors of their inactivation an important priority.  In this work, we report a new series of inhibitors of monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH).  Among them, (±)-oxiran-2-ylmethyl 6-(1,1'-biphenyl-4-yl)hexanoate (I) and (2R)-(-)-oxiran-2-ylmethyl(4-benzylphenyl)acetate (II) stand out as potent inhibitors of human recombinant MAGL (IC50 (I) = 4.1 μM; IC50 (II) = 2.4 μM), rat brain monoacylglycerol hydrolysis (IC50 (I) = 1.8 μM; IC50 (II) = 0.68 μM), and rat brain FAAH (IC50 (I) = 5.1 μM; IC50 (II) = 0.29 μM).  Importantly, and in contrast to the other previously described MAGL inhibitors, these compds. behave as reversible inhibitors either of competitive (I) or noncompetitive nature (II).  Hence, they could be useful to explore the therapeutic potential of reversible MAGL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4rdcY3AOsWrVg90H21EOLACvtfcHk0ljGngSwQasUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLnJ&md5=917fd37043fd3ba4ecdfc4f5ac2c032a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201327p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201327p%26sid%3Dliteratum%253Aachs%26aulast%3DCisneros%26aufirst%3DJ.%2BA.%26aulast%3DBjorklund%26aufirst%3DE.%26aulast%3DGonzalez-Gil%26aufirst%3DI.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DMedrano%26aufirst%3DF.%2BJ.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DStructure-activity%2520relationship%2520of%2520a%2520new%2520series%2520of%2520reversible%2520dual%2520monoacylglycerol%2520lipase%252Ffatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D824%26epage%3D836%26doi%3D10.1021%2Fjm201327p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Torres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipriano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heden, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorklund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13765</span>– <span class="NLM_lpage">13770</span>, <span class="refDoi"> DOI: 10.1002/anie.201407807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fanie.201407807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=13765-13770&author=G.+Hernandez-Torresauthor=M.+Ciprianoauthor=E.+Hedenauthor=E.+Bjorklundauthor=A.+Canalesauthor=D.+Zianauthor=A.+Feliuauthor=M.+Mechaauthor=C.+Guazaauthor=C.+J.+Fowlerauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguez&title=A+reversible+and+selective+inhibitor+of+monoacylglycerol+lipase+ameliorates+multiple+sclerosis&doi=10.1002%2Fanie.201407807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis</span></div><div class="casAuthors">Hernandez-Torres, Gloria; Cipriano, Mariateresa; Heden, Erika; Bjoerklund, Emmelie; Canales, Angeles; Zian, Debora; Feliu, Ana; Mecha, Miriam; Guaza, Carmen; Fowler, Christopher J.; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">13765-13770</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is the enzyme responsible for the inactivation of the endocannabinoid 2-arachidonoylglycerol (2-AG).  MAGL inhibitors show analgesic and tissue-protecting effects in several disease models.  However, the few efficient and selective MAGL inhibitors described to date block the enzyme irreversibly, and this can lead to pharmacol. tolerance.  Hence, addnl. classes of MAGL inhibitors are needed to validate this enzyme as a therapeutic target.  Here we report a potent, selective, and reversible MAGL inhibitor (IC50=0.18 μM) which is active in vivo and ameliorates the clin. progression of a multiple sclerosis (MS) mouse model without inducing undesirable CB1-mediated side effects.  These results support the interest in MAGL as a target for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzujCPuidHArVg90H21EOLACvtfcHk0ljGngSwQasUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF&md5=6cd7f2080f95bbc05daaebba21ee1be2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407807%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Torres%26aufirst%3DG.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DHeden%26aufirst%3DE.%26aulast%3DBjorklund%26aufirst%3DE.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DZian%26aufirst%3DD.%26aulast%3DFeliu%26aufirst%3DA.%26aulast%3DMecha%26aufirst%3DM.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DA%2520reversible%2520and%2520selective%2520inhibitor%2520of%2520monoacylglycerol%2520lipase%2520ameliorates%2520multiple%2520sclerosis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D13765%26epage%3D13770%26doi%3D10.1002%2Fanie.201407807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orcajo-Rincón, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrecillas, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuthrich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Development of non-peptide ligands of growth factor receptor-bound protein 2-Src homology 2 domain using molecular modeling and NMR spectroscopy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1021/jm101478n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101478n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1096-1100&author=A.+L.+Orcajo-Rinc%C3%B3nauthor=S.+Ortega-Guti%C3%A9rrezauthor=P.+Serranoauthor=I.+R.+Torrecillasauthor=K.+Wuthrichauthor=M.+Campilloauthor=L.+Pardoauthor=A.+Visoauthor=B.+Benham%C3%BAauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Development+of+non-peptide+ligands+of+growth+factor+receptor-bound+protein+2-Src+homology+2+domain+using+molecular+modeling+and+NMR+spectroscopy&doi=10.1021%2Fjm101478n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of non-peptide ligands of growth factor receptor-bound protein 2-Src homology 2 domain using molecular modeling and NMR spectroscopy</span></div><div class="casAuthors">Orcajo-Rincon, Angel L.; Ortega-Gutierrez, Silvia; Serrano, Pedro; Torrecillas, Ivan R.; Wuthrich, Kurt; Campillo, Mercedes; Pardo, Leonardo; Viso, Alma; Benhamu, Bellinda; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1096-1100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a novel series of non-peptide ligands that inhibit the growth factor receptor-bound protein 2 (Grb2)-Src homol. 2 (SH2) domain binding, designed using a combined computational and NMR-driven approach.  We have identified a new lead compd., 1n (IC50 = 56 μM), which is cytotoxic in HER2-pos. breast cancer cells and disrupts the interaction between HER2 and Grb2.  Thus, 1n can be used as a scaffold for the development of efficient Grb2-SH2 domain binding inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJfdc1Jl8RnLVg90H21EOLACvtfcHk0ljGngSwQasUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKmurk%253D&md5=a0830a8066568b99da33d44a2503d404</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm101478n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101478n%26sid%3Dliteratum%253Aachs%26aulast%3DOrcajo-Rinc%25C3%25B3n%26aufirst%3DA.%2BL.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DSerrano%26aufirst%3DP.%26aulast%3DTorrecillas%26aufirst%3DI.%2BR.%26aulast%3DWuthrich%26aufirst%3DK.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DViso%26aufirst%3DA.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DDevelopment%2520of%2520non-peptide%2520ligands%2520of%2520growth%2520factor%2520receptor-bound%2520protein%25202-Src%2520homology%25202%2520domain%2520using%2520molecular%2520modeling%2520and%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1096%26epage%3D1100%26doi%3D10.1021%2Fjm101478n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Troupiotis-Tsailaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gil, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govaerts, C.</span></span> <span> </span><span class="NLM_article-title">Ligand chain length drives activation of lipid G protein-coupled receptors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2020</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-02104-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fs41598-017-02104-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28515494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BC1crosVShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2020&author=A.+Troupiotis-Tsailakiauthor=J.+Zachmannauthor=I.+Gonzalez-Gilauthor=A.+Gonzalezauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguezauthor=L.+Pardoauthor=C.+Govaerts&title=Ligand+chain+length+drives+activation+of+lipid+G+protein-coupled+receptors&doi=10.1038%2Fs41598-017-02104-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand chain length drives activation of lipid G protein-coupled receptors</span></div><div class="casAuthors">Troupiotis-Tsailaki Anastassia; Govaerts Cedric; Zachmann Julian; Gonzalez Angel; Pardo Leonardo; Gonzalez-Gil Ines; Ortega-Gutierrez Silvia; Lopez-Rodriguez Maria L</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2020</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) is a lipid mediator that can activate five cell membrane G protein-coupled receptors (GPCRs) which carry a variety of essential functions and are promising drug targets.  S1P is composed of a polar zwitterionic head-group and a hydrophobic alkyl chain.  This implies an activation mechanism of its cognate receptor that must be significantly different from what is known for prototypical GPCRs (ie receptor to small hydrophilic ligands).  Here we aim to identify the structural features responsible for S1P agonism by combining molecular dynamics simulations and functional assays using S1P analogs of different alkyl chain lengths.  We propose that high affinity binding involves polar interactions between the lipid head-group and receptor side chains while activation is due to hydrophobic interactions between the lipid tail and residues in a distinct binding site.  We observe that ligand efficacy is directly related to alkyl chain length but also varies with receptor subtypes in correlation with the size of this binding pocket.  Integrating experimental and computational data, we propose an activation mechanism for the S1P receptors involving agonist-induced conformational events that are conserved throughout class A GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxLKh8DGKPB-WhZTslLrfffW6udTcc2eaOGfLDBujL77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crosVShtg%253D%253D&md5=336c30282c49124f008c93fab462212e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-02104-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-02104-5%26sid%3Dliteratum%253Aachs%26aulast%3DTroupiotis-Tsailaki%26aufirst%3DA.%26aulast%3DZachmann%26aufirst%3DJ.%26aulast%3DGonzalez-Gil%26aufirst%3DI.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DGovaerts%26aufirst%3DC.%26atitle%3DLigand%2520chain%2520length%2520drives%2520activation%2520of%2520lipid%2520G%2520protein-coupled%2520receptors%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D2020%26doi%3D10.1038%2Fs41598-017-02104-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baksh, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussrow, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhop, D. J.</span></span> <span> </span><span class="NLM_article-title">Label-free quantification of membrane-ligand interactions using backscattering interferometry</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1038/nbt.1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnbt.1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=21399645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=357-360&author=M.+M.+Bakshauthor=A.+K.+Kussrowauthor=M.+Mileniauthor=M.+G.+Finnauthor=D.+J.+Bornhop&title=Label-free+quantification+of+membrane-ligand+interactions+using+backscattering+interferometry&doi=10.1038%2Fnbt.1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Label-free quantification of membrane-ligand interactions using backscattering interferometry</span></div><div class="casAuthors">Baksh, Michael M.; Kussrow, Amanda K.; Mileni, Mauro; Finn, M. G.; Bornhop, Darryl J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-360</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although membrane proteins are ubiquitous within all living organisms and represent the majority of drug targets, a general method for direct, label-free measurement of ligand binding to native membranes has not been reported.  Here we show that backscattering interferometry (BSI) can accurately quantify ligand-receptor binding affinities in a variety of membrane environments.  By detecting minute changes in the refractive index of a soln., BSI allows binding interactions of proteins with their ligands to be measured at picomolar concns.  Equil. binding consts. in the micromolar to picomolar range were obtained for small- and large-mol. interactions in both synthetic and cell-derived membranes without the use of labels or supporting substrates.  The simple and low-cost hardware, high sensitivity and label-free nature of BSI should make it readily applicable to the study of many membrane-assocd. proteins of biochem. and pharmacol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoykKg8qC1LcLVg90H21EOLACvtfcHk0ljd2bs5CKduGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVGmsLo%253D&md5=be739d26330d94118b72d9e7d4ef0c77</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1790%26sid%3Dliteratum%253Aachs%26aulast%3DBaksh%26aufirst%3DM.%2BM.%26aulast%3DKussrow%26aufirst%3DA.%2BK.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DBornhop%26aufirst%3DD.%2BJ.%26atitle%3DLabel-free%2520quantification%2520of%2520membrane-ligand%2520interactions%2520using%2520backscattering%2520interferometry%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D357%26epage%3D360%26doi%3D10.1038%2Fnbt.1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bornhop, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussrow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, H. S.</span></span> <span> </span><span class="NLM_article-title">Free-solution, label-free molecular interactions studied by back-scattering interferometry</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1732</span>– <span class="NLM_lpage">1736</span>, <span class="refDoi"> DOI: 10.1126/science.1146559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1126%2Fscience.1146559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=17885132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1732-1736&author=D.+J.+Bornhopauthor=J.+C.+Lathamauthor=A.+Kussrowauthor=D.+A.+Markovauthor=R.+D.+Jonesauthor=H.+S.+Sorensen&title=Free-solution%2C+label-free+molecular+interactions+studied+by+back-scattering+interferometry&doi=10.1126%2Fscience.1146559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Free-Solution, Label-Free Molecular Interactions Studied by Back-Scattering Interferometry</span></div><div class="casAuthors">Bornhop, Darryl J.; Latham, Joey C.; Kussrow, Amanda; Markov, Dmitry A.; Jones, Richard D.; Sorensen, Henrik S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5845</span>),
    <span class="NLM_cas:pages">1732-1736</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Free-soln., label-free mol. interactions were investigated with back-scattering interferometry in a simple optical train composed of a helium-neon laser, a microfluidic channel, and a position sensor.  Mol. binding interactions between proteins, ions and protein, and small mols. and protein, were detd. with high dynamic range dissocn. consts. (Kd spanning six decades) and unmatched sensitivity (picomolar Kd's and detection limits of 10,000s of mols.).  With this technique, equil. dissocn. consts. were quantified for protein A and IgG, interleukin-2 with its monoclonal antibody, and calmodulin with calcium ion Ca2+, a small mol. inhibitor, the protein calcineurin, and the M13 peptide.  The high sensitivity of back-scattering interferometry and small vols. of microfluidics allowed the entire calmodulin assay to be performed with 200 pmol of solute.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr12XhHV8KSuLVg90H21EOLACvtfcHk0ljd2bs5CKduGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsLnP&md5=53447d03bc300515bc6cfed45829707d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.1146559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1146559%26sid%3Dliteratum%253Aachs%26aulast%3DBornhop%26aufirst%3DD.%2BJ.%26aulast%3DLatham%26aufirst%3DJ.%2BC.%26aulast%3DKussrow%26aufirst%3DA.%26aulast%3DMarkov%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BD.%26aulast%3DSorensen%26aufirst%3DH.%2BS.%26atitle%3DFree-solution%252C%2520label-free%2520molecular%2520interactions%2520studied%2520by%2520back-scattering%2520interferometry%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1732%26epage%3D1736%26doi%3D10.1126%2Fscience.1146559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussrow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhop, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1194/jlr.D089938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1194%2Fjlr.D089938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30463988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=212-217&author=H.+Mizunoauthor=Y.+Kiharaauthor=A.+Kussrowauthor=A.+Chenauthor=M.+Rayauthor=R.+Riveraauthor=D.+J.+Bornhopauthor=J.+Chun&title=Lysophospholipid+G+protein-coupled+receptor+binding+parameters+as+determined+by+backscattering+interferometry&doi=10.1194%2Fjlr.D089938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry</span></div><div class="casAuthors">Mizuno, Hirotaka; Kihara, Yasuyuki; Kussrow, Amanda; Chen, Allison; Ray, Manisha; Rivera, Richard; Bornhop, Darryl J.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-217</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) activates cognate G protein-coupled receptors (GPCRs) to initiate biol. signaling cascades.  Lysophospholipid (LP) receptor binding properties remain incompletely assessed because of difficulties with ligand lipophilicity and lipid "stickiness.".  These inherent attributes produce high levels of nonspecific binding within cell-membrane prepns. used to assess GPCRs, as has been shown in classical binding assays using radiolabeled ligands, making accurate measurements of lipid binding kinetics difficult to achieve.  Backscattering interferometry (BSI) is an optical technol. that measures mol. binding interactions by reporting changes in the refractive index of a soln. after binding events.  Here, we report the use of BSI to assess LPA1 for its ability to bind to naturally occurring lipids and a synthetic LPA1 antagonist (ONO-9780307), under both primary- and competition-binding conditions.  Assessment of 12 different lipids demonstrated that the known LP ligand, 1-oleoyl-LPA, as well as an endocannabinoid metabolite, anandamide phosphate, are specific ligands for LPA1, whereas other LPs tested were not.  Newly detd. dissocn. consts. (Kd values) for orthosteric lipid ligands approximated 10-9 M, substantially lower (i.e., with higher affinity) than measured Kd values in classical binding or cell-based assays.  These results demonstrate that BSI may have particular utility in assessing binding interactions between lipid receptors and their lipid ligands and could provide new screening approaches for lipid receptor identification and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJJdrxjiIhP7Vg90H21EOLACvtfcHk0ljd2bs5CKduGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2isg%253D%253D&md5=ef555e0beb730efd6bab2723289d3fd6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1194%2Fjlr.D089938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.D089938%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DKussrow%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DBornhop%26aufirst%3DD.%2BJ.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520G%2520protein-coupled%2520receptor%2520binding%2520parameters%2520as%2520determined%2520by%2520backscattering%2520interferometry%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2019%26volume%3D60%26spage%3D212%26epage%3D217%26doi%3D10.1194%2Fjlr.D089938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omotuyi, O. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Lys39-Lysophosphatidate carbonyl oxygen interaction locks LPA1 N-terminal cap to the orthosteric site and partners Arg124 during receptor activation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13343</span>, <span class="refDoi"> DOI: 10.1038/srep13343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fsrep13343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=26268898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhs7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13343&author=O.+I.+Omotuyiauthor=J.+Nagaiauthor=H.+Ueda&title=Lys39-Lysophosphatidate+carbonyl+oxygen+interaction+locks+LPA1+N-terminal+cap+to+the+orthosteric+site+and+partners+Arg124+during+receptor+activation&doi=10.1038%2Fsrep13343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Lys39-Lysophosphatidate Carbonyl Oxygen Interaction Locks LPA1 N-terminal Cap to the Orthosteric Site and partners Arg124 During Receptor Activation</span></div><div class="casAuthors">Omotuyi, Olaposi I.; Nagai, Jun; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13343</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) receptor 1 (LPA1) is a member of the G protein-coupled receptors mediating the biol. response to LPA species.  Lack of detailed mechanism underlying LPA/LPA1 interaction has hampered the development of specific antagonists.  Here, novel N-terminal Lys39 has been identified as a key residue during LPA-type agonist binding and LPA1 activation.  Anal. of the mol. dynamics (MD) trajectories showed that LPA-type agonist but not VPC-32183 (antagonist) evolved structures with classical GPCR activation signatures such as reduced cytoplasmic transmembrane (TM) 3/TM6 dynamic network, ruptured ionic lock, and formation of a continuous and highly ordered internal water pathway was also obsd.  In activated state, LPA-type agonists interact with Arg124 (R3.28), Gln125 (Q3.29), Lys294 (K7.36) and a novel N-terminal Lys39.  Site-directed mutagenesis showed complete loss of intracellular calcium mobilization in B103 cells expressing R3.28A and Lys39Ala when treated with LPA-type agonists.  Structurally, LPA-type agonist via Carbonyl-oxygen/Lys39 interaction facilitated the formation of a hypothetical N-terminal cap tightly packed over LPA1 heptahelical bundle.  This packing may represent a key mechanism to distinguish an apo-receptor from bound LPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKt34LmuE5M7Vg90H21EOLACvtfcHk0lhNGCvbl9c_ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhs7fP&md5=101fc4c79026f0f089ac359dfb32940d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fsrep13343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13343%26sid%3Dliteratum%253Aachs%26aulast%3DOmotuyi%26aufirst%3DO.%2BI.%26aulast%3DNagai%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLys39-Lysophosphatidate%2520carbonyl%2520oxygen%2520interaction%2520locks%2520LPA1%2520N-terminal%2520cap%2520to%2520the%2520orthosteric%2520site%2520and%2520partners%2520Arg124%2520during%2520receptor%2520activation%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13343%26doi%3D10.1038%2Fsrep13343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandy-Szekeres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsonkov, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordalski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpsoe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojarski, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">GPCRdb in 2018: adding GPCR structure models and ligands</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">D440</span>, <span class="refDoi"> DOI: 10.1093/nar/gkx1109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkx1109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=29155946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGisLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=D440&author=G.+Pandy-Szekeresauthor=C.+Munkauthor=T.+M.+Tsonkovauthor=S.+Mordalskiauthor=K.+Harpsoeauthor=A.+S.+Hauserauthor=A.+J.+Bojarskiauthor=D.+E.+Gloriam&title=GPCRdb+in+2018%3A+adding+GPCR+structure+models+and+ligands&doi=10.1093%2Fnar%2Fgkx1109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">GPCRdb in 2018: adding GPCR structure models and ligands</span></div><div class="casAuthors">Pandy-Szekeres, Gaspar; Munk, Christian; Tsonkov, Tsonko M.; Mordalski, Stefan; Harpsoee, Kasper; Hauser, Alexander S.; Bojarski, Andrzej J.; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D440-D446</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">G protein-coupled receptors are the most abundant mediators of both human signaling processes and therapeutic effects.  Herein, we report GPCRomewide homol. models of unprecedented quality, and roughly 150 000 GPCR ligands with data on biol. activities and com. availability.  Based on the strategy of 'Less model - more Xtal', each model exploits both a main template and alternative local templates.  This achieved higher similarity to new structures than any of the existing resources, and refined crystal structures with missing or distorted regions.  Models are provided for inactive, intermediate and active states-except for classes C and F that so far only have inactive templates.  The ligand database has sep. browsers for: (i) target selection by receptor, family or class, (ii) ligand filtering based on cross-expt. activities (min, max and mean) or chem. properties, (iii) ligand source data and (iv) com. availability.  SMILES structures and activity spreadsheets can be downloaded for further processing.  Furthermore, three recent landmark publications on GPCR drugs, G protein selectivity and genetic variants have been accompanied with resources that now let readers view and analyze the findings themselves in GPCRdb.  Altogether, this update will enable scientific investigation for the wider GPCR community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptWfqUUDwXB7Vg90H21EOLACvtfcHk0lhNGCvbl9c_ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGisLbE&md5=0cf77dd5ea934548a2d3a0ca69991f60</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkx1109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkx1109%26sid%3Dliteratum%253Aachs%26aulast%3DPandy-Szekeres%26aufirst%3DG.%26aulast%3DMunk%26aufirst%3DC.%26aulast%3DTsonkov%26aufirst%3DT.%2BM.%26aulast%3DMordalski%26aufirst%3DS.%26aulast%3DHarpsoe%26aufirst%3DK.%26aulast%3DHauser%26aufirst%3DA.%2BS.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DGPCRdb%2520in%25202018%253A%2520adding%2520GPCR%2520structure%2520models%2520and%2520ligands%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26spage%3DD440%26doi%3D10.1093%2Fnar%2Fgkx1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><a href="https://gpcrdb.org/structure/homology_models/lpar1_human_active" class="extLink">https://gpcrdb.org/structure/homology_models/lpar1_human_active</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fgpcrdb.org%2Fstructure%2Fhomology_models%2Flpar1_human_active."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrandiz-Huertas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathivanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lujan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span> <span> </span><span class="NLM_article-title">AlphaCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">18345</span>– <span class="NLM_lpage">18350</span>, <span class="refDoi"> DOI: 10.1073/pnas.1420252111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1073%2Fpnas.1420252111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25489075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVClu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=18345-18350&author=I.+Devesaauthor=C.+Ferrandiz-Huertasauthor=S.+Mathivananauthor=C.+Wolfauthor=R.+Lujanauthor=J.+P.+Changeuxauthor=A.+Ferrer-Montiel&title=AlphaCGRP+is+essential+for+algesic+exocytotic+mobilization+of+TRPV1+channels+in+peptidergic+nociceptors&doi=10.1073%2Fpnas.1420252111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors</span></div><div class="casAuthors">Devesa, Isabel; Ferrandiz-Huertas, Clotilde; Mathivanan, Sakthikumar; Wolf, Christoph; Lujan, Rafael; Changeux, Jean-Pierre; Ferrer-Montiel, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">18345-18350</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proalgesic sensitization of peripheral nociceptors in painful syndromes is a complex mol. process poorly understood that involves mobilization of thermosensory receptors to the neuronal surface.  However, whether recruitment of vesicular thermoTRP channels is a general mechanism underlying sensitization of all nociceptor types or is subtype-specific remains controversial.  We report that sensitization-induced Ca2+-dependent exocytotic insertion of transient receptor potential vanilloid 1 (TRPV1) receptors to the neuronal plasma membrane is a mechanism specifically used by peptidergic nociceptors to potentiate their excitability.  Notably, we found that TRPV1 is present in large dense-core vesicles (LDCVs) that were mobilized to the neuronal surface in response to a sensitizing insult.  Deletion or silencing of calcitonin-gene-related peptide alpha (αCGRP) gene expression drastically reduced proalgesic TRPV1 potentiation in peptidergic nociceptors by abrogating its Ca2+-dependent exocytotic recruitment.  These findings uncover a context-dependent mol. mechanism of TRPV1 algesic sensitization and a previously unrecognized role of αCGRP in LDCV mobilization in peptidergic nociceptors.  Furthermore, these results imply that concurrent secretion of neuropeptides and channels in peptidergic C-type nociceptors facilitates a rapid modulation of pain signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ3Tyws7KHP7Vg90H21EOLACvtfcHk0lhNGCvbl9c_ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVClu7nM&md5=ab44102a74ca27e84e7af9017c047102</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420252111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420252111%26sid%3Dliteratum%253Aachs%26aulast%3DDevesa%26aufirst%3DI.%26aulast%3DFerrandiz-Huertas%26aufirst%3DC.%26aulast%3DMathivanan%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DC.%26aulast%3DLujan%26aufirst%3DR.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26atitle%3DAlphaCGRP%2520is%2520essential%2520for%2520algesic%2520exocytotic%2520mobilization%2520of%2520TRPV1%2520channels%2520in%2520peptidergic%2520nociceptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D18345%26epage%3D18350%26doi%3D10.1073%2Fpnas.1420252111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathivanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span> <span> </span><span class="NLM_article-title">Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">178</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.3389%2Ffphar.2016.00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=27445816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=178&author=S.+Mathivananauthor=I.+Devesaauthor=J.+P.+Changeuxauthor=A.+Ferrer-Montiel&title=Bradykinin+induces+TRPV1+exocytotic+recruitment+in+peptidergic+nociceptors&doi=10.3389%2Ffphar.2016.00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors</span></div><div class="casAuthors">Mathivanan, Sakthikumar; Devesa, Isabel; Changeux, Jean-Pierre; Ferrer-Montiel, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178/1-178/12</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Transient receptor potential vanilloid I (TRPV1) sensitization in peripheral nociceptors is a prominent phenomenon that occurs in inflammatory pain conditions.  Pro-algesic agents can potentiate TRPV1 activity in nociceptors through both stimulation of its channel gating and mobilization of channels to the neuronal surface in a context dependent manner.  A recent study reported that ATP-induced TRPV1 sensitization in peptidergic nociceptors involves the exocytotic release of channels trafficked by large dense core vesicles (LDCVs) that cargo alpha-calcitonin gene related peptide alpha (α CGRP).  We hypothesized that, similar to ATP, bradykinin may also use different mechanisms to sensitize TRPV1 channels in peptidergic and non-peptidergic nociceptors.  We found that bradykinin notably enhances the excitability of peptidergic nociceptors, and sensitizes TRPV1, primarily through the bradykinin receptor 2 pathway.  Notably, bradykinin sensitization of TRPV1 in peptidergic nociceptors was significantly blocked by inhibiting Ca2+-dependent neuronal exocytosis.  In addn., silencing α CGRP gene expression, but not substance P, drastically reduced bradykinin-induced TRPV1 sensitization in peptidergic nociceptors.  Taken together, these findings indicate that bradykinin-induced sensitization of TRPV1 in peptidergic nociceptors is partially mediated by the exocytotic mobilization of new channels trafficked by α CGRP-loaded LDCVs to the neuronal membrane.  Our findings further imply a central role of α CGRP peptidergic nociceptors in peripheral algesic sensitization, and substantiate that inhibition of LDCVs exocytosis is a valuable therapeutic strategy to treat pain, as it concurrently reduces the release of pro-inflammatory peptides and the membrane recruitment of thermoTRP channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSg5S0ByjjbVg90H21EOLACvtfcHk0lhi-yYc9f36Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtbrM&md5=df50f7e0e3f49c1feaf5f19eb8cb9f9c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00178%26sid%3Dliteratum%253Aachs%26aulast%3DMathivanan%26aufirst%3DS.%26aulast%3DDevesa%26aufirst%3DI.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26atitle%3DBradykinin%2520induces%2520TRPV1%2520exocytotic%2520recruitment%2520in%2520peptidergic%2520nociceptors%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D178%26doi%3D10.3389%2Ffphar.2016.00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Animal models of neuropathic pain</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1111/j.1472-8206.2009.00801.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fj.1472-8206.2009.00801.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=20030738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1-28&author=A.+S.+Jaggiauthor=V.+Jainauthor=N.+Singh&title=Animal+models+of+neuropathic+pain&doi=10.1111%2Fj.1472-8206.2009.00801.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of neuropathic pain</span></div><div class="casAuthors">Jaggi, Amteshwar Singh; Jain, Vivek; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-28</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Animal models are pivotal for understanding the mechanism of neuropathic pain and development of effective therapy for its optimal management.  A battery of neuropathic pain models has been developed to simulate the clin. pain conditions with diverse etiol.  The present review exhaustively discusses the methodol., behavioral alterations, limitations, and advantages of about 40 different animal models of neuropathic pain along with their modifications.  Development of these models has contributed immensely in understanding the chronic pain and underlying peripheral as well as central pathogenic mechanisms.  Furthermore, research has resulted in the development of new therapeutic agents for neuropathic pain management, and the preclin. data obtained using these animal models have been successively translated to effective pain management in clin. setup also.  As each animal model has been created with specific methodol. and results tend to vary largely with the slight changes related to methodol., therefore, it is essential that data from different models should be reported and interpreted in the context of the specific pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-2tLxHzZ1ubVg90H21EOLACvtfcHk0lhi-yYc9f36Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D&md5=85f8149349f673e11ecba18d4e94a599</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2009.00801.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2009.00801.x%26sid%3Dliteratum%253Aachs%26aulast%3DJaggi%26aufirst%3DA.%2BS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DAnimal%2520models%2520of%2520neuropathic%2520pain%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D25%26spage%3D1%26epage%3D28%26doi%3D10.1111%2Fj.1472-8206.2009.00801.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seltzer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shir, Y.</span></span> <span> </span><span class="NLM_article-title">A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(90)91074-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2F0304-3959%2890%2991074-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1982347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADyaK3M3gsVejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1990&pages=205-218&author=Z.+Seltzerauthor=R.+Dubnerauthor=Y.+Shir&title=A+novel+behavioral+model+of+neuropathic+pain+disorders+produced+in+rats+by+partial+sciatic+nerve+injury&doi=10.1016%2F0304-3959%2890%2991074-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury</span></div><div class="casAuthors">Seltzer Z; Dubner R; Shir Y</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-18</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">Partial nerve injury is the main cause of causalgiform pain disorders in humans.  We present here a novel animal model of this condition.  In rats we unilaterally ligated about half of the sciatic nerve high in the thigh.  Within a few hours after the operation, and for several months thereafter, the rats developed guarding behavior of the ipsilateral hind paw and licked it often, suggesting the possibility of spontaneous pain.  The plantar surface of the foot was evenly hyperesthetic to non-noxious and noxious stimuli.  None of the rats autotomized.  There was a sharp decrease in the withdrawal thresholds bilaterally in response to repetitive Von Frey hair stimulation at the plantar side.  After a series of such stimuli in the operated side, light touch elicited aversive responses, suggesting allodynia to touch.  The withdrawal thresholds to CO2 laser heat pulses were markedly lowered bilaterally.  Suprathreshold noxious heat pulses elicited exaggerated responses unilaterally, suggesting thermal hyperalgesia.  Pin-prick evoked such exaggerated responses bilaterally (mechanical hyperalgesia).  In a companion report, we show that these abnormalities critically depend on the sympathetic outflow.  Based on the immediate onset and long-lasting perpetuation of similar symptoms, such as touch-evoked allodynia and hyperalgesia, and the resemblance of the contralateral phenomena to 'mirror image' pains in some humans with causalgia, we suggest that this preparation may serve as a model for syndromes of the causalgiform variety that are triggered by partial nerve injury and maintained by sympathetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2IPcK77P8gkH3Rlp_k91zfW6udTcc2eZRyLFF3HfnP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3gsVejtA%253D%253D&md5=b22a068bfd793328f55939e110547c1c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2890%2991074-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252890%252991074-S%26sid%3Dliteratum%253Aachs%26aulast%3DSeltzer%26aufirst%3DZ.%26aulast%3DDubner%26aufirst%3DR.%26aulast%3DShir%26aufirst%3DY.%26atitle%3DA%2520novel%2520behavioral%2520model%2520of%2520neuropathic%2520pain%2520disorders%2520produced%2520in%2520rats%2520by%2520partial%2520sciatic%2520nerve%2520injury%26jtitle%3DPain%26date%3D1990%26volume%3D43%26spage%3D205%26epage%3D218%26doi%3D10.1016%2F0304-3959%2890%2991074-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopper, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooks, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of lysophosphatidic acid: conformationally restricted backbone mimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1021/jm970809v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970809v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlOlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=963-970&author=D.+W.+Hopperauthor=S.+P.+Raganauthor=S.+B.+Hooksauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Structure-activity+relationships+of+lysophosphatidic+acid%3A+conformationally+restricted+backbone+mimetics&doi=10.1021%2Fjm970809v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Lysophosphatidic Acid: Conformationally Restricted Backbone Mimetics</span></div><div class="casAuthors">Hopper, Darrin W.; Ragan, Seamus P.; Hooks, Shelley B.; Lynch, Kevin R.; Macdonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) has assocd. with it an intriguing cell biol. that is thought to be mediated through its interaction with G-protein coupled receptor(s).  In an effort to extend the structure-activity relationships of LPA, the authors have produced a series of LPA analogs in which the glycerol core in LPA was replaced with conformationally restricted aryl substructures.  The aryl substructures encompassed aminophenol, resorcinol, dihydroxy benzophenone, and tocopherol systems.  The benzophenone moiety was investigated both as a conformationally restricting substructure for LPA and as a possible photoreactive alkylating agent for the LPA receptor(s).  All LPA analogs were evaluated for their potency and efficacy in mobilizing calcium ions from internal stores in MDA MB-231 cells.  Ten of the 14 analogs exhibited activity in this assay at doses ≤5 μM; none of the compds. exhibited nonreceptor-mediated lytic activity at this maximal concn.  The receptor response showed surprising tolerance for manipulation in the backbone region of LPA, although none of the compds. were equipotent to LPA.  This tolerance for a variety of structures has given the authors new leads into the realization of novel agonists and antagonists of the LPA receptor(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRptogGsLUxbVg90H21EOLACvtfcHk0lhHcEIzHdF1dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlOlurs%253D&md5=f63c79b319afa7138b47f1befd47dc57</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm970809v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970809v%26sid%3Dliteratum%253Aachs%26aulast%3DHopper%26aufirst%3DD.%2BW.%26aulast%3DRagan%26aufirst%3DS.%2BP.%26aulast%3DHooks%26aufirst%3DS.%2BB.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DStructure-activity%2520relationships%2520of%2520lysophosphatidic%2520acid%253A%2520conformationally%2520restricted%2520backbone%2520mimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D963%26epage%3D970%26doi%3D10.1021%2Fjm970809v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDock Tools4: automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDock+Tools4%3A+automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lhHcEIzHdF1dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDock%2520Tools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">W665</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1093/nar/gkh381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkh381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=15215472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=W665-667&author=T.+J.+Dolinskyauthor=J.+E.+Nielsenauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=PDB2PQR%3A+an+automated+pipeline+for+the+setup+of+Poisson-Boltzmann+electrostatics+calculations&doi=10.1093%2Fnar%2Fgkh381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span></div><div class="casAuthors">Dolinsky, Todd J.; Nielsen, Jens E.; McCammon, J. Andrew; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Web Server</span>),
    <span class="NLM_cas:pages">W665-W667</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Continuum solvation models, such as Poisson-Boltzmann and Generalized Born methods, have become increasingly popular tools for investigating the influence of electrostatics on biomol. structure, energetics and dynamics.  However, the use of such methods requires accurate and complete structural data as well as force field parameters such as at. charges and radii.  Unfortunately, the limiting step in continuum electrostatics calcns. is often the addn. of missing at. coordinates to mol. structures from the Protein Data Bank and the assignment of parameters to biomol. structures.  To address this problem, we have developed the PDB2PQR web service (http://agave.wustl.edu/pdb2pqr/).  This server automates many of the common tasks of prepg. structures for continuum electrostatics calcns., including adding a limited no. of missing heavy atoms to biomol. structures, estg. titrn. states and protonating biomols. in a manner consistent with favorable hydrogen bonding, assigning charge and radius parameters from a variety of force fields, and finally generating "PQR" output compatible with several popular computational biol. packages.  This service is intended to facilitate the setup and execution of electrostatics calcns. for both experts and non-experts and thereby broaden the accessibility to the biol. community of continuum electrostatics analyses of biomol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-GebFAmzzkrVg90H21EOLACvtfcHk0lhHcEIzHdF1dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D&md5=678d2d58f5cb2c1dd862e2d71cf9dbe1</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkh381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkh381%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520an%2520automated%2520pipeline%2520for%2520the%2520setup%2520of%2520Poisson-Boltzmann%2520electrostatics%2520calculations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DW665%26epage%3D667%26doi%3D10.1093%2Fnar%2Fgkh381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W522</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkm276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=17488841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W522-525&author=T.+J.+Dolinskyauthor=P.+Czodrowskiauthor=H.+Liauthor=J.+E.+Nielsenauthor=J.+H.+Jensenauthor=G.+Klebeauthor=N.+A.+Baker&title=PDB2PQR%3A+expanding+and+upgrading+automated+preparation+of+biomolecular+structures+for+molecular+simulations&doi=10.1093%2Fnar%2Fgkm276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations</span></div><div class="casAuthors">Dolinsky Todd J; Czodrowski Paul; Li Hui; Nielsen Jens E; Jensen Jan H; Klebe Gerhard; Baker Nathan A</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W522-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Real-world observable physical and chemical characteristics are increasingly being calculated from the 3D structures of biomolecules.  Methods for calculating pK(a) values, binding constants of ligands, and changes in protein stability are readily available, but often the limiting step in computational biology is the conversion of PDB structures into formats ready for use with biomolecular simulation software.  The continued sophistication and integration of biomolecular simulation methods for systems- and genome-wide studies requires a fast, robust, physically realistic and standardized protocol for preparing macromolecular structures for biophysical algorithms.  As described previously, the PDB2PQR web server addresses this need for electrostatic field calculations (Dolinsky et al., Nucleic Acids Research, 32, W665-W667, 2004).  Here we report the significantly expanded PDB2PQR that includes the following features: robust standalone command line support, improved pK(a) estimation via the PROPKA framework, ligand parameterization via PEOE_PB charge methodology, expanded set of force fields and easily incorporated user-defined parameters via XML input files, and improvement of atom addition and optimization code.  These features are available through a new web interface (http://pdb2pqr.sourceforge.net/), which offers users a wide range of options for PDB file conversion, modification and parameterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKn5zO1OOtqIxhnOQkIHOxfW6udTcc2eaRges11W9jX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGltQ%253D%253D&md5=18883d2f9a6f30dba143a4a2ca80b0d8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm276%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520expanding%2520and%2520upgrading%2520automated%2520preparation%2520of%2520biomolecular%2520structures%2520for%2520molecular%2520simulations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW522%26epage%3D525%26doi%3D10.1093%2Fnar%2Fgkm276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sondergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2284</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/ct200133y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200133y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=2284-2295&author=C.+R.+Sondergaardauthor=M.+H.+Olssonauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=Improved+treatment+of+ligands+and+coupling+effects+in+empirical+calculation+and+rationalization+of+pKa+values&doi=10.1021%2Fct200133y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values</span></div><div class="casAuthors">Sondergaard, Chresten R.; Olsson, Mats H. M.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2284-2295</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The new empirical rules for protein pKa predictions implemented in the PROPKA3.0 software package have been extended to the prediction of pKa shifts of active site residues and ionizable ligand groups in protein-ligand complexes.  The authors present new algorithms that allow pKa shifts due to inductive (i.e., covalently coupled) intraligand interactions, as well as noncovalently coupled interligand interactions in multiligand complexes, to be included in the prediction.  The no. of different ligand chem. groups that are automatically recognized has been increased to 18, and the general implementation has been changed so that new functional groups can be added easily by the user, aided by a new and more general protonation scheme.  Except for a few cases, the new algorithms in PROPKA3.1 are found to yield results similar to or better than those obtained with PROPKA2.0.  Finally, the authors present a novel algorithm that identifies noncovalently coupled ionizable groups, where pKa prediction may be esp. difficult.  This is a general improvement to PROPKA and is applied to proteins with and without ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEiJYZqkno7Vg90H21EOLACvtfcHk0ljKbmDOljUs_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D&md5=cf4d4e20d6daa70de6ac623915e78160</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fct200133y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200133y%26sid%3Dliteratum%253Aachs%26aulast%3DSondergaard%26aufirst%3DC.%2BR.%26aulast%3DOlsson%26aufirst%3DM.%2BH.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DImproved%2520treatment%2520of%2520ligands%2520and%2520coupling%2520effects%2520in%2520empirical%2520calculation%2520and%2520rationalization%2520of%2520pKa%2520values%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D2284%26epage%3D2295%26doi%3D10.1021%2Fct200133y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Very fast empirical prediction and rationalization of protein pKa values</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1002/prot.20660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fprot.20660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=16231289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlaltLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=704-721&author=H.+Liauthor=A.+D.+Robertsonauthor=J.+H.+Jensen&title=Very+fast+empirical+prediction+and+rationalization+of+protein+pKa+values&doi=10.1002%2Fprot.20660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Very fast empirical prediction and rationalization of protein pKa values</span></div><div class="casAuthors">Li, Hui; Robertson, Andrew D.; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">704-721</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A very fast empirical method is presented for structure-based protein pKa prediction and rationalization.  The desolvation effects and intra-protein interactions, which cause variations in pKa values of protein ionizable groups, are empirically related to the positions and chem. nature of the groups proximate to the pKa sites.  A computer program is written to automatically predict pKa values based on these empirical relationships within a couple of seconds.  Unusual pKa values at buried active sites, which are among the most interesting protein pKa values, are predicted very well with the empirical method.  A test on 233 carboxyl, 12 cysteine, 45 histidine, and 24 lysine pKa values in various proteins shows a root-mean-square deviation (RMSD) of 0.89 from exptl. values.  Removal of the 29 pKa values that are upper or lower limits results in an RMSD = 0.79 for the remaining 285 pKa values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYkiHyYz6FobVg90H21EOLACvtfcHk0ljKbmDOljUs_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlaltLnN&md5=9e33529954c65867929326b99dac493b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fprot.20660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20660%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DVery%2520fast%2520empirical%2520prediction%2520and%2520rationalization%2520of%2520protein%2520pKa%2520values%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2005%26volume%3D61%26spage%3D704%26epage%3D721%26doi%3D10.1002%2Fprot.20660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dramburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein-ligand complexes</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1002/prot.21110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fprot.21110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=16927370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCjtr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=424-437&author=P.+Czodrowskiauthor=I.+Dramburgauthor=C.+A.+Sotrifferauthor=G.+Klebe&title=Development%2C+validation%2C+and+application+of+adapted+PEOE+charges+to+estimate+pKa+values+of+functional+groups+in+protein-ligand+complexes&doi=10.1002%2Fprot.21110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein-ligand complexes</span></div><div class="casAuthors">Czodrowski, Paul; Dramburg, Ingo; Sotriffer, Christoph A.; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-437</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">For routine pKa calcns. of protein-ligand complexes in drug design, the PEOE method to compute partial charges was modified.  The new method is applicable to a large scope of proteins and ligands.  The adapted charges were parameterized using exptl. free energies of solvation of amino acids and small org. ligands.  For a data set of 80 small org. mols., a correlation coeff. of r2 = 0.78 between calcd. and exptl. solvation free energies was obtained.  Continuum electrostatics pKa calcns. based on the Poisson-Boltzmann equation were carried out on a validation set of nine proteins for which 132 exptl. pKa values are known.  In total, an overall RMSD of 0.88 log units between calcd. and exptl. detd. data is achieved.  In particular, the predictions of significantly shifted pKa values are satisfactory, and reasonable ests. of protonation states in the active sites of lysozyme and xylanase could be obtained.  Application of the charge-assignment and pKa-calcn. procedure to protein-ligand complexes provides clear structural interpretations of exptl. obsd. changes of protonation states of functional groups upon complex formation.  This information is essential for the interpretation of thermodn. data of protein-ligand complex formation and provides the basis for the reliable factorization of the free energy of binding in enthalpic and entropic contributions.  The modified charge-assignment procedure forms the basis for future automated pKa calcns. of protein-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQLEkjojL36bVg90H21EOLACvtfcHk0ljKbmDOljUs_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCjtr%252FO&md5=e19cbb62940e4352ee45fa8ff90e12bb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fprot.21110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21110%26sid%3Dliteratum%253Aachs%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DDramburg%26aufirst%3DI.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DDevelopment%252C%2520validation%252C%2520and%2520application%2520of%2520adapted%2520PEOE%2520charges%2520to%2520estimate%2520pKa%2520values%2520of%2520functional%2520groups%2520in%2520protein-ligand%2520complexes%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2006%26volume%3D65%26spage%3D424%26epage%3D437%26doi%3D10.1002%2Fprot.21110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salentin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haupt, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adasme, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, M.</span></span> <span> </span><span class="NLM_article-title">PLIP: fully automated protein-ligand interaction profiler</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">W443</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1093/nar/gkv315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkv315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25873628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVymtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=W443-447&author=S.+Salentinauthor=S.+Schreiberauthor=V.+J.+Hauptauthor=M.+F.+Adasmeauthor=M.+Schroeder&title=PLIP%3A+fully+automated+protein-ligand+interaction+profiler&doi=10.1093%2Fnar%2Fgkv315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">PLIP: fully automated protein-ligand interaction profiler</span></div><div class="casAuthors">Salentin, Sebastian; Schreiber, Sven; Haupt, V. Joachim; Adasme, Melissa F.; Schroeder, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W443-W447</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The characterization of interactions in protein-ligand complexes is essential for research in structural bioinformatics, drug discovery and biol.  However, comprehensive tools are not freely available to the research community.  Here, we present the protein-ligand interaction profiler (PLIP), a novel web service for fully automated detection and visualization of relevant non-covalent protein-ligand contacts in 3D structures, freely available at projects.biotec.tu-dresden.de/plip-web.  The input is either a Protein Data Bank structure, a protein or ligand name, or a custom protein-ligand complex (e.g. from docking).  In contrast to other tools, the rule-based PLIP algorithm does not require any structure prepn.  It returns a list of detected interactions on single atom level, covering seven interaction types (hydrogen bonds, hydrophobic contacts, pi-stacking, pi-cation interactions, salt bridges, water bridges and halogen bonds).  PLIP stands out by offering publication-ready images, PyMOL sesions files to generate custom images and parsable result files to facilitate successive data processing.  The full python source code is available for download on the website.  PLIP's command-line mode allows for high-throughput interaction profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgMd-_C9BUCbVg90H21EOLACvtfcHk0liF-u8f565-rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVymtbrI&md5=4878881a7bd715e5585682876e102e65</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv315%26sid%3Dliteratum%253Aachs%26aulast%3DSalentin%26aufirst%3DS.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DHaupt%26aufirst%3DV.%2BJ.%26aulast%3DAdasme%26aufirst%3DM.%2BF.%26aulast%3DSchroeder%26aufirst%3DM.%26atitle%3DPLIP%253A%2520fully%2520automated%2520protein-ligand%2520interaction%2520profiler%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2015%26volume%3D43%26spage%3DW443%26epage%3D447%26doi%3D10.1093%2Fnar%2Fgkv315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Ramos, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabasquer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Nogales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrecillas, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Ordonez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcos-Ramiro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar-Garrido, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrano, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">A potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor improves survival in Ras-driven acute myeloid leukemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6035</span>– <span class="NLM_lpage">6046</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00145</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00145" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFaqsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6035-6046&author=N.+I.+Marin-Ramosauthor=M.+Balabasquerauthor=F.+J.+Ortega-Nogalesauthor=I.+R.+Torrecillasauthor=A.+Gil-Ordonezauthor=B.+Marcos-Ramiroauthor=P.+Aguilar-Garridoauthor=I.+Cushmanauthor=A.+Romeroauthor=F.+J.+Medranoauthor=C.+Gajateauthor=F.+Mollinedoauthor=M.+R.+Philipsauthor=M.+Campilloauthor=M.+Gallardoauthor=M.+Martin-Fontechaauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=A+potent+isoprenylcysteine+carboxylmethyltransferase+%28ICMT%29+inhibitor+improves+survival+in+Ras-driven+acute+myeloid+leukemia&doi=10.1021%2Facs.jmedchem.9b00145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Balabasquer, Moises; Ortega-Nogales, Francisco J.; Torrecillas, Ivan R.; Gil-Ordonez, Ana; Marcos-Ramiro, Beatriz; Aguilar-Garrido, Pedro; Cushman, Ian; Romero, Antonio; Medrano, Francisco J.; Gajate, Consuelo; Mollinedo, Faustino; Philips, Mark R.; Campillo, Mercedes; Gallardo, Miguel; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6035-6046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy.  However, the paucity of inhibitors has precluded the clin. validation of this approach.  In this work we report a potent ICMT inhibitor, compd. 3 [UCM-1336, IC50 = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras.  Compd. 3 significantly impairs the membrane assocn. of the four Ras isoforms, leading to a decrease of Ras activity and to inhibition of Ras downstream signaling pathways.  In addn., it induces cell death in a variety of Ras-mutated tumor cell lines and increases survival in an in vivo model of acute myeloid leukemia.  Because ICMT inhibition impairs the activity of the four Ras isoforms regardless of its activating mutation, compd. 3 surmounts many of the common limitations of available Ras inhibitors described so far.  In addn., these results validate ICMT as a valuable target for the treatment of Ras-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQdAP3zRIM7Vg90H21EOLACvtfcHk0liF-u8f565-rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFaqsbzP&md5=99eacad9ac479cc0604a46b66d039e8e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00145%26sid%3Dliteratum%253Aachs%26aulast%3DMarin-Ramos%26aufirst%3DN.%2BI.%26aulast%3DBalabasquer%26aufirst%3DM.%26aulast%3DOrtega-Nogales%26aufirst%3DF.%2BJ.%26aulast%3DTorrecillas%26aufirst%3DI.%2BR.%26aulast%3DGil-Ordonez%26aufirst%3DA.%26aulast%3DMarcos-Ramiro%26aufirst%3DB.%26aulast%3DAguilar-Garrido%26aufirst%3DP.%26aulast%3DCushman%26aufirst%3DI.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DMedrano%26aufirst%3DF.%2BJ.%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DMollinedo%26aufirst%3DF.%26aulast%3DPhilips%26aufirst%3DM.%2BR.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DGallardo%26aufirst%3DM.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DA%2520potent%2520isoprenylcysteine%2520carboxylmethyltransferase%2520%2528ICMT%2529%2520inhibitor%2520improves%2520survival%2520in%2520Ras-driven%2520acute%2520myeloid%2520leukemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6035%26epage%3D6046%26doi%3D10.1021%2Facs.jmedchem.9b00145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Couce, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomares, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordomi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernangomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">Chemical probes for the recognition of cannabinoid receptors in native systems</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6896</span>– <span class="NLM_lpage">6899</span>, <span class="refDoi"> DOI: 10.1002/anie.201200467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fanie.201200467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot12gu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6896-6899&author=L.+Martin-Couceauthor=M.+Martin-Fontechaauthor=O.+Palomaresauthor=L.+Mestreauthor=A.+Cordomiauthor=M.+Hernangomezauthor=S.+Palmaauthor=L.+Pardoauthor=C.+Guazaauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=Chemical+probes+for+the+recognition+of+cannabinoid+receptors+in+native+systems&doi=10.1002%2Fanie.201200467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Probes for the Recognition of Cannabinoid Receptors in Native Systems</span></div><div class="casAuthors">Martin-Couce, Lidia; Martin-Fontecha, Mar; Palomares, Oscar; Mestre, Leyre; Cordomi, Arnau; Hernangomez, Miriam; Palma, Sara; Pardo, Leonardo; Guaza, Carmen; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6896-6899, S6896/1-S6896/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">To find endocannabinoid-based probes with affinities for CB1 and CB2 receptors, the authors focused their efforts on the synthetic high-affinity cannabinoid ligands HU210 and HU308.  The authors carried out the reaction between ligand HU210 and N(+)-biotinyl-6-aminohexanoic acid in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and 4-dimethylaminopyridine, to yield compds. I and II (25% and 14% yields, resp.).  Esterification of ligand HU308 with N-(+)-biotinyl-6-aminohexanoic acid gave deriv. III in 55% yield.  Compds. I-III were tested for their affinities to CB1 and CB2 receptors, showing Ki values in the nanomolar range.  Compds. I-III were used for in vitro labeling of cannabinoid receptors in transiently transfected hippocampal neuronal (HT22) cells, in native neurons and microglia, and the monocytic cell line THP-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrYrn0SQ_QNbVg90H21EOLACvtfcHk0lh8OADlUtrHPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot12gu7Y%253D&md5=e285625998ba61e71d1d555019c2e2fb</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fanie.201200467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201200467%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Couce%26aufirst%3DL.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DPalomares%26aufirst%3DO.%26aulast%3DMestre%26aufirst%3DL.%26aulast%3DCordomi%26aufirst%3DA.%26aulast%3DHernangomez%26aufirst%3DM.%26aulast%3DPalma%26aufirst%3DS.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DChemical%2520probes%2520for%2520the%2520recognition%2520of%2520cannabinoid%2520receptors%2520in%2520native%2520systems%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D6896%26epage%3D6899%26doi%3D10.1002%2Fanie.201200467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ankit Uniyal, P. A. Shantanu, Shivani Vaidya, Daria A. Belinskaia, Natalia N. Shestakova, Rajnish Kumar, Sanjay Singh, <span class="NLM_string-name hlFld-ContribAuthor">Vinod Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">Tozasertib Attenuates Neuropathic Pain by Interfering with Aurora Kinase and KIF11 Mediated Nociception. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (11)
                                     , 1948-1960. <a href="https://doi.org/10.1021/acschemneuro.1c00043" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00043%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DTozasertib%252BAttenuates%252BNeuropathic%252BPain%252Bby%252BInterfering%252Bwith%252BAurora%252BKinase%252Band%252BKIF11%252BMediated%252BNociception%26aulast%3DUniyal%26aufirst%3DAnkit%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23012021%26date%3D17052021%26date%3D24052021%26volume%3D12%26issue%3D11%26spage%3D1948%26epage%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel Obeng, Takato Hiranita, Francisco León, Lance R. McMahon, <span class="NLM_string-name hlFld-ContribAuthor">Christopher R. McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6523-6548. <a href="https://doi.org/10.1021/acs.jmedchem.1c00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BApproaches%25252C%252BDrug%252BCandidates%25252C%252Band%252BTargets%252Bin%252BPain%252BDrug%252BDiscovery%26aulast%3DObeng%26aufirst%3DSamuel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6523%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alessio Nocentini, Vincenzo Alterio, Silvia Bua, Laura Micheli, Davide Esposito, Martina Buonanno, Gianluca Bartolucci, Sameh M. Osman, Zeid A. ALOthman, Roberto Cirilli, Marco Pierini, Simona Maria Monti, Lorenzo Di Cesare Mannelli, Paola Gratteri, Carla Ghelardini, Giuseppina De Simone, <span class="NLM_string-name hlFld-ContribAuthor">Claudiu T. Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Phenyl(thio)phosphon(amid)ate Benzenesulfonamides as Potent and Selective Inhibitors of Human Carbonic Anhydrases II and VII Counteract Allodynia in a Mouse Model of Oxaliplatin-Induced Neuropathy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5185-5200. <a href="https://doi.org/10.1021/acs.jmedchem.9b02135" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02135%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhenyl%252528thio%252529phosphon%252528amid%252529ate%252BBenzenesulfonamides%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BHuman%252BCarbonic%252BAnhydrases%252BII%252Band%252BVII%252BCounteract%252BAllodynia%252Bin%252Ba%252BMouse%252BModel%252Bof%252BOxaliplatin-Induced%252BNeuropathy%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D14052020%26date%3D04052020%26volume%3D63%26issue%3D10%26spage%3D5185%26epage%3D5200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhagyalalitha  Meduri</span>, <span class="hlFld-ContribAuthor ">Gurubasavaraj Veeranna  Pujar</span>, <span class="hlFld-ContribAuthor ">T.  Durai Ananda Kumar</span>, <span class="hlFld-ContribAuthor ">H.S.  Akshatha</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Sethu</span>, <span class="hlFld-ContribAuthor ">Manisha  Singh</span>, <span class="hlFld-ContribAuthor ">Abhinav  Kanagarla</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113574. <a href="https://doi.org/10.1016/j.ejmech.2021.113574" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113574%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLysophosphatidic%252Bacid%252B%252528LPA%252529%252Breceptor%252Bmodulators%25253A%252BStructural%252Bfeatures%252Band%252Brecent%252Bdevelopment%26aulast%3DMeduri%26aufirst%3DBhagyalalitha%26date%3D2021%26volume%3D222%26spage%3D113574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus  Leo</span>, <span class="hlFld-ContribAuthor ">Linda-Isabell  Schmitt</span>, <span class="hlFld-ContribAuthor ">Patricia  Küsterarent</span>, <span class="hlFld-ContribAuthor ">Andrea  Kutritz</span>, <span class="hlFld-ContribAuthor ">Tienush  Rassaf</span>, <span class="hlFld-ContribAuthor ">Christoph  Kleinschnitz</span>, <span class="hlFld-ContribAuthor ">Ulrike B.  Hendgen-Cotta</span>, <span class="hlFld-ContribAuthor ">Tim  Hagenacker</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (22)
                                     , 8636. <a href="https://doi.org/10.3390/ijms21228636" title="DOI URL">https://doi.org/10.3390/ijms21228636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21228636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21228636%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPlatinum-Based%252BDrugs%252BCause%252BMitochondrial%252BDysfunction%252Bin%252BCultured%252BDorsal%252BRoot%252BGanglion%252BNeurons%26aulast%3DLeo%26aufirst%3DMarkus%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D22%26spage%3D8636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Etienne  Guillot</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Le Bail</span>, <span class="hlFld-ContribAuthor ">Pascal  Paul</span>, <span class="hlFld-ContribAuthor ">Valérie  Fourgous</span>, <span class="hlFld-ContribAuthor ">Pascale  Briand</span>, <span class="hlFld-ContribAuthor ">Michel  Partiseti</span>, <span class="hlFld-ContribAuthor ">Bruno  Cornet</span>, <span class="hlFld-ContribAuthor ">Philip  Janiak</span>, <span class="hlFld-ContribAuthor ">Christophe  Philippo</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>374 </em>
                                    (2)
                                     , 283-294. <a href="https://doi.org/10.1124/jpet.120.265454" title="DOI URL">https://doi.org/10.1124/jpet.120.265454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.120.265454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.120.265454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DLysophosphatidic%252BAcid%252BReceptor%252BAgonism%25253A%252BDiscovery%252Bof%252BPotent%252BNonlipid%252BBenzofuran%252BEthanolamine%252BStructures%26aulast%3DGuillot%26aufirst%3DEtienne%26date%3D2020%26date%3D2020%26volume%3D374%26issue%3D2%26spage%3D283%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroshi  Ueda</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Neyama</span>, <span class="hlFld-ContribAuthor ">Yosuke  Matsushita</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (8)
                                     , 1906. <a href="https://doi.org/10.3390/cells9081906" title="DOI URL">https://doi.org/10.3390/cells9081906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9081906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9081906%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DLysophosphatidic%252BAcid%252BReceptor%252B1-%252Band%252B3-Mediated%252BHyperalgesia%252Band%252BHypoalgesia%252Bin%252BDiabetic%252BNeuropathic%252BPain%252BModels%252Bin%252BMice%26aulast%3DUeda%26aufirst%3DHiroshi%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D8%26spage%3D1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Dong Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Jin  Seo</span>, <span class="hlFld-ContribAuthor ">Gabor J.  Tigyi</span>, <span class="hlFld-ContribAuthor ">Byung Ju  Lee</span>, <span class="hlFld-ContribAuthor ">Il Ho  Jang</span>. </span><span class="cited-content_cbyCitation_article-title">The role of lysophosphatidic acid receptor 1 in inflammatory response induced by lipopolysaccharide from Porphyromonas gingivalis in human periodontal ligament stem cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oral Biology</span><span> <strong>2020,</strong> <em>45 </em>
                                    (2)
                                     , 42-50. <a href="https://doi.org/10.11620/IJOB.2020.45.2.42" title="DOI URL">https://doi.org/10.11620/IJOB.2020.45.2.42</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.11620/IJOB.2020.45.2.42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.11620%2FIJOB.2020.45.2.42%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oral%2520Biology%26atitle%3DThe%252Brole%252Bof%252Blysophosphatidic%252Bacid%252Breceptor%252B1%252Bin%252Binflammatory%252Bresponse%252Binduced%252Bby%252Blipopolysaccharide%252Bfrom%252BPorphyromonas%252Bgingivalis%252Bin%252Bhuman%252Bperiodontal%252Bligament%252Bstem%252Bcells%26aulast%3DKim%26aufirst%3DDong%2BHee%26date%3D2020%26volume%3D45%26issue%3D2%26spage%3D42%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative LPA<sub>1</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of new LPA<sub>1</sub> agonists <b>4</b>–<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4</b>–<b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Glycerol or alcohol derivatives (<b>27</b>–<b>33</b>), 2,4,6-collidine, DCM, −78 °C to rt, 24 h, 36–99%; (b) TFA, DCM, rt, 16–18 h, 52–99%; (c) trimethylsilyldiazomethane, HBF<sub>4</sub>, DCM, 0 °C, 90 min, 38%; (d) (i) KHF<sub>2</sub>, CH<sub>3</sub>OH/H<sub>2</sub>O, rt, 30 min, 99%; (ii) TMSCl, CH<sub>3</sub>CN/H<sub>2</sub>O, rt, 1 h, 60%; (e) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, MW, 160 °C, 45 min, 18%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>12</b>–<b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCC, DMAP, DCM, −20 °C to rt, 16 h, 12–49%; (b) TFA, DCM, rt, 4–5 h, 90–99%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>17</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCC, DMAP, DCM, −20 °C to rt, 16 h, 10–58%; (b) (i) TMSBr, DCM, rt, 4 h; (ii) MeOH/H<sub>2</sub>O, rt, 1 h, 90%; (c) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 74–99%.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>69</b>–<b>72</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of (<i>S</i>)- and (<i>R</i>)-<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <sup><i>i</i></sup>Pr<sub>2</sub>NP(OBn)<sub>2</sub>, 1<i>H</i>-tetrazole, DCM, rt, 2 h; (ii) <i>m</i>CPBA, DCM, −30 °C, 90 min, 86–95%; (b) TBABr, TFA, CHCl<sub>3</sub>, rt, 10 min, 89–99%; (c) <b>53</b>, DCC, DMAP, DCM, rt, 18 h, 68–73%; (d) H<sub>2</sub>, 10% Pd/C EtOH, rt, 97–99%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Analogues of Compound (<i>S</i>)-<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>52</b>, 11-phenylundecanoic acid, or palmitoleic acid, DCC, DMAP, DCM, rt, 5 h, 55–96%; (b) oleoyl chloride, pyridine, DCM, rt, 18 h, 15%; (c) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 72–80%; (d) TFA, DCM, rt, 5 h, 81–93%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Amides <b>85</b>–<b>87</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) palmitoleic acid, EDC, HOBt, DMF, rt, 18 h, 37%; (b) oleoyl chloride, Et<sub>3</sub>N, DCM, rt, 18 h, 46%; (c) TFA, DCM, rt, 18 h, 69–99%; (d) TFA, DCM, rt, 16 h, 99%; (e) <i>N</i>-hydroxysuccinimidyl ester of <b>53</b>, Et<sub>3</sub>N, DCM, rt, 12 h, 48%; (f) MgBr<sub>2</sub>·OEt<sub>2</sub>, Et<sub>2</sub>O, rt, 4 h, 99%; (g) H<sub>2</sub>, 10% Pd/C, EtOH, rt.</p></p></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Two images (0°–180° views) of the binding mode between (<i>S</i>)-<b>17</b> and the LPA<sub>1</sub>receptor (active conformation) as predicted by docking calculations. Blue lines represent hydrogen bonds and gray dashed lines hydrophobic interactions. Residues marked in green are reported in the literature<a onclick="showRef(event, 'ref33 ref45'); return false;" href="javascript:void(0);" class="ref ref33 ref45">(33,45)</a> to bind to other agonists. The LPA<sub>1</sub> active state model was retrieved from the GPCRdb<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> (structure file provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound (<i>S</i>)-<b>17</b> induces neurite retraction. B103 neuroblastoma cells overexpressing EGFP–LPA<sub>1</sub> receptor were treated with (A, D) vehicle (0.1% fatty acid free bovine serum albumin), (B) LPA, or (C, E) (<i>S</i>)-<b>17</b>. Cells were then fixed and stained with phalloidin and DAPI and analyzed under fluorescence microscopy for visualization of LPA (green), cell morphology (red), and nuclei (blue). The number of cells with retracted neurites was counted and expressed as the percentage of the total number of cells (F). The data shown correspond to the mean ± SEM of the number of cells counted in two independent experiments and three different slides per experiment. *<i>p</i> < 0.05; **<i>p</i> < 0.01 vs BSA (Student’s <i>t</i> test). Samples were imaged under the same conditions using a Zeiss fluorescence microscope (A–C, bars 100 μm) or Zeiss fluorescence confocal microscope (D, E, bars 10 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound (<i>S</i>)-<b>17</b> induces cellular migration. B103 neuroblastoma cells overexpressing LPA<sub>1</sub> receptor were seeded (2.5 × 10<sup>5</sup> cells) into the upper chamber of the transwell, and vehicle (0.1% fatty acid free bovine serum albumin), LPA (1 μM), or (<i>S</i>)-<b>17</b> (1 μM) was added in the lower chamber. After allowing the cells to migrate for 5 h, migratory cells were stained with 0.1% crystal violet solution and counted. Images shown are representative of the migratory cells in the presence of (A) vehicle, (B) LPA (1 μM), or (C) (<i>S</i>)-<b>17</b> (1 μM). (D) Data in the bar graph correspond to the mean ± SEM of the number of cells counted in two independent experiments and three different transwell chambers per experiment. *<i>p</i> < 0.05; **<i>p</i> < 0.01 vs BSA (Student’s <i>t</i> test). Samples were imaged under the same conditions by using a Zeiss microscope (bar 50 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound (<i>S</i>)-<b>17</b> induces internalization of the LPA<sub>1</sub> receptor. B103 neuroblastoma cells overexpressing EGFP–LPA<sub>1</sub> were treated with (A) vehicle (0.1% fatty acid free bovine serum albumin), (B) LPA (1 μM), or (C) (<i>S</i>)-<b>17</b> (1 μM). The cells were then fixed, stained with phalloidin and DAPI, and analyzed under fluorescence microscopy for visualization of LPA<sub>1</sub> (green), cell morphology (red), and nuclei (blue). Green fluorescence in the cytosol in panels B and C shows internalization of the LPA<sub>1</sub>, which, in the absence of agonist, appears almost exclusively in the cell membrane. Images shown are representative of two independent experiments and at least three different fields per experiment. All samples were imaged under the same conditions using a Zeiss fluorescence confocal microscope (bar 10 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Repeated application of (<i>S</i>)-<b>17</b> reduces the activation of DRG neurons. Measurement of calcium-influx peak intensity elicited on cultured neonatal sensory neurons upon two repetitive applications of 10 μM LPA (A) or (<i>S</i>)-<b>17</b> (B) and one of 500 nM capsaicin (Caps). A10 s pulse of 40 mM KCl was applied to distinguish neuronal viability. Data represent fluorescence expressed as mean ± SEM. First pulse was compared to the second by <i>t</i> test paired values, ***<i>p</i> < 0.001. All neurons that responded to LPA or (<i>S</i>)-<b>17</b> were also activated by capsaicin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Repeated application of (<i>S</i>)-<b>17</b> decreases neuronal firing activity of DRG neurons. Graphs show the 10 μM LPA (A) or (<i>S</i>)-<b>17</b> (B) on mediated neuronal firing activity on neonatal rat DRG neurons. LPA and (<i>S</i>)-<b>17</b> were applied in two consecutive pulses. Neurons were exposed to 500 nM capsaicin (Caps) at the end of the recording to measure TRPV1 sensitivity of the neuronal networks exposed to LPA or (<i>S</i>)-<b>17</b>. Data represent mean spike frequency (Hz) and are expressed as mean ± SEM. Number of cultures ≥2. Comparison between pulses was performed by <i>t</i> test paired values. *<i>p</i> < 0.05; ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Acetic acid-induced writhing responses were decreased by repeated (<i>S</i>)-<b>17</b> administration. Mice received a daily dose of vehicle (3% BSA) or (<i>S</i>)-<b>17</b> (10 mg/kg) for 5 days. On the last day, mice were injected with 0.6% acetic acid solution (AA) 60 min after the administration of (<i>S</i>)-<b>17</b>. Data show mean ± SEM of writhes observed by experimenters blind to experimental conditions. *<i>p</i> < 0.05 compared with (<i>S</i>)-<b>17</b>-treated group (Student’s <i>t</i> test); **<i>p</i> < 0.0001 compared with AA group (one-way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/medium/jm9b01287_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound (<i>S</i>)-<b>17</b> significantly attenuates mechanical hypersensitivity after SNI in mice, an animal model of NP. Effect of ip injection of (<i>S</i>)-<b>17</b> (10 mg/kg) or vehicle on nociceptive behavior over time in mice with SNI. Data are expressed as mean ± SEM, <i>n</i> = 10/group. ****<i>p</i> < 0.0001, **<i>p</i> < 0.01 compared with vehicle-treated group (two-way repeated measures ANOVA with Bonferroni’s post hoc test for multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01287/20200306/images/large/jm9b01287_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01287&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 61 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">LPA receptors: subtypes and biological actions</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.010909.105753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1146%2Fannurev.pharmtox.010909.105753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=20055701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=157-186&author=J.+W.+Choiauthor=D.+R.+Herrauthor=K.+Noguchiauthor=Y.+C.+Yungauthor=C.+W.+Leeauthor=T.+Mutohauthor=M.+E.+Linauthor=S.+T.+Teoauthor=K.+E.+Parkauthor=A.+N.+Mosleyauthor=J.+Chun&title=LPA+receptors%3A+subtypes+and+biological+actions&doi=10.1146%2Fannurev.pharmtox.010909.105753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptors: subtypes and biological actions</span></div><div class="casAuthors">Choi, Ji Woong; Herr, Deron R.; Noguchi, Kyoko; Yung, Yun C.; Lee, Chang-Wook; Mutoh, Tetsuji; Lin, Mu-En; Teo, Siew T.; Park, Kristine E.; Mosley, Alycia N.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-186</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling mol. by binding to and activating at least 5 known G protein-coupled receptors (GPCRs): LPA1-LPA5.  They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice.  The biol. roles of LPA are diverse and include developmental, physiol., and pathophysiol. effects.  This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors.  Studies using cloned receptors and genetic knockout mice were instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ systems such as the nervous system.  This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru4MuMgWgZ7LVg90H21EOLACvtfcHk0lgRkTxfQ36X-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D&md5=995861e6d3dcc7193eba9b4948b4811d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.010909.105753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.010909.105753%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DPark%26aufirst%3DK.%2BE.%26aulast%3DMosley%26aufirst%3DA.%2BN.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptors%253A%2520subtypes%2520and%2520biological%2520actions%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D157%26epage%3D186%26doi%3D10.1146%2Fannurev.pharmtox.010909.105753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maceyka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophospholipid receptor nomenclature review: IUPHAR Review 8</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">3575</span>– <span class="NLM_lpage">3594</span>, <span class="refDoi"> DOI: 10.1111/bph.12678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fbph.12678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=24602016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKltr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3575-3594&author=Y.+Kiharaauthor=M.+Maceykaauthor=S.+Spiegelauthor=J.+Chun&title=Lysophospholipid+receptor+nomenclature+review%3A+IUPHAR+Review+8&doi=10.1111%2Fbph.12678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptor nomenclature review: IUPHAR Review 8</span></div><div class="casAuthors">Kihara, Yasuyuki; Maceyka, Michael; Spiegel, Sarah; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3575-3594</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Lysophospholipids encompass a diverse range of small, membrane-derived phospholipids that act as extracellular signals.  The signalling properties are mediated by 7-transmembrane GPCRs, constituent members of which have continued to be identified after their initial discovery in the mid-1990s.  Here we briefly review this class of receptors, with a particular emphasis on their protein and gene nomenclatures that reflect their cognate ligands.  There are six lysophospholipid receptors that interact with lysophosphatidic acid (LPA): protein names LPA1 - LPA6 and italicized gene names LPAR1-LPAR6 (human) and Lpar1-Lpar6 (non-human).  There are five sphingosine 1-phosphate (S1P) receptors: protein names S1P1-S1P5 and italicized gene names S1PR1-S1PR5 (human) and S1pr1-S1pr5 (non-human).  Recent addns. to the lysophospholipid receptor family have resulted in the proposed names for a lysophosphatidyl inositol (LPI) receptor - protein name LPI1 and gene name LPIR1 (human) and Lpir1 (non-human) - and three lysophosphatidyl serine receptors - protein names LyPS1, LyPS2, LyPS3 and gene names LYPSR1-LYPSR3 (human) and Lypsr1-Lypsr3 (non-human) along with a variant form that does not appear to exist in humans that is provisionally named LyPS2L.  This nomenclature incorporates previous recommendations from the International Union of Basic and Clin. Pharmacol., the Human Genome Organization, the Gene Nomenclature Committee, and the Mouse Genome Informatix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhfJ41i-PyrVg90H21EOLACvtfcHk0lgRkTxfQ36X-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKltr3E&md5=e3d6ec17060a9981ff3711c28c18b7e3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fbph.12678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12678%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520receptor%2520nomenclature%2520review%253A%2520IUPHAR%2520Review%25208%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3575%26epage%3D3594%26doi%3D10.1111%2Fbph.12678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaho, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hla, T.</span></span> <span> </span><span class="NLM_article-title">Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">6299</span>– <span class="NLM_lpage">6320</span>, <span class="refDoi"> DOI: 10.1021/cr200273u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200273u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WksLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6299-6320&author=V.+A.+Blahoauthor=T.+Hla&title=Regulation+of+mammalian+physiology%2C+development%2C+and+disease+by+the+sphingosine+1-phosphate+and+lysophosphatidic+acid+receptors&doi=10.1021%2Fcr200273u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Mammalian Physiology, Development, and Disease by the Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors</span></div><div class="casAuthors">Blaho, Victoria A.; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6299-6320</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on the current state and understanding of all bona fide memebers of the sphingosine 1-phosphate and lysophosphatidic acid receptor families, wtih emphasis on their contribution to the regulation of specific cell types in various systems, such as lymphatic and cardiovascular system, immune system, stem cells, nervous system, and reproductive system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZd8pE9-qccbVg90H21EOLACvtfcHk0lh50wdlysBAAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WksLzJ&md5=ba7a9d8bf106c3a443589249ffef2ca4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr200273u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200273u%26sid%3Dliteratum%253Aachs%26aulast%3DBlaho%26aufirst%3DV.%2BA.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520mammalian%2520physiology%252C%2520development%252C%2520and%2520disease%2520by%2520the%2520sphingosine%25201-phosphate%2520and%2520lysophosphatidic%2520acid%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6299%26epage%3D6320%26doi%3D10.1021%2Fcr200273u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Insights into the pharmacological relevance of lysophospholipid receptors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01622.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fj.1476-5381.2011.01622.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=21838759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=829-844&author=T.+Mutohauthor=R.+Riveraauthor=J.+Chun&title=Insights+into+the+pharmacological+relevance+of+lysophospholipid+receptors&doi=10.1111%2Fj.1476-5381.2011.01622.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the pharmacological relevance of lysophospholipid receptors</span></div><div class="casAuthors">Mutoh, Tetsuji; Rivera, Richard; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">829-844</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery of lysophospholipid (LP) 7-transmembrane, G protein-coupled receptors (GPCRs) that began in the 1990s, together with research into the functional roles of the major LPs known as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), have opened new research avenues into their biol. processes and mechanisms.  Major examples of LP signaling effects include embryogenesis, nervous system development, vascular development, uterine implantation, immune cell trafficking, and inflammatory reactions.  LP signaling also influences the pathophysiol. of many diseases including cancer, autoimmune and inflammatory diseases, which indicate that LP receptors may be attractive targets for pharmacol. therapies.  A key example of such a therapeutic agent is the S1P receptor modulator FTY720, which upon phosphorylation and continued drug exposure, acts as an S1P receptor functional antagonist.  This compd. (also known as fingolimod or Gilenya) has recently been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.  Continued basic and translational research on LP signaling should provide novel insights into both basic biol. mechanisms, as well as novel therapeutic approaches to combat a range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qOGwbmBPirVg90H21EOLACvtfcHk0lh50wdlysBAAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D&md5=cf240e202ccfa00c40366f7309e36b78</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01622.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01622.x%26sid%3Dliteratum%253Aachs%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520the%2520pharmacological%2520relevance%2520of%2520lysophospholipid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D829%26epage%3D844%26doi%3D10.1111%2Fj.1476-5381.2011.01622.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddard, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirendil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid signaling in the nervous system</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.neuron.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25695267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1SitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2015&pages=669-682&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=H.+Mirendilauthor=J.+Chun&title=Lysophosphatidic+acid+signaling+in+the+nervous+system&doi=10.1016%2Fj.neuron.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic Acid Signaling in the Nervous System</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Mirendil, Hope; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">669-682</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The brain is composed of many lipids with varied forms that serve not only as structural components but also as essential signaling mols.  Lysophosphatidic acid (LPA) is an important bioactive lipid species that is part of the lysophospholipid (LP) family.  LPA is primarily derived from membrane phospholipids and signals through six cognate G protein-coupled receptors (GPCRs), LPA1-6.  These receptors are expressed on most cell types within central and peripheral nervous tissues and have been functionally linked to many neural processes and pathways.  This Review covers a current understanding of LPA signaling in the nervous system, with particular focus on the relevance of LPA to both physiol. and diseased states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0xVVbnrMJR7Vg90H21EOLACvtfcHk0lh50wdlysBAAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1SitbY%253D&md5=df1b32a1816062199c2561b0638212c4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DMirendil%26aufirst%3DH.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520signaling%2520in%2520the%2520nervous%2520system%26jtitle%3DNeuron%26date%3D2015%26volume%3D85%26spage%3D669%26epage%3D682%26doi%3D10.1016%2Fj.neuron.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llona-Minguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghassemian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helleday, T.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2015.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.plipres.2015.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25704399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtlCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=51-75&author=S.+Llona-Minguezauthor=A.+Ghassemianauthor=T.+Helleday&title=Lysophosphatidic+acid+receptor+%28LPAR%29+modulators%3A+The+current+pharmacological+toolbox&doi=10.1016%2Fj.plipres.2015.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox</span></div><div class="casAuthors">Llona-Minguez, Sabin; Ghassemian, Artin; Helleday, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-75</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lysophosphatidic acids (LPA) are key lipid-signalling mols. that regulate a remarkably diverse set of cellular events, such as motility, chemotaxis, cell cycle progression, viability, and wound healing.  The physiol. and pathophysiol. consequences of LPA signalling are evident and misregulation of LPA signalling can lead to pathologies like cancer, atherosclerosis, ischemia, and fibrosis.  LPA exerts its biol. actions mainly through several types of G protein-coupled receptors, some of which display opposing or redundant effects.  For this reason, selective LPA receptor small-mol. ligands can shine light on LPA biol. and present an exciting opportunity for drug discovery endeavors.  This review provides insights into the detailed chem. nature and pharmacol. profile of the small-mols. thus far developed as LPA receptor modulators, as well as information on the prepn. of key pharmaceuticals.  This summary will facilitate future research efforts and nurture collaboration between chemists and biologists working in this emerging field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiRAFaoJ2JmbVg90H21EOLACvtfcHk0lhAk3TIAfGWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtlCrtr4%253D&md5=9427a8a1e7a51be2f5f65e0c53cf0400</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2015.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2015.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DLlona-Minguez%26aufirst%3DS.%26aulast%3DGhassemian%26aufirst%3DA.%26aulast%3DHelleday%26aufirst%3DT.%26atitle%3DLysophosphatidic%2520acid%2520receptor%2520%2528LPAR%2529%2520modulators%253A%2520The%2520current%2520pharmacological%2520toolbox%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2015%26volume%3D58%26spage%3D51%26epage%3D75%26doi%3D10.1016%2Fj.plipres.2015.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddard, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1194/jlr.R046458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1194%2Fjlr.R046458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=24643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1192-1214&author=Y.+C.+Yungauthor=N.+C.+Stoddardauthor=J.+Chun&title=LPA+receptor+signaling%3A+pharmacology%2C+physiology%2C+and+pathophysiology&doi=10.1194%2Fjlr.R046458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptor signaling: pharmacology, physiology, and pathophysiology</span></div><div class="casAuthors">Yung, Yun C.; Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1214</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biol. actions and demonstrates medicinal relevance.  LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors.  These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs.  LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies.  These studies have revealed physiol. and pathophysiol. influences on virtually every organ system and developmental stage of an organism.  These include the nervous, cardiovascular, reproductive, and pulmonary systems.  Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity.  These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7Ll3PB1oubVg90H21EOLACvtfcHk0lhAk3TIAfGWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyls7nK&md5=77271408ffda2fab00e7e0a0f32540d9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046458%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptor%2520signaling%253A%2520pharmacology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1192%26epage%3D1214%26doi%3D10.1194%2Fjlr.R046458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tigyi, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balazs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span> <span> </span><span class="NLM_article-title">Regulation of tumor cell - microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2018.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.jbior.2018.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30243984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGmu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=183-193&author=G.+J.+Tigyiauthor=J.+Yueauthor=D.+D.+Normanauthor=E.+Szaboauthor=A.+Baloghauthor=L.+Balazsauthor=G.+Zhaoauthor=S.+C.+Lee&title=Regulation+of+tumor+cell+-+microenvironment+interaction+by+the+autotaxin-lysophosphatidic+acid+receptor+axis&doi=10.1016%2Fj.jbior.2018.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis</span></div><div class="casAuthors">Tigyi, Gabor J.; Yue, Junming; Norman, Derek D.; Szabo, Erzsebet; Balogh, Andrea; Balazs, Louisa; Zhao, Guannan; Lee, Sue Chin</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">183-193</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The lipid mediator lysophosphatidic acid (LPA) in biol. fluids is primarily produced by cleavage of lysophospholipids by the lysophospholipase D enzyme Autotaxin (ATX).  LPA has been identified and abundantly detected in the culture medium of various cancer cell types, tumor effusates, and ascites fluid of cancer patients.  Our current understanding of the physiol. role of LPA established its role in fundamental biol. responses that include cell proliferation, metab., neuronal differentiation, angiogenesis, cell migration, hematopoiesis, inflammation, immunity, wound healing, regulation of cell excitability, and the promotion of cell survival by protecting against apoptotic death.  These essential biol. responses elicited by LPA are seemingly hijacked by cancer cells in many ways; transcriptional upregulation of ATX leading to increased LPA levels, enhanced expression of multiple LPA GPCR subtypes, and the downregulation of its metabolic breakdown.  Recent studies have shown that overexpression of ATX and LPA GPCR can lead to malignant transformation, enhanced proliferation of cancer stem cells, increased invasion and metastasis, reprogramming of the tumor microenvironment and the metastatic niche, and development of resistance to chemo-, immuno-, and radiation-therapy of cancer.  The fundamental role of LPA in cancer progression and the therapeutic inhibition of the ATX-LPA axis, although highly appealing, remains unexploited as drug development to these targets has not reached into the clinic yet.  The purpose of this brief review is to highlight some unique signaling mechanisms engaged by the ATX-LPA axis and emphasize the therapeutic potential that lies in blocking the mol. targets of the LPA system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7gL_yPvwNRbVg90H21EOLACvtfcHk0lhAk3TIAfGWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGmu7vM&md5=be1c9117ed3c0be419eda98ca74a68d7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2018.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2018.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DTigyi%26aufirst%3DG.%2BJ.%26aulast%3DYue%26aufirst%3DJ.%26aulast%3DNorman%26aufirst%3DD.%2BD.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DBalogh%26aufirst%3DA.%26aulast%3DBalazs%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%2BC.%26atitle%3DRegulation%2520of%2520tumor%2520cell%2520-%2520microenvironment%2520interaction%2520by%2520the%2520autotaxin-lysophosphatidic%2520acid%2520receptor%2520axis%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2019%26volume%3D71%26spage%3D183%26epage%3D193%26doi%3D10.1016%2Fj.jbior.2018.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hisano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hla, T.</span></span> <span> </span><span class="NLM_article-title">Bioactive lysolipids in cancer and angiogenesis</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.pharmthera.2018.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30048709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyitLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2019&pages=91-98&author=Y.+Hisanoauthor=T.+Hla&title=Bioactive+lysolipids+in+cancer+and+angiogenesis&doi=10.1016%2Fj.pharmthera.2018.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive lysolipids in cancer and angiogenesis</span></div><div class="casAuthors">Hisano, Yu; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  While normal angiogenesis is crit. for development and tissue growth, pathol. angiogenesis is important for the growth and spread of cancers by supplying nutrients and oxygen as well as providing a conduit for distant metastasis.  The interaction among extracellular matrix mols., tumor cells, endothelial cells, fibroblasts, and immune cells is crit. in pathol. angiogenesis, in which various angiogenic growth factors, chemokines, and lipid mediators produced from these cells as well as hypoxic microenvironment promote angiogenesis by regulating expression and/or activity of various related genes.  Sphingosine 1-phosphate and lysophosphatidic acid, bioactive lipid mediators which act via specific G protein-coupled receptors, play crit. roles in angiogenesis.  In addn., other lipid mediators including prostaglandin E2, lipoxin, and resolvins are produced in a stimulus-dependent manner and have pro- or anti-angiogenic effects, presumably through their specific GPCRs.  Dysregulated lipid mediator signaling pathways are obsd. in the contxt of some tumors.  This review will focus on LPA and S1P, two bioactive lipid mediators in their regulation of angiogenesis and cell migration that are crit. for tumor growth and spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwSxGLzui3O7Vg90H21EOLACvtfcHk0ljHkryDhnSP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyitLrK&md5=562462bf612c7cf15b175aae811cb34c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DHisano%26aufirst%3DY.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DBioactive%2520lysolipids%2520in%2520cancer%2520and%2520angiogenesis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D193%26spage%3D91%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2018.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J. P.</span></span> <span> </span><span class="NLM_article-title">Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCjsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=527-553&author=Y.+M.+Liuauthor=K.+Nepaliauthor=J.+P.+Liou&title=Idiopathic+pulmonary+fibrosis%3A+current+status%2C+recent+progress%2C+and+emerging+targets&doi=10.1021%2Facs.jmedchem.6b00935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets</span></div><div class="casAuthors">Liu, Yi-Min; Nepali, Kunal; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">527-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Idiopathic pulmonary fibrosis (IPF), a chronic and progressive fibrosing interstitial pneumonia is a fatal lung disease with a median survival time of 3-5 years.  Problems in accurate diagnosis, poor prognosis, limited clin. therapy and high mortality rate together demonstrate that the development of efficient therapeutic strategies for IPF is an important future endeavor.  Deeper understanding of pathogenesis and identification of biomarkers and pathways involved might lead in the future to the emergence of some agents as novel therapeutics for IPF.  This review article presents the pathogenesis, therapeutic interventions, treatment approaches, and strategies employed for the design of antifibrotic agents for the treatment of IPF along with the patent literature from the last 10 years.  With a dozen antifibrotic agents with exciting preclin. potential in the armory, it seems certain that some of them will advance to clin. stage investigations.  The results of clin. trials for some of the new agents are also awaited, to assess their benefits in terms of efficacy and survival benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizofQCxRDlrVg90H21EOLACvtfcHk0ljHkryDhnSP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCjsLjK&md5=9c6f4f3ebde53b7d2afa625b8de4cf4d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DNepali%26aufirst%3DK.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26atitle%3DIdiopathic%2520pulmonary%2520fibrosis%253A%2520current%2520status%252C%2520recent%2520progress%252C%2520and%2520emerging%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D527%26epage%3D553%26doi%3D10.1021%2Facs.jmedchem.6b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tager, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCamera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polosukhin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi-Shah, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1038/nm1685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+A.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak&doi=10.1038%2Fnm1685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0ljHkryDhnSP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D45%26epage%3D54%26doi%3D10.1038%2Fnm1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juarez-Contreras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Lazaro, S. L.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid and ion channels as molecular mediators of pain</span>. <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">462</span>, <span class="refDoi"> DOI: 10.3389/fnmol.2018.00462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.3389%2Ffnmol.2018.00462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30618613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlymt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=462&author=R.+Juarez-Contrerasauthor=T.+Rosenbaumauthor=S.+L.+Morales-Lazaro&title=Lysophosphatidic+acid+and+ion+channels+as+molecular+mediators+of+pain&doi=10.3389%2Ffnmol.2018.00462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid and ion channels as molecular mediators of pain</span></div><div class="casAuthors">Juarez-Contreras, Rebeca; Rosenbaum, Tamara; Morales-Lazaro, Sara L.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">462</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Lysophosphatidic acid or LPA is a phospholipid which has been extensively linked to the generation and maintenance of pain.  Several ion channels have also been shown to participate in this pathol. process but the link between LPA and these proteins in pain has just recently gained interest.  In this respect, the field has advanced by detg. the mol. mechanisms by which LPA promotes changes in the function of some ion channels.  While some of the actions of LPA include modulation of signaling pathways assocd. to its specific receptors, other include a direct interaction with a region in the structure of ion channels to affect their gating properties.  Here, we focus on the known effects of LPA on some transient receptor potential, sodium, potassium, and calcium channels.  As the field moves forward, mechanisms are unveiled with the hope of understanding the underlying causes of pain in order to target these and control this pathophysiol. state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ1JsRESw-XrVg90H21EOLACvtfcHk0li1Csjb2UjnuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlymt7zK&md5=399af2cf9eeb5c2320d60691d1cf41a4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2018.00462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2018.00462%26sid%3Dliteratum%253Aachs%26aulast%3DJuarez-Contreras%26aufirst%3DR.%26aulast%3DRosenbaum%26aufirst%3DT.%26aulast%3DMorales-Lazaro%26aufirst%3DS.%2BL.%26atitle%3DLysophosphatidic%2520acid%2520and%2520ion%2520channels%2520as%2520molecular%2520mediators%2520of%2520pain%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2018%26volume%3D11%26spage%3D462%26doi%3D10.3389%2Ffnmol.2018.00462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashid, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contos, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1038/nm1060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnm1060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=15195086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=712-718&author=M.+Inoueauthor=M.+H.+Rashidauthor=R.+Fujitaauthor=J.+J.+Contosauthor=J.+Chunauthor=H.+Ueda&title=Initiation+of+neuropathic+pain+requires+lysophosphatidic+acid+receptor+signaling&doi=10.1038%2Fnm1060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling</span></div><div class="casAuthors">Inoue, Makoto; Rashid, Md Harunor; Fujita, Ryousuke; Contos, James J. A.; Chun, Jerold; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">712-718</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid with activity in the nervous system mediated by G-protein-coupled receptors.  Here, we examd. the role of LPA signaling in the development of neuropathic pain by pharmacol. and genetic approaches, including the use of mice lacking the LPA1 receptor.  Wild-type animals with nerve injury develop behavioral allodynia and hyperalgesia paralleled by demyelination in the dorsal root and increased expression of both the protein kinase C γ-isoform within the spinal cord dorsal horn and the α2δ1 calcium channel subunit in dorsal root ganglia.  Intrathecal injection of LPA induced behavioral, morphol. and biochem. changes similar to those obsd. after nerve ligation.  In contrast, mice lacking a single LPA receptor (LPA1, also known as EDG2) that activates the Rho-Rho kinase pathway do not develop signs of neuropathic pain after peripheral nerve injury.  Inhibitors of Rho and Rho kinase also prevented these signs of neuropathic pain.  These results imply that receptor-mediated LPA signaling is crucial in the initiation of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTzbCOHf9jX7Vg90H21EOLACvtfcHk0li1Csjb2UjnuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Gjsbo%253D&md5=15f4760e4fd3b46c97c289be7b430058</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnm1060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1060%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DRashid%26aufirst%3DM.%2BH.%26aulast%3DFujita%26aufirst%3DR.%26aulast%3DContos%26aufirst%3DJ.%2BJ.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DInitiation%2520of%2520neuropathic%2520pain%2520requires%2520lysophosphatidic%2520acid%2520receptor%2520signaling%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D712%26epage%3D718%26doi%3D10.1038%2Fnm1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">17608</span>– <span class="NLM_lpage">17617</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.330183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1074%2Fjbc.M111.330183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=22461625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFSntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=17608-17617&author=M.+E.+Linauthor=R.+R.+Riveraauthor=J.+Chun&title=Targeted+deletion+of+LPA5+identifies+novel+roles+for+lysophosphatidic+acid+signaling+in+development+of+neuropathic+pain&doi=10.1074%2Fjbc.M111.330183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Deletion of LPA5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain</span></div><div class="casAuthors">Lin, Mu-En; Rivera, Richard R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">17608-17617</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid that serves as an extracellular signaling mol. acting through cognate G protein-coupled receptors designated LPA1-6 that mediate a wide range of both normal and pathol. effects.  Previously, LPA1, a Gαi-coupled receptor (which also couples to other Gα proteins) to reduce cAMP, was shown to be essential for the initiation of neuropathic pain in the partial sciatic nerve ligation (PSNL) mouse model.  Subsequent gene expression studies identified LPA5, a Gα12/13- and Gq-coupled receptor that increases cAMP, in a subset of dorsal root ganglion neurons and also within neurons of the spinal cord dorsal horn in a pattern complementing, yet distinct from LPA1, suggesting its possible involvement in neuropathic pain.  We therefore generated an Lpar5 null mutant by targeted deletion followed by PSNL challenge.  Homozygous null mutants did not show obvious base-line phenotypic defects.  However, following PSNL, LPA5-deficient mice were protected from developing neuropathic pain.  They also showed reduced phosphorylated cAMP response element-binding protein expression within neurons of the dorsal horn despite continued up-regulation of the characteristic pain-related markers Caα2δ1 and glial fibrillary acidic protein, results that were distinct from those previously obsd. for LPA1 deletion.  These data expand the influences of LPA signaling in neuropathic pain through a second LPA receptor subtype, LPA5, involving a mechanistically distinct downstream signaling pathway compared with LPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TrpAIPAZTrVg90H21EOLACvtfcHk0li1Csjb2UjnuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFSntLc%253D&md5=cf64de15dc5a69abaa96499de85d8c75</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.330183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.330183%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DRivera%26aufirst%3DR.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DTargeted%2520deletion%2520of%2520LPA5%2520identifies%2520novel%2520roles%2520for%2520lysophosphatidic%2520acid%2520signaling%2520in%2520development%2520of%2520neuropathic%2520pain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D17608%26epage%3D17617%26doi%3D10.1074%2Fjbc.M111.330183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoddard, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span>. <i>Biomol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.4062/biomolther.2014.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.4062%2Fbiomolther.2014.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1-11&author=N.+C.+Stoddardauthor=J.+Chun&title=Promising+pharmacological+directions+in+the+world+of+lysophosphatidic+acid+signaling&doi=10.4062%2Fbiomolther.2014.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Promising pharmacological directions in the world of lysophosphatidic acid signaling</span></div><div class="casAuthors">Stoddard, Nicole C.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">BTIHA3</span>;
        ISSN:<span class="NLM_cas:issn">1976-9148</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a signaling lipid that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6.  These receptors initiate signaling cascades relevant to development, maintenance, and healing processes throughout the body.  The diversity and specificity of LPA signaling, esp. in relation to cancer and autoimmune disorders, makes LPA receptor modulation an attractive target for drug development.  Several LPAR-specific analogs and small mols. have been synthesized and are efficacious in attenuating pathol. in disease models.  To date, at least three compds. have passed phase I and phase II clin. trials for idiopathic pulmonary fibrosis and systemic sclerosis.  This review focuses on the promising therapeutic directions emerging in LPA signaling toward ameliorating several diseases, including cancer, fibrosis, arthritis, hydrocephalus, and traumatic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEf1nGhuRyPrVg90H21EOLACvtfcHk0ljbjMOgiU-2lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Oht78%253D&md5=53d877ee381f9363918850f0b499bb11</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4062%2Fbiomolther.2014.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4062%252Fbiomolther.2014.109%26sid%3Dliteratum%253Aachs%26aulast%3DStoddard%26aufirst%3DN.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DPromising%2520pharmacological%2520directions%2520in%2520the%2520world%2520of%2520lysophosphatidic%2520acid%2520signaling%26jtitle%3DBiomol.%2520Ther.%26date%3D2015%26volume%3D23%26spage%3D1%26epage%3D11%26doi%3D10.4062%2Fbiomolther.2014.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophospholipid receptors in drug discovery</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2014.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.yexcr.2014.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25499971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVygt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2015&pages=171-177&author=Y.+Kiharaauthor=H.+Mizunoauthor=J.+Chun&title=Lysophospholipid+receptors+in+drug+discovery&doi=10.1016%2Fj.yexcr.2014.11.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptors in drug discovery</span></div><div class="casAuthors">Kihara, Yasuyuki; Mizuno, Hirotaka; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-177</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysophospholipids (LPs), including lysophosphatidic acid (LPA), sphingosine 1-phospate (S1P), lysophosphatidylinositol (LPI), and lysophosphatidylserine (LysoPS), are bioactive lipids that transduce signals through their specific cell-surface G protein-coupled receptors, LPA1-6, S1P1-5, LPI1, and LysoPS1-3, resp.  These LPs and their receptors have been implicated in both physiol. and pathophysiol. processes such as autoimmune diseases, neurodegenerative diseases, fibrosis, pain, cancer, inflammation, metabolic syndrome, bone formation, fertility, organismal development, and other effects on most organ systems.  Advances in the LP receptor field have enabled the development of novel small mols. targeting LP receptors for several diseases.  Most notably, fingolimod (FTY720, Gilenya, Novartis), an S1P receptor modulator, became the first FDA-approved medicine as an orally bioavailable drug for treating relapsing forms of multiple sclerosis.  This success is currently being followed by multiple, mechanistically related compds. targeting S1P receptor subtypes, which are in various stages of clin. development.  In addn., an LPA1 antagonist, BMS-986020 (Bristol-Myers Squibb), is in Phase 2 clin. development for treating idiopathic pulmonary fibrosis, as a distinct compd., SAR100842 (Sanofi) for the treatment of systemic sclerosis and related fibrotic diseases.  This review summarizes the current state of drug discovery in the LP receptor field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtxRltguGZnLVg90H21EOLACvtfcHk0ljbjMOgiU-2lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVygt7%252FI&md5=fc286c4c8862b052b2b263dd07f02755</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2014.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2014.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520receptors%2520in%2520drug%2520discovery%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2015%26volume%3D333%26spage%3D171%26epage%3D177%26doi%3D10.1016%2Fj.yexcr.2014.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, G. K.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.neuropharm.2016.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=27059127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=608-617&author=M.+Velascoauthor=C.+O%E2%80%99Sullivanauthor=G.+K.+Sheridan&title=Lysophosphatidic+acid+receptors+%28LPARs%29%3A+Potential+targets+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.neuropharm.2016.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain</span></div><div class="casAuthors">Velasco, Maria; O'Sullivan, Catherine; Sheridan, Graham K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">608-617</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neuropathic pain can arise from lesions to peripheral or central nerve fibers leading to spontaneous action potential generation and a lowering of the nociceptive threshold.  Clin., neuropathic pain can manifest in many chronic disease states such as cancer, diabetes or multiple sclerosis (MS).  The bioactive lipid, lysophosphatidic acid (LPA), via activation of its receptors (LPARs), is thought to play a central role in both triggering and maintaining neuropathic pain.  In particular, following an acute nerve injury, the excitatory neurotransmitters glutamate and substance P are released from primary afferent neurons leading to upregulated synthesis of lysophosphatidylcholine (LPC), the precursor for LPA prodn.  LPC is converted to LPA by autotaxin (ATX), which can then activate macrophages/microglia and modulate neuronal functioning.  A ubiquitous feature of animal models of neuropathic pain is demyelination of damaged nerves.  It is thought that LPA contributes to demyelination through several different mechanisms.  Firstly, high levels of LPA are produced following macrophage/microglial activation that triggers a self-sustaining feed-forward loop of de novo LPA synthesis.  Secondly, macrophage/microglial activation contributes to inflammation-mediated demyelination of axons, thus initiating neuropathic pain.  Therefore, targeting LPA prodn. and/or the family of LPA-activated G protein-coupled receptors (GPCRs) may prove to be fruitful clin. approaches to treating demyelination and the accompanying neuropathic pain.  This review discusses our current understanding of the role of LPA/LPAR signalling in the initiation of neuropathic pain and suggests potential targeted strategies for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBnp_IOtLNnbVg90H21EOLACvtfcHk0ljbjMOgiU-2lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOnsbw%253D&md5=306e8b37719a3bc2b2af82666d3e7b7e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DVelasco%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%26aulast%3DSheridan%26aufirst%3DG.%2BK.%26atitle%3DLysophosphatidic%2520acid%2520receptors%2520%2528LPARs%2529%253A%2520Potential%2520targets%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D608%26epage%3D617%26doi%3D10.1016%2Fj.neuropharm.2016.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">S55</span>– <span class="NLM_lpage">S65</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000000813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1097%2Fj.pain.0000000000000813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28151833" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2017&pages=S55-S65&author=H.+Ueda&title=Lysophosphatidic+acid+signaling+is+the+definitive+mechanism+underlying+neuropathic+pain&doi=10.1097%2Fj.pain.0000000000000813"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000000813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000000813%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLysophosphatidic%2520acid%2520signaling%2520is%2520the%2520definitive%2520mechanism%2520underlying%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2017%26volume%3D158%26spage%3DS55%26epage%3DS65%26doi%3D10.1097%2Fj.pain.0000000000000813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colloca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhassira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarnitsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccleston, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S. N.</span></span> <span> </span><span class="NLM_article-title">Neuropathic pain</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17002</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2017.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnrdp.2017.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28205574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17002&author=L.+Collocaauthor=T.+Ludmanauthor=D.+Bouhassiraauthor=R.+Baronauthor=A.+H.+Dickensonauthor=D.+Yarnitskyauthor=R.+Freemanauthor=A.+Truiniauthor=N.+Attalauthor=N.+B.+Finnerupauthor=C.+Ecclestonauthor=E.+Kalsoauthor=D.+L.+Bennettauthor=R.+H.+Dworkinauthor=S.+N.+Raja&title=Neuropathic+pain&doi=10.1038%2Fnrdp.2017.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain</span></div><div class="casAuthors">Colloca Luana; Ludman Taylor; Bouhassira Didier; Baron Ralf; Dickenson Anthony H; Yarnitsky David; Freeman Roy; Truini Andrea; Attal Nadine; Finnerup Nanna B; Eccleston Christopher; Eccleston Christopher; Kalso Eija; Bennett David L; Dworkin Robert H; Raja Srinivasa N</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7-10% of the general population.  Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the ageing global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.  Indeed, imbalances between excitatory and inhibitory somatosensory signalling, alterations in ion channels and variability in the way that pain messages are modulated in the central nervous system all have been implicated in neuropathic pain.  The burden of chronic neuropathic pain seems to be related to the complexity of neuropathic symptoms, poor outcomes and difficult treatment decisions.  Importantly, quality of life is impaired in patients with neuropathic pain owing to increased drug prescriptions and visits to health care providers, as well as the morbidity from the pain itself and the inciting disease.  Despite challenges, progress in the understanding of the pathophysiology of neuropathic pain is spurring the development of new diagnostic procedures and personalized interventions, which emphasize the need for a multidisciplinary approach to the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtG6bfcFGVpLJzI8owOhpDfW6udTcc2eYO0MdBTGMZD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3nsFWqsQ%253D%253D&md5=003498925636e0a417267ad96d446782</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.2%26sid%3Dliteratum%253Aachs%26aulast%3DColloca%26aufirst%3DL.%26aulast%3DLudman%26aufirst%3DT.%26aulast%3DBouhassira%26aufirst%3DD.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DYarnitsky%26aufirst%3DD.%26aulast%3DFreeman%26aufirst%3DR.%26aulast%3DTruini%26aufirst%3DA.%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DEccleston%26aufirst%3DC.%26aulast%3DKalso%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26atitle%3DNeuropathic%2520pain%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2017%26volume%3D3%26spage%3D17002%26doi%3D10.1038%2Fnrdp.2017.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.05987.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fj.1471-4159.2009.05987.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=19222705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=603-610&author=L.+Maauthor=M.+Matsumotoauthor=W.+Xieauthor=M.+Inoueauthor=H.+Ueda&title=Evidence+for+lysophosphatidic+acid+1+receptor+signaling+in+the+early+phase+of+neuropathic+pain+mechanisms+in+experiments+using+Ki-16425%2C+a+lysophosphatidic+acid+1+receptor+antagonist&doi=10.1111%2Fj.1471-4159.2009.05987.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist</span></div><div class="casAuthors">Ma, Lin; Matsumoto, Misaki; Xie, Weijiao; Inoue, Makoto; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">603-610</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Lysophosphatidic acid is a bioactive lipid mediator with neuronal activities.  We previously reported a crucial role for lysophosphatidic acid 1 receptor-mediated signaling in neuropathic pain mechanisms.  Intrathecal administration of lysophosphatidic acid (1 nmol) induced abnormal pain behaviors, such as thermal hyperalgesia, mech. allodynia, A-fiber hypersensitization, and C-fiber hyposensitization, all of which were also obsd. in partial sciatic nerve injury-induced neuropathic pain.  Ki-16425 (30 mg/kg, i.p.), a lysophosphatidic acid 1 receptor antagonist, completely blocked lysophosphatidic acid-induced neuropathic pain-like behaviors, when administered 30 min but not 90 min before lysophosphatidic acid injection, suggesting that Ki-16425 is a short-lived inhibitor.  The blockade of nerve injury-induced neuropathic pain by Ki-16425 was max. as late as 3 h after the injury but not after this crit. period.  The administration of Ki-16425 at 3 h but not at 6 h after injury also blocked neurochem. changes, including up-regulation of voltage-gated calcium channel α2δ-1 subunit expression in dorsal root ganglion and redn. of substance P expression in the spinal dorsal horn.  All of these results using Ki-16425 suggest that lysophosphatidic acid 1 receptor-mediated signaling which underlies the development of neuropathic pain works at an early stage of the crit. period after nerve injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJPsXQUIYYjLVg90H21EOLACvtfcHk0lhqv9EDmtM9bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKnsrw%253D&md5=70bba2d18056fe13b05fac0e01bdf6da</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.05987.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.05987.x%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DEvidence%2520for%2520lysophosphatidic%2520acid%25201%2520receptor%2520signaling%2520in%2520the%2520early%2520phase%2520of%2520neuropathic%2520pain%2520mechanisms%2520in%2520experiments%2520using%2520Ki-16425%252C%2520a%2520lysophosphatidic%2520acid%25201%2520receptor%2520antagonist%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D109%26spage%3D603%26epage%3D610%26doi%3D10.1111%2Fj.1471-4159.2009.05987.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1186%2F1744-8069-5-64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=19912636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BD1MjotFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=64&author=L.+Maauthor=H.+Uchidaauthor=J.+Nagaiauthor=M.+Inoueauthor=J.+Chunauthor=J.+Aokiauthor=H.+Ueda&title=Lysophosphatidic+acid-3+receptor-mediated+feed-forward+production+of+lysophosphatidic+acid%3A+an+initiator+of+nerve+injury-induced+neuropathic+pain&doi=10.1186%2F1744-8069-5-64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain</span></div><div class="casAuthors">Ma Lin; Uchida Hitoshi; Nagai Jun; Inoue Makoto; Chun Jerold; Aoki Junken; Ueda Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We previously reported that intrathecal injection of lysophosphatidylcholine (LPC) induced neuropathic pain through activation of the lysophosphatidic acid (LPA)-1 receptor, possibly via conversion to LPA by autotaxin (ATX).  RESULTS:  We examined in vivo LPA-induced LPA production using a biological titration assay with B103 cells expressing LPA1 receptors.  Intrathecal administration of LPC caused time-related production of LPA in the spinal dorsal horn and dorsal roots, but not in the dorsal root ganglion, spinal nerve or sciatic nerve.  LPC-induced LPA production was markedly diminished in ATX heterozygotes, and was abolished in mice that were deficient in LPA3, but not LPA1 or LPA2 receptors.  Similar time-related and LPA3 receptor-mediated production of LPA was observed following intrathecal administration of LPA.  In an in vitro study using spinal cord slices, LPA-induced LPA production was also mediated by ATX and the LPA3 receptor.  Intrathecal administration of LPA, in contrast, induced neuropathic pain, which was abolished in mice deficient in LPA1 or LPA3 receptors.  CONCLUSION:  These findings suggest that feed-forward LPA production is involved in LPA-induced neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOdtdCr68yBhJ5E29YNGvQfW6udTcc2eYO0MdBTGMZD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjotFWqtQ%253D%253D&md5=71f28dbea8f1f2732e8d88143cad5d4a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-64%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DUchida%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DJ.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLysophosphatidic%2520acid-3%2520receptor-mediated%2520feed-forward%2520production%2520of%2520lysophosphatidic%2520acid%253A%2520an%2520initiator%2520of%2520nerve%2520injury-induced%2520neuropathic%2520pain%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D64%26doi%3D10.1186%2F1744-8069-5-64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morabito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustizieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattioli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragozzino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oddi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verderio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, S.</span></span> <span> </span><span class="NLM_article-title">TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15292</span>, <span class="refDoi"> DOI: 10.1038/ncomms15292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fncomms15292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28489079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BC1crlslKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15292&author=M.+C.+Marroneauthor=A.+Morabitoauthor=M.+Giustizieriauthor=V.+Chiurchiuauthor=A.+Leutiauthor=M.+Mattioliauthor=S.+Marinelliauthor=L.+Rigantiauthor=M.+Lombardiauthor=E.+Muranaauthor=A.+Totaroauthor=D.+Piomelliauthor=D.+Ragozzinoauthor=S.+Oddiauthor=M.+Maccarroneauthor=C.+Verderioauthor=S.+Marinelli&title=TRPV1+channels+are+critical+brain+inflammation+detectors+and+neuropathic+pain+biomarkers+in+mice&doi=10.1038%2Fncomms15292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice</span></div><div class="casAuthors">Marrone Maria Cristina; Morabito Annunziato; Giustizieri Michela; Mattioli Marzia; Marinelli Sara; Marinelli Silvia; Marrone Maria Cristina; Giustizieri Michela; Chiurchiu Valerio; Leuti Alessandro; Mattioli Marzia; Totaro Antonio; Oddi Sergio; Maccarrone Mauro; Marinelli Silvia; Morabito Annunziato; Chiurchiu Valerio; Maccarrone Mauro; Marinelli Sara; Verderio Claudia; Riganti Loredana; Verderio Claudia; Lombardi Marta; Murana Emanuele; Ragozzino Davide; Piomelli Daniele; Ragozzino Davide; Oddi Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15292</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The capsaicin receptor TRPV1 has been widely characterized in the sensory system as a key component of pain and inflammation.  A large amount of evidence shows that TRPV1 is also functional in the brain although its role is still debated.  Here we report that TRPV1 is highly expressed in microglial cells rather than neurons of the anterior cingulate cortex and other brain areas.  We found that stimulation of microglial TRPV1 controls cortical microglia activation per se and indirectly enhances glutamatergic transmission in neurons by promoting extracellular microglial microvesicles shedding.  Conversely, in the cortex of mice suffering from neuropathic pain, TRPV1 is also present in neurons affecting their intrinsic electrical properties and synaptic strength.  Altogether, these findings identify brain TRPV1 as potential detector of harmful stimuli and a key player of microglia to neuron communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_P31OZw-1AVMGsG_HTXYFfW6udTcc2eboJcbdKwQWY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crlslKksg%253D%253D&md5=1d6a32f0a63bc278058e311b32a535b3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms15292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15292%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DM.%2BC.%26aulast%3DMorabito%26aufirst%3DA.%26aulast%3DGiustizieri%26aufirst%3DM.%26aulast%3DChiurchiu%26aufirst%3DV.%26aulast%3DLeuti%26aufirst%3DA.%26aulast%3DMattioli%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DS.%26aulast%3DRiganti%26aufirst%3DL.%26aulast%3DLombardi%26aufirst%3DM.%26aulast%3DMurana%26aufirst%3DE.%26aulast%3DTotaro%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DRagozzino%26aufirst%3DD.%26aulast%3DOddi%26aufirst%3DS.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DVerderio%26aufirst%3DC.%26aulast%3DMarinelli%26aufirst%3DS.%26atitle%3DTRPV1%2520channels%2520are%2520critical%2520brain%2520inflammation%2520detectors%2520and%2520neuropathic%2520pain%2520biomarkers%2520in%2520mice%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15292%26doi%3D10.1038%2Fncomms15292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Lazaro, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorente, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierra-Ramirez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Romero, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Renteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Flores, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islas, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13092</span>, <span class="refDoi"> DOI: 10.1038/ncomms13092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fncomms13092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=27721373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GnsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13092&author=S.+L.+Morales-Lazaroauthor=I.+Llorenteauthor=F.+Sierra-Ramirezauthor=A.+E.+Lopez-Romeroauthor=M.+Ortiz-Renteriaauthor=B.+Serrano-Floresauthor=S.+A.+Simonauthor=L.+D.+Islasauthor=T.+Rosenbaum&title=Inhibition+of+TRPV1+channels+by+a+naturally+occurring+omega-9+fatty+acid+reduces+pain+and+itch&doi=10.1038%2Fncomms13092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch</span></div><div class="casAuthors">Morales-Lazaro, Sara L.; Llorente, Itzel; Sierra-Ramirez, Felix; Lopez-Romero, Ana E.; Ortiz-Renteria, Miguel; Serrano-Flores, Barbara; Simon, Sidney A.; Islas, Leon D.; Rosenbaum, Tamara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13092</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transient receptor potential vanilloid 1 (TRPV1) ion channel is mainly found in primary nociceptive afferents whose activity has been linked to pathophysiol. conditions including pain, itch and inflammation.  Consequently, it is important to identify naturally occurring antagonists of this channel.  Here we show that a naturally occurring monounsatd. fatty acid, oleic acid, inhibits TRPV1 activity, and also pain and itch responses in mice by interacting with the vanilloid (capsaicin)-binding pocket and promoting the stabilization of a closed state conformation.  Moreover, we report an itch-inducing mol., cyclic phosphatidic acid, that activates TRPV1 and whose pruritic activity, as well as that of histamine, occurs through the activation of this ion channel.  These findings provide insights into the mol. basis of oleic acid inhibition of TRPV1 and also into a way of reducing the pathophysiol. effects resulting from its activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowG-C7OwYVAbVg90H21EOLACvtfcHk0lg0MgMkBZRYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GnsbfJ&md5=a9b538704686bd547de931f5b306c4c4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fncomms13092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13092%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Lazaro%26aufirst%3DS.%2BL.%26aulast%3DLlorente%26aufirst%3DI.%26aulast%3DSierra-Ramirez%26aufirst%3DF.%26aulast%3DLopez-Romero%26aufirst%3DA.%2BE.%26aulast%3DOrtiz-Renteria%26aufirst%3DM.%26aulast%3DSerrano-Flores%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DS.%2BA.%26aulast%3DIslas%26aufirst%3DL.%2BD.%26aulast%3DRosenbaum%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520TRPV1%2520channels%2520by%2520a%2520naturally%2520occurring%2520omega-9%2520fatty%2520acid%2520reduces%2520pain%2520and%2520itch%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13092%26doi%3D10.1038%2Fncomms13092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Posadas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picazo-Juarez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorente, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jara-Oseguera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Lazaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante-Alcalde, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islas, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, T.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/nchembio.712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnchembio.712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gt7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=78-85&author=A.+Nieto-Posadasauthor=G.+Picazo-Juarezauthor=I.+Llorenteauthor=A.+Jara-Osegueraauthor=S.+Morales-Lazaroauthor=D.+Escalante-Alcaldeauthor=L.+D.+Islasauthor=T.+Rosenbaum&title=Lysophosphatidic+acid+directly+activates+TRPV1+through+a+C-terminal+binding+site&doi=10.1038%2Fnchembio.712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site</span></div><div class="casAuthors">Nieto-Posadas, Andres; Picazo-Juarez, Giovanni; Llorente, Itzel; Jara-Oseguera, Andres; Morales-Lazaro, Sara; Escalante-Alcalde, Diana; Islas, Leon D.; Rosenbaum, Tamara</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-85</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Since 1992, there has been growing evidence that the bioactive phospholipid lysophosphatidic acid (LPA), whose amts. are increased upon tissue injury, activates primary nociceptors resulting in neuropathic pain.  The TRPV1 ion channel is expressed in primary afferent nociceptors and is activated by phys. and chem. stimuli.  Here we show that in control mice LPA produces acute pain-like behaviors, which are substantially reduced in Trpv1-null animals.  Our data also demonstrate that LPA activates TRPV1 through a unique mechanism that is independent of G protein-coupled receptors, contrary to what has been widely shown for other ion channels, by directly interacting with the C terminus of the channel.  We conclude that TRPV1 is a direct mol. target of the pain-producing mol. LPA and that this constitutes, to our knowledge, the first example of LPA binding directly to an ion channel to acutely regulate its function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-yrDUVv1cOrVg90H21EOLACvtfcHk0lg0MgMkBZRYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gt7zL&md5=50afa5380912eaa311bbd41da9696c37</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.712%26sid%3Dliteratum%253Aachs%26aulast%3DNieto-Posadas%26aufirst%3DA.%26aulast%3DPicazo-Juarez%26aufirst%3DG.%26aulast%3DLlorente%26aufirst%3DI.%26aulast%3DJara-Oseguera%26aufirst%3DA.%26aulast%3DMorales-Lazaro%26aufirst%3DS.%26aulast%3DEscalante-Alcalde%26aufirst%3DD.%26aulast%3DIslas%26aufirst%3DL.%2BD.%26aulast%3DRosenbaum%26aufirst%3DT.%26atitle%3DLysophosphatidic%2520acid%2520directly%2520activates%2520TRPV1%2520through%2520a%2520C-terminal%2520binding%2520site%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D78%26epage%3D85%26doi%3D10.1038%2Fnchembio.712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumruker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heining, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmouder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtin, P.</span></span> <span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1038/nrd3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis&doi=10.1038%2Fnrd3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0ljfn4trtLlehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897%26doi%3D10.1038%2Fnrd3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huwiler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zangemeister-Wittke, U.</span></span> <span> </span><span class="NLM_article-title">The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.pharmthera.2017.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=29127024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2018&pages=34-49&author=A.+Huwilerauthor=U.+Zangemeister-Wittke&title=The+sphingosine+1-phosphate+receptor+modulator+fingolimod+as+a+therapeutic+agent%3A+Recent+findings+and+new+perspectives&doi=10.1016%2Fj.pharmthera.2017.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives</span></div><div class="casAuthors">Huwiler, Andrea; Zangemeister-Wittke, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-49</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The immunomodulatory drug fingolimod (FTY720, GilenyaR) was approved for oral treatment of relapsing-remitting multiple sclerosis, due to its impressive efficacy and good tolerability.  Pharmacol., it acts as an unselective agonist of sphingosine 1-phosphate receptors (S1PR) and as a selective functional antagonist of the S1P1 subtype by induction of receptor downregulation.  Since S1P1 is crucial for the regulation of lymphocyte trafficking, its downregulation causes redistribution of the immune cells to secondary lymphoid tissues, resulting in the depletion from the circulation and hence immunosuppression.  Numerous preclin. studies have since been performed with the aim to increase the spectrum of potential indications for fingolimod with emphasis on other autoimmune disorders and diseases assocd. with inflammation and uncontrolled cell proliferation, including cancer.  As an alternative to fingolimod, novel S1PR modulators with a more selective receptor activation profile and improved pharmacokinetic performance and tolerability have also been developed.  Preclin. and clin. studies are ongoing to investigate their therapeutic potential.  This review discusses the most relevant preclin. and clin. findings from S1PR-targeting and from less-well defined off-target effects reported in the literature, and reveals perspectives for using fingolimod and functionally-related derivs. and new formulations in the management of an increasing no. of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxIFabr0iscrVg90H21EOLACvtfcHk0ljfn4trtLlehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLrK&md5=dfe07cfa6544d89f24f3a90f2fe99088</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DZangemeister-Wittke%26aufirst%3DU.%26atitle%3DThe%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520fingolimod%2520as%2520a%2520therapeutic%2520agent%253A%2520Recent%2520findings%2520and%2520new%2520perspectives%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D185%26spage%3D34%26epage%3D49%26doi%3D10.1016%2Fj.pharmthera.2017.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonnalagadda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaho, V. A.</span></span> <span> </span><span class="NLM_article-title">Fingolimod: Lessons learned and new opportunities for treating multiple sclerosis and other disorders</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010818-021358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1146%2Fannurev-pharmtox-010818-021358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30625282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms12rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=149-170&author=J.+Chunauthor=Y.+Kiharaauthor=D.+Jonnalagaddaauthor=V.+A.+Blaho&title=Fingolimod%3A+Lessons+learned+and+new+opportunities+for+treating+multiple+sclerosis+and+other+disorders&doi=10.1146%2Fannurev-pharmtox-010818-021358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders</span></div><div class="casAuthors">Chun, Jerold; Kihara, Yasuyuki; Jonnalagadda, Deepa; Blaho, Victoria A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">149-170</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration-approved oral therapy for relapsing forms of multiple sclerosis (MS).  Research on modified fungal metabolites converged with basic science studies that had identified lysophospholipid (LP) sphingosine 1-phosphate (S1P) receptors, providing mechanistic insights on fingolimod while validating LP receptors as drug targets.  Mechanism of action (MOA) studies identified receptor-mediated processes involving the immune system and the central nervous system (CNS).  These dual actions represent a more general theme for S1P and likely other LP receptor modulators.  Fingolimod's direct CNS activities likely contribute to its efficacy in MS, with particular relevance to treating progressive disease stages and forms that involve neurodegeneration.  The evolving understanding of fingolimod's MOA has provided strategies for developing next-generation compds. with superior attributes, suggesting new ways to target S1P as well as other LP receptor modulators for novel therapeutics in the CNS and other organ systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXXtaxAvhsIrVg90H21EOLACvtfcHk0ljfn4trtLlehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms12rsQ%253D%253D&md5=e59dccb5360c3fd980ee55d4fd647461</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010818-021358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010818-021358%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DJonnalagadda%26aufirst%3DD.%26aulast%3DBlaho%26aufirst%3DV.%2BA.%26atitle%3DFingolimod%253A%2520Lessons%2520learned%2520and%2520new%2520opportunities%2520for%2520treating%2520multiple%2520sclerosis%2520and%2520other%2520disorders%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2019%26volume%3D59%26spage%3D149%26epage%3D170%26doi%3D10.1146%2Fannurev-pharmtox-010818-021358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gil, I. Z.D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zian, D.</span></span> <span> </span><span class="NLM_article-title">The status of the lysophosphatidic acid receptor type 1 (LPA1R)</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1039/C4MD00333K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1039%2FC4MD00333K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFynsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=13-23&author=I.+Z.D.+Gonzalez-Gilauthor=H.+V%C3%A1zquez-Villaauthor=S.+Ortega-Guti%C3%A9rrezauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguezauthor=D.+Zian&title=The+status+of+the+lysophosphatidic+acid+receptor+type+1+%28LPA1R%29&doi=10.1039%2FC4MD00333K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The status of the lysophosphatidic acid receptor type 1 (LPA1R)</span></div><div class="casAuthors">Gonzalez-Gil, Ines; Zian, Debora; Vazquez-Villa, Henar; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-23</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Lysophospholipids are lipid mols. that are receiving growing attention because, in addn. to their structural function in the cell membrane, they are now regarded as important regulators for diverse biol. functions through activation of specific receptors.  These receptors have been characterized during the last two decades as G protein-coupled receptors (GPCRs) and, among them, two families stand out: lysophosphatidic acid (LPA1-6) and sphingosine 1-phoshate (S1P1-5) receptors.  Despite their interest, the high structural similarity between them has restrained the development of selective and high affinity ligands and therefore the elucidation of the role of these receptors in the central nervous system (CNS).  This review provides an overview about the different LPA receptors with a special focus on the LPA1 subtype from a medicinal chem. perspective.  It summarizes the most recent developments in the search for selective and specific agonists and antagonists of the LPA1 receptor and highlights their current status in the drug development pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqspIAyjerkAbVg90H21EOLACvtfcHk0lj0YUB_yehRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFynsb7I&md5=82923b68a6e2717c063f95602963a8e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC4MD00333K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00333K%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Gil%26aufirst%3DI.%2BZ.D.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26aulast%3DZian%26aufirst%3DD.%26atitle%3DThe%2520status%2520of%2520the%2520lysophosphatidic%2520acid%2520receptor%2520type%25201%2520%2528LPA1R%2529%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D13%26epage%3D23%26doi%3D10.1039%2FC4MD00333K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prestwich, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serban, M.</span></span> <span> </span><span class="NLM_article-title">Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1781</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">594</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2008.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.bbalip.2008.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=18454946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=588-594&author=G.+D.+Prestwichauthor=J.+Gajewiakauthor=H.+Zhangauthor=X.+Xuauthor=G.+Yangauthor=M.+Serban&title=Phosphatase-resistant+analogues+of+lysophosphatidic+acid%3A+agonists+promote+healing%2C+antagonists+and+autotaxin+inhibitors+treat+cancer&doi=10.1016%2Fj.bbalip.2008.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatase-resistant analogues of lysophosphatidic acid: Agonists promote healing, antagonists and autotaxin inhibitors treat cancer</span></div><div class="casAuthors">Prestwich, Glenn D.; Gajewiak, Joanna; Zhang, Honglu; Xu, Xiaoyu; Yang, Guanghui; Serban, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">588-594</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Isoform-selective agonists and antagonists of the lysophosphatidic acid (LPA) G protein-coupled receptors (GPCRs) have important potential applications in cell biol. and therapy.  LPA GPCRs regulate cancer cell proliferation, invasion, angiogenesis, and also biochem. resistance to chemotherapy- and radiotherapy-induced apoptosis.  LPA and its analogs also are feedback inhibitors of the enzyme lysophospholipase D (lysoPLD, a.k.a., autotaxin, ATX), a central regulator of invasion and metastasis.  For cancer therapy, the optimal therapeutic profile would be a metabolically-stabilized, pan-LPA receptor antagonist that also inhibited lysoPLD.  For protection of gastrointestinal mucosa and lymphocytes, LPA agonists would be desirable to minimize or reverse radiation or chem.-induced injury.  Analogs of lysophosphatidic acid (LPA) that are chem. modified to be less susceptible to phospholipases and phosphatases show activity as long-lived receptor-specific agonists and antagonists for LPA receptors, as well as inhibitors for the lysoPLD activity of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbAx_0KTH-bVg90H21EOLACvtfcHk0lj0YUB_yehRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbnM&md5=bb1b32df29c8abe58284d7c455a4612a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DGajewiak%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DSerban%26aufirst%3DM.%26atitle%3DPhosphatase-resistant%2520analogues%2520of%2520lysophosphatidic%2520acid%253A%2520agonists%2520promote%2520healing%252C%2520antagonists%2520and%2520autotaxin%2520inhibitors%2520treat%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D588%26epage%3D594%26doi%3D10.1016%2Fj.bbalip.2008.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreihofer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heasley, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhin, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span> <span> </span><span class="NLM_article-title">Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1124/mol.60.6.1173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1124%2Fmol.60.6.1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=11723223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1173-1180&author=C.+E.+Heiseauthor=W.+L.+Santosauthor=A.+M.+Schreihoferauthor=B.+H.+Heasleyauthor=Y.+V.+Mukhinauthor=T.+L.+Macdonaldauthor=K.+R.+Lynch&title=Activity+of+2-substituted+lysophosphatidic+acid+%28LPA%29+analogs+at+LPA+receptors%3A+discovery+of+a+LPA1%2FLPA3+receptor+antagonist&doi=10.1124%2Fmol.60.6.1173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist</span></div><div class="casAuthors">Heise, Christopher E.; Santos, Webster L.; Schreihofer, Ann M.; Heasley, Brian H.; Mukhin, Yurii V.; Macdonald, Timothy L.; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1173-1180</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The physiol. implications of lysophosphatidic acid occupancy of individual receptors are largely unknown because selective agonists/antagonists are unavailable currently.  The mol. cloning of three high-affinity lysophosphatidic acid receptors, LPA1, LPA2, and LPA3, provides a platform for developing receptor type-selective ligands.  Starting with an N-acyl ethanolamide phosphate LPA analog, we made a series of substitutions at the second carbon to generate compds. with varying spatial, stereochem., and electronic characteristics.  Anal. of this series at each recombinant LPA receptor using a guanosine 5'-O-(3-[35S]thio)triphosphate (GTP[γ35S]) binding assay revealed sharp differences in activity.  Our results suggest that these receptors have one spatially restrictive binding pocket that interacts with the 2-substituted moieties and prefers small hydrophobic groups and hydrogen bonding functionalities.  The agonist activity predicted by the GTP[γ35S] binding assay was reflected in the activity of a subset of compds. in increasing arterial pressure in anesthetized rats.  One compd. with a bulky hydrophobic group (VPC12249) was a dual LPA1/LPA3 competitive antagonist.  Several compds. that had smaller side chains were LPA1-selective agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHdbLqk7fOkbVg90H21EOLACvtfcHk0lj0YUB_yehRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVOitro%253D&md5=c3acc6cc4520590f581d3c215e3740e6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.6.1173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.6.1173%26sid%3Dliteratum%253Aachs%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DSantos%26aufirst%3DW.%2BL.%26aulast%3DSchreihofer%26aufirst%3DA.%2BM.%26aulast%3DHeasley%26aufirst%3DB.%2BH.%26aulast%3DMukhin%26aufirst%3DY.%2BV.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DActivity%2520of%25202-substituted%2520lysophosphatidic%2520acid%2520%2528LPA%2529%2520analogs%2520at%2520LPA%2520receptors%253A%2520discovery%2520of%2520a%2520LPA1%252FLPA3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1173%26epage%3D1180%26doi%3D10.1124%2Fmol.60.6.1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heasley, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3473</span>– <span class="NLM_lpage">3476</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.bmcl.2004.04.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=15177455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3473-3476&author=W.+L.+Santosauthor=B.+H.+Heasleyauthor=R.+Jaroszauthor=K.+M.+Carterauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Synthesis+and+biological+evaluation+of+phosphonic+and+thiophosphoric+acid+derivatives+of+lysophosphatidic+acid&doi=10.1016%2Fj.bmcl.2004.04.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid</span></div><div class="casAuthors">Santos, Webster L.; Heasley, Brian H.; Jarosz, Renata; Carter, Karen M.; Lynch, Kevin R.; Macdonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3473-3476</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Using an N-oleoyl ethanolamide scaffold, a series of phosphate polar head group analogs of LPA comprised of various α-substituted phosphonates and thiophosphates was prepd.  In a broken cell GTP[γ35S] binding assay, agonist activity was evaluated at the three LPA receptors of the endothelial differentiation gene (Edg) family.  This study has resulted in the discovery of a non-hydrolyzable LPA1-selective agonist.  Addnl., thiophosphate I bears an isosteric phosphate mimetic that confers agonism at the LPA1 receptor but not LPA2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7CKG5c-ljsLVg90H21EOLACvtfcHk0lj0YUB_yehRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gnu7o%253D&md5=8c303b1a4b5989b06171a688c0ef661d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.061%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DW.%2BL.%26aulast%3DHeasley%26aufirst%3DB.%2BH.%26aulast%3DJarosz%26aufirst%3DR.%26aulast%3DCarter%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520phosphonic%2520and%2520thiophosphoric%2520acid%2520derivatives%2520of%2520lysophosphatidic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3473%26epage%3D3476%26doi%3D10.1016%2Fj.bmcl.2004.04.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, E.</span>; <span class="NLM_string-name">Kondo, Y.</span>; <span class="NLM_string-name">Shishikura, J.</span>; <span class="NLM_string-name">Takahashi, M.</span>; <span class="NLM_string-name">Sakamoto, K.</span>; <span class="NLM_string-name">Soga, T.</span>; <span class="NLM_string-name">Orita, M.</span></span> <span> </span><span class="NLM_article-title">Benzyl-12b-methyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine derivatives as LPA receptor agonists</span>. Japanese Patent <span class="NLM_patent">JP 2008297278 A</span> <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E.+Kawanami&author=Y.+Kondo&author=J.+Shishikura&author=M.+Takahashi&author=K.+Sakamoto&author=T.+Soga&author=M.+Orita&title=Benzyl-12b-methyl-1%2C2%2C3%2C4%2C6%2C7%2C12%2C12b-octahydroindolo%5B2%2C3-a%5Dquinolizine+derivatives+as+LPA+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawanami%26aufirst%3DE.%26atitle%3DBenzyl-12b-methyl-1%252C2%252C3%252C4%252C6%252C7%252C12%252C12b-octahydroindolo%255B2%252C3-a%255Dquinolizine%2520derivatives%2520as%2520LPA%2520receptor%2520agonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terakado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshaviak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmar-Rovira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of antagonist bound human lysophosphatidic acid receptor 1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1633</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.cell.2015.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=26091040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Squ73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1633-1643&author=J.+E.+Chrencikauthor=C.+B.+Rothauthor=M.+Terakadoauthor=H.+Kurataauthor=R.+Omiauthor=Y.+Kiharaauthor=D.+Warshaviakauthor=S.+Nakadeauthor=G.+Asmar-Roviraauthor=M.+Mileniauthor=H.+Mizunoauthor=M.+T.+Griffithauthor=C.+Rodgersauthor=G.+W.+Hanauthor=J.+Velasquezauthor=J.+Chunauthor=R.+C.+Stevensauthor=M.+A.+Hanson&title=Crystal+structure+of+antagonist+bound+human+lysophosphatidic+acid+receptor+1&doi=10.1016%2Fj.cell.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of antagonist bound human lysophosphatidic acid receptor 1</span></div><div class="casAuthors">Chrencik, Jill E.; Roth, Christopher B.; Terakado, Masahiko; Kurata, Haruto; Omi, Rie; Kihara, Yasuyuki; Warshaviak, Dora; Nakade, Shinji; Asmar-Rovira, Guillermo; Mileni, Mauro; Mizuno, Hirotaka; Griffith, Mark T.; Rodgers, Caroline; Han, Gye Won; Velasquez, Jeffrey; Chun, Jerold; Stevens, Raymond C.; Hanson, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1633-1643</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lipid biol. continues to emerge as an area of significant therapeutic interest, particularly as the result of an enhanced understanding of the wealth of signaling mols. with diverse physiol. properties.  This growth in knowledge is epitomized by lysophosphatidic acid (LPA), which functions through interactions with at least 6 cognate G protein-coupled receptors.  Here, the authors present 3 crystal structures of LPA1 in complex with antagonist tool compds. selected and designed through structural and stability analyses.  Structural anal. combined with mol. dynamics identified a basis for ligand access to the LPA1 binding pocket from the extracellular space contrasting with the proposed access for the sphingosine 1-phosphate receptor.  Characteristics of the LPA1 binding pocket raised the possibility of promiscuous ligand recognition of phosphorylated endocannabinoids.  Cell-based assays confirmed this hypothesis, linking the distinct receptor systems through metabolically related ligands with potential functional and therapeutic implications for treatment of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrool6xhfptULVg90H21EOLACvtfcHk0ljKkAoKq-P5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Squ73O&md5=ac5af6b8dd80b5311e95a8eb133957b5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DTerakado%26aufirst%3DM.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DOmi%26aufirst%3DR.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DWarshaviak%26aufirst%3DD.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DAsmar-Rovira%26aufirst%3DG.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DRodgers%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DVelasquez%26aufirst%3DJ.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520antagonist%2520bound%2520human%2520lysophosphatidic%2520acid%2520receptor%25201%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1633%26epage%3D1643%26doi%3D10.1016%2Fj.cell.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parrill, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tigyi, G.</span></span> <span> </span><span class="NLM_article-title">Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1831</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2012.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2Fj.bbalip.2012.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=2-12&author=A.+L.+Parrillauthor=G.+Tigyi&title=Integrating+the+puzzle+pieces%3A+the+current+atomistic+picture+of+phospholipid-G+protein+coupled+receptor+interactions&doi=10.1016%2Fj.bbalip.2012.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Integrating the puzzle pieces: The current atomistic picture of phospholipid-G protein coupled receptor interactions</span></div><div class="casAuthors">Parrill, Abby L.; Tigyi, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1831</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  A compelling question of how phospholipids interact with their target receptors has been of interest since the first receptor-mediated effects were reported.  The recent report of a crystal structure for the S1P1 receptor in complex with an antagonist phospholipid provides interesting perspective on the insights that had previously been gained through structure-activity studies of the phospholipids, as well as modeling and mutagenesis studies of the receptors.  This review integrates these varied lines of investigation in the context of their various contributions to our current understanding of phospholipid-receptor interactions.  This article is part of a Special Issue entitled Advances in Lysophospholipid Research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra2WiZKB7wybVg90H21EOLACvtfcHk0ljKkAoKq-P5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWmsr%252FE&md5=dc7142f1c65a2a4c4a7d9df3ad5d75d6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2012.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2012.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DIntegrating%2520the%2520puzzle%2520pieces%253A%2520the%2520current%2520atomistic%2520picture%2520of%2520phospholipid-G%2520protein%2520coupled%2520receptor%2520interactions%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2013%26volume%3D1831%26spage%3D2%26epage%3D12%26doi%3D10.1016%2Fj.bbalip.2012.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span> <span> </span><span class="NLM_article-title">Carboxylic acid (bio)isosteres in drug design</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fcmdc.201200585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=23361977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=385-395&author=C.+Ballatoreauthor=D.+M.+Hurynauthor=A.+B.+Smith&title=Carboxylic+acid+%28bio%29isosteres+in+drug+design&doi=10.1002%2Fcmdc.201200585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylic Acid (Bio)Isosteres in Drug Design</span></div><div class="casAuthors">Ballatore, Carlo; Huryn, Donna M.; Smith, Amos B.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-395</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The carboxylic acid functional group can be an important constituent of a pharmacophore, however, the presence of this moiety can also be responsible for significant drawbacks, including metabolic instability, toxicity, as well as limited passive diffusion across biol. membranes.  To avoid some of these shortcomings while retaining the desired attributes of the carboxylic acid moiety, medicinal chemists often investigate the use of carboxylic acid (bio)isosteres.  The same type of strategy can also be effective for a variety other purposes, for example, to increase the selectivity of a biol. active compd. or to create new intellectual property.  Several carboxylic acid isosteres have been reported, however, the outcome of any isosteric replacement cannot be readily predicted as this strategy is generally found to be dependent upon the particular context (i.e., the characteristic properties of the drug and the drug-target).  As a result, screening of a panel of isosteres is typically required.  In this context, the discovery and development of novel carboxylic acid surrogates that could complement the existing palette of isosteres remains an important area of research.  The goal of this Minireview is to provide an overview of the most commonly employed carboxylic acid (bio)isosteres and to present representative examples demonstrating the use and utility of each isostere in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEcl3NtfHu7Vg90H21EOLACvtfcHk0liwHTg-eGbpfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D&md5=cff8233af1c386439789a0e4ebcb4331</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200585%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DCarboxylic%2520acid%2520%2528bio%2529isosteres%2520in%2520drug%2520design%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D385%26epage%3D395%26doi%3D10.1002%2Fcmdc.201200585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lassalas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasfargeas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayendran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Structure property relationships of carboxylic acid isosteres</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3183</span>– <span class="NLM_lpage">3203</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3183-3203&author=P.+Lassalasauthor=B.+Gayauthor=C.+Lasfargeasauthor=M.+J.+Jamesauthor=V.+Tranauthor=K.+G.+Vijayendranauthor=K.+R.+Brundenauthor=M.+C.+Kozlowskiauthor=C.+J.+Thomasauthor=A.+B.+Smithauthor=D.+M.+Hurynauthor=C.+Ballatore&title=Structure+property+relationships+of+carboxylic+acid+isosteres&doi=10.1021%2Facs.jmedchem.5b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Property Relationships of Carboxylic Acid Isosteres</span></div><div class="casAuthors">Lassalas, Pierrik; Gay, Bryant; Lasfargeas, Caroline; James, Michael J.; Tran, Van; Vijayendran, Krishna G.; Brunden, Kurt R.; Kozlowski, Marisa C.; Thomas, Craig J.; Smith, Amos B.; Huryn, Donna M.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3183-3203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of a carboxylic acid with a surrogate structure, or (bio)-isostere, is a classical strategy in medicinal chem.  The general underlying principle is that by maintaining the features of the carboxylic acid crit. for biol. activity, but appropriately modifying the physicochem. properties, improved analogs may result.  In this context, a systematic assessment of the physicochem. properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design.  Herein we report the structure-property relationships (SPR) of 35 phenylpropionic acid derivs., in which the carboxylic acid moiety is replaced with a series of known isosteres.  The data set generated provides an assessment of the relative impact on the physicochem. properties that these replacements may have compared to the carboxylic acid analog.  As such, this study presents a framework for how to rationally apply isosteric replacements of the carboxylic acid functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIF98i2ITNrLVg90H21EOLACvtfcHk0liwHTg-eGbpfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D&md5=34490fc72fdb321d8c9751bef1bf79c5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01963%26sid%3Dliteratum%253Aachs%26aulast%3DLassalas%26aufirst%3DP.%26aulast%3DGay%26aufirst%3DB.%26aulast%3DLasfargeas%26aufirst%3DC.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DTran%26aufirst%3DV.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DKozlowski%26aufirst%3DM.%2BC.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DStructure%2520property%2520relationships%2520of%2520carboxylic%2520acid%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3183%26epage%3D3203%26doi%3D10.1021%2Facs.jmedchem.5b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0liwHTg-eGbpfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisneros, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorklund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gil, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrano, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1021/jm201327p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201327p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=824-836&author=J.+A.+Cisnerosauthor=E.+Bjorklundauthor=I.+Gonzalez-Gilauthor=Y.+Huauthor=A.+Canalesauthor=F.+J.+Medranoauthor=A.+Romeroauthor=S.+Ortega-Gutierrezauthor=C.+J.+Fowlerauthor=M.+L.+Lopez-Rodriguez&title=Structure-activity+relationship+of+a+new+series+of+reversible+dual+monoacylglycerol+lipase%2Ffatty+acid+amide+hydrolase+inhibitors&doi=10.1021%2Fjm201327p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of a New Series of Reversible Dual Monoacylglycerol Lipase/Fatty Acid Amide Hydrolase Inhibitors</span></div><div class="casAuthors">Cisneros, Jose A.; Bjorklund, Emmelie; Gonzalez-Gil, Ines; Hu, Yanling; Canales, Angeles; Medrano, Francisco J.; Romero, Antonio; Ortega-Gutierrez, Silvia; Fowler, Christopher J.; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">824-836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), play independent and nonredundant roles in the body.  This makes the development of both selective and dual inhibitors of their inactivation an important priority.  In this work, we report a new series of inhibitors of monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH).  Among them, (±)-oxiran-2-ylmethyl 6-(1,1'-biphenyl-4-yl)hexanoate (I) and (2R)-(-)-oxiran-2-ylmethyl(4-benzylphenyl)acetate (II) stand out as potent inhibitors of human recombinant MAGL (IC50 (I) = 4.1 μM; IC50 (II) = 2.4 μM), rat brain monoacylglycerol hydrolysis (IC50 (I) = 1.8 μM; IC50 (II) = 0.68 μM), and rat brain FAAH (IC50 (I) = 5.1 μM; IC50 (II) = 0.29 μM).  Importantly, and in contrast to the other previously described MAGL inhibitors, these compds. behave as reversible inhibitors either of competitive (I) or noncompetitive nature (II).  Hence, they could be useful to explore the therapeutic potential of reversible MAGL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4rdcY3AOsWrVg90H21EOLACvtfcHk0lgAcAzfbM4dSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1CrsLnJ&md5=917fd37043fd3ba4ecdfc4f5ac2c032a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201327p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201327p%26sid%3Dliteratum%253Aachs%26aulast%3DCisneros%26aufirst%3DJ.%2BA.%26aulast%3DBjorklund%26aufirst%3DE.%26aulast%3DGonzalez-Gil%26aufirst%3DI.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DMedrano%26aufirst%3DF.%2BJ.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DStructure-activity%2520relationship%2520of%2520a%2520new%2520series%2520of%2520reversible%2520dual%2520monoacylglycerol%2520lipase%252Ffatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D824%26epage%3D836%26doi%3D10.1021%2Fjm201327p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Torres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipriano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heden, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorklund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span> <span> </span><span class="NLM_article-title">A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13765</span>– <span class="NLM_lpage">13770</span>, <span class="refDoi"> DOI: 10.1002/anie.201407807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fanie.201407807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=13765-13770&author=G.+Hernandez-Torresauthor=M.+Ciprianoauthor=E.+Hedenauthor=E.+Bjorklundauthor=A.+Canalesauthor=D.+Zianauthor=A.+Feliuauthor=M.+Mechaauthor=C.+Guazaauthor=C.+J.+Fowlerauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguez&title=A+reversible+and+selective+inhibitor+of+monoacylglycerol+lipase+ameliorates+multiple+sclerosis&doi=10.1002%2Fanie.201407807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis</span></div><div class="casAuthors">Hernandez-Torres, Gloria; Cipriano, Mariateresa; Heden, Erika; Bjoerklund, Emmelie; Canales, Angeles; Zian, Debora; Feliu, Ana; Mecha, Miriam; Guaza, Carmen; Fowler, Christopher J.; Ortega-Gutierrez, Silvia; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">13765-13770</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is the enzyme responsible for the inactivation of the endocannabinoid 2-arachidonoylglycerol (2-AG).  MAGL inhibitors show analgesic and tissue-protecting effects in several disease models.  However, the few efficient and selective MAGL inhibitors described to date block the enzyme irreversibly, and this can lead to pharmacol. tolerance.  Hence, addnl. classes of MAGL inhibitors are needed to validate this enzyme as a therapeutic target.  Here we report a potent, selective, and reversible MAGL inhibitor (IC50=0.18 μM) which is active in vivo and ameliorates the clin. progression of a multiple sclerosis (MS) mouse model without inducing undesirable CB1-mediated side effects.  These results support the interest in MAGL as a target for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzujCPuidHArVg90H21EOLACvtfcHk0lgAcAzfbM4dSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCit7vF&md5=6cd7f2080f95bbc05daaebba21ee1be2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407807%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Torres%26aufirst%3DG.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DHeden%26aufirst%3DE.%26aulast%3DBjorklund%26aufirst%3DE.%26aulast%3DCanales%26aufirst%3DA.%26aulast%3DZian%26aufirst%3DD.%26aulast%3DFeliu%26aufirst%3DA.%26aulast%3DMecha%26aufirst%3DM.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DA%2520reversible%2520and%2520selective%2520inhibitor%2520of%2520monoacylglycerol%2520lipase%2520ameliorates%2520multiple%2520sclerosis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D13765%26epage%3D13770%26doi%3D10.1002%2Fanie.201407807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orcajo-Rincón, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutiérrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrecillas, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuthrich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">Development of non-peptide ligands of growth factor receptor-bound protein 2-Src homology 2 domain using molecular modeling and NMR spectroscopy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1021/jm101478n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101478n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1096-1100&author=A.+L.+Orcajo-Rinc%C3%B3nauthor=S.+Ortega-Guti%C3%A9rrezauthor=P.+Serranoauthor=I.+R.+Torrecillasauthor=K.+Wuthrichauthor=M.+Campilloauthor=L.+Pardoauthor=A.+Visoauthor=B.+Benham%C3%BAauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Development+of+non-peptide+ligands+of+growth+factor+receptor-bound+protein+2-Src+homology+2+domain+using+molecular+modeling+and+NMR+spectroscopy&doi=10.1021%2Fjm101478n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of non-peptide ligands of growth factor receptor-bound protein 2-Src homology 2 domain using molecular modeling and NMR spectroscopy</span></div><div class="casAuthors">Orcajo-Rincon, Angel L.; Ortega-Gutierrez, Silvia; Serrano, Pedro; Torrecillas, Ivan R.; Wuthrich, Kurt; Campillo, Mercedes; Pardo, Leonardo; Viso, Alma; Benhamu, Bellinda; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1096-1100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a novel series of non-peptide ligands that inhibit the growth factor receptor-bound protein 2 (Grb2)-Src homol. 2 (SH2) domain binding, designed using a combined computational and NMR-driven approach.  We have identified a new lead compd., 1n (IC50 = 56 μM), which is cytotoxic in HER2-pos. breast cancer cells and disrupts the interaction between HER2 and Grb2.  Thus, 1n can be used as a scaffold for the development of efficient Grb2-SH2 domain binding inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJfdc1Jl8RnLVg90H21EOLACvtfcHk0lgAcAzfbM4dSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKmurk%253D&md5=a0830a8066568b99da33d44a2503d404</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm101478n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101478n%26sid%3Dliteratum%253Aachs%26aulast%3DOrcajo-Rinc%25C3%25B3n%26aufirst%3DA.%2BL.%26aulast%3DOrtega-Guti%25C3%25A9rrez%26aufirst%3DS.%26aulast%3DSerrano%26aufirst%3DP.%26aulast%3DTorrecillas%26aufirst%3DI.%2BR.%26aulast%3DWuthrich%26aufirst%3DK.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DViso%26aufirst%3DA.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DDevelopment%2520of%2520non-peptide%2520ligands%2520of%2520growth%2520factor%2520receptor-bound%2520protein%25202-Src%2520homology%25202%2520domain%2520using%2520molecular%2520modeling%2520and%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1096%26epage%3D1100%26doi%3D10.1021%2Fjm101478n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Troupiotis-Tsailaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gil, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govaerts, C.</span></span> <span> </span><span class="NLM_article-title">Ligand chain length drives activation of lipid G protein-coupled receptors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2020</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-02104-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fs41598-017-02104-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=28515494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BC1crosVShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2020&author=A.+Troupiotis-Tsailakiauthor=J.+Zachmannauthor=I.+Gonzalez-Gilauthor=A.+Gonzalezauthor=S.+Ortega-Gutierrezauthor=M.+L.+Lopez-Rodriguezauthor=L.+Pardoauthor=C.+Govaerts&title=Ligand+chain+length+drives+activation+of+lipid+G+protein-coupled+receptors&doi=10.1038%2Fs41598-017-02104-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand chain length drives activation of lipid G protein-coupled receptors</span></div><div class="casAuthors">Troupiotis-Tsailaki Anastassia; Govaerts Cedric; Zachmann Julian; Gonzalez Angel; Pardo Leonardo; Gonzalez-Gil Ines; Ortega-Gutierrez Silvia; Lopez-Rodriguez Maria L</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2020</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) is a lipid mediator that can activate five cell membrane G protein-coupled receptors (GPCRs) which carry a variety of essential functions and are promising drug targets.  S1P is composed of a polar zwitterionic head-group and a hydrophobic alkyl chain.  This implies an activation mechanism of its cognate receptor that must be significantly different from what is known for prototypical GPCRs (ie receptor to small hydrophilic ligands).  Here we aim to identify the structural features responsible for S1P agonism by combining molecular dynamics simulations and functional assays using S1P analogs of different alkyl chain lengths.  We propose that high affinity binding involves polar interactions between the lipid head-group and receptor side chains while activation is due to hydrophobic interactions between the lipid tail and residues in a distinct binding site.  We observe that ligand efficacy is directly related to alkyl chain length but also varies with receptor subtypes in correlation with the size of this binding pocket.  Integrating experimental and computational data, we propose an activation mechanism for the S1P receptors involving agonist-induced conformational events that are conserved throughout class A GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxLKh8DGKPB-WhZTslLrfffW6udTcc2eY8-INsOTfmFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crosVShtg%253D%253D&md5=336c30282c49124f008c93fab462212e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-02104-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-02104-5%26sid%3Dliteratum%253Aachs%26aulast%3DTroupiotis-Tsailaki%26aufirst%3DA.%26aulast%3DZachmann%26aufirst%3DJ.%26aulast%3DGonzalez-Gil%26aufirst%3DI.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DGovaerts%26aufirst%3DC.%26atitle%3DLigand%2520chain%2520length%2520drives%2520activation%2520of%2520lipid%2520G%2520protein-coupled%2520receptors%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D2020%26doi%3D10.1038%2Fs41598-017-02104-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baksh, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussrow, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mileni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhop, D. J.</span></span> <span> </span><span class="NLM_article-title">Label-free quantification of membrane-ligand interactions using backscattering interferometry</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1038/nbt.1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fnbt.1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=21399645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=357-360&author=M.+M.+Bakshauthor=A.+K.+Kussrowauthor=M.+Mileniauthor=M.+G.+Finnauthor=D.+J.+Bornhop&title=Label-free+quantification+of+membrane-ligand+interactions+using+backscattering+interferometry&doi=10.1038%2Fnbt.1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Label-free quantification of membrane-ligand interactions using backscattering interferometry</span></div><div class="casAuthors">Baksh, Michael M.; Kussrow, Amanda K.; Mileni, Mauro; Finn, M. G.; Bornhop, Darryl J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-360</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although membrane proteins are ubiquitous within all living organisms and represent the majority of drug targets, a general method for direct, label-free measurement of ligand binding to native membranes has not been reported.  Here we show that backscattering interferometry (BSI) can accurately quantify ligand-receptor binding affinities in a variety of membrane environments.  By detecting minute changes in the refractive index of a soln., BSI allows binding interactions of proteins with their ligands to be measured at picomolar concns.  Equil. binding consts. in the micromolar to picomolar range were obtained for small- and large-mol. interactions in both synthetic and cell-derived membranes without the use of labels or supporting substrates.  The simple and low-cost hardware, high sensitivity and label-free nature of BSI should make it readily applicable to the study of many membrane-assocd. proteins of biochem. and pharmacol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoykKg8qC1LcLVg90H21EOLACvtfcHk0liX19PZIJD0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVGmsLo%253D&md5=be739d26330d94118b72d9e7d4ef0c77</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1790%26sid%3Dliteratum%253Aachs%26aulast%3DBaksh%26aufirst%3DM.%2BM.%26aulast%3DKussrow%26aufirst%3DA.%2BK.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DBornhop%26aufirst%3DD.%2BJ.%26atitle%3DLabel-free%2520quantification%2520of%2520membrane-ligand%2520interactions%2520using%2520backscattering%2520interferometry%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D357%26epage%3D360%26doi%3D10.1038%2Fnbt.1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bornhop, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussrow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, H. S.</span></span> <span> </span><span class="NLM_article-title">Free-solution, label-free molecular interactions studied by back-scattering interferometry</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1732</span>– <span class="NLM_lpage">1736</span>, <span class="refDoi"> DOI: 10.1126/science.1146559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1126%2Fscience.1146559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=17885132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1732-1736&author=D.+J.+Bornhopauthor=J.+C.+Lathamauthor=A.+Kussrowauthor=D.+A.+Markovauthor=R.+D.+Jonesauthor=H.+S.+Sorensen&title=Free-solution%2C+label-free+molecular+interactions+studied+by+back-scattering+interferometry&doi=10.1126%2Fscience.1146559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Free-Solution, Label-Free Molecular Interactions Studied by Back-Scattering Interferometry</span></div><div class="casAuthors">Bornhop, Darryl J.; Latham, Joey C.; Kussrow, Amanda; Markov, Dmitry A.; Jones, Richard D.; Sorensen, Henrik S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5845</span>),
    <span class="NLM_cas:pages">1732-1736</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Free-soln., label-free mol. interactions were investigated with back-scattering interferometry in a simple optical train composed of a helium-neon laser, a microfluidic channel, and a position sensor.  Mol. binding interactions between proteins, ions and protein, and small mols. and protein, were detd. with high dynamic range dissocn. consts. (Kd spanning six decades) and unmatched sensitivity (picomolar Kd's and detection limits of 10,000s of mols.).  With this technique, equil. dissocn. consts. were quantified for protein A and IgG, interleukin-2 with its monoclonal antibody, and calmodulin with calcium ion Ca2+, a small mol. inhibitor, the protein calcineurin, and the M13 peptide.  The high sensitivity of back-scattering interferometry and small vols. of microfluidics allowed the entire calmodulin assay to be performed with 200 pmol of solute.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr12XhHV8KSuLVg90H21EOLACvtfcHk0liX19PZIJD0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsLnP&md5=53447d03bc300515bc6cfed45829707d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.1146559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1146559%26sid%3Dliteratum%253Aachs%26aulast%3DBornhop%26aufirst%3DD.%2BJ.%26aulast%3DLatham%26aufirst%3DJ.%2BC.%26aulast%3DKussrow%26aufirst%3DA.%26aulast%3DMarkov%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DR.%2BD.%26aulast%3DSorensen%26aufirst%3DH.%2BS.%26atitle%3DFree-solution%252C%2520label-free%2520molecular%2520interactions%2520studied%2520by%2520back-scattering%2520interferometry%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1732%26epage%3D1736%26doi%3D10.1126%2Fscience.1146559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussrow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhop, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span> <span> </span><span class="NLM_article-title">Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1194/jlr.D089938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1194%2Fjlr.D089938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=30463988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=212-217&author=H.+Mizunoauthor=Y.+Kiharaauthor=A.+Kussrowauthor=A.+Chenauthor=M.+Rayauthor=R.+Riveraauthor=D.+J.+Bornhopauthor=J.+Chun&title=Lysophospholipid+G+protein-coupled+receptor+binding+parameters+as+determined+by+backscattering+interferometry&doi=10.1194%2Fjlr.D089938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry</span></div><div class="casAuthors">Mizuno, Hirotaka; Kihara, Yasuyuki; Kussrow, Amanda; Chen, Allison; Ray, Manisha; Rivera, Richard; Bornhop, Darryl J.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-217</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) activates cognate G protein-coupled receptors (GPCRs) to initiate biol. signaling cascades.  Lysophospholipid (LP) receptor binding properties remain incompletely assessed because of difficulties with ligand lipophilicity and lipid "stickiness.".  These inherent attributes produce high levels of nonspecific binding within cell-membrane prepns. used to assess GPCRs, as has been shown in classical binding assays using radiolabeled ligands, making accurate measurements of lipid binding kinetics difficult to achieve.  Backscattering interferometry (BSI) is an optical technol. that measures mol. binding interactions by reporting changes in the refractive index of a soln. after binding events.  Here, we report the use of BSI to assess LPA1 for its ability to bind to naturally occurring lipids and a synthetic LPA1 antagonist (ONO-9780307), under both primary- and competition-binding conditions.  Assessment of 12 different lipids demonstrated that the known LP ligand, 1-oleoyl-LPA, as well as an endocannabinoid metabolite, anandamide phosphate, are specific ligands for LPA1, whereas other LPs tested were not.  Newly detd. dissocn. consts. (Kd values) for orthosteric lipid ligands approximated 10-9 M, substantially lower (i.e., with higher affinity) than measured Kd values in classical binding or cell-based assays.  These results demonstrate that BSI may have particular utility in assessing binding interactions between lipid receptors and their lipid ligands and could provide new screening approaches for lipid receptor identification and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJJdrxjiIhP7Vg90H21EOLACvtfcHk0liaSB-grJnv6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2isg%253D%253D&md5=ef555e0beb730efd6bab2723289d3fd6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1194%2Fjlr.D089938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.D089938%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DKussrow%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DBornhop%26aufirst%3DD.%2BJ.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophospholipid%2520G%2520protein-coupled%2520receptor%2520binding%2520parameters%2520as%2520determined%2520by%2520backscattering%2520interferometry%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2019%26volume%3D60%26spage%3D212%26epage%3D217%26doi%3D10.1194%2Fjlr.D089938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omotuyi, O. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, H.</span></span> <span> </span><span class="NLM_article-title">Lys39-Lysophosphatidate carbonyl oxygen interaction locks LPA1 N-terminal cap to the orthosteric site and partners Arg124 during receptor activation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13343</span>, <span class="refDoi"> DOI: 10.1038/srep13343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1038%2Fsrep13343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=26268898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhs7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13343&author=O.+I.+Omotuyiauthor=J.+Nagaiauthor=H.+Ueda&title=Lys39-Lysophosphatidate+carbonyl+oxygen+interaction+locks+LPA1+N-terminal+cap+to+the+orthosteric+site+and+partners+Arg124+during+receptor+activation&doi=10.1038%2Fsrep13343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Lys39-Lysophosphatidate Carbonyl Oxygen Interaction Locks LPA1 N-terminal Cap to the Orthosteric Site and partners Arg124 During Receptor Activation</span></div><div class="casAuthors">Omotuyi, Olaposi I.; Nagai, Jun; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13343</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) receptor 1 (LPA1) is a member of the G protein-coupled receptors mediating the biol. response to LPA species.  Lack of detailed mechanism underlying LPA/LPA1 interaction has hampered the development of specific antagonists.  Here, novel N-terminal Lys39 has been identified as a key residue during LPA-type agonist binding and LPA1 activation.  Anal. of the mol. dynamics (MD) trajectories showed that LPA-type agonist but not VPC-32183 (antagonist) evolved structures with classical GPCR activation signatures such as reduced cytoplasmic transmembrane (TM) 3/TM6 dynamic network, ruptured ionic lock, and formation of a continuous and highly ordered internal water pathway was also obsd.  In activated state, LPA-type agonists interact with Arg124 (R3.28), Gln125 (Q3.29), Lys294 (K7.36) and a novel N-terminal Lys39.  Site-directed mutagenesis showed complete loss of intracellular calcium mobilization in B103 cells expressing R3.28A and Lys39Ala when treated with LPA-type agonists.  Structurally, LPA-type agonist via Carbonyl-oxygen/Lys39 interaction facilitated the formation of a hypothetical N-terminal cap tightly packed over LPA1 heptahelical bundle.  This packing may represent a key mechanism to distinguish an apo-receptor from bound LPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKt34LmuE5M7Vg90H21EOLACvtfcHk0liaSB-grJnv6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhs7fP&md5=101fc4c79026f0f089ac359dfb32940d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fsrep13343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13343%26sid%3Dliteratum%253Aachs%26aulast%3DOmotuyi%26aufirst%3DO.%2BI.%26aulast%3DNagai%26aufirst%3DJ.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLys39-Lysophosphatidate%2520carbonyl%2520oxygen%2520interaction%2520locks%2520LPA1%2520N-terminal%2520cap%2520to%2520the%2520orthosteric%2520site%2520and%2520partners%2520Arg124%2520during%2520receptor%2520activation%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13343%26doi%3D10.1038%2Fsrep13343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandy-Szekeres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsonkov, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordalski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpsoe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojarski, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">GPCRdb in 2018: adding GPCR structure models and ligands</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">D440</span>, <span class="refDoi"> DOI: 10.1093/nar/gkx1109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkx1109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=29155946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGisLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=D440&author=G.+Pandy-Szekeresauthor=C.+Munkauthor=T.+M.+Tsonkovauthor=S.+Mordalskiauthor=K.+Harpsoeauthor=A.+S.+Hauserauthor=A.+J.+Bojarskiauthor=D.+E.+Gloriam&title=GPCRdb+in+2018%3A+adding+GPCR+structure+models+and+ligands&doi=10.1093%2Fnar%2Fgkx1109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">GPCRdb in 2018: adding GPCR structure models and ligands</span></div><div class="casAuthors">Pandy-Szekeres, Gaspar; Munk, Christian; Tsonkov, Tsonko M.; Mordalski, Stefan; Harpsoee, Kasper; Hauser, Alexander S.; Bojarski, Andrzej J.; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D440-D446</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">G protein-coupled receptors are the most abundant mediators of both human signaling processes and therapeutic effects.  Herein, we report GPCRomewide homol. models of unprecedented quality, and roughly 150 000 GPCR ligands with data on biol. activities and com. availability.  Based on the strategy of 'Less model - more Xtal', each model exploits both a main template and alternative local templates.  This achieved higher similarity to new structures than any of the existing resources, and refined crystal structures with missing or distorted regions.  Models are provided for inactive, intermediate and active states-except for classes C and F that so far only have inactive templates.  The ligand database has sep. browsers for: (i) target selection by receptor, family or class, (ii) ligand filtering based on cross-expt. activities (min, max and mean) or chem. properties, (iii) ligand source data and (iv) com. availability.  SMILES structures and activity spreadsheets can be downloaded for further processing.  Furthermore, three recent landmark publications on GPCR drugs, G protein selectivity and genetic variants have been accompanied with resources that now let readers view and analyze the findings themselves in GPCRdb.  Altogether, this update will enable scientific investigation for the wider GPCR community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptWfqUUDwXB7Vg90H21EOLACvtfcHk0liaSB-grJnv6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGisLbE&md5=0cf77dd5ea934548a2d3a0ca69991f60</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkx1109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkx1109%26sid%3Dliteratum%253Aachs%26aulast%3DPandy-Szekeres%26aufirst%3DG.%26aulast%3DMunk%26aufirst%3DC.%26aulast%3DTsonkov%26aufirst%3DT.%2BM.%26aulast%3DMordalski%26aufirst%3DS.%26aulast%3DHarpsoe%26aufirst%3DK.%26aulast%3DHauser%26aufirst%3DA.%2BS.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DGPCRdb%2520in%25202018%253A%2520adding%2520GPCR%2520structure%2520models%2520and%2520ligands%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26spage%3DD440%26doi%3D10.1093%2Fnar%2Fgkx1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><a href="https://gpcrdb.org/structure/homology_models/lpar1_human_active" class="extLink">https://gpcrdb.org/structure/homology_models/lpar1_human_active</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fgpcrdb.org%2Fstructure%2Fhomology_models%2Flpar1_human_active."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrandiz-Huertas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathivanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lujan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span> <span> </span><span class="NLM_article-title">AlphaCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">18345</span>– <span class="NLM_lpage">18350</span>, <span class="refDoi"> DOI: 10.1073/pnas.1420252111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1073%2Fpnas.1420252111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25489075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVClu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=18345-18350&author=I.+Devesaauthor=C.+Ferrandiz-Huertasauthor=S.+Mathivananauthor=C.+Wolfauthor=R.+Lujanauthor=J.+P.+Changeuxauthor=A.+Ferrer-Montiel&title=AlphaCGRP+is+essential+for+algesic+exocytotic+mobilization+of+TRPV1+channels+in+peptidergic+nociceptors&doi=10.1073%2Fpnas.1420252111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors</span></div><div class="casAuthors">Devesa, Isabel; Ferrandiz-Huertas, Clotilde; Mathivanan, Sakthikumar; Wolf, Christoph; Lujan, Rafael; Changeux, Jean-Pierre; Ferrer-Montiel, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">18345-18350</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proalgesic sensitization of peripheral nociceptors in painful syndromes is a complex mol. process poorly understood that involves mobilization of thermosensory receptors to the neuronal surface.  However, whether recruitment of vesicular thermoTRP channels is a general mechanism underlying sensitization of all nociceptor types or is subtype-specific remains controversial.  We report that sensitization-induced Ca2+-dependent exocytotic insertion of transient receptor potential vanilloid 1 (TRPV1) receptors to the neuronal plasma membrane is a mechanism specifically used by peptidergic nociceptors to potentiate their excitability.  Notably, we found that TRPV1 is present in large dense-core vesicles (LDCVs) that were mobilized to the neuronal surface in response to a sensitizing insult.  Deletion or silencing of calcitonin-gene-related peptide alpha (αCGRP) gene expression drastically reduced proalgesic TRPV1 potentiation in peptidergic nociceptors by abrogating its Ca2+-dependent exocytotic recruitment.  These findings uncover a context-dependent mol. mechanism of TRPV1 algesic sensitization and a previously unrecognized role of αCGRP in LDCV mobilization in peptidergic nociceptors.  Furthermore, these results imply that concurrent secretion of neuropeptides and channels in peptidergic C-type nociceptors facilitates a rapid modulation of pain signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ3Tyws7KHP7Vg90H21EOLACvtfcHk0lgygvINNFpXgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVClu7nM&md5=ab44102a74ca27e84e7af9017c047102</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420252111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420252111%26sid%3Dliteratum%253Aachs%26aulast%3DDevesa%26aufirst%3DI.%26aulast%3DFerrandiz-Huertas%26aufirst%3DC.%26aulast%3DMathivanan%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DC.%26aulast%3DLujan%26aufirst%3DR.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26atitle%3DAlphaCGRP%2520is%2520essential%2520for%2520algesic%2520exocytotic%2520mobilization%2520of%2520TRPV1%2520channels%2520in%2520peptidergic%2520nociceptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D18345%26epage%3D18350%26doi%3D10.1073%2Fpnas.1420252111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathivanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span> <span> </span><span class="NLM_article-title">Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">178</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.3389%2Ffphar.2016.00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=27445816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=178&author=S.+Mathivananauthor=I.+Devesaauthor=J.+P.+Changeuxauthor=A.+Ferrer-Montiel&title=Bradykinin+induces+TRPV1+exocytotic+recruitment+in+peptidergic+nociceptors&doi=10.3389%2Ffphar.2016.00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors</span></div><div class="casAuthors">Mathivanan, Sakthikumar; Devesa, Isabel; Changeux, Jean-Pierre; Ferrer-Montiel, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178/1-178/12</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Transient receptor potential vanilloid I (TRPV1) sensitization in peripheral nociceptors is a prominent phenomenon that occurs in inflammatory pain conditions.  Pro-algesic agents can potentiate TRPV1 activity in nociceptors through both stimulation of its channel gating and mobilization of channels to the neuronal surface in a context dependent manner.  A recent study reported that ATP-induced TRPV1 sensitization in peptidergic nociceptors involves the exocytotic release of channels trafficked by large dense core vesicles (LDCVs) that cargo alpha-calcitonin gene related peptide alpha (α CGRP).  We hypothesized that, similar to ATP, bradykinin may also use different mechanisms to sensitize TRPV1 channels in peptidergic and non-peptidergic nociceptors.  We found that bradykinin notably enhances the excitability of peptidergic nociceptors, and sensitizes TRPV1, primarily through the bradykinin receptor 2 pathway.  Notably, bradykinin sensitization of TRPV1 in peptidergic nociceptors was significantly blocked by inhibiting Ca2+-dependent neuronal exocytosis.  In addn., silencing α CGRP gene expression, but not substance P, drastically reduced bradykinin-induced TRPV1 sensitization in peptidergic nociceptors.  Taken together, these findings indicate that bradykinin-induced sensitization of TRPV1 in peptidergic nociceptors is partially mediated by the exocytotic mobilization of new channels trafficked by α CGRP-loaded LDCVs to the neuronal membrane.  Our findings further imply a central role of α CGRP peptidergic nociceptors in peripheral algesic sensitization, and substantiate that inhibition of LDCVs exocytosis is a valuable therapeutic strategy to treat pain, as it concurrently reduces the release of pro-inflammatory peptides and the membrane recruitment of thermoTRP channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSg5S0ByjjbVg90H21EOLACvtfcHk0lgygvINNFpXgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtbrM&md5=df50f7e0e3f49c1feaf5f19eb8cb9f9c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00178%26sid%3Dliteratum%253Aachs%26aulast%3DMathivanan%26aufirst%3DS.%26aulast%3DDevesa%26aufirst%3DI.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26atitle%3DBradykinin%2520induces%2520TRPV1%2520exocytotic%2520recruitment%2520in%2520peptidergic%2520nociceptors%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D178%26doi%3D10.3389%2Ffphar.2016.00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Animal models of neuropathic pain</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1111/j.1472-8206.2009.00801.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1111%2Fj.1472-8206.2009.00801.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=20030738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1-28&author=A.+S.+Jaggiauthor=V.+Jainauthor=N.+Singh&title=Animal+models+of+neuropathic+pain&doi=10.1111%2Fj.1472-8206.2009.00801.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of neuropathic pain</span></div><div class="casAuthors">Jaggi, Amteshwar Singh; Jain, Vivek; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-28</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Animal models are pivotal for understanding the mechanism of neuropathic pain and development of effective therapy for its optimal management.  A battery of neuropathic pain models has been developed to simulate the clin. pain conditions with diverse etiol.  The present review exhaustively discusses the methodol., behavioral alterations, limitations, and advantages of about 40 different animal models of neuropathic pain along with their modifications.  Development of these models has contributed immensely in understanding the chronic pain and underlying peripheral as well as central pathogenic mechanisms.  Furthermore, research has resulted in the development of new therapeutic agents for neuropathic pain management, and the preclin. data obtained using these animal models have been successively translated to effective pain management in clin. setup also.  As each animal model has been created with specific methodol. and results tend to vary largely with the slight changes related to methodol., therefore, it is essential that data from different models should be reported and interpreted in the context of the specific pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-2tLxHzZ1ubVg90H21EOLACvtfcHk0lgygvINNFpXgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslKrsb4%253D&md5=85f8149349f673e11ecba18d4e94a599</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2009.00801.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2009.00801.x%26sid%3Dliteratum%253Aachs%26aulast%3DJaggi%26aufirst%3DA.%2BS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DAnimal%2520models%2520of%2520neuropathic%2520pain%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D25%26spage%3D1%26epage%3D28%26doi%3D10.1111%2Fj.1472-8206.2009.00801.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seltzer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shir, Y.</span></span> <span> </span><span class="NLM_article-title">A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(90)91074-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1016%2F0304-3959%2890%2991074-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1982347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADyaK3M3gsVejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1990&pages=205-218&author=Z.+Seltzerauthor=R.+Dubnerauthor=Y.+Shir&title=A+novel+behavioral+model+of+neuropathic+pain+disorders+produced+in+rats+by+partial+sciatic+nerve+injury&doi=10.1016%2F0304-3959%2890%2991074-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury</span></div><div class="casAuthors">Seltzer Z; Dubner R; Shir Y</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-18</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">Partial nerve injury is the main cause of causalgiform pain disorders in humans.  We present here a novel animal model of this condition.  In rats we unilaterally ligated about half of the sciatic nerve high in the thigh.  Within a few hours after the operation, and for several months thereafter, the rats developed guarding behavior of the ipsilateral hind paw and licked it often, suggesting the possibility of spontaneous pain.  The plantar surface of the foot was evenly hyperesthetic to non-noxious and noxious stimuli.  None of the rats autotomized.  There was a sharp decrease in the withdrawal thresholds bilaterally in response to repetitive Von Frey hair stimulation at the plantar side.  After a series of such stimuli in the operated side, light touch elicited aversive responses, suggesting allodynia to touch.  The withdrawal thresholds to CO2 laser heat pulses were markedly lowered bilaterally.  Suprathreshold noxious heat pulses elicited exaggerated responses unilaterally, suggesting thermal hyperalgesia.  Pin-prick evoked such exaggerated responses bilaterally (mechanical hyperalgesia).  In a companion report, we show that these abnormalities critically depend on the sympathetic outflow.  Based on the immediate onset and long-lasting perpetuation of similar symptoms, such as touch-evoked allodynia and hyperalgesia, and the resemblance of the contralateral phenomena to 'mirror image' pains in some humans with causalgia, we suggest that this preparation may serve as a model for syndromes of the causalgiform variety that are triggered by partial nerve injury and maintained by sympathetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2IPcK77P8gkH3Rlp_k91zfW6udTcc2eZJ0zDfHg_2uLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3gsVejtA%253D%253D&md5=b22a068bfd793328f55939e110547c1c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2890%2991074-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252890%252991074-S%26sid%3Dliteratum%253Aachs%26aulast%3DSeltzer%26aufirst%3DZ.%26aulast%3DDubner%26aufirst%3DR.%26aulast%3DShir%26aufirst%3DY.%26atitle%3DA%2520novel%2520behavioral%2520model%2520of%2520neuropathic%2520pain%2520disorders%2520produced%2520in%2520rats%2520by%2520partial%2520sciatic%2520nerve%2520injury%26jtitle%3DPain%26date%3D1990%26volume%3D43%26spage%3D205%26epage%3D218%26doi%3D10.1016%2F0304-3959%2890%2991074-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopper, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooks, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of lysophosphatidic acid: conformationally restricted backbone mimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1021/jm970809v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970809v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlOlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=963-970&author=D.+W.+Hopperauthor=S.+P.+Raganauthor=S.+B.+Hooksauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Structure-activity+relationships+of+lysophosphatidic+acid%3A+conformationally+restricted+backbone+mimetics&doi=10.1021%2Fjm970809v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Lysophosphatidic Acid: Conformationally Restricted Backbone Mimetics</span></div><div class="casAuthors">Hopper, Darrin W.; Ragan, Seamus P.; Hooks, Shelley B.; Lynch, Kevin R.; Macdonald, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) has assocd. with it an intriguing cell biol. that is thought to be mediated through its interaction with G-protein coupled receptor(s).  In an effort to extend the structure-activity relationships of LPA, the authors have produced a series of LPA analogs in which the glycerol core in LPA was replaced with conformationally restricted aryl substructures.  The aryl substructures encompassed aminophenol, resorcinol, dihydroxy benzophenone, and tocopherol systems.  The benzophenone moiety was investigated both as a conformationally restricting substructure for LPA and as a possible photoreactive alkylating agent for the LPA receptor(s).  All LPA analogs were evaluated for their potency and efficacy in mobilizing calcium ions from internal stores in MDA MB-231 cells.  Ten of the 14 analogs exhibited activity in this assay at doses ≤5 μM; none of the compds. exhibited nonreceptor-mediated lytic activity at this maximal concn.  The receptor response showed surprising tolerance for manipulation in the backbone region of LPA, although none of the compds. were equipotent to LPA.  This tolerance for a variety of structures has given the authors new leads into the realization of novel agonists and antagonists of the LPA receptor(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRptogGsLUxbVg90H21EOLACvtfcHk0ljwh0yzE37PqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlOlurs%253D&md5=f63c79b319afa7138b47f1befd47dc57</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm970809v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970809v%26sid%3Dliteratum%253Aachs%26aulast%3DHopper%26aufirst%3DD.%2BW.%26aulast%3DRagan%26aufirst%3DS.%2BP.%26aulast%3DHooks%26aufirst%3DS.%2BB.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DStructure-activity%2520relationships%2520of%2520lysophosphatidic%2520acid%253A%2520conformationally%2520restricted%2520backbone%2520mimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D963%26epage%3D970%26doi%3D10.1021%2Fjm970809v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDock Tools4: automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDock+Tools4%3A+automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljwh0yzE37PqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDock%2520Tools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">W665</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1093/nar/gkh381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkh381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=15215472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=W665-667&author=T.+J.+Dolinskyauthor=J.+E.+Nielsenauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=PDB2PQR%3A+an+automated+pipeline+for+the+setup+of+Poisson-Boltzmann+electrostatics+calculations&doi=10.1093%2Fnar%2Fgkh381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span></div><div class="casAuthors">Dolinsky, Todd J.; Nielsen, Jens E.; McCammon, J. Andrew; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Web Server</span>),
    <span class="NLM_cas:pages">W665-W667</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Continuum solvation models, such as Poisson-Boltzmann and Generalized Born methods, have become increasingly popular tools for investigating the influence of electrostatics on biomol. structure, energetics and dynamics.  However, the use of such methods requires accurate and complete structural data as well as force field parameters such as at. charges and radii.  Unfortunately, the limiting step in continuum electrostatics calcns. is often the addn. of missing at. coordinates to mol. structures from the Protein Data Bank and the assignment of parameters to biomol. structures.  To address this problem, we have developed the PDB2PQR web service (http://agave.wustl.edu/pdb2pqr/).  This server automates many of the common tasks of prepg. structures for continuum electrostatics calcns., including adding a limited no. of missing heavy atoms to biomol. structures, estg. titrn. states and protonating biomols. in a manner consistent with favorable hydrogen bonding, assigning charge and radius parameters from a variety of force fields, and finally generating "PQR" output compatible with several popular computational biol. packages.  This service is intended to facilitate the setup and execution of electrostatics calcns. for both experts and non-experts and thereby broaden the accessibility to the biol. community of continuum electrostatics analyses of biomol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-GebFAmzzkrVg90H21EOLACvtfcHk0ljwh0yzE37PqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D&md5=678d2d58f5cb2c1dd862e2d71cf9dbe1</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkh381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkh381%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520an%2520automated%2520pipeline%2520for%2520the%2520setup%2520of%2520Poisson-Boltzmann%2520electrostatics%2520calculations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DW665%26epage%3D667%26doi%3D10.1093%2Fnar%2Fgkh381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W522</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkm276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=17488841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W522-525&author=T.+J.+Dolinskyauthor=P.+Czodrowskiauthor=H.+Liauthor=J.+E.+Nielsenauthor=J.+H.+Jensenauthor=G.+Klebeauthor=N.+A.+Baker&title=PDB2PQR%3A+expanding+and+upgrading+automated+preparation+of+biomolecular+structures+for+molecular+simulations&doi=10.1093%2Fnar%2Fgkm276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations</span></div><div class="casAuthors">Dolinsky Todd J; Czodrowski Paul; Li Hui; Nielsen Jens E; Jensen Jan H; Klebe Gerhard; Baker Nathan A</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W522-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Real-world observable physical and chemical characteristics are increasingly being calculated from the 3D structures of biomolecules.  Methods for calculating pK(a) values, binding constants of ligands, and changes in protein stability are readily available, but often the limiting step in computational biology is the conversion of PDB structures into formats ready for use with biomolecular simulation software.  The continued sophistication and integration of biomolecular simulation methods for systems- and genome-wide studies requires a fast, robust, physically realistic and standardized protocol for preparing macromolecular structures for biophysical algorithms.  As described previously, the PDB2PQR web server addresses this need for electrostatic field calculations (Dolinsky et al., Nucleic Acids Research, 32, W665-W667, 2004).  Here we report the significantly expanded PDB2PQR that includes the following features: robust standalone command line support, improved pK(a) estimation via the PROPKA framework, ligand parameterization via PEOE_PB charge methodology, expanded set of force fields and easily incorporated user-defined parameters via XML input files, and improvement of atom addition and optimization code.  These features are available through a new web interface (http://pdb2pqr.sourceforge.net/), which offers users a wide range of options for PDB file conversion, modification and parameterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKn5zO1OOtqIxhnOQkIHOxfW6udTcc2ea_t8rPKjTVFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGltQ%253D%253D&md5=18883d2f9a6f30dba143a4a2ca80b0d8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm276%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520expanding%2520and%2520upgrading%2520automated%2520preparation%2520of%2520biomolecular%2520structures%2520for%2520molecular%2520simulations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW522%26epage%3D525%26doi%3D10.1093%2Fnar%2Fgkm276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sondergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2284</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/ct200133y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200133y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=2284-2295&author=C.+R.+Sondergaardauthor=M.+H.+Olssonauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=Improved+treatment+of+ligands+and+coupling+effects+in+empirical+calculation+and+rationalization+of+pKa+values&doi=10.1021%2Fct200133y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values</span></div><div class="casAuthors">Sondergaard, Chresten R.; Olsson, Mats H. M.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2284-2295</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The new empirical rules for protein pKa predictions implemented in the PROPKA3.0 software package have been extended to the prediction of pKa shifts of active site residues and ionizable ligand groups in protein-ligand complexes.  The authors present new algorithms that allow pKa shifts due to inductive (i.e., covalently coupled) intraligand interactions, as well as noncovalently coupled interligand interactions in multiligand complexes, to be included in the prediction.  The no. of different ligand chem. groups that are automatically recognized has been increased to 18, and the general implementation has been changed so that new functional groups can be added easily by the user, aided by a new and more general protonation scheme.  Except for a few cases, the new algorithms in PROPKA3.1 are found to yield results similar to or better than those obtained with PROPKA2.0.  Finally, the authors present a novel algorithm that identifies noncovalently coupled ionizable groups, where pKa prediction may be esp. difficult.  This is a general improvement to PROPKA and is applied to proteins with and without ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEiJYZqkno7Vg90H21EOLACvtfcHk0ljidveAwSaCSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D&md5=cf4d4e20d6daa70de6ac623915e78160</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fct200133y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200133y%26sid%3Dliteratum%253Aachs%26aulast%3DSondergaard%26aufirst%3DC.%2BR.%26aulast%3DOlsson%26aufirst%3DM.%2BH.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DImproved%2520treatment%2520of%2520ligands%2520and%2520coupling%2520effects%2520in%2520empirical%2520calculation%2520and%2520rationalization%2520of%2520pKa%2520values%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D2284%26epage%3D2295%26doi%3D10.1021%2Fct200133y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Very fast empirical prediction and rationalization of protein pKa values</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1002/prot.20660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fprot.20660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=16231289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlaltLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=704-721&author=H.+Liauthor=A.+D.+Robertsonauthor=J.+H.+Jensen&title=Very+fast+empirical+prediction+and+rationalization+of+protein+pKa+values&doi=10.1002%2Fprot.20660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Very fast empirical prediction and rationalization of protein pKa values</span></div><div class="casAuthors">Li, Hui; Robertson, Andrew D.; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">704-721</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A very fast empirical method is presented for structure-based protein pKa prediction and rationalization.  The desolvation effects and intra-protein interactions, which cause variations in pKa values of protein ionizable groups, are empirically related to the positions and chem. nature of the groups proximate to the pKa sites.  A computer program is written to automatically predict pKa values based on these empirical relationships within a couple of seconds.  Unusual pKa values at buried active sites, which are among the most interesting protein pKa values, are predicted very well with the empirical method.  A test on 233 carboxyl, 12 cysteine, 45 histidine, and 24 lysine pKa values in various proteins shows a root-mean-square deviation (RMSD) of 0.89 from exptl. values.  Removal of the 29 pKa values that are upper or lower limits results in an RMSD = 0.79 for the remaining 285 pKa values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYkiHyYz6FobVg90H21EOLACvtfcHk0ljidveAwSaCSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlaltLnN&md5=9e33529954c65867929326b99dac493b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fprot.20660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20660%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DVery%2520fast%2520empirical%2520prediction%2520and%2520rationalization%2520of%2520protein%2520pKa%2520values%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2005%26volume%3D61%26spage%3D704%26epage%3D721%26doi%3D10.1002%2Fprot.20660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dramburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein-ligand complexes</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1002/prot.21110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fprot.21110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=16927370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCjtr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=424-437&author=P.+Czodrowskiauthor=I.+Dramburgauthor=C.+A.+Sotrifferauthor=G.+Klebe&title=Development%2C+validation%2C+and+application+of+adapted+PEOE+charges+to+estimate+pKa+values+of+functional+groups+in+protein-ligand+complexes&doi=10.1002%2Fprot.21110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein-ligand complexes</span></div><div class="casAuthors">Czodrowski, Paul; Dramburg, Ingo; Sotriffer, Christoph A.; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-437</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">For routine pKa calcns. of protein-ligand complexes in drug design, the PEOE method to compute partial charges was modified.  The new method is applicable to a large scope of proteins and ligands.  The adapted charges were parameterized using exptl. free energies of solvation of amino acids and small org. ligands.  For a data set of 80 small org. mols., a correlation coeff. of r2 = 0.78 between calcd. and exptl. solvation free energies was obtained.  Continuum electrostatics pKa calcns. based on the Poisson-Boltzmann equation were carried out on a validation set of nine proteins for which 132 exptl. pKa values are known.  In total, an overall RMSD of 0.88 log units between calcd. and exptl. detd. data is achieved.  In particular, the predictions of significantly shifted pKa values are satisfactory, and reasonable ests. of protonation states in the active sites of lysozyme and xylanase could be obtained.  Application of the charge-assignment and pKa-calcn. procedure to protein-ligand complexes provides clear structural interpretations of exptl. obsd. changes of protonation states of functional groups upon complex formation.  This information is essential for the interpretation of thermodn. data of protein-ligand complex formation and provides the basis for the reliable factorization of the free energy of binding in enthalpic and entropic contributions.  The modified charge-assignment procedure forms the basis for future automated pKa calcns. of protein-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQLEkjojL36bVg90H21EOLACvtfcHk0lgw1otknzcdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCjtr%252FO&md5=e19cbb62940e4352ee45fa8ff90e12bb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fprot.21110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21110%26sid%3Dliteratum%253Aachs%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DDramburg%26aufirst%3DI.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DDevelopment%252C%2520validation%252C%2520and%2520application%2520of%2520adapted%2520PEOE%2520charges%2520to%2520estimate%2520pKa%2520values%2520of%2520functional%2520groups%2520in%2520protein-ligand%2520complexes%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2006%26volume%3D65%26spage%3D424%26epage%3D437%26doi%3D10.1002%2Fprot.21110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salentin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haupt, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adasme, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, M.</span></span> <span> </span><span class="NLM_article-title">PLIP: fully automated protein-ligand interaction profiler</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">W443</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1093/nar/gkv315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1093%2Fnar%2Fgkv315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=25873628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVymtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=W443-447&author=S.+Salentinauthor=S.+Schreiberauthor=V.+J.+Hauptauthor=M.+F.+Adasmeauthor=M.+Schroeder&title=PLIP%3A+fully+automated+protein-ligand+interaction+profiler&doi=10.1093%2Fnar%2Fgkv315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">PLIP: fully automated protein-ligand interaction profiler</span></div><div class="casAuthors">Salentin, Sebastian; Schreiber, Sven; Haupt, V. Joachim; Adasme, Melissa F.; Schroeder, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W443-W447</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The characterization of interactions in protein-ligand complexes is essential for research in structural bioinformatics, drug discovery and biol.  However, comprehensive tools are not freely available to the research community.  Here, we present the protein-ligand interaction profiler (PLIP), a novel web service for fully automated detection and visualization of relevant non-covalent protein-ligand contacts in 3D structures, freely available at projects.biotec.tu-dresden.de/plip-web.  The input is either a Protein Data Bank structure, a protein or ligand name, or a custom protein-ligand complex (e.g. from docking).  In contrast to other tools, the rule-based PLIP algorithm does not require any structure prepn.  It returns a list of detected interactions on single atom level, covering seven interaction types (hydrogen bonds, hydrophobic contacts, pi-stacking, pi-cation interactions, salt bridges, water bridges and halogen bonds).  PLIP stands out by offering publication-ready images, PyMOL sesions files to generate custom images and parsable result files to facilitate successive data processing.  The full python source code is available for download on the website.  PLIP's command-line mode allows for high-throughput interaction profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgMd-_C9BUCbVg90H21EOLACvtfcHk0lgw1otknzcdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVymtbrI&md5=4878881a7bd715e5585682876e102e65</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv315%26sid%3Dliteratum%253Aachs%26aulast%3DSalentin%26aufirst%3DS.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DHaupt%26aufirst%3DV.%2BJ.%26aulast%3DAdasme%26aufirst%3DM.%2BF.%26aulast%3DSchroeder%26aufirst%3DM.%26atitle%3DPLIP%253A%2520fully%2520automated%2520protein-ligand%2520interaction%2520profiler%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2015%26volume%3D43%26spage%3DW443%26epage%3D447%26doi%3D10.1093%2Fnar%2Fgkv315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin-Ramos, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabasquer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Nogales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrecillas, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Ordonez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcos-Ramiro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar-Garrido, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrano, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollinedo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">A potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor improves survival in Ras-driven acute myeloid leukemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6035</span>– <span class="NLM_lpage">6046</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00145</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00145" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFaqsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6035-6046&author=N.+I.+Marin-Ramosauthor=M.+Balabasquerauthor=F.+J.+Ortega-Nogalesauthor=I.+R.+Torrecillasauthor=A.+Gil-Ordonezauthor=B.+Marcos-Ramiroauthor=P.+Aguilar-Garridoauthor=I.+Cushmanauthor=A.+Romeroauthor=F.+J.+Medranoauthor=C.+Gajateauthor=F.+Mollinedoauthor=M.+R.+Philipsauthor=M.+Campilloauthor=M.+Gallardoauthor=M.+Martin-Fontechaauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=A+potent+isoprenylcysteine+carboxylmethyltransferase+%28ICMT%29+inhibitor+improves+survival+in+Ras-driven+acute+myeloid+leukemia&doi=10.1021%2Facs.jmedchem.9b00145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia</span></div><div class="casAuthors">Marin-Ramos, Nagore I.; Balabasquer, Moises; Ortega-Nogales, Francisco J.; Torrecillas, Ivan R.; Gil-Ordonez, Ana; Marcos-Ramiro, Beatriz; Aguilar-Garrido, Pedro; Cushman, Ian; Romero, Antonio; Medrano, Francisco J.; Gajate, Consuelo; Mollinedo, Faustino; Philips, Mark R.; Campillo, Mercedes; Gallardo, Miguel; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6035-6046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy.  However, the paucity of inhibitors has precluded the clin. validation of this approach.  In this work we report a potent ICMT inhibitor, compd. 3 [UCM-1336, IC50 = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras.  Compd. 3 significantly impairs the membrane assocn. of the four Ras isoforms, leading to a decrease of Ras activity and to inhibition of Ras downstream signaling pathways.  In addn., it induces cell death in a variety of Ras-mutated tumor cell lines and increases survival in an in vivo model of acute myeloid leukemia.  Because ICMT inhibition impairs the activity of the four Ras isoforms regardless of its activating mutation, compd. 3 surmounts many of the common limitations of available Ras inhibitors described so far.  In addn., these results validate ICMT as a valuable target for the treatment of Ras-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQdAP3zRIM7Vg90H21EOLACvtfcHk0lgw1otknzcdfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFaqsbzP&md5=99eacad9ac479cc0604a46b66d039e8e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00145%26sid%3Dliteratum%253Aachs%26aulast%3DMarin-Ramos%26aufirst%3DN.%2BI.%26aulast%3DBalabasquer%26aufirst%3DM.%26aulast%3DOrtega-Nogales%26aufirst%3DF.%2BJ.%26aulast%3DTorrecillas%26aufirst%3DI.%2BR.%26aulast%3DGil-Ordonez%26aufirst%3DA.%26aulast%3DMarcos-Ramiro%26aufirst%3DB.%26aulast%3DAguilar-Garrido%26aufirst%3DP.%26aulast%3DCushman%26aufirst%3DI.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DMedrano%26aufirst%3DF.%2BJ.%26aulast%3DGajate%26aufirst%3DC.%26aulast%3DMollinedo%26aufirst%3DF.%26aulast%3DPhilips%26aufirst%3DM.%2BR.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DGallardo%26aufirst%3DM.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DA%2520potent%2520isoprenylcysteine%2520carboxylmethyltransferase%2520%2528ICMT%2529%2520inhibitor%2520improves%2520survival%2520in%2520Ras-driven%2520acute%2520myeloid%2520leukemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6035%26epage%3D6046%26doi%3D10.1021%2Facs.jmedchem.9b00145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Couce, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomares, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordomi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernangomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rodriguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Gutierrez, S.</span></span> <span> </span><span class="NLM_article-title">Chemical probes for the recognition of cannabinoid receptors in native systems</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6896</span>– <span class="NLM_lpage">6899</span>, <span class="refDoi"> DOI: 10.1002/anie.201200467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=10.1002%2Fanie.201200467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot12gu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6896-6899&author=L.+Martin-Couceauthor=M.+Martin-Fontechaauthor=O.+Palomaresauthor=L.+Mestreauthor=A.+Cordomiauthor=M.+Hernangomezauthor=S.+Palmaauthor=L.+Pardoauthor=C.+Guazaauthor=M.+L.+Lopez-Rodriguezauthor=S.+Ortega-Gutierrez&title=Chemical+probes+for+the+recognition+of+cannabinoid+receptors+in+native+systems&doi=10.1002%2Fanie.201200467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Probes for the Recognition of Cannabinoid Receptors in Native Systems</span></div><div class="casAuthors">Martin-Couce, Lidia; Martin-Fontecha, Mar; Palomares, Oscar; Mestre, Leyre; Cordomi, Arnau; Hernangomez, Miriam; Palma, Sara; Pardo, Leonardo; Guaza, Carmen; Lopez-Rodriguez, Maria L.; Ortega-Gutierrez, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6896-6899, S6896/1-S6896/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">To find endocannabinoid-based probes with affinities for CB1 and CB2 receptors, the authors focused their efforts on the synthetic high-affinity cannabinoid ligands HU210 and HU308.  The authors carried out the reaction between ligand HU210 and N(+)-biotinyl-6-aminohexanoic acid in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and 4-dimethylaminopyridine, to yield compds. I and II (25% and 14% yields, resp.).  Esterification of ligand HU308 with N-(+)-biotinyl-6-aminohexanoic acid gave deriv. III in 55% yield.  Compds. I-III were tested for their affinities to CB1 and CB2 receptors, showing Ki values in the nanomolar range.  Compds. I-III were used for in vitro labeling of cannabinoid receptors in transiently transfected hippocampal neuronal (HT22) cells, in native neurons and microglia, and the monocytic cell line THP-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrYrn0SQ_QNbVg90H21EOLACvtfcHk0lhYgB6vvIzW1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot12gu7Y%253D&md5=e285625998ba61e71d1d555019c2e2fb</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fanie.201200467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201200467%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Couce%26aufirst%3DL.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DPalomares%26aufirst%3DO.%26aulast%3DMestre%26aufirst%3DL.%26aulast%3DCordomi%26aufirst%3DA.%26aulast%3DHernangomez%26aufirst%3DM.%26aulast%3DPalma%26aufirst%3DS.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26aulast%3DOrtega-Gutierrez%26aufirst%3DS.%26atitle%3DChemical%2520probes%2520for%2520the%2520recognition%2520of%2520cannabinoid%2520receptors%2520in%2520native%2520systems%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D6896%26epage%3D6899%26doi%3D10.1002%2Fanie.201200467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pqr" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pqr','PDB','2pqr'); return false;">PDB: 2pqr</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01287">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_74174"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01287?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01287</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_001.csv">CSV</a>)</p></li><li><p class="inline">Representative plots of BSI signal vs ligand concentration for the determination of affinity constant, reversibility and stability studies, representative calcium microfluorography recordings on neonatal rat cultures, experimental protocol for microelectrode array (MEA) and representative MEA recordings, effect of acute administration of (<i>S</i>)-<b>17</b> in the acetic acid-induced writhing responses, effect of (<i>S</i>)-<b>17</b> in the exploratory or locomotor activity of mice, activity at LPA<sub>2</sub> and LPA<sub>3</sub> receptors for all compounds with agonist activity at the LPA<sub>1</sub> receptor, detailed synthetic procedures, and characterization data of all intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Structure of the LPA<sub>1</sub> receptor (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_001.csv">jm9b01287_si_001.csv (2.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_002.pdf">jm9b01287_si_002.pdf (1.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01287/suppl_file/jm9b01287_si_003.pdb">jm9b01287_si_003.pdb (184.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01287&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01287%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01287" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679952b91cbc23f8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
